<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Cardiovascular disease</title><meta name="description" content="Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="CVD, Heart disease, Cardio disease"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Cardiovascular_disease"/><meta property="og:title" content="Cardiovascular disease"/><meta property="og:description" content="Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic..."/><meta property="og:url" content="https://grokipedia.com/page/Cardiovascular_disease"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Cardiovascular disease"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:44.669Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Cardiovascular disease"/><meta name="twitter:description" content="Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="dd2bc0f4594a284aada97653b7657e87-373568da8c68b4a7-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=dd2bc0f4594a284aada97653b7657e87,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.821427081022293,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cardiovascular-disease" class="transition-opacity hover:opacity-100 opacity-50">Cardiovascular disease</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#overview" class="transition-opacity hover:opacity-100 opacity-50">Overview</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#definition-and-classification" class="transition-opacity hover:opacity-100 opacity-50">Definition and Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#signs-and-symptoms" class="transition-opacity hover:opacity-100 opacity-50">Signs and Symptoms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#global-burden-and-mortality" class="transition-opacity hover:opacity-100 opacity-50">Global Burden and Mortality</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#types" class="transition-opacity hover:opacity-100 opacity-50">Types</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#coronary-artery-disease" class="transition-opacity hover:opacity-100 opacity-50">Coronary Artery Disease</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cerebrovascular-disease" class="transition-opacity hover:opacity-100 opacity-50">Cerebrovascular Disease</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#peripheral-artery-disease" class="transition-opacity hover:opacity-100 opacity-50">Peripheral Artery Disease</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#heart-failure-and-cardiomyopathies" class="transition-opacity hover:opacity-100 opacity-50">Heart Failure and Cardiomyopathies</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#arrhythmias-and-valvular-disease" class="transition-opacity hover:opacity-100 opacity-50">Arrhythmias and Valvular Disease</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pathophysiology" class="transition-opacity hover:opacity-100 opacity-50">Pathophysiology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#atherosclerosis-mechanisms" class="transition-opacity hover:opacity-100 opacity-50">Atherosclerosis Mechanisms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#thrombosis-and-plaque-rupture" class="transition-opacity hover:opacity-100 opacity-50">Thrombosis and Plaque Rupture</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#inflammatory-processes" class="transition-opacity hover:opacity-100 opacity-50">Inflammatory Processes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#endothelial-dysfunction" class="transition-opacity hover:opacity-100 opacity-50">Endothelial Dysfunction</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Risk Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#non-modifiable-risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Non-Modifiable Risk Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#modifiable-lifestyle-risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Modifiable Lifestyle Risk Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#environmental-and-occupational-risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Environmental and Occupational Risk Factors</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#emerging-risk-factors" class="transition-opacity hover:opacity-100 opacity-50">Emerging Risk Factors</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prevention" class="transition-opacity hover:opacity-100 opacity-50">Prevention</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#primary-prevention-strategies" class="transition-opacity hover:opacity-100 opacity-50">Primary Prevention Strategies</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#secondary-prevention-approaches" class="transition-opacity hover:opacity-100 opacity-50">Secondary Prevention Approaches</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dietary-interventions" class="transition-opacity hover:opacity-100 opacity-50">Dietary Interventions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacological-prevention" class="transition-opacity hover:opacity-100 opacity-50">Pharmacological Prevention</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnosis-and-screening" class="transition-opacity hover:opacity-100 opacity-50">Diagnosis and Screening</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnostic-tests-and-imaging" class="transition-opacity hover:opacity-100 opacity-50">Diagnostic Tests and Imaging</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#risk-assessment-tools" class="transition-opacity hover:opacity-100 opacity-50">Risk Assessment Tools</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#early-detection-challenges" class="transition-opacity hover:opacity-100 opacity-50">Early Detection Challenges</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#management-and-treatment" class="transition-opacity hover:opacity-100 opacity-50">Management and Treatment</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-interventions" class="transition-opacity hover:opacity-100 opacity-50">Acute Interventions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#chronic-disease-management" class="transition-opacity hover:opacity-100 opacity-50">Chronic Disease Management</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#surgical-and-interventional-procedures" class="transition-opacity hover:opacity-100 opacity-50">Surgical and Interventional Procedures</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lifestyle-and-rehabilitation" class="transition-opacity hover:opacity-100 opacity-50">Lifestyle and Rehabilitation</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#epidemiology" class="transition-opacity hover:opacity-100 opacity-50">Epidemiology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#historical-trends" class="transition-opacity hover:opacity-100 opacity-50">Historical Trends</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#current-global-patterns" class="transition-opacity hover:opacity-100 opacity-50">Current Global Patterns</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#projections-to-2050" class="transition-opacity hover:opacity-100 opacity-50">Projections to 2050</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#early-descriptions-and-theories" class="transition-opacity hover:opacity-100 opacity-50">Early Descriptions and Theories</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#20th-century-breakthroughs" class="transition-opacity hover:opacity-100 opacity-50">20th-Century Breakthroughs</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#post-2000-developments" class="transition-opacity hover:opacity-100 opacity-50">Post-2000 Developments</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#controversies-and-debates" class="transition-opacity hover:opacity-100 opacity-50">Controversies and Debates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lipid-hypothesis-critiques" class="transition-opacity hover:opacity-100 opacity-50">Lipid Hypothesis Critiques</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dietary-fat-and-carbohydrate-roles" class="transition-opacity hover:opacity-100 opacity-50">Dietary Fat and Carbohydrate Roles</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#statin-overuse-and-pharmaceutical-influence" class="transition-opacity hover:opacity-100 opacity-50">Statin Overuse and Pharmaceutical Influence</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#inflammation-as-primary-driver" class="transition-opacity hover:opacity-100 opacity-50">Inflammation as Primary Driver</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#research-directions" class="transition-opacity hover:opacity-100 opacity-50">Research Directions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#genetic-and-molecular-advances" class="transition-opacity hover:opacity-100 opacity-50">Genetic and Molecular Advances</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#technological-innovations" class="transition-opacity hover:opacity-100 opacity-50">Technological Innovations</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#public-health-policy-implications" class="transition-opacity hover:opacity-100 opacity-50">Public Health Policy Implications</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="cardiovascular-disease" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Cardiovascular disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_80qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic stroke.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> CVD is the leading cause of death globally, responsible for an estimated 19.8 million fatalities in 2022, representing about one-third of all deaths worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The burden of CVD has intensified over recent decades, with 437 million disability-adjusted life-years (DALYs) lost in 2023, a 1.4-fold increase from 1990 levels, driven by aging populations and rising prevalence of modifiable risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Key behavioral contributors include tobacco smoking, physical inactivity, excessive alcohol consumption, and diets high in processed foods and sodium, which elevate intermediate risks such as hypertension, hyperlipidemia, diabetes, and obesity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Empirical evidence from large cohort studies underscores that these factors causally drive endothelial dysfunction, inflammation, and plaque instability, with smoking alone accounting for up to 20% of attributable CVD burden in some populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> While genetic predispositions exist, population-level data show that over 80% of premature CVD deaths could be averted through primary prevention targeting these modifiable elements, as demonstrated by declines in smoking and cholesterol levels offsetting rises in obesity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_101abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Therapeutic advances, including statins for lipid management, antihypertensive agents, and revascularization procedures like angioplasty, have improved survival rates for acute events, yet controversies persist over over-reliance on pharmacological interventions without concurrent lifestyle modifications, as long-term adherence to drugs alone yields suboptimal outcomes compared to integrated approaches.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Globally, low- and middle-income countries bear 75% of CVD mortality despite lower historical incidence, highlighting disparities in access to diagnostics and the need for causal interventions over symptomatic treatments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Ongoing research emphasizes precision in risk stratification, incorporating biomarkers like C-reactive protein for inflammation, to better predict and mitigate progression from subclinical atherosclerosis to clinical disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<h2 id="overview" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Overview<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="definition-and-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Definition and Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular disease (CVD), also known as heart and circulatory disease, encompasses a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, congenital heart disease, and conditions like deep vein thrombosis and pulmonary embolism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> These disorders primarily involve structural or functional abnormalities leading to impaired blood flow or cardiac function, often culminating in acute events like myocardial infarction or stroke.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> The term CVD is used interchangeably with circulatory system diseases in epidemiological contexts, emphasizing their collective impact on morbidity and mortality worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Standard classification of CVD follows the International Classification of Diseases, 11th Revision (ICD-11), under Chapter 11: Diseases of the circulatory system, which organizes conditions into hierarchical codes for diagnostic and statistical purposes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Key categories include hypertensive diseases (BA00-BA04), ischaemic heart diseases (BA40-BA6Z), pulmonary heart disease and diseases of pulmonary circulation (BA80-BA8Z), and other forms such as cardiomyopathies (BC40-BC4Z) and cerebrovascular diseases (8B00-8B9Z).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> This framework standardizes reporting across healthcare systems, facilitating global comparisons of prevalence and outcomes, though it excludes isolated hypertension unless complicated by organ damage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Alternative categorizations, such as those from the Framingham Heart Study, focus on risk stratification rather than taxonomic grouping, estimating 10-year probabilities of CVD events based on factors like age, cholesterol levels, and blood pressure for primary prevention.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_104abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The scope of CVD is projected to expand significantly, with global prevalence expected to increase by 90% from 2025 to 2050 due to population aging, rising obesity, and socioeconomic shifts, despite potential declines in age-standardized rates in some regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> In the United States, clinical CVD (excluding uncomplicated hypertension) is forecasted to affect 45 million adults by 2050, up from current levels, representing about 15% of the adult population and driven by demographic changes and persistent risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> These projections underscore the need for precise classification to track epidemiological trends and allocate resources effectively.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h3 id="signs-and-symptoms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Signs and Symptoms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular diseases often manifest asymptomatically in early stages, with symptoms emerging due to myocardial ischemia, reduced cardiac output, or vascular occlusion disrupting tissue perfusion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> Common nonspecific indicators include chest pain or discomfort, shortness of breath (dyspnea) during exertion or at rest, persistent fatigue, and palpitations, which reflect inadequate oxygen delivery to the heart muscle or systemic hypoperfusion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In coronary artery disease, angina pectoris presents as substernal pressure, tightness, or aching exacerbated by physical activity and alleviated by rest, stemming from transient myocardial ischemia; acute myocardial infarction intensifies this with prolonged severe pain radiating to the arm, jaw, or back, often accompanied by nausea, diaphoresis, and dyspnea.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> Heart failure symptoms arise from ventricular dysfunction causing pulmonary congestion or systemic venous backup, manifesting as orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, and exertional fatigue due to impaired forward flow and elevated filling pressures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_106abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Peripheral artery disease typically features intermittent claudication, a cramping leg pain in calves, thighs, or buttocks triggered by walking and relieved within minutes of rest, resulting from lower limb ischemia during increased metabolic demand; advanced cases may include rest pain, nonhealing ulcers, or tissue loss.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> Cerebrovascular disease, particularly ischemic stroke, produces acute focal deficits from cerebral hypoperfusion, such as unilateral weakness or numbness, aphasia, visual field loss, ataxia, or sudden severe headache, often without preceding warning.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_106qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Arrhythmias may cause irregular heartbeats, syncope, or presyncope from erratic electrical conduction impairing hemodynamics, while valvular disorders contribute symptoms like exertional dyspnea or angina from pressure or volume overload.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_87abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Symptoms vary by subtype but universally signal underlying pathophysiological disruptions in blood flow or cardiac function rather than extrinsic factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<h3 id="global-burden-and-mortality" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Global Burden and Mortality<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular disease (CVD) is the leading cause of mortality worldwide, responsible for 19.2 million deaths in 2023, equivalent to one in three global deaths.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> This figure reflects a rise from 13.1 million CVD deaths in 1990, driven by population growth, aging demographics, and persistent modifiable risk factors including hypertension, high body mass index, tobacco use, and dyslipidemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> In 2023, the global age-adjusted CVD death rate stood at 235.18 per 100,000 population, with a prevalence of 612.06 million cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_108abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">The burden extends beyond mortality to disability-adjusted life years (DALYs), a metric combining years of life lost (YLLs) due to premature death and years lived with disability (YLDs). CVD accounted for 437 million DALYs in 2023, marking a 1.4-fold increase from 320 million in 1990, with ischemic heart disease and stroke comprising the largest shares.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> YLLs dominate DALYs for CVD, reflecting its acute lethality, while YLDs highlight chronic impacts like heart failure. Projections from 2025 to 2050 forecast a 73.4% rise in crude mortality and a 54.7% increase in crude DALYs globally, attributable to demographic shifts rather than worsening age-specific risks, as effective interventions against modifiable factors could mitigate age-standardized declines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regional variations underscore the influence of lifestyle-driven risks over structural barriers alone. Low- and middle-income countries bear a disproportionate load, with CVD deaths rising sharply in regions like Southeast Asia and sub-Saharan Africa due to surging obesity, diabetes, and urbanization-linked sedentary behavior, despite lower historical exposure compared to high-income nations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> In contrast, high-income areas exhibit stabilizing or declining age-adjusted rates through risk factor control, illustrating that behavioral modificationsâ€”such as reduced smoking and improved dietâ€”can substantially alleviate burden irrespective of economic context.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Economic costs amplify this impact; in the United States, CVD-related expenditures are projected to triple to $1.8 trillion by 2050, reflecting untreated modifiable risks amid population changes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<h2 id="types" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Types<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="coronary-artery-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Coronary Artery Disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Coronary artery disease (CAD), also known as coronary heart disease, involves the progressive accumulation of atherosclerotic plaques in the coronary arteries, which supply oxygenated blood to the myocardium. This buildup narrows the arterial lumen, impairs blood flow, and can lead to myocardial ischemia when oxygen demand exceeds supply. Plaques consist primarily of lipids, cholesterol, inflammatory cells, and fibrous tissue, with empirical studies showing that significant stenosis (â‰¥50% narrowing) often correlates with clinical symptoms, though subclinical atherosclerosis affects up to 42% of middle-aged adults in population-based imaging cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">CAD manifests clinically along a spectrum from chronic stable ischemia to acute events. Stable angina pectoris presents as predictable, exertional chest discomfort relieved by rest or nitroglycerin, resulting from fixed obstructions typically exceeding 70% stenosis that limit flow reserve during increased demand. In contrast, acute coronary syndrome (ACS) encompasses unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI), driven by plaque rupture or erosion triggering thrombus formation and abrupt occlusion. Unstable angina differs from stable by occurring at rest or with minimal provocation, signaling imminent risk of infarction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">As the leading cause of death in the United States, CAD accounted for 371,506 fatalities in 2022, representing the most common form of heart disease and contributing substantially to overall cardiovascular mortality. Approximately 1 in 20 adults aged 20 and older have diagnosed CAD, with prevalence rising sharply with age and risk factors. Globally, CAD drives the majority of ischemic heart disease burdens, underscoring its role as the primary killer within cardiovascular pathologies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ccabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<h3 id="cerebrovascular-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cerebrovascular Disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cerebrovascular disease refers to pathological conditions affecting the blood vessels that supply the brain, primarily manifesting as stroke, which involves sudden interruption of blood flow leading to brain tissue damage. Strokes are classified into ischemic, accounting for approximately 65-87% of cases globally through arterial occlusion by thrombus or embolus, and hemorrhagic, comprising about 15-30% via vessel rupture causing intracerebral or subarachnoid bleeding.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> Ischemic subtypes include thrombotic strokes from local plaque buildup and embolic from distant clots, often originating from atrial fibrillation or cardiac sources.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> Hemorrhagic events typically stem from hypertension-induced vessel fragility or aneurysms. Transient ischemic attack (TIA), or &quot;mini-stroke,&quot; involves temporary focal ischemia without permanent infarction, resolving within 24 hours but signaling high risk for subsequent full stroke.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_sdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Epidemiologically, cerebrovascular disease imposes a substantial global burden, with stroke incidence reaching over 7.8 million ischemic cases in 2021 alone, alongside rising trends in both ischemic and hemorrhagic subtypes due to aging populations and persistent risk factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> In 2021, ischemic stroke constituted 65.3% of total stroke burden, intracerebral hemorrhage 28.8%, and subarachnoid hemorrhage the remainder, with overall prevalence exceeding 100 million cases worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> Unlike coronary artery disease, which primarily affects myocardial function, cerebrovascular events yield focal brain deficits, contributing to stroke as the second-leading cause of death and primary cause of long-term disability, with projections indicating a 50% increase in cases by 2050 absent interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_odqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Risk factors for cerebrovascular disease substantially overlap with those for coronary artery disease, including hypertension, smoking, diabetes, dyslipidemia, and atrial fibrillation, though hypertension exerts a particularly dominant causal role in both ischemic and hemorrhagic subtypes via endothelial damage and vessel wall stress.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> Modifying hypertension in midlife yields the greatest gains in life-years free of cardiovascular events, with a 2025 analysis estimating up to a decade of extended healthy lifespan when combined with smoking cessation, surpassing benefits from other factors like obesity control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_geabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup> These shared risks underscore systemic atherosclerosis and thrombosis as common pathways, yet cerebrovascular outcomes diverge in emphasizing brain-specific vulnerabilities, such as collateral circulation limitations exacerbating ischemic penumbra.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Clinically, cerebrovascular disease produces distinct neurological sequelae, including hemiparesis, aphasia, visual field defects, and cognitive impairments, contrasting with the chest pain and heart failure predominant in coronary events; up to one-third of survivors develop dementia, and most retain partial deficits hindering workforce participation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ceqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> TIA, while not causing infarction, correlates with 10-15% stroke risk within 90 days, necessitating urgent secondary prevention focused on antiplatelet therapy and risk factor optimization to avert progression to permanent deficits.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_keqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></span>
<h3 id="peripheral-artery-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Peripheral Artery Disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Peripheral artery disease (PAD) refers to the narrowing or occlusion of arteries supplying blood to the limbs, most commonly the lower extremities, resulting from atherosclerotic plaque buildup that impairs perfusion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> This condition manifests as a peripheral extension of systemic atherosclerosis, serving as an indicator of widespread vascular pathology that elevates risks for coronary and cerebrovascular events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ofqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The primary symptom is intermittent claudication, characterized by exertional muscle pain, cramping, or fatigue in the calves, thighs, or buttocks that resolves with rest due to inadequate oxygen delivery during activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> In severe cases, critical limb ischemia develops, featuring rest pain, non-healing ulcers, or gangrene, which can necessitate amputation if untreated.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ogabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> Up to 50-90% of cases remain asymptomatic, contributing to delayed recognition.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Globally, PAD affected approximately 236 million adults as of 2019, with prevalence rising 72% from 65.8 million in 1990 to 113.4 million, driven by aging populations and rising comorbidities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> Age-standardized prevalence reached about 5.6% by 2015, with projections estimating 360 million cases by 2050, particularly in low- and middle-income regions where rates exceed 20% in some areas.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ogqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> In the United States, 7-12 million individuals are impacted.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> Despite this burden, PAD is frequently underdiagnosed, with 2024-2025 analyses attributing this to the predominance of silent disease, symptom variability, and disparities in screening, notably among women and those with limited healthcare access.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ggqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1ogqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_20gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup> PAD patients face a 2-3 times higher mortality risk from cardiovascular causes compared to those without, underscoring its role as a sentinel for multisite atherosclerosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2cgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span>
<h3 id="heart-failure-and-cardiomyopathies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Heart Failure and Cardiomyopathies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Heart failure manifests as a pathophysiological state in which the heart cannot generate sufficient cardiac output to satisfy tissue perfusion needs at rest or during exertion, stemming from impaired systolic or diastolic function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> Systolic heart failure, also termed heart failure with reduced ejection fraction (HFrEF), involves diminished myocardial contractility, typically with left ventricular ejection fraction below 40%, leading to ventricular dilation and inadequate forward flow.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ghqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> In contrast, diastolic heart failure, or heart failure with preserved ejection fraction (HFpEF), arises from stiff ventricular walls that hinder relaxation and filling during diastole, preserving ejection fraction above 50% but compromising stroke volume through elevated end-diastolic pressures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ohqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> These distinctions arise from underlying myocardial remodeling and extracellular matrix alterations, with HFrEF more often linked to myocyte loss and HFpEF to fibrosis and hypertrophy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Epidemiological data indicate heart failure prevalence escalates sharply with age, reflecting cumulative insults from comorbidities and demographic shifts toward older populations. In the United States, an estimated 6.7 million adults over age 20 had heart failure in recent assessments, with projections reaching 8.7 million by 2030 due to extended lifespans and improved acute cardiovascular survival.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> Globally, heart failure burdens approximately 64 million individuals, with incidence rates climbing in aging societies as diastolic variants predominate in the elderly, driven by factors like hypertension-induced stiffness rather than overt ischemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_giabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup> Lifetime risk stands at about 24% in developed nations, underscoring the condition&#x27;s progression from subclinical ventricular dysfunction to overt pump failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiomyopathies encompass primary disorders of the myocardium that directly precipitate heart failure through structural and functional derangements, distinct from secondary failures due to coronary or valvular pathology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup> Classified by etiology, genetic forms predominate in hypertrophic cardiomyopathy (HCM), where mutations in sarcomeric genes like MYH7 or MYBPC3 disrupt contractile proteins, yielding asymmetric septal hypertrophy and diastolic impairment in up to 1 in 500 individuals worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_giqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup> Dilated cardiomyopathy (DCM) often blends genetic (e.g., titin variants) and acquired elements, manifesting as eccentric remodeling with systolic dysfunction and chamber enlargement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup> Acquired cardiomyopathies, such as those from viral myocarditis or cardiotoxic chemotherapies, induce inflammatory or infiltrative damage, while restrictive variants like amyloidosis feature rigid ventricles from protein deposition, severely limiting preload.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup> Arrhythmogenic right ventricular cardiomyopathy involves fibrofatty replacement, genetically tied to desmosomal genes, but primarily affects systolic performance over electrical instability in isolation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup> These entities collectively amplify heart failure risk, with genetic screening revealing familial patterns in 20-50% of cases depending on subtype, enabling early intervention absent in purely acquired processes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1giqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup></span>
<h3 id="arrhythmias-and-valvular-disease" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Arrhythmias and Valvular Disease<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Arrhythmias encompass disorders of the heart&#x27;s electrical conduction system, resulting in abnormal heart rates or rhythms that can originate from the atria, ventricles, or conduction pathways. These conditions are classified broadly as bradyarrhythmias (heart rates below 60 beats per minute) or tachyarrhythmias (rates exceeding 100 beats per minute), with further subdivision based on site of origin and mechanism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup> Atrial fibrillation (AFib), the most common sustained arrhythmia, affects approximately 44 million individuals worldwide and becomes increasingly prevalent with age, reaching up to 9% in those aged 80 to 89 years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> AFib predisposes to thromboembolism via stasis in the left atrial appendage, elevating ischemic stroke risk fivefold and accounting for 15 to 20% of such events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_sjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> Lifetime risk of developing AFib is about 1 in 4 for individuals aged 40 or older.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Ventricular arrhythmias, including tachycardia and fibrillation, contribute to 75 to 80% of sudden cardiac deaths, estimated at 184,000 to 450,000 annually in the United States.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> Non-atherosclerotic etiologies include structural abnormalities in the conduction system, such as disruptions in Purkinje fibers, which propagate electrical impulses. A 2025 Mayo Clinic study identified previously unrecognized intramyocardial Purkinje tissue comprising over 60% of human myocardial Purkinje fiber content, visualized via the biomarker myosin light chain 4 (MYL4), offering new insights into rhythm management and potential pacing targets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Valvular heart disease involves structural or functional impairment of one or more cardiac valves, leading to stenosis (narrowing) or regurgitation (leakage). Primary forms arise from intrinsic valve pathology rather than secondary effects like ischemia. Aortic stenosis, predominantly calcific and degenerative, affects about 9 million people globally and is the most common valvular lesion in developed nations, often manifesting in the elderly due to progressive leaflet calcification independent of coronary atherosclerosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Mitral regurgitation frequently stems from myxomatous degeneration or prolapse, a genetic predisposition causing leaflet redundancy and annular dilation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Rheumatic heart disease, resulting from autoimmune damage post-group A streptococcal infection, remains a leading cause of valvular pathology in low-income regions, primarily affecting mitral and aortic valves with fibrosis and fusion leading to stenosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup> In contrast, degenerative causes predominate in high-income settings, driven by age-related wear, calcification, or congenital anomalies like bicuspid aortic valves, which accelerate stenosis through mechanical stress and lipid-mediated inflammation distinct from plaque buildup in arteries.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_glabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup> Overall, valvular disease impacts 5 to 10% of the population, with aortic stenosis as the predominant fatal type in epidemiological surveys.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_olabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_slabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup> These pathologies impair hemodynamics, promoting atrial enlargement and arrhythmias like AFib through volume overload or pressure gradients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_14labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup></span>
<h2 id="pathophysiology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Pathophysiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="atherosclerosis-mechanisms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Atherosclerosis Mechanisms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Atherosclerosis involves the progressive buildup of plaques in arterial walls, primarily driven by the retention and modification of low-density lipoprotein (LDL) particles in the intima layer. Endothelial dysfunction, often triggered by hemodynamic shear stress or risk factors such as hypertension and smoking, increases vascular permeability, allowing LDL to infiltrate the subendothelial space.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> Once retained by proteoglycans, LDL undergoes oxidative modification by reactive oxygen species (ROS) generated from sources like NADPH oxidase in endothelial cells and smooth muscle cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup> This oxidation transforms native LDL into oxidized LDL (oxLDL), which is more atherogenic than unmodified LDL due to its ability to promote inflammation and cellular uptake independent of regulatory feedback.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_omqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> Oxidative stress, rather than mere lipid accumulation, serves as a critical initiator, as evidenced by the heightened ROS production in early lesion formation preceding significant plaque development.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Macrophages recruited to the intima via chemokines bind and internalize oxLDL through scavenger receptors such as CD36 and LOX-1, bypassing the homeostatic LDL receptor pathway.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup> This unregulated uptake leads to cholesterol ester accumulation within lysosomes, forming lipid-laden foam cells that characterize the initial fatty streak lesions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup> Foam cells secrete pro-inflammatory cytokines like interleukin-1Î² and tumor necrosis factor-Î±, amplifying local oxidative stress and attracting additional monocytes while impairing cholesterol efflux through downregulation of transporters such as ABCA1.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_onabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup> Empirical data from animal models demonstrate that inhibiting foam cell formation reduces early plaque size, underscoring its causal role in lesion progression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">As plaques advance, foam cells and dying macrophages contribute to a necrotic core, prompting vascular smooth muscle cells (SMCs) to migrate from the media, proliferate, and deposit extracellular matrix components like collagen and elastin to form a fibrous cap.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> Continued ROS-mediated signaling sustains SMC phenotypic switching toward a pro-inflammatory, synthetic state, further promoting plaque instability through matrix metalloproteinase activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup> Human histopathological studies confirm that oxidative modifications correlate more strongly with advanced plaque features than total lipid content alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_onqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Among LDL subclasses, small dense LDL (sdLDL) particles exhibit greater atherogenicity than larger, buoyant ones, independent of total LDL cholesterol levels. SdLDL penetrates arterial walls more readily due to reduced size (diameter â‰¤257 Ã…ngstroms) and binds more avidly to proteoglycans, enhancing retention.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup> These particles are also more susceptible to oxidation owing to lower antioxidant content and polyunsaturated fatty acid enrichment, yielding highly pro-inflammatory oxLDL.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_goabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup> Prospective cohort studies, such as those analyzing NMR spectroscopy data, show sdLDL strongly predicts cardiovascular events, with odds ratios exceeding those for total LDL-C; for instance, elevated sdLDL associates with a 1.5- to 3-fold increased risk after adjusting for standard lipids.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ooabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup> This evidence challenges overreliance on total cholesterol metrics, as particle size and density better reflect causal oxidation propensity in causal realism frameworks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup></span>
<h3 id="thrombosis-and-plaque-rupture" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Thrombosis and Plaque Rupture<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Thrombosis in cardiovascular disease often culminates from the acute rupture of atherosclerotic plaques, where disruption of the fibrous cap exposes thrombogenic substrates such as collagen, tissue factor, and lipid-rich necrotic core to circulating blood elements, triggering platelet adhesion, activation, and the coagulation cascade.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> This exposure leads to rapid thrombus formation, which can partially or completely occlude the vessel lumen, resulting in ischemia and events like myocardial infarction or stroke.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup> Plaque rupture accounts for the majority of acute coronary syndromes, with pathological analyses indicating it as the underlying mechanism in 60-70% of fatal cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_opabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The process aligns with an adaptation of Virchow&#x27;s triadâ€”endothelial (or plaque surface) injury, local hemodynamic disturbances, and hypercoagulabilityâ€”to arterial contexts. Rupture equates to vessel wall damage by breaching the endothelial barrier and revealing procoagulant surfaces; stenotic plaques induce flow stasis or turbulence proximally, promoting thrombus propagation; and systemic factors like elevated fibrinogen or platelet reactivity exacerbate clot stability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup> In non-ruptured scenarios, such as plaque erosion, thrombosis arises from denudation without cap fracture, but rupture predominates in thrombotic occlusions, comprising about 44-73% of culprit lesions in acute syndromes per intravascular imaging.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[108]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Intravascular optical coherence tomography (OCT) and ultrasound (IVUS) provide empirical visualization of rupture features, including cap discontinuities, cavity formation, and thrombus apposition, with OCT detecting these at resolutions up to 10-20 micrometers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> Studies using combined OCT-IVUS in ST-elevation myocardial infarction cohorts report plaque rupture in 64.8% of culprit sites, often with underlying large necrotic cores and minimal calcification, underscoring the acute destabilization&#x27;s role over chronic progression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup> These imaging modalities confirm that ruptured plaques exhibit thinner caps (&lt;65 micrometers) pre-event in prospective data, though in vivo rupture incidence remains event-driven rather than routinely quantifiable in stable disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_oqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> Thrombus composition post-rupture typically includes platelet-rich aggregates initially, transitioning to fibrin-dominant structures, influenced by shear stress and local geometry.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup></span>
<h3 id="inflammatory-processes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Inflammatory Processes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Inflammatory processes in cardiovascular disease involve the recruitment of immune cells, such as monocytes and T lymphocytes, to the arterial wall, where they differentiate into macrophages that engulf oxidized lipids and release pro-inflammatory cytokines including interleukin-1Î² (IL-1Î²), IL-6, and tumor necrosis factor-Î± (TNF-Î±).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> These cytokines amplify local inflammation, promote smooth muscle cell proliferation, and destabilize atherosclerotic plaques by inducing matrix metalloproteinases that degrade fibrous caps.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_grabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup> Adaptive immune responses, including T-cell activation, further sustain chronic inflammation, contributing to plaque progression independent of lipid accumulation alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_orabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[115]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">C-reactive protein (CRP), an acute-phase reactant produced by hepatocytes in response to IL-6, serves as a biomarker of systemic inflammation and predicts cardiovascular events, with high-sensitivity CRP (hsCRP) levels above 2 mg/L associated with increased risk of myocardial infarction and stroke.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup> While mainstream paradigms prioritize lipid-driven atherogenesis, evidence indicates CRP may exert causal effects by impairing endothelial function, facilitating monocyte adhesion, and promoting plaque instability, as supported by observational data and animal models where CRP binding to oxidized LDL exacerbates lesion formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_grqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_orqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup> Mendelian randomization studies estimating genetically elevated CRP levels yield risk ratios for coronary heart disease comparable to observational associations, suggesting a direct pathogenic role beyond mere correlation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Clinical trials targeting inflammatory pathways provide empirical support for inflammation as a primary driver, challenging lipid-centric models. In the CANTOS trial, canakinumabâ€”an IL-1Î² inhibitorâ€”reduced major adverse cardiovascular events by 15% in post-myocardial infarction patients with elevated hsCRP, without altering lipid profiles, demonstrating that cytokine blockade mitigates risk through anti-inflammatory mechanisms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup> Similarly, low-dose colchicine (0.5 mg daily), which inhibits inflammasome activation and cytokine release, lowered cardiovascular event rates by 25-30% in patients with coronary artery disease, further evidenced by reduced hsCRP and IL-6 levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gsabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[121]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_osabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup> These findings underscore systemic cytokine-mediated inflammation as a modifiable causal factor, with benefits accruing irrespective of cholesterol reduction.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Upstream triggers of these processes include chronic infections, which induce persistent immune activation and cytokine storms contributing to atherogenesis; for instance, pathogens like periodontal bacteria or Chlamydia pneumoniae correlate with accelerated plaque formation via endothelial activation and systemic inflammatory markers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[123]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gsqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup> Chronic psychosocial stress similarly drives inflammation by activating the hypothalamic-pituitary-adrenal axis, elevating cortisol and pro-inflammatory cytokines like IL-6, which foster a hypercoagulable state and lipid oxidation, accounting for elevated cardiovascular risk in stressed cohorts independent of traditional factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_osqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[125]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_10sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[126]</sup> This causal chainâ€”from stressors to immune dysregulationâ€”highlights inflammation&#x27;s role as an integrator of environmental insults into vascular pathology.</span>
<h3 id="endothelial-dysfunction" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Endothelial Dysfunction<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Endothelial dysfunction refers to the impaired functioning of the vascular endothelium, the monolayer of cells lining blood vessels, which serves as a critical barrier regulating vascular tone, permeability, inflammation, and thrombosis. This dysfunction manifests as a reduction in endothelium-dependent vasodilation, primarily due to decreased bioavailability of nitric oxide (NO), a key vasoprotective molecule produced by endothelial nitric oxide synthase (eNOS). Empirical evidence from human studies demonstrates that endothelial dysfunction precedes and contributes to cardiovascular disease progression by promoting vasoconstriction, leukocyte adhesion, and platelet aggregation, thereby increasing vascular resistance and thrombotic risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[127]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[128]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The core mechanism involves impaired NO production and increased oxidative stress, where reactive oxygen species (ROS) such as superoxide inactivate NO, forming peroxynitrite and exacerbating barrier failure. In conditions like hypertension and hypercholesterolemia, eNOS uncouplingâ€”wherein the enzyme produces superoxide instead of NOâ€”further diminishes NO levels, leading to endothelial barrier disruption and heightened permeability. Studies in endothelial cell models confirm that inhibiting NO synthesis directly induces dysfunction, mimicking vascular failure observed in vivo. This foundational impairment contrasts with downstream effects like plaque formation, as it initiates the loss of the endothelium&#x27;s anti-atherogenic and anti-thrombotic properties.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[129]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[130]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[131]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Endothelial dysfunction exhibits a bidirectional relationship with insulin resistance, a hallmark of metabolic disorders preceding cardiovascular events. Insulin resistance selectively impairs insulin signaling in endothelium via disrupted phosphoinositide 3-kinase (PI3K)/Akt pathways, which normally activate eNOS, while preserving mitogenic pathways that promote inflammation. Clinical data from insulin-resistant individuals show reduced flow-mediated dilationâ€”a marker of endothelial functionâ€”correlating with hyperinsulinemia levels as low as those post-overnight fasting, independent of hyperglycemia. This linkage underscores causal realism in metabolic-vascular interplay, where endothelial NO deficiency worsens insulin-mediated glucose uptake, perpetuating resistance and vascular barrier failure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cuqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kuqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[135]</sup></span>
<h2 id="risk-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Risk Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="non-modifiable-risk-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Non-Modifiable Risk Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Age is the most potent non-modifiable risk factor for cardiovascular disease (CVD), with incidence and mortality rates rising exponentially after approximately age 40, driven by cumulative vascular wear, reduced regenerative capacity, and progressive stiffening of arteries. In adults over 80 years, CVD prevalence reaches 89.3% in males and 91.8% in females, reflecting the dominance of chronological aging in disease manifestation. The percentage of adults with at least one CVD risk factor also escalates with age, from 27.0% in those aged 20-39 to 42.6% in those 65 and older, underscoring age&#x27;s independent contribution beyond modifiable factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[136]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[137]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Sex influences CVD risk profiles, with males exhibiting higher susceptibility prior to female menopause, attributable to protective effects of estrogen on endothelial function and lipid metabolism in premenopausal women. Premenopausal women experience lower age-adjusted CVD rates compared to men, but this gap narrows post-menopause, where women&#x27;s risk accelerates and often surpasses men&#x27;s when adjusted for age, leading to later but equally severe presentations. Women typically manifest CVD about 10 years later than men, yet postmenopausal prognosis for events like acute coronary syndrome worsens relative to age-matched males.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[138]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[139]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[140]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Genetic predisposition, including family history, confers verifiable heritability for CVD outcomes, as evidenced by twin studies showing genetic contributions of 57% in males and 38% in females to coronary heart disease mortality. Conditions like familial hypercholesterolemia (FH), a monogenic disorder affecting LDL receptor function, illustrate causal genetic impact, with prevalence around 1 in 311 individuals and a twofold elevation in coronary heart disease risk even at moderate LDL-C levels. FH-affected individuals face markedly higher premature atherosclerotic CVD incidence, such as 14.9 per 1000 person-years for atherosclerotic CVD in primary prevention cohorts, emphasizing polygenic and monogenic pathways without implying determinism, as environmental interactions modulate expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[141]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[142]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[143]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[144]</sup></span>
<h3 id="modifiable-lifestyle-risk-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Modifiable Lifestyle Risk Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Tobacco smoking exhibits a robust dose-response relationship with cardiovascular disease (CVD) risk, where even low levels of consumption substantially elevate incidence of coronary heart disease and stroke. A meta-analysis of prospective studies found that smoking approximately one cigarette per day confers about half the excess risk of smoking 20 cigarettes per day for these outcomes, underscoring the absence of a safe threshold. Current smoking at least doubles the risk for major CVD subtypes, including acute myocardial infarction and heart failure, with benefits from cessation accruing rapidlyâ€”heavy smokers quitting experience significant risk reduction within five years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[145]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[146]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[147]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Physical inactivity independently heightens CVD risk, with sedentary behavior linked to increased all-cause and cardiovascular mortality through mechanisms like impaired endothelial function and metabolic dysregulation. Prospective cohort data indicate that prolonged sitting, such as in occupational settings, associates with a 34% higher CVD mortality risk compared to more active patterns. Regular moderate-to-vigorous physical activity mitigates this, reducing nonfatal cardiac events by 18% and total cardiac events by 29%, highlighting the causal protective role of habitual movement over mere avoidance of sedentariness.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_92qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[148]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Dietary patterns emphasizing refined sugars and processed carbohydrates drive inflammation and metabolic disturbances more directly than saturated fats, contrary to earlier emphases in some guidelines. High added sugar intake triples CVD mortality risk via elevated blood pressure and chronic low-grade inflammation, while replacing saturated fats with sugars exacerbates obesity and related complications. Meta-analyses challenge the saturated fat-CVD link, showing no consistent harm when contextualized against carbohydrate quality, with evidence favoring whole-food sources of fats over isolated nutrient fears.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[150]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[151]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Alcohol consumption follows a J-shaped curve for CVD outcomes, where light-to-moderate intake (up to one drink daily) correlates with 22% lower cardiovascular mortality compared to abstinence, likely due to effects on HDL cholesterol and hemostasis, while heavy use (&gt;3 drinks daily) sharply elevates risks via hypertension and cardiomyopathy. This pattern holds in meta-analyses of cohort studies, though causality remains debated amid confounding by former drinkers in abstainer groups; excess consumption nullifies benefits and amplifies harm.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[153]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[154]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic sleep deprivation, defined as â‰¤5-6 hours nightly, elevates CVD incidence by 20-48% in prospective cohorts, through pathways including sympathetic overactivation and insulin resistance. Short sleep duration specifically heightens coronary heart disease risk, with irregularity compounding effects independent of duration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[155]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[156]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic stress, proxied by elevated cortisol levels, associates with up to fivefold higher myocardial infarction risk in cohort analyses, mediating via endothelial damage and plaque instability. Hair cortisol measurements confirm this link, with higher chronic exposure correlating to prevalent hypertension and prior CVD events, emphasizing behavioral management of psychosocial stressors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[157]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[158]</sup></span>
<h3 id="environmental-and-occupational-risk-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Environmental and Occupational Risk Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Air pollution, particularly fine particulate matter (PM2.5), has been empirically linked to increased cardiovascular disease (CVD) incidence and mortality through mechanisms including endothelial dysfunction, inflammation, and oxidative stress. A meta-analysis of 35 studies reported that a short-term increase of 10 Î¼g/mÂ³ in PM2.5 concentrations is associated with a 2.12% elevated risk of CVD-related hospitalization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[159]</sup> Long-term exposure to PM2.5 at moderate levels (e.g., 5-15 Î¼g/mÂ³) correlates with higher risks of acute myocardial infarction, ischemic heart disease mortality, and overall CVD mortality, with hazard ratios indicating approximately 10-20% increased risk per 10 Î¼g/mÂ³ increment in cohort studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[160]</sup> These associations persist after adjusting for confounders like smoking and socioeconomic status, underscoring direct causal pathways from particulate inhalation to vascular damage rather than indirect effects via inequality, as particulate-induced systemic inflammation drives outcomes independently of neighborhood deprivation metrics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[161]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Occupational exposures contribute to CVD risk via chronic stressors and toxicants. Shift work, especially night shifts, disrupts circadian rhythms, elevating CVD event risk by 17% overall and 26% for coronary heart disease morbidity compared to day work, based on systematic reviews of prospective studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_96abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[162]</sup> This risk arises from prolonged sympathetic activation, sleep disruption, and metabolic dysregulation, with meta-analyses confirming higher odds for hypertension and arrhythmias among shift workers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[163]</sup> Chemical exposures, such as solvents, metals, and pesticides, further compound hazards; occupational solvent exposure is linked to electrocardiographic abnormalities and increased myocardial infarction incidence, while high pesticide exposure raises 10-year CVD event rates by up to 40% in exposed cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[164]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_t6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[165]</sup> Metals like cadmium show probable but not definitive atherosclerotic effects, with prevalence rates of 8.5% for metal exposures in CVD cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_156abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[166]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_196abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[167]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Ionizing radiation exposure, often occupational in medical or nuclear workers, induces CVD through DNA damage, fibrosis, and accelerated atherosclerosis. In atomic bomb survivors, doses of 0-4 Gy (primarily 0-2 Gy) exhibit a dose-response relationship with heart disease and stroke risks, with excess relative risks of 14% per Gy for circulatory mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_96qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[168]</sup> Systematic reviews of low-dose exposures (&lt;0.5 Gy) confirm elevated circulatory disease incidence, including in cohorts with cumulative doses from repeated medical imaging or occupational sources.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[169]</sup> These findings highlight radiation&#x27;s role in endothelial injury and plaque instability, distinct from acute high-dose effects like burns.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[170]</sup></span>
<h3 id="emerging-risk-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Emerging Risk Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Emerging risk factors for cardiovascular disease encompass understudied contributors supported by recent empirical evidence, including post-infectious sequelae, microbial dysbiosis, novel dietary exposures, and stress-mediated autonomic perturbations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[171]</sup> These factors highlight causal pathways beyond traditional risks, such as persistent inflammation or metabolic disruptions, with studies from 2024 onward quantifying their independent contributions through longitudinal cohorts and mechanistic analyses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[172]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Post-acute sequelae of SARS-CoV-2 infection, often termed long COVID, elevate cardiovascular risk through mechanisms like endothelial injury and chronic inflammation. A 2025 analysis found long COVID associated with significantly higher odds of subsequent cardiovascular diagnoses, including arrhythmias and heart failure, persisting beyond four weeks post-recovery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[173]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[174]</sup> Large-scale epidemiological data from September 2025 confirmed increased incidences of pericarditis, cardiomyopathy, and dysrhythmias, attributing these to viral-induced microvascular damage rather than mere correlation with acute severity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[175]</sup> Vaccination mitigates these risks by reducing infection-related cardiac events, underscoring a causal link via viral persistence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_118abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[176]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Gut microbiome composition influences cardiovascular outcomes via metabolite production, such as trimethylamine N-oxide (TMAO), which promotes atherosclerosis. April 2024 research identified specific cholesterol-consuming bacteria that lower serum lipids and heart disease risk, with abundance correlating inversely to event rates in cohort studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[177]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[178]</sup> A June 2024 study on microbial age showed that a &quot;younger&quot; gut profileâ€”rich in diverse, anti-inflammatory taxaâ€”counteracts elevated cardiovascular risk in metabolically unhealthy individuals, independent of chronological age.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[171]</sup> Dysbiosis, often from antibiotic use or poor fiber intake, drives progression through short-chain fatty acid imbalances, as evidenced by multi-omics analyses linking taxa shifts to plaque instability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_118qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[179]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Ultra-processed foods (UPFs), characterized by high additive content and low nutrient density, contribute via glycemic spikes, oxidative stress, and gut permeability alterations. A March 2025 NIH-linked study reported high UPF intake associated with elevated heart disease and stroke incidence in U.S. adults, with each 100 grams daily increase raising hypertension and event risks by measurable increments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[180]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[181]</sup> February 2024 meta-analyses across millions confirmed UPF exposure heightens cardiometabolic mortality by 19%, mechanistically tied to systemic inflammation rather than caloric excess alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[172]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_119abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[182]</sup> Subgroup data from 2024 trials differentiated harmful UPF subtypes, like emulsified snacks, from neutral ones, emphasizing formulation over processing category.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_199abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[183]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic psychological stress and anxiety exert causal effects on cardiovascular disease through autonomic nervous system imbalance, reducing heart rate variability and favoring sympathetic dominance. June 2024 NHLBI findings linked lower variabilityâ€”indicative of vagal withdrawalâ€”to stress-induced myocardial vulnerability, with prospective data showing doubled event rates in high-stress cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_99qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[184]</sup> Anxiety triggers this via hypothalamic-pituitary-adrenal activation, leading to endothelial dysfunction and plaque rupture, as quantified in 2024 reviews of sympathetic overdrive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[185]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_p9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[186]</sup> Unlike bidirectional associations, intervention trials demonstrate that autonomic modulation (e.g., via biofeedback) attenuates risk, supporting causality over confound.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_119qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[187]</sup></span>
<h2 id="prevention" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Prevention<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="primary-prevention-strategies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Primary Prevention Strategies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Primary prevention of cardiovascular disease targets individuals without established disease through population-level lifestyle modifications that address modifiable risk factors, reducing incidence by up to 80% in adherent groups according to cohort data.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[188]</sup> Empirical evidence from randomized controlled trials and meta-analyses prioritizes smoking avoidance, physical activity, nutrient-dense dietary patterns, and weight maintenance over pharmaceutical approaches in low-to-moderate risk populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[189]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Avoidance or cessation of tobacco use constitutes the most impactful single intervention, with risk of coronary heart disease declining by approximately 50% within one year of quitting and normalizing to never-smoker levels after 15 years.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[190]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[191]</sup> Prospective studies indicate that even brief cessation yields measurable reductions in endothelial dysfunction and atherogenesis, underscoring causal links via oxidative stress and platelet activation mechanisms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[147]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regular physical activity, specifically 150 minutes per week of moderate-intensity aerobic exercise, correlates with a 14% lower risk of coronary heart disease events in large prospective cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[192]</sup> Dose-response meta-analyses affirm that this thresholdâ€”equivalent to 8.75 metabolic equivalent task-hours weeklyâ€”optimally balances CVD prevention with feasibility, yielding 20-30% reductions in all-cause mortality when sustained.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[193]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[194]</sup> Resistance training adjuncts further enhance vascular compliance, though aerobic modalities predominate in risk attenuation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Dietary strategies emphasizing whole, unprocessed foods outperform restrictive low-fat paradigms, which meta-analyses show yield inferior improvements in lipid profiles and inflammation markers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[195]</sup> The PREDIMED trial demonstrated that a Mediterranean-style diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by 30% relative to a advised low-fat diet in high-risk primary prevention participants, driven by polyphenols&#x27; anti-atherogenic effects rather than mere caloric restriction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[196]</sup> Low-carbohydrate variants similarly match or exceed low-fat outcomes for weight and triglyceride control without adverse cardiovascular shifts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[197]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Maintaining healthy body weight via consistent caloric deficits of 500-750 kcal daily facilitates 5-10% loss, directly lowering visceral adiposity and associated proinflammatory cytokines that propel atherosclerosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[198]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[199]</sup> Randomized interventions confirm this approach ameliorates insulin resistance and hypertension precursors independently of exercise volume, though long-term adherence challenges persist absent behavioral reinforcement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ldabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[200]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacologic prophylaxis, such as statins or antihypertensives, is contraindicated for primary prevention in normotensive or low-cholesterol individuals due to net harm from side effects outweighing benefits in meta-analyses of low-risk cohorts; lifestyle primacy holds except in documented high-risk subsets like familial hypercholesterolemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[188]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[201]</sup></span>
<h3 id="secondary-prevention-approaches" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Secondary Prevention Approaches<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Secondary prevention strategies for cardiovascular disease (CVD) aim to reduce the incidence of recurrent events in individuals who have already experienced a major vascular occurrence, such as myocardial infarction, stroke, or peripheral artery disease revascularization. These interventions, grounded in clinical trial evidence and guidelines, emphasize multifactorial risk reduction through pharmacological therapies, structured rehabilitation, and targeted control of modifiable factors like hypertension and dyslipidemia. Implementation post-event has been associated with up to 75% relative risk reduction in recurrent events when comprehensive programs are adhered to, though global underutilization persists, with only about 20-30% of eligible patients participating in core components like cardiac rehabilitation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[202]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_deqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[203]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiac rehabilitation (CR) programs form a foundational element, delivering supervised exercise, behavioral counseling, and education on medication adherence and lifestyle factors. Meta-analyses of randomized trials demonstrate that CR reduces cardiovascular mortality by 20-30% and all-cause mortality by 13-26% in patients with coronary heart disease, with additional benefits including improved exercise capacity (mean increase of 1-2 METs) and reduced hospital readmissions by 20-30%. Core components, updated in 2024 guidelines, include initial risk stratification, medically supervised exercise (typically 36 sessions over 12 weeks), nutritional counseling, and smoking cessation support, with hybrid virtual options expanding access amid low referral rates (often &lt;50% in eligible populations).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[204]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[205]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Blood pressure (BP) control yields among the highest gains in life-years saved post-event, with modeling from global risk factor analyses estimating that achieving systolic BP &lt;130 mm Hg averts 10-15% of recurrent CVD events compared to higher thresholds. The 2025 AHA/ACC hypertension guideline recommends targeting &lt;130/80 mm Hg in most post-CVD patients using combinations of ACE inhibitors, ARBs, or beta-blockers, supported by trials showing 20-25% relative risk reductions in stroke and heart failure recurrence; intensive targets (&lt;120 mm Hg systolic) further lower major adverse cardiovascular events by 10-15% in high-risk subgroups like those with diabetes, though with increased risks of hypotension and renal impairment requiring individualized monitoring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[206]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Pharmacological prophylaxis targets thrombosis and atherosclerosis progression. High-intensity statin therapy (e.g., atorvastatin 40-80 mg or rosuvastatin 20-40 mg daily) is recommended to reduce LDL cholesterol &lt;70 mg/dL or by â‰¥50%, achieving 20-30% relative reductions in major vascular events based on trials like IMPROVE-IT and ODYSSEY OUTCOMES. Antiplatelet agents, including lifelong low-dose aspirin (75-100 mg) and initial dual therapy with P2Y12 inhibitors (e.g., clopidogrel or ticagrelor for 6-12 months post-acute coronary syndrome), prevent stent thrombosis and recurrent infarction, with meta-analyses confirming 20-25% risk reductions. Renin-angiotensin system inhibitors (ACEIs or ARBs) and beta-blockers are indicated for patients with left ventricular dysfunction or persistent angina, reducing mortality by 15-20% in heart failure subsets. Adherence to these regimens via polypill formulations has shown 10-15% improvements in persistence rates, addressing the gap where only 40-60% of patients maintain full secondary prevention pharmacotherapy long-term.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[207]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[208]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[209]</sup></span>
<h3 id="dietary-interventions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Dietary Interventions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Dietary interventions for preventing cardiovascular disease emphasize modifications to macronutrient composition and eating patterns to address causal factors such as insulin resistance, dyslipidemia, and inflammation, rather than solely targeting isolated nutrients like cholesterol. Randomized controlled trials, including the Women&#x27;s Health Initiative Dietary Modification Trial involving 48,835 postmenopausal women followed for 8.1 years, demonstrated that a low-fat dietary pattern reducing total fat intake by 11.0% and saturated fat by 4.2% yielded no significant reduction in coronary heart disease (hazard ratio 0.97; 95% CI, 0.88-1.07), stroke (HR 0.98; 95% CI, 0.83-1.15), or total cardiovascular events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[210]</sup> This outcome critiques longstanding guidelines prioritizing low-fat intake, as the intervention failed to alter CVD incidence despite promoting fruits, vegetables, and grains over fats.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[211]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Low-carbohydrate diets, restricting carbohydrates to under 130 g/day while allowing higher fat and protein intake, have shown superior effects on cardiometabolic risk factors in meta-analyses of randomized trials. A 2020 systematic review of 23 studies found low-carbohydrate diets significantly lowered triglycerides by 0.31 mmol/L, increased HDL cholesterol by 0.06 mmol/L, and reduced body weight by 1.30 kg compared to low-fat diets, though LDL cholesterol rose modestly by 0.12 mmol/L; these shifts align with improved insulin sensitivity and reduced atherogenic dyslipidemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[212]</sup> Long-term observational data from the Nurses&#x27; Health Study, tracking 82,802 women over 20 years, indicated that lower-carbohydrate scores (emphasizing plant-based sources) correlated with no increased coronary heart disease risk (relative risk 0.94 for lowest vs. highest quintile).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[213]</sup> Such diets address root causes like hyperglycemia, outperforming low-fat approaches in reversing type 2 diabetesâ€”a key CVD driverâ€”in programs like Virta Health&#x27;s continuous care intervention, where 60% of participants achieved diabetes remission at one year alongside improved lipid profiles.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_phqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[214]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regarding specific fats, saturated fatty acids exhibit neutrality or context-dependent effects on CVD risk, challenging demonization in dietary guidelines. A 2020 JACC review reassessed evidence, concluding that saturated fats from whole foods like dairy and meat do not independently elevate CVD when carbohydrate intake is controlled, as replacement with refined carbs exacerbates harm via glycation and inflammation; prospective cohorts like PURE (135,335 participants across 18 countries) linked higher saturated fat intake to lower stroke risk (HR 0.79 per 5% energy increase).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup> In contrast, industrial trans fats unequivocally promote endothelial dysfunction and plaque formation; jurisdictions banning partially hydrogenated oils, such as New York counties from 2007, saw cardiovascular mortality decline by 4.5% (p=0.02) two years post-ban, attributing reductions to lowered LDL oxidation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[215]</sup> Polyunsaturated fats from seed oils (e.g., soybean, corn), rich in omega-6 linoleic acid, show mixed outcomes: while short-term RCTs suggest LDL-lowering when substituting saturated fats, long-term data raise concerns over oxidative stress and inflammation from high n-6:n-3 ratios, with no clear CVD mortality benefit in population studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_piabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[216]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[217]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Intermittent fasting, such as time-restricted eating (e.g., 16:8 protocol), modulates circadian metabolism and caloric intake to mitigate obesity-related CVD risks. A 2025 meta-analysis of pairwise comparisons reported reductions in systolic blood pressure (mean difference -4.43 mmHg), fasting glucose (-3.72 mg/dL), and triglycerides (-10.86 mg/dL) across 11 randomized trials, supporting cardiometabolic improvements without adverse cardiac events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[218]</sup> The INTERFAST-MI trial (n=112 post-myocardial infarction patients) found 16:8 fasting safe, enhancing left ventricular ejection fraction by 3% at 3 months versus controls.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[219]</sup> However, a 2024 observational analysis of NHANES data (20,078 adults) associated 8-hour eating windows with 91% higher CVD mortality risk (HR 1.91; 95% CI, 1.20-3.03), potentially confounded by self-selection or reverse causation in unhealthy individuals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_piqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[220]</sup> Causal inference favors fasting&#x27;s benefits in controlled settings, prioritizing empirical trial data over associative epidemiology.</span>
<h3 id="pharmacological-prevention" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacological Prevention<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Low-dose aspirin (75-100 mg daily) is recommended selectively for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in adults aged 40-59 years with a 10-year ASCVD risk of 10% or greater and low bleeding risk, as it reduces nonfatal myocardial infarction by approximately 26% relative risk but increases major bleeding by 58%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[221]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_djqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[222]</sup> However, initiation is not advised for adults aged 60 years or older, where bleeding risks outweigh cardiovascular benefits, with no net reduction in all-cause mortality observed across trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ljqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[221]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[223]</sup> This approach targets the causal pathway of platelet aggregation and thrombosis but requires individualized assessment, as absolute risk reductions are modest (e.g., 0.38% over 10 years for coronary events in high-risk groups).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[188]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Statins, such as atorvastatin or rosuvastatin, are indicated for primary prevention in adults with elevated low-density lipoprotein cholesterol (LDL-C) or a 10-year ASCVD risk of 7.5% or higher, achieving relative reductions of 20-25% in major cardiovascular events through LDL-C lowering of 30-50%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[224]</sup> Meta-analyses of randomized trials confirm efficacy in reducing nonfatal myocardial infarction and stroke, with one study reporting a 25% relative risk reduction for major vascular events per 1 mmol/L LDL-C decrease, though absolute benefits in primary prevention are small (e.g., 1.6% reduction in heart attacks over 5 years, number needed to treat of 62).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[225]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[226]</sup> No significant all-cause mortality benefit emerges in low-risk populations (&lt;5% 10-year risk), and debates persist over overprescription driven by relative risk emphasis, with critics noting high numbers needed to treat (e.g., 140 for stroke prevention) and underreporting of adverse effects like myopathy (1-5% incidence) or diabetes risk increase (9% relative).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[227]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[228]</sup> While statins address dyslipidemiaâ€”a proxy for atherogenic pathwaysâ€”their pleiotropic effects (e.g., anti-inflammatory) contribute, but evidence quality varies, with some analyses questioning net benefit in those under 7.5% risk due to pharma-funded trial biases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_19kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[229]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1dkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[225]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Antihypertensive agents, including angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers, and thiazide diuretics, are recommended for primary prevention in adults with hypertension (systolic blood pressure â‰¥130 mm Hg or diastolic â‰¥80 mm Hg) and elevated cardiovascular risk per tools like the 2025 PREVENT equations (â‰¥7.5% 10-year risk).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[206]</sup> Blood pressure reduction of 5 mm Hg systolic lowers major cardiovascular event risk by 10% regardless of baseline levels, with trials showing 20-25% relative reductions in stroke and 10-15% in myocardial infarction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[230]</sup> Causal targeting of hemodynamic stress on endothelium and vessels yields benefits even in stage 1 hypertension with risk factors, though absolute reductions depend on baseline (e.g., 2-3% over 5 years in moderate cases), and combination therapy may be needed for goal attainment (&lt;130/80 mm Hg).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[206]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[231]</sup> Side effects like orthostasis or electrolyte shifts necessitate monitoring, but overall, therapy prevents organ damage more effectively than risk proxies alone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[232]</sup></span>
<h2 id="diagnosis-and-screening" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Diagnosis and Screening<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="diagnostic-tests-and-imaging" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Diagnostic Tests and Imaging<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Electrocardiography (ECG or EKG) is a primary noninvasive test that records the electrical activity of the heart to detect arrhythmias, ischemia, or infarction, typically performed within minutes using surface electrodes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[233]</sup> It identifies abnormalities such as ST-segment elevation in acute coronary syndromes with high sensitivity for certain patterns, though specificity varies by clinical context.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[234]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Echocardiography employs ultrasound waves to visualize cardiac structures, assess ventricular function, valvular integrity, and ejection fraction, often as a transthoracic or transesophageal variant for enhanced resolution.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[235]</sup> This modality detects wall motion abnormalities indicative of ischemia or cardiomyopathy, with Doppler techniques quantifying blood flow velocities and pressures noninvasively.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[236]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Coronary angiography, an invasive procedure via catheter insertion, delivers contrast dye to opacify coronary arteries, confirming stenosis severity and guiding interventions like stenting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[237]</sup> It remains the gold standard for anatomical assessment of obstructive disease, achieving near-100% accuracy in lesion detection when combined with fractional flow reserve measurements.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hnabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Advanced imaging includes cardiac computed tomography (CT) angiography for noninvasive coronary lumen evaluation and magnetic resonance imaging (MRI) for myocardial viability and perfusion without ionizing radiation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[238]</sup> Stress echocardiography or nuclear perfusion imaging complements these by revealing inducible ischemia under pharmacological or exercise provocation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[239]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">By 2025, artificial intelligence (AI) integration has enhanced diagnostic precision across modalities, automating segmentation in echocardiography to reduce variability and improve ejection fraction quantification by up to 20% in multicenter trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[240]</sup> AI algorithms in CT and MRI accelerate reconstruction, minimizing artifacts and enabling rapid plaque characterization, with applications in real-time guidance for angiography showing reduced procedural times.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[241]</sup> These tools, validated in prospective studies, prioritize empirical outcomes like sensitivity for stenosis detection exceeding 90% while addressing overfitting through diverse datasets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_poabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[242]</sup></span>
<h3 id="risk-assessment-tools" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Risk Assessment Tools<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Risk assessment tools for cardiovascular disease (CVD) utilize multivariable statistical models to estimate an individual&#x27;s short- or long-term probability of experiencing events such as myocardial infarction, stroke, or CVD-related death, aiding in the prioritization of preventive measures like statin therapy or lifestyle changes. These models typically integrate factors including age, sex, blood pressure, lipid profiles, smoking status, and diabetes, derived from large cohort studies with Cox proportional hazards regression or similar methods. Validation involves metrics like C-statistic for discrimination and calibration plots for accuracy, though performance varies across populations due to differences in baseline risk and comorbidities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[243]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The Framingham Risk Score, developed from the Framingham Heart Study&#x27;s prospective data collected since 1948, predicts 10-year risk of hard coronary heart disease (myocardial infarction or coronary death) in adults aged 30-79 without prior coronary disease or diabetes. It incorporates age, total cholesterol, HDL cholesterol, systolic blood pressure (untreated or treated), current smoking, and diabetes status, categorizing risk as low (&lt;10%), intermediate (10-20%), or high (&gt;20%). Validated in U.S. cohorts, it demonstrates a C-statistic of approximately 0.76 for coronary events but tends to overestimate risk in lower-prevalence European populations and underperforms in non-White groups due to cohort homogeneity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[244]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[245]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For European populations, the SCORE2 algorithm, released by the European Society of Cardiology in 2021, estimates 10-year risk of first-onset fatal and non-fatal major CVD events (atherosclerotic and heart failure-related) in individuals aged 40-69 free of prior CVD. It uses age, sex, smoking, systolic blood pressure, and non-HDL cholesterol, recalibrated with data from 45 cohorts encompassing over 250,000 participants and contemporary event rates from 13 million person-years. SCORE2 improves calibration over its predecessor SCORE, with a pooled C-statistic of 0.72-0.74, and a variant SCORE2-OP extends predictions to ages 70-79 using adjusted baselines. It recommends thresholds of â‰¥5% for low-moderate risk and â‰¥10% for high-very high risk to initiate intensified prevention.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[243]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[246]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[247]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Emerging polygenic risk scores (PRS) complement traditional models by quantifying genetic liability through weighted sums of thousands of common variants identified via genome-wide association studies. For coronary artery disease, PRS derived from European-ancestry meta-analyses (e.g., CARDIoGRAMplusC4D) can identify 8% of individuals with 2-3 times the average genetic risk, independent of clinical factors, with net reclassification improvements up to 10-20% when integrated into scores like Framingham or ASCVD. A 2022 American Heart Association scientific statement endorses PRS for coronary artery disease and atrial fibrillation risk stratification, noting enhanced prediction in early adulthood where traditional scores are less informative due to low absolute risk. Recent 2024-2025 advances include AI-optimized PRS and multi-ancestry adaptations, demonstrating clinical utility in reclassifying 5-10% of intermediate-risk patients toward statin eligibility, though implementation lags due to genotyping costs and equity concerns in non-European populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[248]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[249]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[250]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[251]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Critiques of these tools highlight over-reliance on LDL cholesterol (often proxied via non-HDL or derived from total/HDL), which, while causally linked to atherosclerosis per Mendelian randomization evidence, fails as a standalone predictor due to overlapping distributions between cases and controls, yielding false positives/negatives in up to 50% of assessments. Small dense LDL subfractions, rather than total LDL concentration, correlate more strongly with plaque progression and events (hazard ratios 1.5-2.0 per standard deviation increase), yet standard models omit particle size or count via advanced assays like NMR spectroscopy. Variability in LDL levels over time independently doubles CVD risk beyond mean exposure, and cumulative &quot;cholesterol-years&quot; better capture lifetime atherogenic burden than snapshot measures. These limitations underscore the need for multimodal integration, including inflammation markers (e.g., hsCRP) or apolipoprotein B, to refine predictions without discounting LDL&#x27;s centrality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[252]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_drabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[253]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hrabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[254]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lrabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[255]</sup></span>
<h3 id="early-detection-challenges" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Early Detection Challenges<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular disease frequently advances asymptomatically for years, complicating early identification as individuals may lack overt symptoms until advanced stages, such as myocardial infarction or heart failure. Studies indicate that subclinical coronary plaque is present in approximately 49% of asymptomatic middle-aged adults, with prevalence rising with age and risk factors like hypertension. Pre-heart failure stages affect 11% to 42.7% of populations, particularly the elderly and those with comorbidities, underscoring how silent progression evades routine clinical detection without proactive measures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[256]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dsabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[257]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Current risk assessment tools, including the 2024 American Heart Association PREVENT equations, aim to predict cardiovascular events earlier by incorporating variables like age, blood pressure, cholesterol, and kidney function, enabling identification of high-risk individuals before symptoms emerge. However, challenges persist in model generalizability, interpretability, and external validation, limiting their applicability across diverse populations. Routine screening modalities like electrocardiography yield inadequate evidence of net benefit in asymptomatic adults, with potential harms from false positives outweighing advantages per U.S. Preventive Services Task Force assessments.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[258]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dsqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[259]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Access disparities exacerbate detection barriers, with rural and socioeconomically disadvantaged areas facing shortages of cardiologists and lower screening rates for risk factors like hypertension. Racial and income-based inequities result in fewer preventive screenings among Black, Hispanic, and low-income groups, contributing to delayed diagnoses despite evidence that targeted, proactive strategies can double early CVD identification rates. While such screenings demonstrate cost-effectiveness and improved outcomes when implemented, systemic gaps in healthcare infrastructure hinder equitable application.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[260]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[261]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_htabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[262]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ltabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[263]</sup></span>
<h2 id="management-and-treatment" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Management and Treatment<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="acute-interventions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acute Interventions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Primary percutaneous coronary intervention (PCI) represents the preferred reperfusion strategy for patients presenting with ST-elevation myocardial infarction (STEMI), demonstrating superior outcomes compared to thrombolytic therapy in reducing short-term mortality when performed promptly.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[264]</sup> Guidelines recommend achieving a door-to-balloon time of 90 minutes or less from hospital arrival, as delays beyond this threshold correlate with increased in-hospital and long-term mortality risks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_huqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[265]</sup> For instance, symptom onset-to-balloon times exceeding 2 hours or door-to-balloon times over 60 minutes independently predict higher 90-day mortality rates, with each 30-minute delay elevating risk by approximately 7-10% in observational cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_puqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[266]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_11uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[267]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Thrombolytic therapy, involving agents such as alteplase or tenecteplase, serves as an alternative when primary PCI cannot be executed within 120 minutes of first medical contact, particularly in rural or resource-limited settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[209]</sup> This approach achieves myocardial reperfusion in about 50-60% of cases but carries higher rates of hemorrhagic complications and reinfarction compared to PCI, resulting in 20-30% greater 30-day mortality in direct comparisons from randomized trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[268]</sup> Prehospital fibrinolysis followed by routine angiography within 3-24 hours can mitigate some deficits in high-risk patients unable to access timely PCI, though overall survival benefits diminish with treatment delays beyond 3 hours from symptom onset.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pvabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[269]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Adjunctive pharmacotherapies during acute reperfusion include immediate aspirin administration (162-325 mg chewed) to inhibit platelet aggregation, reducing early mortality by 23% in meta-analyses of STEMI trials, alongside P2Y12 inhibitors like ticagrelor or prasugrel for dual antiplatelet effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[270]</sup> Anticoagulation with heparin or bivalirudin supports procedural success in PCI, while beta-blockers and statins are initiated concurrently to limit infarct expansion, though their acute mortality impact is secondary to timely revascularization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hvqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[209]</sup> In non-STEMI acute coronary syndromes, urgent angiography and revascularization within 2 hours for high-risk features (e.g., refractory angina or hemodynamic instability) further underscore the time-sensitive nature of interventions to avert progression to full infarction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pvqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[271]</sup></span>
<h3 id="chronic-disease-management" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Chronic Disease Management<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic management of cardiovascular disease emphasizes sustained pharmacological control of risk factors and symptoms to mitigate progression and recurrent events. Guideline-directed medical therapy (GDMT) typically includes combinations of antihypertensives, lipid-lowering agents, antiplatelet drugs, and disease-specific therapies such as beta-blockers or mineralocorticoid receptor antagonists for heart failure. The 2023 AHA/ACC guideline for chronic coronary disease recommends lifelong therapy with high-intensity statins for most patients with atherosclerotic cardiovascular disease, alongside blood pressure targets below 130/80 mmHg using ACE inhibitors or ARBs as first-line agents in those with comorbidities like diabetes or chronic kidney disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[272]</sup> Similarly, the 2024 ESC guidelines for chronic coronary syndromes advocate for combination therapy including aspirin indefinitely and P2Y12 inhibitors for at least 12 months post-event, with proton pump inhibitors to reduce gastrointestinal bleeding risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[273]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Polypharmacy, defined as concurrent use of five or more medications, is inherent to GDMT in chronic CVD, particularly in heart failure where patients often require diuretics, ACE inhibitors, beta-blockers, and aldosterone antagonists simultaneously. While this multimodal approach yields net benefitsâ€”such as a 20-30% relative risk reduction in major adverse cardiovascular events through optimized risk factor controlâ€”polypharmacy elevates risks of drug-drug interactions, adverse effects like hypotension or renal impairment, and hospitalization rates by up to 1.5-fold in older adults.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[274]</sup> Deprescribing strategies, informed by periodic reassessment of net benefit, are recommended to minimize burden without compromising efficacy, as evidenced by trials showing safe discontinuation of certain agents in stable patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[275]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Medication adherence directly influences outcomes, with meta-analyses demonstrating that high adherence (&gt;80%) to preventive pharmacotherapy correlates with 15-25% lower all-cause mortality and reduced hospitalizations compared to low adherence (&lt;50%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[276]</sup> Poor adherence, affecting 30-50% of CVD patients due to factors like pill burden or side effects, causally exacerbates disease progression, as non-adherent individuals exhibit 1.5-2-fold higher risks of cardiovascular death independent of baseline severity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[277]</sup> Interventions such as simplified regimens, patient education, and electronic reminders improve adherence rates by 10-20%, underscoring the need for routine monitoring via refill data or self-reports during follow-up visits every 3-6 months.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[278]</sup> Long-term success hinges on balancing therapeutic intensity with tolerability, prioritizing evidence from randomized trials over observational associations.</span>
<h3 id="surgical-and-interventional-procedures" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Surgical and Interventional Procedures<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Coronary artery bypass grafting (CABG) involves surgically creating new pathways for blood flow around blocked coronary arteries using grafts from the saphenous vein or internal mammary artery, typically performed via median sternotomy on cardiopulmonary bypass.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[279]</sup> In randomized controlled trials such as the SYNTAX trial, CABG demonstrated lower rates of major adverse cardiac or cerebrovascular events (12.4% vs. 17.8% at 1 year) compared to percutaneous coronary intervention (PCI) in patients with complex multivessel disease, primarily due to reduced need for repeat revascularization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[280]</sup> Long-term data from meta-analyses indicate CABG provides superior 10-year survival in multivessel coronary artery disease, with hazard ratios favoring CABG over PCI (e.g., HR 0.79 for mortality at 4 years in adjusted analyses).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[281]</sup> However, CABG carries higher perioperative risks, including stroke (1-2% incidence), particularly in trials like EXCEL for left main disease where excess cerebrovascular events occurred post-CABG.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_122qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[282]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Percutaneous coronary intervention (PCI), including balloon angioplasty and drug-eluting stent placement, offers a less invasive alternative for revascularization, achieving procedural success rates exceeding 95% in contemporary practice.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[283]</sup> RCTs such as those pooled for left main disease show PCI noninferior to CABG for short-term safety in select patients without diabetes or complex anatomy, with lower early stroke risk but higher rates of target vessel revascularization (e.g., 12.9% vs. 7.6% at 5 years in EXCEL).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[284]</sup> In multivessel disease meta-analyses of over 4,000 patients, PCI matched CABG for 1-2 year composite outcomes but diverged at longer follow-up, with CABG reducing myocardial infarction and mortality in higher SYNTAX scores (&gt;22).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[285]</sup> PCI remains preferred for acute settings like ST-elevation myocardial infarction, where door-to-balloon times under 90 minutes correlate with improved survival.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_123abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[286]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Transcatheter aortic valve replacement (TAVR) deploys a prosthetic valve via catheter access, primarily for severe aortic stenosis in patients at intermediate or high surgical risk, with procedural success rates around 96-98%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[287]</sup> Landmark trials like PARTNER 1 showed TAVR noninferior to surgical aortic valve replacement (SAVR) at 5 years for all-cause mortality in high-risk cohorts (67.8% vs. 62.4%), though with higher rates of vascular complications and paravalvular leak.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[288]</sup> In low-risk patients, the Evolut Low Risk trial reported TAVR noninferior for 2-year composite death or disabling stroke (7.7% vs. 9.2%), expanding indications since FDA approval for broader use in 2019.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[289]</sup> Meta-analyses confirm comparable short-term (up to 2 years) mortality between TAVR and SAVR, but longer-term data (&gt;5 years) suggest potential TAVR disadvantages in durability and reintervention needs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_123qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[290]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For combined coronary and valvular disease, hybrid approaches like PCI plus TAVR versus CABG plus SAVR yield similar periprocedural mortality (0.7-0.8%) but differ in long-term outcomes, with surgical strategies showing lower 5-year death or stroke in some registries (16.2% vs. 27.8%).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[291]</sup> Patient selection via heart team evaluation, incorporating anatomic complexity and comorbidities, guides procedure choice, as evidenced by guideline-directed algorithms prioritizing CABG for diabetes with multivessel involvement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[292]</sup> Ongoing trials continue to refine these interventions&#x27; roles amid evolving stent and valve technologies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[284]</sup></span>
<h3 id="lifestyle-and-rehabilitation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Lifestyle and Rehabilitation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Lifestyle modifications following a cardiovascular event or diagnosis emphasize sustained behavioral changes to mitigate recurrent risk, including smoking cessation, which halves the excess cardiovascular mortality risk within one year of quitting among former smokers with established disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[293]</sup> Combining smoking cessation with initiation of regular exercise post-event yields a 46% reduction in subsequent cardiovascular disease incidence compared to continued smoking without exercise.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[294]</sup> Adoption of diets rich in whole grains, fruits, and vegetables, such as the Mediterranean pattern, supports weight control and endothelial function, with adherence linked to lower composite cardiovascular endpoints in secondary prevention cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[295]</sup> Regular physical activity, targeting 150 minutes weekly of moderate aerobic exercise, improves cardiorespiratory fitness and reduces all-cause mortality by approximately 15% per 1000-step daily increment in rehabilitated patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_125abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[204]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiac rehabilitation programs, typically spanning 8-12 weeks, integrate supervised exercise training with education on risk factor management, yielding dose-dependent improvements in prognosis; participation correlates with lower five-year mortality rates, with each additional session attended reducing all-cause death risk incrementally.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[296]</sup> Core components encompass physician-prescribed aerobic and resistance exercises, nutritional counseling, psychosocial evaluations for depression and anxiety, and monitoring of modifiable risks like hypertension and dyslipidemia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[204]</sup> Meta-analyses of randomized trials demonstrate that exercise-based rehabilitation reduces cardiovascular mortality by 20-30% and hospital readmissions in coronary heart disease patients, independent of contemporary pharmacotherapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[297]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_125qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[298]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Outcomes hinge on patient adherence and individual accountability, as non-completion rates exceed 50% in many programs due to barriers like transportation or motivation, underscoring the need for personalized strategies to foster long-term compliance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[299]</sup> Programs incorporating psychosocial support address mental health factors that impede lifestyle persistence, with completers showing sustained gains in quality of life and reduced major adverse cardiovascular events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[300]</sup> Evidence from large cohorts affirms that rehabilitation&#x27;s benefitsâ€”such as enhanced exercise capacity and risk factor controlâ€”partially mediate mortality reductions, emphasizing causal links via improved vascular function and metabolic health rather than mere correlation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[301]</sup></span>
<h2 id="epidemiology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Epidemiology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="historical-trends" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Historical Trends<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In high-income countries, age-adjusted mortality rates from cardiovascular disease (CVD) began declining in the mid-20th century, reversing earlier increases observed from the 1930s to 1950s. In the United States, age-adjusted heart disease mortality per 100,000 population fell by 56% from 307.4 in 1950 to 134.6 in 1996, using the 1940 population as reference; this trend continued, with an overall 66% reduction in age-adjusted heart disease mortality from 761 per 100,000 in 1970 to 258 in 2022. Similar patterns emerged across Western Europe and other high-income nations by the 1960s, where CVD mortality peaked before substantial declines, contributing to gains in life expectancy of approximately 0.15 years annually since the 1950s through reduced all-cause mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[302]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[303]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[304]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[305]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Key drivers included reductions in modifiable risk factors, particularly smoking prevalence, alongside improvements in medical interventions. Declines in tobacco use accounted for a significant portion of the drop in coronary heart disease deaths, with population-level smoking reductions correlating to thousands of averted fatalities and extended life-years; for instance, post-1960s anti-smoking efforts in the US and Europe halved adult smoking rates by the 2000s, directly lowering CVD incidence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[306]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[307]</sup> Smoking bans in public spaces, implemented widely from the 1990s onward (e.g., in California in 1995 and EU directives by 2000s), produced rapid effects, reducing hospital admissions for heart attacks by up to 20-40% within months to a year in affected regions, as secondhand smoke exposure fell sharply.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[308]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[309]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_u8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[310]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Therapeutic advances amplified these prevention gains, with blood pressure control, lipid-lowering therapies, and acute care (e.g., thrombolysis and revascularization post-1980s) preventing secondary events and contributing roughly 40-50% of the mortality reduction in modeling studies from the US and Europe. Dietary shifts toward lower saturated fat intake and increased awareness of hypertension also played roles, though causal attributions vary; empirical data link these to parallel drops in serum cholesterol levels (e.g., 10-15% reductions in US adults from 1960-1990). Despite these trends, disparities persisted, with slower declines among lower socioeconomic groups due to uneven risk factor control.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[304]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[302]</sup></span>
<h3 id="current-global-patterns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Current Global Patterns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cardiovascular diseases (CVDs) accounted for 19.2 million deaths globally in 2023, comprising about 32% of all deaths and marking an increase from 13.1 million in 1990, driven by population growth and aging alongside persistent risk factors such as hypertension and poor diet.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Ischemic heart disease and stroke represented the primary causes, responsible for roughly 85% of these fatalities, with disability-adjusted life years (DALYs) totaling 437 million, a 1.4-fold rise since 1990.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_129qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> The global prevalence of CVD reached approximately 612 million cases, with an age-standardized rate of 7,179 per 100,000 population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1a9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Over 80% of CVD deaths occur in low- and middle-income countries, where limited access to preventive care and treatment exacerbates outcomes compared to high-income regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Age-standardized mortality rates remain highest in Central and Eastern Europe, Central Asia, and parts of sub-Saharan Africa, often exceeding 400 deaths per 100,000 due to elevated prevalence of smoking, alcohol use, and uncontrolled hypertension.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[311]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qaabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[312]</sup> In contrast, Western Europe and North America exhibit lower age-adjusted ratesâ€”around 150-200 per 100,000â€”reflecting better management of risk factors through screening and pharmacotherapy, though absolute numbers persist due to aging populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Asia bears a disproportionate absolute burden, with South and East Asia contributing the largest shares of deaths and DALYs owing to massive population sizes and accelerating urbanization, which has fueled rises in obesity, diabetes, and processed food consumption since the early 2000s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[312]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> For instance, high blood pressure underlies a significant portion of CVD events in these regions, with prevalence rates often surpassing 30% in adults.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[312]</sup> Latin America and the Middle East also show elevated rates linked to similar socioeconomic transitions, while sub-Saharan Africa faces growing ischemic heart disease alongside longstanding rheumatic conditions, though underreporting may inflate disparities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> These patterns underscore causal links to modifiable risks like tobacco use (active in 15-20% of global CVD deaths) and air pollution, which disproportionately affect densely populated developing areas.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1aaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[313]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1eaqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<h3 id="projections-to-2050" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Projections to 2050<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Projections from the Global Burden of Disease study indicate that between 2025 and 2050, global cardiovascular disease (CVD) prevalence will increase by 90.0%, crude mortality by 73.4%, and crude disability-adjusted life years (DALYs) by 54.7%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_abqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> These estimates account for current trends in demographics, epidemiology, and healthcare access, with population growth and aging identified as primary drivers adding substantial absolute burden despite potential declines in age-standardized rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ibqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Aging populations, particularly in low- and middle-income countries where 80% of older individuals are expected to reside by 2050, will amplify CVD incidence as age remains the strongest non-modifiable risk factor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_acabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[314]</sup> Demographic shifts, including rising life expectancy (projected to increase globally by 4.6 years from 2022 to 2050), will extend exposure to cumulative risks, outweighing gains from improved survival post-diagnosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_icabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[315]</sup> Population expansion in regions with high fertility rates and urbanization will further elevate crude metrics, even as metabolic risks like obesity and diabetes contribute to non-communicable disease transitions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[316]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Modifiable risk factors offer mitigation potential; age-standardized DALYs attributable to behavioral and metabolic risks, such as smoking, high body-mass index, and hypertension, are forecasted to decline through targeted interventions, reflecting historical successes in tobacco control and blood pressure management.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_acqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[317]</sup> However, rising prevalences of obesity and diabetes in aging cohorts could offset these gains, necessitating sustained policy efforts in prevention to curb absolute increases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_icqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Regional variations persist, with Asia anticipating a 91.2% rise in crude CVD mortality despite a 23.0% drop in age-standardized rates, underscoring the dominance of demographic forces over risk factor improvements.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qcqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[318]</sup></span>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="early-descriptions-and-theories" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Early Descriptions and Theories<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The Ebers Papyrus, dating to approximately 1550 BCE, contains some of the earliest recorded descriptions of cardiovascular symptoms, including chest pain and conditions suggestive of heart involvement, such as references to the heart as the center of bodily functions, emotions, and vitality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[319]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[320]</sup> Ancient Egyptian texts portrayed the heart as a key organ connected to vessels throughout the body, with treatments involving herbal remedies and incantations aimed at restoring balance, though these lacked empirical validation for vascular pathologies later identified in mummified remains showing atherosclerosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_meabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[321]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[322]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In ancient Greece, Hippocrates (c. 460â€“370 BCE) advanced humoral theory, positing that diseases, including those affecting the heart, arose from imbalances among four bodily fluidsâ€”blood, phlegm, yellow bile, and black bileâ€”without recognizing the heart&#x27;s role as a pump or the circulatory system&#x27;s mechanics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[323]</sup> This framework influenced Galen (c. 129â€“216 CE), who described the heart as a furnace processing vital spirits from inhaled air, attributing cardiac disorders to humoral excesses or deficiencies rather than structural or obstructive causes, a view perpetuated for centuries but ultimately contradicted by anatomical evidence of coronary narrowing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ieqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[324]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_meqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[323]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">By the 18th century, observational descriptions shifted toward symptom-based recognition without reliance on humoral explanations. William Heberden presented the first detailed account of angina pectoris in 1768 before the Royal College of Physicians, characterizing it as a &quot;disorder of the breast&quot; with violent chest pain exacerbated by motion and relieved by rest, affecting about 20 cases he documented, distinct from indigestion or rheumatism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_afabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[325]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_efabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[326]</sup> Published in 1772, Heberden&#x27;s work highlighted the condition&#x27;s prognostic gravity, linking it empirically to exertion and older age, though causal mechanisms remained elusive until later vascular discoveries disproved purely humoral origins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[327]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qfabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[328]</sup></span>
<h3 id="20th-century-breakthroughs" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">20th-Century Breakthroughs<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In 1913, Russian pathologist Nikolai Anitschkow conducted experiments feeding rabbits pure cholesterol dissolved in vegetable oil, resulting in the development of atherosclerotic plaques in their aortas and coronary arteries, providing early experimental evidence for a causal link between elevated blood cholesterol and atherosclerosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[329]</sup> These findings, published in St. Petersburg, marked a pivotal shift toward recognizing dietary lipids as a potential driver of vascular pathology, though the induced hypercholesterolemia in rabbits far exceeded typical human levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_igabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[330]</sup> Anitschkow&#x27;s work laid foundational support for the lipid hypothesis, influencing subsequent research despite initial skepticism regarding its applicability to humans.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[331]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The Framingham Heart Study, launched in 1948 by the U.S. Public Health Service, enrolled 5,209 residents of Framingham, Massachusetts, for long-term prospective observation, yielding landmark identifications of modifiable risk factors for coronary heart disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[332]</sup> By the early 1960s, analyses revealed hypertension, elevated serum cholesterol, and cigarette smoking as independent predictors of cardiovascular events, with high blood pressure linked to a 2-3 fold increased risk of heart disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_igqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[333]</sup> The study further quantified obesity&#x27;s role in exacerbating these factors and established the multifactorial nature of atherosclerosis progression, enabling population-level risk stratification models that reduced U.S. cardiovascular mortality by informing public health interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[334]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Diagnostic innovations transformed cardiovascular assessment in the early 20th century, beginning with Willem Einthoven&#x27;s 1903 invention of the string galvanometer electrocardiograph, which enabled non-invasive detection of arrhythmias and ischemic changes, earning him the 1924 Nobel Prize in Physiology or Medicine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ahabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[335]</sup> In 1929, Werner Forssmann pioneered cardiac catheterization by self-inserting a ureteral catheter into his own right ventricle under fluoroscopy, proving safe access to the heart for pressure measurements and contrast imaging, a technique refined in the 1940s-1950s for coronary angiography to visualize blockages.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ihabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[335]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Therapeutic advances accelerated mid-century, with John Gibbon&#x27;s 1953 development of the heart-lung machine enabling the first successful open-heart surgery for atrial septal defect closure in 1954, facilitating repairs of congenital defects and valvular diseases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ahqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[335]</sup> Coronary artery bypass grafting emerged in 1967 when RenÃ© Favaloro used the saphenous vein to bypass occlusions, improving survival in severe angina patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ihqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[335]</sup> Pharmacologically, Akira Endo&#x27;s 1970s isolation of microbial inhibitors of HMG-CoA reductase culminated in lovastatin&#x27;s FDA approval in 1987 as the first statin, reducing LDL cholesterol by up to 30% and demonstrating efficacy in slowing atherosclerosis progression in clinical trials.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[336]</sup> These interventions collectively halved age-adjusted cardiovascular death rates in developed nations by century&#x27;s end through combined diagnostic precision, surgical repair, and lipid-lowering therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[337]</sup></span>
<h3 id="post-2000-developments" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Post-2000 Developments<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The completion of the Human Genome Project in 2003 catalyzed genomic advancements in cardiovascular disease, facilitating genome-wide association studies that identified over 200 genetic loci linked to coronary artery disease risk by 2010.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[338]</sup> These efforts expanded to polygenic risk scores by the 2010s, integrating thousands of variants to quantify inherited susceptibility to atherosclerotic events with improved predictive accuracy beyond traditional factors like LDL cholesterol.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[339]</sup> Clinical guidelines began incorporating genetic testing for conditions such as familial hypercholesterolemia and cardiomyopathies around 2010, enabling earlier interventions based on monogenic causes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[340]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the 2010s and 2020s, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as liraglutide and semaglutide, transitioned from diabetes therapies to established cardiovascular protectants following cardiovascular outcome trials. The LEADER trial in 2016 demonstrated liraglutide reduced major adverse cardiovascular events (MACE) by 13% in patients with type 2 diabetes and high CVD risk, prompting regulatory approvals for cardioprotective indications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ajabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[341]</sup> Semaglutide&#x27;s SELECT trial, reported in 2023, extended these benefits to non-diabetic individuals with obesity and preexisting CVD, showing a 20% MACE reduction driven by fewer myocardial infarctions and strokes, with effects linked to weight loss, reduced inflammation, and hemodynamic improvements rather than solely glucose control.01375-3/fulltext) Multiple meta-analyses confirmed class-wide MACE reductions of 12-15% across GLP-1 RAs in diverse high-risk populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ijabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[342]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Advancements in understanding the cardiac conduction system emerged in the 2020s, with innovations in physiological mapping and pacing techniques. Conduction system pacing, introduced clinically around 2017, targeted the His-Purkinje network to restore synchronized ventricular activation, outperforming traditional right ventricular pacing in preserving ejection fraction and reducing heart failure hospitalizations in randomized trials by 2020.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ajqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[343]</sup> In October 2025, Mayo Clinic researchers identified a novel biomarker exclusive to the human Purkinje network using advanced imaging, revealing previously unrecognized anatomical features that enhance targeting for arrhythmias and regenerative therapies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ijqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> These discoveries built on single-cell sequencing from the early 2020s, which delineated conduction cell heterogeneity and glial interactions, informing potential gene-editing strategies for conduction defects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[344]</sup></span>
<h2 id="controversies-and-debates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Controversies and Debates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="lipid-hypothesis-critiques" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Lipid Hypothesis Critiques<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Critics contend that the lipid hypothesis, which posits elevated serum cholesterolâ€”particularly low-density lipoprotein cholesterol (LDL-C)â€”as a primary causal factor in atherosclerosis and cardiovascular disease (CVD), rests on flawed observational associations rather than robust causal evidence. Numerous reviews highlight that contradictory studies outnumber supportive ones, with correlations often failing to establish causation due to confounding factors like reverse causality, where early disease elevates cholesterol as a response rather than a driver.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_alabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[345]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ilabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[346]</sup> This perspective is echoed in analyses questioning the hypothesis&#x27;s foundational postulates, including the assumption that saturated fat intake directly raises blood cholesterol to pathogenic levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qlabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[346]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A key empirical challenge arises from findings in older populations, where higher total cholesterol (TC) and LDL-C levels correlate inversely with all-cause mortality. A 2016 systematic review in <em>BMJ Open</em>, analyzing 19 cohort studies involving over 68,000 participants aged 60 and older, reported that high LDL-C was associated with reduced mortality in most cohorts, with no studies showing increased risk from elevated levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ilqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[347]</sup> This inverse relationship persists after adjustments for confounders, suggesting low cholesterol may signal frailty, malnutrition, or terminal illness rather than confer protection, thus undermining the hypothesis&#x27;s universality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qlqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[347]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[348]</sup> Similar patterns appear in subsequent analyses, such as a 2023 study linking optimal long-term survival to LDL-C ranges of 100â€“189 mg/dL, far above aggressive lowering targets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1alqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[349]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Nuances in LDL composition further complicate the hypothesis&#x27;s reliance on aggregate LDL-C measures. Small, dense LDL particles exhibit greater atherogenicityâ€”due to easier arterial penetration, oxidative susceptibility, and prolonged circulationâ€”compared to large, buoyant subtypes, yet standard assays capture only cholesterol mass, not particle size or number.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_amabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[350]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_imabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[351]</sup> Prospective data indicate that adjusting for particle characteristics attenuates or eliminates LDL-C&#x27;s apparent risk association, with metrics like LDL particle number (LDL-P) or apolipoprotein B (reflecting particle count) providing superior CVD prediction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[352]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[253]</sup> Critics argue this heterogeneity implies that uniform LDL-C targeting overlooks metabolic contexts, such as insulin resistance promoting dense particles independently of total cholesterol.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1amabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[353]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Even proponents acknowledge evidential shifts; the American Heart Association&#x27;s 2019 science advisory concluded that dietary cholesterol minimally influences blood levels in most individuals, decoupling intake from serum causality and highlighting genetic variability in absorption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_amqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[354]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_imqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[355]</sup> Reappraisals of randomized trials further note that while LDL-C reduction via statins yields CVD event benefits, all-cause mortality gains remain modest (e.g., 1% absolute risk reduction over 5 years in primary prevention), raising questions about broad causal attribution amid potential pleiotropic effects or harms like muscle toxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[356]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[357]</sup> These critiques, often from researchers outside dominant pharmaceutical-aligned consensus, emphasize the need for causal validation beyond correlations, including Mendelian randomization studies showing familial hypercholesterolemia&#x27;s risks tied more to lifelong exposure than acute levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1amqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[357]</sup></span>
<h3 id="dietary-fat-and-carbohydrate-roles" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Dietary Fat and Carbohydrate Roles<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Multiple meta-analyses of randomized controlled trials and prospective cohort studies have concluded that dietary saturated fat intake is not significantly associated with increased risk of cardiovascular disease (CVD) events or mortality, challenging long-standing dietary guidelines that recommended strict limitation of saturated fats.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_anqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[358]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_enqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[359]</sup> For instance, a 2020 reassessment in the Journal of the American College of Cardiology found no beneficial effects on CVD outcomes from reducing saturated fat consumption, particularly when replaced by refined carbohydrates rather than polyunsaturated fats.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mnqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup> This evidence has prompted critiques of nutritional guidelines, such as those from the American Heart Association, for overemphasizing saturated fat restriction based on early observational data that conflated saturated fats with trans fats and processed foods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_unqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[360]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, replacement of saturated fats with polyunsaturated fatty acids in controlled trials has shown modest reductions in CVD risk, estimated at 19-21% in some analyses, but benefits diminish or reverse when substituted with carbohydrates, highlighting the importance of what replaces saturated fats rather than saturated fats themselves.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[361]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[362]</sup> A 2018 BMJ review on dietary fats and cardiometabolic health underscored these nuances, noting that guidelines often fail to distinguish between food matricesâ€”such as whole-fat dairy or unprocessed meats, which show neutral or protective effectsâ€”and isolated saturated fatty acids, while ignoring potential harms from carbohydrate-driven metabolic shifts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_moabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[363]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">High intake of refined and processed carbohydrates, including added sugars like sucrose and high-fructose corn syrup, promotes insulin resistance, a key causal pathway in atherosclerosis and CVD progression, independent of total fat consumption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[364]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[365]</sup> Epidemiological and mechanistic studies link excessive refined carbohydrate consumption to elevated triglycerides, small dense LDL particles, and endothelial dysfunction via chronic hyperinsulinemia and hepatic de novo lipogenesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_moqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[366]</sup> For example, prospective data indicate that diets high in glycemic load from processed carbs increase coronary heart disease risk by fostering visceral adiposity and inflammation, effects exacerbated in insulin-resistant individuals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_uoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[367]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Randomized trials comparing low-carbohydrate, higher-fat diets to low-fat, higher-carbohydrate regimens demonstrate superior improvements in CVD risk markersâ€”such as HDL cholesterol, triglycerides, and insulin sensitivityâ€”with the former, alongside greater weight loss, suggesting that carbohydrate restriction may mitigate CVD risk more effectively than fat restriction in metabolically vulnerable populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_apabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[368]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_epabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[197]</sup> These findings align with causal evidence from metabolic ward studies, where high-carb intake induces postprandial hyperglycemia and oxidative stress, contrasting with the metabolic stability of fats from whole foods.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[369]</sup> However, long-term adherence and individual variability, including genetic factors influencing fat metabolism, remain areas of ongoing debate, with some observational data showing elevated LDL in strict low-carb contexts warranting personalized approaches over blanket guidelines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_upabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[370]</sup></span>
<h3 id="statin-overuse-and-pharmaceutical-influence" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Statin Overuse and Pharmaceutical Influence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Critics have argued that the widespread prescription of statins for cardiovascular disease prevention reflects commercial distortion by pharmaceutical interests, leading to overuse particularly in primary prevention among low-risk populations. Cardiologist Aseem Malhotra, in analyses published in 2025, contended that industry-funded trials and guidelines exaggerate benefits while minimizing harms, influencing clinical practice to prioritize lipid-lowering drugs over lifestyle measures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[371]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[372]</sup> This perspective aligns with broader evidence of drug company practices that overplay relative risk reductions in marketing while downplaying absolute benefits and adverse events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[373]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In primary prevention, the absolute risk reduction (ARR) from statins is typically low, often less than 1% over five years for major cardiovascular events, translating to a number needed to treat (NNT) exceeding 50 to prevent one heart attack. For instance, meta-analyses of trials in individuals without prior heart disease show a 1.6% ARR for avoiding myocardial infarction after five years of therapy, with even smaller gains for stroke (0.37%) or mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[226]</sup> These modest effects contrast with relative risk reductions of 20-30% often highlighted in promotional materials, potentially misleading prescribers and patients about net benefits in low-risk groups.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[374]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Statin side effects, including muscle pain, weakness, elevated diabetes risk, and hepatic dysfunction, appear underreported in clinical trials and post-marketing surveillance, with U.S. Food and Drug Administration data indicating that only 0.01% to 44% of adverse drug events for statins are captured. Observational studies report muscle symptoms in up to 10-20% of users, higher than the 5% or less in randomized controlled trials, which may exclude susceptible individuals or rely on subjective reporting biased toward continuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_arabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[375]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_erabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[376]</sup> This discrepancy contributes to overuse, as evidenced by retrospective analyses showing potential statin excess in 60% of older community-dwelling patients without clear indications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mrabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[377]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For primary prevention, lifestyle interventionsâ€”such as adopting a Mediterranean-style diet, regular physical activity, and smoking cessationâ€”demonstrate superior risk reduction compared to statins alone, with healthy behaviors linked to up to 50% lower coronary artery disease incidence in population studies. Modeling suggests that comprehensive lifestyle strategies outperform moderate statin regimens in averting events among those without established disease, emphasizing their role as first-line options before pharmacological escalation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_arqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[378]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_erqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[379]</sup> Pharmaceutical influence on guidelines has been critiqued for sidelining such non-drug approaches, potentially driven by revenue incentives from blockbuster statin sales exceeding billions annually.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mrqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[371]</sup></span>
<h3 id="inflammation-as-primary-driver" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Inflammation as Primary Driver<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Proponents of inflammation as the primary causal driver of cardiovascular disease argue that inflammatory processes initiate and propagate atherosclerosis, with lipid accumulation serving as a secondary response rather than the root cause. Experimental and histopathological evidence demonstrates that endothelial dysfunction, triggered by inflammatory cytokines and immune activation, precedes plaque formation, independent of cholesterol levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_asqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[380]</sup> This view challenges lipid-centric models by emphasizing innate immunity&#x27;s role in oxidizing trapped lipoproteins and recruiting monocytes, which amplify lesion progression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_isqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[381]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">C-reactive protein (CRP), an acute-phase reactant and marker of systemic inflammation, has been shown to predict cardiovascular events more robustly than low-density lipoprotein (LDL) cholesterol in multiple cohorts. In a prospective analysis of 27,939 apparently healthy women followed for up to eight years, CRP levels stratified risk across LDL categories, with each standard deviation increase in CRP conferring a 1.5-fold higher relative risk of first cardiovascular events, surpassing LDL&#x27;s predictive power.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_atabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[382]</sup> Similarly, among statin-treated patients post-acute coronary syndrome, residual inflammatory risk indexed by high-sensitivity CRP outperformed LDL in forecasting recurrent events, suggesting inflammation sustains atherothrombosis even when lipids are controlled.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_itabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[383]</sup> These findings support causal inference from trials like JUPITER, where rosuvastatin&#x27;s benefits correlated more closely with CRP reduction than LDL lowering.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[384]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Infectious and immune mechanisms further bolster inflammation&#x27;s primacy, as detailed in a 2018 review synthesizing human, experimental, and biomarker data. Pathogens such as <em>Chlamydia pneumoniae</em> and periodontal bacteria provoke chronic vascular inflammation, linking infection to plaque instability and thrombosis via Toll-like receptor activation and cytokine storms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_itqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[385]</sup> This refutes pure atherothrombosis models by highlighting how immune dysregulation integrates traditional risksâ€”smoking, hypertensionâ€”into inflammatory cascades, with clinical trials like CANTOS demonstrating interleukin-1Î² inhibition reduces events by 15-20% irrespective of lipid profiles.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_qtqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[386]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Gut-derived endotoxemia exemplifies an upstream inflammatory trigger, where dysbiosis-induced lipopolysaccharide (LPS) translocation from permeable barriers elevates circulating endotoxins, fostering metabolic inflammation and endothelial damage. In patients with coronary artery disease, LPS levels correlate with plaque burden and adverse outcomes, independent of dyslipidemia, as LPS activates NLRP3 inflammasomes to promote foam cell formation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_auabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[387]</sup> Observational data from high-risk cohorts show metabolic endotoxemia amplifies atherosclerosis in obesity and diabetes, with interventions like prebiotics modulating microbiota to lower CVD markers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iuabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[388]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Critiques of the lipid hypothesis underscore these shifts, positing that elevated LDL reflects oxidative stress and inflammation rather than causing it de novo. Epidemiological reanalyses reveal weak causal links between saturated fats and heart disease when confounders like trans fats or refined carbs are isolated, with inflammation metrics like CRP explaining variance better in familial hypercholesterolemia cases lacking early events.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_auqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[345]</sup> This perspective, advanced by researchers questioning statin universality, urges mechanistic reframing toward anti-inflammatory strategies, though mainstream consensus retains lipids&#x27; contributory role amid ongoing debates over trial designs favoring pharmaceutical endpoints.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_iuqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[389]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_muqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[390]</sup></span>
<h2 id="research-directions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Research Directions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="genetic-and-molecular-advances" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Genetic and Molecular Advances<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Recent advances in genomics have enabled the development of polygenic risk scores (PRS) that integrate thousands of common genetic variants to estimate an individual&#x27;s susceptibility to coronary artery disease and other cardiovascular conditions. These scores capture the cumulative effect of low-penetrance alleles, providing incremental prognostic value beyond traditional clinical risk factors such as age, hypertension, and cholesterol levels. A 2024 study in the European Heart Journal demonstrated that incorporating a CVD-PRS into standard risk models reclassified 10-15% of intermediate-risk individuals into higher or lower categories, enhancing net reclassification improvement by up to 5%. Similarly, analyses from the American College of Cardiology in 2024 confirmed that PRS refines subclinical atherosclerosis prediction when combined with coronary artery calcium scoring, with high PRS individuals showing elevated event rates independent of lifestyle factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[391]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f0abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[392]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">For monogenic disorders like familial hypercholesterolemia (FH), which affects approximately 1 in 250 individuals and elevates LDL cholesterol due to mutations in genes such as LDLR, PCSK9, or APOB, CRISPR-Cas9-based gene editing has emerged as a transformative therapy. In phase 1 trials reported in 2023, a single intravenous dose of VERVE-101, targeting the PCSK9 gene in heterozygous FH patients, achieved durable LDL reductions of 55% at 180 days post-infusion, with no serious adverse events linked to off-target editing. Ongoing trials as of June 2025, including CTX310 and CTX320 from CRISPR Therapeutics, extend this approach to both heterozygous and homozygous FH, demonstrating sustained PCSK9 suppression and LDL lowering without the need for lifelong lipid-lowering drugs. Preclinical studies using AAV-delivered CRISPR to correct LDLR mutations in FH mouse models reduced atherosclerosis burden by restoring receptor function, supporting translation to human applications. These interventions address causal genetic defects directly, potentially preventing premature cardiovascular events in high-risk pedigrees.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[393]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[394]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[395]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">At the molecular level, novel biomarkers reflecting endothelial dysfunction, inflammation, and fibrosis are advancing early detection and risk stratification. Growth differentiation factor-15 (GDF-15), a stress-responsive cytokine, independently predicts major adverse cardiovascular events in population cohorts, with levels elevated prior to clinical manifestation in up to 20% of at-risk individuals. MicroRNAs (miRNAs), such as miR-208a and miR-499, serve as circulating indicators of myocardial injury, offering higher sensitivity than troponins for subclinical damage detection in recent 2024-2025 validations. Extracellular vesicles carrying proteomic cargo have also shown promise in profiling plaque instability, with lipidomic signatures correlating to acute coronary syndrome progression. These biomarkers, when integrated with genetic data, facilitate precision phenotyping, though challenges like assay standardization and population-specific validation persist. An American Heart Association advisory in November 2024 emphasized gene therapy&#x27;s role in targeting molecular pathways, including AAV-vectors for angiogenic factors in ischemic disease, underscoring the shift toward causal, genotype-guided interventions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[396]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[397]</sup></span>
<h3 id="technological-innovations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Technological Innovations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Wearable devices equipped with photoplethysmography (PPG) and electrocardiogram (ECG) capabilities have advanced atrial fibrillation (AFib) detection, enabling real-time monitoring outside clinical settings. For instance, smartwatches like the Apple Watch incorporate ECG signals for AFib identification, with algorithms achieving high sensitivity and specificity in ambulatory populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[398]</sup> A 2025 systematic review confirmed the efficacy of these wearables in detecting arrhythmias, including paroxysmal AFib, through AI-enhanced analysis of heart rate variability, supporting timely interventions in asymptomatic cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[399]</sup> Comparative studies of consumer wearables, such as ECG smart chest patches versus PPG smartwatches, reported diagnostic accuracies exceeding 90% for distinguishing sinus rhythm from AFib, though chest patches demonstrated marginally superior performance in prolonged monitoring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_r2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[400]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Artificial intelligence applications in cardiovascular imaging have progressed toward automated analysis and predictive modeling, particularly in cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In 2025, AI tools facilitate image segmentation, noise reduction, and tissue characterization in MRI, evolving from basic tasks to prognostic assessments of myocardial viability and fibrosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[242]</sup> Scientific statements highlight AI&#x27;s role in streamlining workflows, including patient selection and automated reporting in cardiac CT/MRI, with emerging models predicting adverse events by integrating imaging data with clinical variables.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[241]</sup> Trends include AI-driven image enhancement and generation techniques, which improve diagnostic precision in interventional cardiology, such as real-time guidance during procedures, though challenges persist in validation across diverse populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_r2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[401]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Conduction mapping technologies have refined the visualization of the heart&#x27;s electrical pathways, aiding arrhythmia management and surgical planning. Intraoperative techniques employing multielectrode catheters and fiberoptic confocal microscopy localize the His bundle and conduction tissues during congenital heart surgery, using clockface schematics to generate predictive models and minimize injury risk.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[402]</sup> A Mayo Clinic study in October 2025 revealed novel anatomical details of the conduction system via advanced mapping, providing a bioanatomical framework to enhance understanding of myocardial synchrony and arrhythmogenesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> Three-dimensional electroanatomical mapping systems, modified for pediatric use, reduce radiation exposure while enabling precise velocity assessments near regions of interest, improving accuracy in complex cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_r3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[403]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_v3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[404]</sup></span>
<h3 id="public-health-policy-implications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Public Health Policy Implications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">![Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png][float-right]
Cardiovascular diseases accounted for 19.2 million deaths worldwide in 2023, representing approximately one in three global deaths, with projections indicating a 90% increase in prevalence from 2025 to 2050 driven primarily by aging populations and rising rates of modifiable risk factors such as hypertension, obesity, and smoking.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> Public health policies must target these factors through evidence-supported strategies, including widespread screening and management of hypertension, which can be implemented cost-effectively at primary care levels, potentially averting millions of deaths if treatment coverage reaches 70%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_r4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[405]</sup> Community-based educational interventions have demonstrated effectiveness in enhancing knowledge of CVD risks, promoting physical activity, and improving dietary practices, thereby reducing incidence without relying on coercive measures.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_134abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[406]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">While regulatory policies such as tobacco taxes and sodium reduction initiatives show population-level benefits in lowering CVD events, skepticism persists regarding broad mandates due to their potential to overlook individual variability in risk and compliance, with evidence favoring voluntary adoption of healthy behaviors like smoking cessation and weight management for sustained risk reduction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[407]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[408]</sup> Policies emphasizing personal risk assessment tools, such as Framingham or ASCVD calculators, enable targeted education on individual modifiable factors, empowering informed decision-making over uniform interventions that may not account for causal heterogeneity in disease onset. Limited health literacy exacerbates CVD morbidity, underscoring the value of accessible, non-mandated educational campaigns to improve outcomes across populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[409]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">To address escalating projections, policies should prioritize modifiable behavioral risksâ€”evidenced by the role of physical inactivity, poor nutrition, and tobacco use in driving the global burdenâ€”rather than narratives centered on socioeconomic equity, which often conflate correlation with causation and divert resources from direct interventions like lifestyle promotion. Empirical data indicate that scaling evidence-based behavioral changes, including regular exercise and smoking avoidance, yields significant CVD prevention independent of structural reforms. Such approaches align with causal mechanisms linking personal habits to arterial health, promoting accountability and efficacy in resource allocation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[410]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[408]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40990886/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40990886/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40990886/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9644238/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9644238/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9644238/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2206916" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206916" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2206916</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/31553287/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/31553287/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/31553287/</a></span></div></li><li id="https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900287-4/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900287-4/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900287-4/fulltext</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK535419/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK535419/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK535419/</a></span></div></li><li id="https://icd.who.int/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://icd.who.int/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://icd.who.int/</a></span></div></li><li id="https://www.findacode.com/icd-11/chapter-11.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.findacode.com/icd-11/chapter-11.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.findacode.com/icd-11/chapter-11.html</a></span></div></li><li id="https://icd.who.int/dev11/l-m/en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://icd.who.int/dev11/l-m/en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://icd.who.int/dev11/l-m/en</a></span></div></li><li id="https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/</a></span></div></li><li id="https://academic.oup.com/eurjpc/advance-article-abstract/doi/10.1093/eurjpc/zwae281/7756567" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurjpc/advance-article-abstract/doi/10.1093/eurjpc/zwae281/7756567" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurjpc/advance-article-abstract/doi/10.1093/eurjpc/zwae281/7756567</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118</a></span></div></li><li id="https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease</a></span></div></li><li id="https://www.cdc.gov/heart-disease/about/index.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/heart-disease/about/index.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/heart-disease/about/index.html</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613</a></span></div></li><li id="https://www.nhlbi.nih.gov/health/coronary-heart-disease/symptoms" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhlbi.nih.gov/health/coronary-heart-disease/symptoms" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhlbi.nih.gov/health/coronary-heart-disease/symptoms</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142</a></span></div></li><li id="https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557</a></span></div></li><li id="https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113</a></span></div></li><li id="https://www.cdc.gov/stroke/signs-symptoms/index.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/stroke/signs-symptoms/index.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/stroke/signs-symptoms/index.html</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015</a></span></div></li><li id="https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf</a></span></div></li><li id="https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/39270739/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/39270739/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/39270739/</a></span></div></li><li id="https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK564304/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK564304/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK564304/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK507799/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK507799/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK507799/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055340" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055340" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055340</a></span></div></li><li id="https://my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.028991" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.028991" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.028991</a></span></div></li><li id="https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048033" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048033" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048033</a></span></div></li><li id="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext</a></span></div></li><li id="https://www.stroke.org/en/about-stroke/types-of-stroke" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.stroke.org/en/about-stroke/types-of-stroke" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.stroke.org/en/about-stroke/types-of-stroke</a></span></div></li><li id="https://www.hopkinsmedicine.org/health/conditions-and-diseases/stroke/types-of-stroke" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/stroke/types-of-stroke" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.hopkinsmedicine.org/health/conditions-and-diseases/stroke/types-of-stroke</a></span></div></li><li id="https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.124.036142" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.124.036142" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.124.036142</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8588679/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8588679/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8588679/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2415879" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2415879" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2415879</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12132760/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12132760/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12132760/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK430927/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK430927/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK430927/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/STR.0000000000000430" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/STR.0000000000000430" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/STR.0000000000000430</a></span></div></li><li id="https://www.cdc.gov/stroke/about/index.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/stroke/about/index.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/stroke/about/index.html</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK430745/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK430745/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK430745/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318258" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318258" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318258</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40590724/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40590724/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40590724/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535</a></span></div></li><li id="https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circresaha.116.303849" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circresaha.116.303849" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circresaha.116.303849</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/36565779/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/36565779/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/36565779/</a></span></div></li><li id="https://spj.science.org/doi/10.34133/research.0702" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://spj.science.org/doi/10.34133/research.0702" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://spj.science.org/doi/10.34133/research.0702</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001153" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001153" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001153</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/ATVBAHA.125.323193" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/ATVBAHA.125.323193" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/ATVBAHA.125.323193</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/22/17/25/PAD-Implications-For-Health-and-Quality-of-Life" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/22/17/25/PAD-Implications-For-Health-and-Quality-of-Life" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/22/17/25/PAD-Implications-For-Health-and-Quality-of-Life</a></span></div></li><li id="https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research</a></span></div></li><li id="https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure</a></span></div></li><li id="https://www.healthline.com/health/heart-failure/systolic-vs-diastolic" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthline.com/health/heart-failure/systolic-vs-diastolic" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthline.com/health/heart-failure/systolic-vs-diastolic</a></span></div></li><li id="https://www.medicalnewstoday.com/articles/systolic-vs-diastolic-heart-failure" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.medicalnewstoday.com/articles/systolic-vs-diastolic-heart-failure" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.medicalnewstoday.com/articles/systolic-vs-diastolic-heart-failure</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3891535/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3891535/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3891535/</a></span></div></li><li id="https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10398425/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10398425/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10398425/</a></span></div></li><li id="https://escholarship.org/content/qt0pr7s2zr/qt0pr7s2zr.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://escholarship.org/content/qt0pr7s2zr/qt0pr7s2zr.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://escholarship.org/content/qt0pr7s2zr/qt0pr7s2zr.pdf</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circresaha.117.309711" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circresaha.117.309711" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circresaha.117.309711</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8484993/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8484993/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8484993/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11976403/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11976403/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11976403/</a></span></div></li><li id="https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1525157812003042" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1525157812003042" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1525157812003042</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK558923/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK558923/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK558923/</a></span></div></li><li id="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20703-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20703-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20703-6</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/01.str.0000166053.83476.4a" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/01.str.0000166053.83476.4a" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/01.str.0000166053.83476.4a</a></span></div></li><li id="https://jamanetwork.com/journals/jamacardiology/fullarticle/2503080" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2503080" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamacardiology/fullarticle/2503080</a></span></div></li><li id="https://www.mercy.net/service/atrial-fibrillation/prevent-stroke-while-living-with-afib/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mercy.net/service/atrial-fibrillation/prevent-stroke-while-living-with-afib/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mercy.net/service/atrial-fibrillation/prevent-stroke-while-living-with-afib/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0146280623005984" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0146280623005984" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0146280623005984</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circep.118.006273" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circep.118.006273" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circep.118.006273</a></span></div></li><li id="https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacep.2025.03.039" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacep.2025.03.039" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacep.2025.03.039</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/35736352/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/35736352/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/35736352/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9228968/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9228968/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9228968/</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.612716/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.612716/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.612716/full</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001254" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001254" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001254</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0140673623027551" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0140673623027551" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0140673623027551</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.123.030895" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.123.030895" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.123.030895</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8885812/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8885812/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8885812/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circresaha.114.302721" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circresaha.114.302721" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circresaha.114.302721</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/12645638/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/12645638/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/12645638/</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.925923/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.925923/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.925923/full</a></span></div></li><li id="https://journals.physiology.org/doi/abs/10.1152/physrev.00047.2003" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.physiology.org/doi/abs/10.1152/physrev.00047.2003" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.physiology.org/doi/abs/10.1152/physrev.00047.2003</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9043520/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9043520/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9043520/</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381520/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381520/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381520/full</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0010865018300560" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0010865018300560" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0010865018300560</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/atvbaha.114.303887" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/atvbaha.114.303887" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/atvbaha.114.303887</a></span></div></li><li id="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00600/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00600/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00600/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9735601/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9735601/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9735601/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9197986/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9197986/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9197986/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8877621/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8877621/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8877621/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.120.019140" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.120.019140" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.120.019140</a></span></div></li><li id="https://academic.oup.com/jcem/article/88/10/4525/2845681" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/jcem/article/88/10/4525/2845681" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/jcem/article/88/10/4525/2845681</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/01.cir.0000131511.50734.44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/01.cir.0000131511.50734.44" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/01.cir.0000131511.50734.44</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK534259/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK534259/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK534259/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0735109705013963" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0735109705013963" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0735109705013963</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK539697/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK539697/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK539697/</a></span></div></li><li id="https://academic.oup.com/eurheartj/article/34/10/719/496744" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurheartj/article/34/10/719/496744" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurheartj/article/34/10/719/496744</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2021.06.050" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2021.06.050" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2021.06.050</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9851427/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9851427/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9851427/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1936879815006950" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1936879815006950" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1936879815006950</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315754" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315754" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315754</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9658900/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9658900/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9658900/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/36361701/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/36361701/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/36361701/</a></span></div></li><li id="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03185-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03185-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03185-z</a></span></div></li><li id="https://www.uscjournal.com/articles/high-sensitivity-c-reactive-protein-atherosclerotic-cardiovascular-disease-measure-or-not?language_content_entity=en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uscjournal.com/articles/high-sensitivity-c-reactive-protein-atherosclerotic-cardiovascular-disease-measure-or-not?language_content_entity=en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uscjournal.com/articles/high-sensitivity-c-reactive-protein-atherosclerotic-cardiovascular-disease-measure-or-not?language_content_entity=en</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/16624260/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/16624260/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/16624260/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3364506/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3364506/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3364506/</a></span></div></li><li id="https://www.atherosclerosis-journal.com/article/S0021-9150%2810%2900663-5/abstract" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.atherosclerosis-journal.com/article/S0021-9150%2810%2900663-5/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.atherosclerosis-journal.com/article/S0021-9150%2810%2900663-5/abstract</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1707914" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1707914" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1707914</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2023.05.055" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2023.05.055" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2023.05.055</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8108024/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8108024/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8108024/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2011.08.015" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2011.08.015" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2011.08.015</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7729114/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7729114/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7729114/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/11801260/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/11801260/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/11801260/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0022399901003026" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0022399901003026" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0022399901003026</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/8151263/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/8151263/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/8151263/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/01.res.87.10.840" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/01.res.87.10.840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/01.res.87.10.840</a></span></div></li><li id="https://cmbl.biomedcentral.com/articles/10.1186/s11658-023-00423-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://cmbl.biomedcentral.com/articles/10.1186/s11658-023-00423-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://cmbl.biomedcentral.com/articles/10.1186/s11658-023-00423-2</a></span></div></li><li id="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.978378/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.978378/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.978378/full</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/16618833/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/16618833/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/16618833/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3594115/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3594115/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3594115/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/hc0502.103333" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/hc0502.103333" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/hc0502.103333</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1155/2016/3634948" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1155/2016/3634948" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1155/2016/3634948</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6616540/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6616540/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6616540/</a></span></div></li><li id="https://www.cdc.gov/nchs/products/databriefs/db540.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/nchs/products/databriefs/db540.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/nchs/products/databriefs/db540.htm</a></span></div></li><li id="https://www.archivesofmedicalscience.com/Menopause-and-women-s-cardiovascular-health-is-it-really-an-obvious-relationship%2C157308%2C0%2C2.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.archivesofmedicalscience.com/Menopause-and-women-s-cardiovascular-health-is-it-really-an-obvious-relationship%2C157308%2C0%2C2.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.archivesofmedicalscience.com/Menopause-and-women-s-cardiovascular-health-is-it-really-an-obvious-relationship%2C157308%2C0%2C2.html</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2590093519300256" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2590093519300256" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2590093519300256</a></span></div></li><li id="https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2819%2930184-7/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2819%2930184-7/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2819%2930184-7/fulltext</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/12270005/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/12270005/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/12270005/</a></span></div></li><li id="https://www.cdc.gov/heart-disease-family-history/about/about-familial-hypercholesterolemia.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/heart-disease-family-history/about/about-familial-hypercholesterolemia.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/heart-disease-family-history/about/about-familial-hypercholesterolemia.html</a></span></div></li><li id="https://jamanetwork.com/journals/jamacardiology/fullarticle/2814372" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2814372" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamacardiology/fullarticle/2814372</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6678686/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6678686/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6678686/</a></span></div></li><li id="https://www.bmj.com/content/360/bmj.j5855" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/360/bmj.j5855" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/360/bmj.j5855</a></span></div></li><li id="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1351-4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1351-4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1351-4</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814094" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814094" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814094</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0828282X24012303" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0828282X24012303" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0828282X24012303</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0033062015300256" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0033062015300256" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0033062015300256</a></span></div></li><li id="https://www.health.harvard.edu/heart-health/the-sweet-danger-of-sugar" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.health.harvard.edu/heart-health/the-sweet-danger-of-sugar" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.health.harvard.edu/heart-health/the-sweet-danger-of-sugar</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2010.01.006" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2010.01.006" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2010.01.006</a></span></div></li><li id="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02911-w" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02911-w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02911-w</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10565718/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10565718/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10565718/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.122.025252" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.122.025252" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.122.025252</a></span></div></li><li id="https://observatoireprevention.org/en/2021/04/07/association-between-chronic-stress-and-heart-attacks/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://observatoireprevention.org/en/2021/04/07/association-between-chronic-stress-and-heart-attacks/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://observatoireprevention.org/en/2021/04/07/association-between-chronic-stress-and-heart-attacks/</a></span></div></li><li id="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04221-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04221-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04221-2</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacadv.2023.100805" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2023.100805" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacadv.2023.100805</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801820" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801820" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801820</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5132637/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5132637/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5132637/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/29247501/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/29247501/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/29247501/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40164421/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40164421/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40164421/</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12014" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12014" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12014</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.119.012569" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.119.012569" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.119.012569</a></span></div></li><li id="https://heart.bmj.com/content/105/6/439" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://heart.bmj.com/content/105/6/439" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://heart.bmj.com/content/105/6/439</a></span></div></li><li id="https://www.sjweh.fi/article/1854" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sjweh.fi/article/1854" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sjweh.fi/article/1854</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2806940/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2806940/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2806940/</a></span></div></li><li id="https://www.bmj.com/content/380/bmj-2022-072924" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/380/bmj-2022-072924" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/380/bmj-2022-072924</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3159113/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3159113/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3159113/</a></span></div></li><li id="https://www.nature.com/articles/s41591-024-03058-8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41591-024-03058-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41591-024-03058-8</a></span></div></li><li id="https://www.bmj.com/content/384/bmj-2023-077310" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/384/bmj-2023-077310" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/384/bmj-2023-077310</a></span></div></li><li id="https://www.thecardiologyadvisor.com/news/long-covid-linked-to-development-of-cardiovascular-disease/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thecardiologyadvisor.com/news/long-covid-linked-to-development-of-cardiovascular-disease/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thecardiologyadvisor.com/news/long-covid-linked-to-development-of-cardiovascular-disease/</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1450470/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1450470/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1450470/full</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0022282825001786" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0022282825001786" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0022282825001786</a></span></div></li><li id="https://www.escardio.org/The-ESC/Press-Office/Press-releases/Major-new-report-sets-out-how-to-tackle-the-profound-and-lasting-impact-of-Covid-19-on-cardiovascular-health" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.escardio.org/The-ESC/Press-Office/Press-releases/Major-new-report-sets-out-how-to-tackle-the-profound-and-lasting-impact-of-Covid-19-on-cardiovascular-health" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.escardio.org/The-ESC/Press-Office/Press-releases/Major-new-report-sets-out-how-to-tackle-the-profound-and-lasting-impact-of-Covid-19-on-cardiovascular-health</a></span></div></li><li id="https://www.nih.gov/news-events/nih-research-matters/gut-bacteria-may-reduce-cholesterol-lower-heart-disease-risk" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nih.gov/news-events/nih-research-matters/gut-bacteria-may-reduce-cholesterol-lower-heart-disease-risk" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nih.gov/news-events/nih-research-matters/gut-bacteria-may-reduce-cholesterol-lower-heart-disease-risk</a></span></div></li><li id="https://www.broadinstitute.org/news/scientists-link-certain-gut-bacteria-lower-heart-disease-risk" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.broadinstitute.org/news/scientists-link-certain-gut-bacteria-lower-heart-disease-risk" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.broadinstitute.org/news/scientists-link-certain-gut-bacteria-lower-heart-disease-risk</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0914508725001261" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0914508725001261" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0914508725001261</a></span></div></li><li id="https://www.nhlbi.nih.gov/news/2025/spotlight-upfs-nih-explores-link-between-ultra-processed-foods-and-heart-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhlbi.nih.gov/news/2025/spotlight-upfs-nih-explores-link-between-ultra-processed-foods-and-heart-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhlbi.nih.gov/news/2025/spotlight-upfs-nih-explores-link-between-ultra-processed-foods-and-heart-disease</a></span></div></li><li id="https://www.acc.org/About-ACC/Press-Releases/2025/05/08/14/10/Eating-Ultra-Processed-Foods-May-Harm-Your-Health" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/About-ACC/Press-Releases/2025/05/08/14/10/Eating-Ultra-Processed-Foods-May-Harm-Your-Health" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/About-ACC/Press-Releases/2025/05/08/14/10/Eating-Ultra-Processed-Foods-May-Harm-Your-Health</a></span></div></li><li id="https://academic.oup.com/eurjpc/advance-article/8173892" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurjpc/advance-article/8173892" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurjpc/advance-article/8173892</a></span></div></li><li id="https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900186-8/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900186-8/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900186-8/fulltext</a></span></div></li><li id="https://www.nhlbi.nih.gov/news/2024/why-mental-stress-can-take-toll-heart" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhlbi.nih.gov/news/2024/why-mental-stress-can-take-toll-heart" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhlbi.nih.gov/news/2024/why-mental-stress-can-take-toll-heart</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacadv.2024.101208" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2024.101208" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacadv.2024.101208</a></span></div></li><li id="https://journals.lww.com/hhmi/fulltext/2024/08040/impact_of_chronic_psychological_stress_on.3.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.lww.com/hhmi/fulltext/2024/08040/impact_of_chronic_psychological_stress_on.3.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.lww.com/hhmi/fulltext/2024/08040/impact_of_chronic_psychological_stress_on.3.aspx</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11872152/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11872152/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11872152/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/cir.0000000000000678" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/cir.0000000000000678" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/cir.0000000000000678</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40611785/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40611785/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40611785/</a></span></div></li><li id="https://www.cdc.gov/tobacco/hcp/patient-care-settings/cardiovascular.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cdc.gov/tobacco/hcp/patient-care-settings/cardiovascular.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cdc.gov/tobacco/hcp/patient-care-settings/cardiovascular.html</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0828282X25000091" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0828282X25000091" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0828282X25000091</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3158733/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3158733/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3158733/</a></span></div></li><li id="https://bjsm.bmj.com/content/57/15/979" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bjsm.bmj.com/content/57/15/979" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bjsm.bmj.com/content/57/15/979</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004</a></span></div></li><li id="https://www.amjmed.com/article/S0002-9343%2811%2900410-4/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.amjmed.com/article/S0002-9343%2811%2900410-4/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.amjmed.com/article/S0002-9343%2811%2900410-4/fulltext</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1800389" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1800389" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1800389</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8017325/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8017325/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8017325/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0002916522045798" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0002916522045798" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0002916522045798</a></span></div></li><li id="https://journals.physiology.org/doi/abs/10.1152/ajpendo.00102.2007" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.physiology.org/doi/abs/10.1152/ajpendo.00102.2007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.physiology.org/doi/abs/10.1152/ajpendo.00102.2007</a></span></div></li><li id="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.880054/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.880054/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.880054/full</a></span></div></li><li id="https://www.uscjournal.com/articles/strategies-secondary-prevention-atherosclerotic-cardiovascular-disease?language_content_entity=en" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uscjournal.com/articles/strategies-secondary-prevention-atherosclerotic-cardiovascular-disease?language_content_entity=en" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uscjournal.com/articles/strategies-secondary-prevention-atherosclerotic-cardiovascular-disease?language_content_entity=en</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10809857/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10809857/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10809857/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289</a></span></div></li><li id="https://www.nature.com/articles/s44325-024-00017-7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s44325-024-00017-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s44325-024-00017-7</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7499366/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7499366/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7499366/</a></span></div></li><li id="https://www.uptodate.com/contents/prevention-of-cardiovascular-disease-events-in-those-with-established-disease-secondary-prevention" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uptodate.com/contents/prevention-of-cardiovascular-disease-events-in-those-with-established-disease-secondary-prevention" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uptodate.com/contents/prevention-of-cardiovascular-disease-events-in-those-with-established-disease-secondary-prevention</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309</a></span></div></li><li id="https://jamanetwork.com/journals/jama/fullarticle/202339" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jama/fullarticle/202339" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jama/fullarticle/202339</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8296783/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8296783/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8296783/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/31935216/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/31935216/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/31935216/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa055317" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa055317" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa055317</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6959586/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6959586/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6959586/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/26620830/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/26620830/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/26620830/</a></span></div></li><li id="https://publichealth.jhu.edu/2025/the-evidence-behind-seed-oils-health-effects" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://publichealth.jhu.edu/2025/the-evidence-behind-seed-oils-health-effects" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://publichealth.jhu.edu/2025/the-evidence-behind-seed-oils-health-effects</a></span></div></li><li id="https://www.heart.org/en/news/2024/08/20/theres-no-reason-to-avoid-seed-oils-and-plenty-of-reasons-to-eat-them" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.heart.org/en/news/2024/08/20/theres-no-reason-to-avoid-seed-oils-and-plenty-of-reasons-to-eat-them" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.heart.org/en/news/2024/08/20/theres-no-reason-to-avoid-seed-oils-and-plenty-of-reasons-to-eat-them</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12289860/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12289860/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12289860/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.123.010936" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.123.010936" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.123.010936</a></span></div></li><li id="https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death</a></span></div></li><li id="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/27/20/41/New-USPSTF-Recommendation-on-Aspirin-in-CVD" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/27/20/41/New-USPSTF-Recommendation-on-Aspirin-in-CVD" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/27/20/41/New-USPSTF-Recommendation-on-Aspirin-in-CVD</a></span></div></li><li id="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication</a></span></div></li><li id="https://jamanetwork.com/journals/jama/fullarticle/2795522" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jama/fullarticle/2795522" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jama/fullarticle/2795522</a></span></div></li><li id="https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/</a></span></div></li><li id="https://www.thennt.com/cms/nnt/statins-persons-low-risk-cardiovascular-disease/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thennt.com/cms/nnt/statins-persons-low-risk-cardiovascular-disease/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thennt.com/cms/nnt/statins-persons-low-risk-cardiovascular-disease/</a></span></div></li><li id="https://bjsm.bmj.com/cgi/rapidpdf/bjsports-2017-098497?ijkey=Rsap0XafljfcOCR&amp;keytype=ref" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bjsm.bmj.com/cgi/rapidpdf/bjsports-2017-098497?ijkey=Rsap0XafljfcOCR&amp;keytype=ref" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bjsm.bmj.com/cgi/rapidpdf/bjsports-2017-098497?ijkey=Rsap0XafljfcOCR&amp;keytype=ref</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S002191502101474X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S002191502101474X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S002191502101474X</a></span></div></li><li id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900590-0/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900590-0/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900590-0/fulltext</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4313888/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4313888/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4313888/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2025.08.001" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.08.001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2025.08.001</a></span></div></li><li id="https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619</a></span></div></li><li id="https://www.nhs.uk/conditions/heart-attack/diagnosis/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhs.uk/conditions/heart-attack/diagnosis/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhs.uk/conditions/heart-attack/diagnosis/</a></span></div></li><li id="https://www.nhlbi.nih.gov/health/heart-tests" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhlbi.nih.gov/health/heart-tests" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhlbi.nih.gov/health/heart-tests</a></span></div></li><li id="https://www.michiganmedicine.org/health-lab/10-heart-tests-your-doctor-might-order-and-what-they-mean" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.michiganmedicine.org/health-lab/10-heart-tests-your-doctor-might-order-and-what-they-mean" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.michiganmedicine.org/health-lab/10-heart-tests-your-doctor-might-order-and-what-they-mean</a></span></div></li><li id="https://www.houstonmethodist.org/blog/articles/2023/apr/5-commonly-ordered-heart-tests-what-they-show/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.houstonmethodist.org/blog/articles/2023/apr/5-commonly-ordered-heart-tests-what-they-show/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.houstonmethodist.org/blog/articles/2023/apr/5-commonly-ordered-heart-tests-what-they-show/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK448128/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK448128/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK448128/</a></span></div></li><li id="https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&amp;contentid=p00208" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&amp;contentid=p00208" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&amp;contentid=p00208</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11772728/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11772728/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11772728/</a></span></div></li><li id="https://pubs.rsna.org/doi/10.1148/radiol.240516" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubs.rsna.org/doi/10.1148/radiol.240516" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubs.rsna.org/doi/10.1148/radiol.240516</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/</a></span></div></li><li id="https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease</a></span></div></li><li id="https://www.mdpi.com/2077-0383/14/21/7570" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/2077-0383/14/21/7570" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/2077-0383/14/21/7570</a></span></div></li><li id="https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts</a></span></div></li><li id="https://www.mdcalc.com/calc/10499/systematic-coronary-risk-evaluation-score2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdcalc.com/calc/10499/systematic-coronary-risk-evaluation-score2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdcalc.com/calc/10499/systematic-coronary-risk-evaluation-score2</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001077" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001077" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001077</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11837432/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11837432/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11837432/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacadv.2025.101803" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2025.101803" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacadv.2025.101803</a></span></div></li><li id="https://academic.oup.com/eurheartj/article-abstract/46/15/1372/8001983" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurheartj/article-abstract/46/15/1372/8001983" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurheartj/article-abstract/46/15/1372/8001983</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6097909/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6097909/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6097909/</a></span></div></li><li id="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.122.027639" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.122.027639" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.122.027639</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2020.08.004" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2020.08.004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2020.08.004</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1936878X22001735" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1936878X22001735" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1936878X22001735</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9177493/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9177493/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9177493/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12059770/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12059770/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12059770/</a></span></div></li><li id="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2024.04.054" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2024.04.054" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2024.04.054</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.123.032919" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.123.032919" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.123.032919</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2023/10/01/01/42/prioritizing-health-proactive-screening-doubles-early-cvd-diagnosis-in-community" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2023/10/01/01/42/prioritizing-health-proactive-screening-doubles-early-cvd-diagnosis-in-community" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2023/10/01/01/42/prioritizing-health-proactive-screening-doubles-early-cvd-diagnosis-in-community</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10492754/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10492754/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10492754/</a></span></div></li><li id="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226907" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226907" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226907</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1208200" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1208200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1208200</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/circoutcomes.110.945311" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/circoutcomes.110.945311" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/circoutcomes.110.945311</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/30778668/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/30778668/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/30778668/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1301092" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1301092" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1301092</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2095752/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2095752/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2095752/</a></span></div></li><li id="https://www.aafp.org/pubs/afp/issues/2017/0215/p232.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aafp.org/pubs/afp/issues/2017/0215/p232.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aafp.org/pubs/afp/issues/2017/0215/p232.html</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/01/01/New-in-Clinical-Guidance" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/01/01/New-in-Clinical-Guidance" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/01/01/New-in-Clinical-Guidance</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168</a></span></div></li><li id="https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.006977" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.006977" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.006977</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2019.03.467" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2019.03.467" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2019.03.467</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2016.06.005" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2016.06.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2016.06.005</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/36116032/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/36116032/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/36116032/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06731" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06731" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06731</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5473156/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5473156/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5473156/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa0804626" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa0804626" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa0804626</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9893531/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9893531/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9893531/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa1909406" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1909406" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa1909406</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6082779/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6082779/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6082779/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4234175/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4234175/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4234175/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10233454/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10233454/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10233454/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1936879824011701" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1936879824011701" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1936879824011701</a></span></div></li><li id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960308-7/abstract" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960308-7/abstract" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960308-7/abstract</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2021.11.062" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2021.11.062" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2021.11.062</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/39806748/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/39806748/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/39806748/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12410434/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12410434/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12410434/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6082775/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6082775/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6082775/</a></span></div></li><li id="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825743" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825743" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825743</a></span></div></li><li id="https://www.nature.com/articles/s41598-022-14603-1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41598-022-14603-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41598-022-14603-1</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10460604/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10460604/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10460604/</a></span></div></li><li id="https://www.mdpi.com/2077-0383/14/15/5573" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/2077-0383/14/15/5573" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/2077-0383/14/15/5573</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/36746187/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/36746187/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/36746187/</a></span></div></li><li id="https://academic.oup.com/eurheartj/article-abstract/44/6/452/7028725" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurheartj/article-abstract/44/6/452/7028725" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurheartj/article-abstract/44/6/452/7028725</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0167527323007209" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0167527323007209" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0167527323007209</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/39337063/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/39337063/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/39337063/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.123.033568" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.123.033568" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.123.033568</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.124.038644" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.124.038644" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.124.038644</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/</a></span></div></li><li id="https://opencardiovascularmedicinejournal.com/VOLUME/12/PAGE/71/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://opencardiovascularmedicinejournal.com/VOLUME/12/PAGE/71/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://opencardiovascularmedicinejournal.com/VOLUME/12/PAGE/71/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2446467/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2446467/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2446467/</a></span></div></li><li id="https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf</a></span></div></li><li id="https://www.npr.org/sections/health-shots/2012/10/29/163889012/after-smoking-is-banned-heart-attacks-drop" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.npr.org/sections/health-shots/2012/10/29/163889012/after-smoking-is-banned-heart-attacks-drop" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.npr.org/sections/health-shots/2012/10/29/163889012/after-smoking-is-banned-heart-attacks-drop</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032302?doi=10.1161/CIRCULATIONAHA.117.032302" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032302?doi=10.1161/CIRCULATIONAHA.117.032302" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032302?doi=10.1161/CIRCULATIONAHA.117.032302</a></span></div></li><li id="https://www.nytimes.com/2009/10/16/science/16smoke.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nytimes.com/2009/10/16/science/16smoke.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nytimes.com/2009/10/16/science/16smoke.html</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease</a></span></div></li><li id="https://world-heart-federation.org/resource/world-heart-report-2024/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://world-heart-federation.org/resource/world-heart-report-2024/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://world-heart-federation.org/resource/world-heart-report-2024/</a></span></div></li><li id="https://www.who.int/news-room/fact-sheets/detail/ageing-and-health" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news-room/fact-sheets/detail/ageing-and-health" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news-room/fact-sheets/detail/ageing-and-health</a></span></div></li><li id="https://www.healthdata.org/sites/default/files/2024-05/GBD_2021_Forecasting_infographic_FINAL_2024.05.16.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthdata.org/sites/default/files/2024-05/GBD_2021_Forecasting_infographic_FINAL_2024.05.16.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthdata.org/sites/default/files/2024-05/GBD_2021_Forecasting_infographic_FINAL_2024.05.16.pdf</a></span></div></li><li id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2025.04.061" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.04.061" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2025.04.061</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11296249/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11296249/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11296249/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/16911907/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/16911907/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/16911907/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0741521414008659" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0741521414008659" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0741521414008659</a></span></div></li><li id="https://www.researchgate.net/publication/249102706_The_Cardiovascular_System_in_Ancient_Egyptian_Thought" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/249102706_The_Cardiovascular_System_in_Ancient_Egyptian_Thought" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/249102706_The_Cardiovascular_System_in_Ancient_Egyptian_Thought</a></span></div></li><li id="https://thoracickey.com/a-historical-overview-of-cardiovascular-medicine-and-heart-failure/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://thoracickey.com/a-historical-overview-of-cardiovascular-medicine-and-heart-failure/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://thoracickey.com/a-historical-overview-of-cardiovascular-medicine-and-heart-failure/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/</a></span></div></li><li id="https://oyc.yale.edu/history/hist-234/lecture-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://oyc.yale.edu/history/hist-234/lecture-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://oyc.yale.edu/history/hist-234/lecture-2</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/</a></span></div></li><li id="https://www.nejm.org/doi/abs/10.1056/NEJM197003262821311" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/abs/10.1056/NEJM197003262821311" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/abs/10.1056/NEJM197003262821311</a></span></div></li><li id="http://www.epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">http://www.epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/</a></span></div></li><li id="https://jamanetwork.com/journals/jama/fullarticle/1845130" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jama/fullarticle/1845130" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jama/fullarticle/1845130</a></span></div></li><li id="https://europepmc.org/article/pmc/1764970" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://europepmc.org/article/pmc/1764970" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://europepmc.org/article/pmc/1764970</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3793599/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3793599/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3793599/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/9395267/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/9395267/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/9395267/</a></span></div></li><li id="https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs</a></span></div></li><li id="https://www.revespcardiol.org/en-cardiovascular-risk-factors-insights-from-articulo-13117552" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.revespcardiol.org/en-cardiovascular-risk-factors-insights-from-articulo-13117552" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.revespcardiol.org/en-cardiovascular-risk-factors-insights-from-articulo-13117552</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4159698/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4159698/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4159698/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/</a></span></div></li><li id="https://www.news-medical.net/health/Statin-History.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/health/Statin-History.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/health/Statin-History.aspx</a></span></div></li><li id="https://ourworldindata.org/cardiovascular-deaths-decline" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ourworldindata.org/cardiovascular-deaths-decline" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ourworldindata.org/cardiovascular-deaths-decline</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3683584/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3683584/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3683584/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.321999" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.321999" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.321999</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.124.035987" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.124.035987" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.124.035987</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40539787/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40539787/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40539787/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacep.2023.06.005" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacep.2023.06.005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacep.2023.06.005</a></span></div></li><li id="https://www.news-medical.net/news/20201117/Scientists-reveal-new-evidence-of-electrical-pathway-in-the-heart.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/news/20201117/Scientists-reveal-new-evidence-of-electrical-pathway-in-the-heart.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/news/20201117/Scientists-reveal-new-evidence-of-electrical-pathway-in-the-heart.aspx</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/18615352/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/18615352/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/18615352/</a></span></div></li><li id="https://www.tandfonline.com/doi/full/10.1080/14017430801983082" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tandfonline.com/doi/full/10.1080/14017430801983082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tandfonline.com/doi/full/10.1080/14017430801983082</a></span></div></li><li id="https://bmjopen.bmj.com/content/6/6/e010401" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/6/6/e010401" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/6/6/e010401</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/27292972/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/27292972/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/27292972/</a></span></div></li><li id="https://bmjopen.bmj.com/content/14/3/e077949" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/14/3/e077949" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/14/3/e077949</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/28460374/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/28460374/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/28460374/</a></span></div></li><li id="https://www.jwatch.org/jw199610010000006/1996/10/01/ldl-particle-size-risk-factor-how-important" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jwatch.org/jw199610010000006/1996/10/01/ldl-particle-size-risk-factor-how-important" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jwatch.org/jw199610010000006/1996/10/01/ldl-particle-size-risk-factor-how-important</a></span></div></li><li id="https://precisionhealthreports.com/ldl-p-vs-apob" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://precisionhealthreports.com/ldl-p-vs-apob" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://precisionhealthreports.com/ldl-p-vs-apob</a></span></div></li><li id="https://www.healthcentral.com/condition/high-cholesterol/cholesterol-particle-size" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.healthcentral.com/condition/high-cholesterol/cholesterol-particle-size" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.healthcentral.com/condition/high-cholesterol/cholesterol-particle-size</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000743" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000743" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000000743</a></span></div></li><li id="https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/12/30/15/23/dietary-cholesterol-and-cardiovascular-risk" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/12/30/15/23/dietary-cholesterol-and-cardiovascular-risk" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/12/30/15/23/dietary-cholesterol-and-cardiovascular-risk</a></span></div></li><li id="https://www.amjmed.com/article/S0002-9343%2818%2930404-2/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.amjmed.com/article/S0002-9343%2818%2930404-2/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.amjmed.com/article/S0002-9343%2818%2930404-2/fulltext</a></span></div></li><li id="https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0735109720356874" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0735109720356874" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0735109720356874</a></span></div></li><li id="https://ajcn.nutrition.org/article/S0002-9165%2823%2901672-6/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ajcn.nutrition.org/article/S0002-9165%2823%2901672-6/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ajcn.nutrition.org/article/S0002-9165%2823%2901672-6/fulltext</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/cir.0000000000000510" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/cir.0000000000000510" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/cir.0000000000000510</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/</a></span></div></li><li id="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1396576/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1396576/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1396576/full</a></span></div></li><li id="https://www.bmj.com/content/361/bmj.k2139" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/361/bmj.k2139" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/361/bmj.k2139</a></span></div></li><li id="https://openheart.bmj.com/content/4/2/e000729" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://openheart.bmj.com/content/4/2/e000729" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://openheart.bmj.com/content/4/2/e000729</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6139832/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6139832/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6139832/</a></span></div></li><li id="https://ajcn.nutrition.org/article/S0002-9165%2822%2903918-1/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ajcn.nutrition.org/article/S0002-9165%2822%2903918-1/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ajcn.nutrition.org/article/S0002-9165%2822%2903918-1/fulltext</a></span></div></li><li id="https://nutritionsource.hsph.harvard.edu/carbohydrates/carbohydrates-and-blood-sugar/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://nutritionsource.hsph.harvard.edu/carbohydrates/carbohydrates-and-blood-sugar/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://nutritionsource.hsph.harvard.edu/carbohydrates/carbohydrates-and-blood-sugar/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4428290/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4428290/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4428290/</a></span></div></li><li id="https://answers.childrenshospital.org/low-carb-diet/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://answers.childrenshospital.org/low-carb-diet/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://answers.childrenshospital.org/low-carb-diet/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacadv.2024.100924" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2024.100924" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacadv.2024.100924</a></span></div></li><li id="https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins</a></span></div></li><li id="https://singjupost.com/transcript-what-big-pharma-doesnt-want-you-to-know-about-statins-dr-aseem-malhotra/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://singjupost.com/transcript-what-big-pharma-doesnt-want-you-to-know-about-statins-dr-aseem-malhotra/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://singjupost.com/transcript-what-big-pharma-doesnt-want-you-to-know-about-statins-dr-aseem-malhotra/</a></span></div></li><li id="https://theconversation.com/time-to-end-drug-company-distortion-of-medical-evidence-127495" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://theconversation.com/time-to-end-drug-company-distortion-of-medical-evidence-127495" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://theconversation.com/time-to-end-drug-company-distortion-of-medical-evidence-127495</a></span></div></li><li id="https://www.aafp.org/pubs/afp/issues/2010/1001/p741.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aafp.org/pubs/afp/issues/2010/1001/p741.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aafp.org/pubs/afp/issues/2010/1001/p741.html</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/28447485/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/28447485/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/28447485/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/atv.0000000000000073" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/atv.0000000000000073" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/atv.0000000000000073</a></span></div></li><li id="https://www.researchgate.net/publication/334547485_Potential_Statin_Overuse_in_Older_Patients_A_Retrospective_Cross-Sectional_Study_Using_French_Health_Insurance_Databases" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/334547485_Potential_Statin_Overuse_in_Older_Patients_A_Retrospective_Cross-Sectional_Study_Using_French_Health_Insurance_Databases" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/334547485_Potential_Statin_Overuse_in_Older_Patients_A_Retrospective_Cross-Sectional_Study_Using_French_Health_Insurance_Databases</a></span></div></li><li id="https://advances.massgeneral.org/cardiovascular/article.aspx?id=1022" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://advances.massgeneral.org/cardiovascular/article.aspx?id=1022" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://advances.massgeneral.org/cardiovascular/article.aspx?id=1022</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8836845/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8836845/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8836845/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/hc0902.104353" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/hc0902.104353" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/hc0902.104353</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9682196/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9682196/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9682196/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa021993" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa021993" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa021993</a></span></div></li><li id="https://www.tctmd.com/news/crp-more-predictive-future-events-ldl-statin-treated-patients" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tctmd.com/news/crp-more-predictive-future-events-ldl-statin-treated-patients" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tctmd.com/news/crp-more-predictive-future-events-ldl-statin-treated-patients</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/12432042/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/12432042/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/12432042/</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1043" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1043" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1043</a></span></div></li><li id="https://clinicaltrials.gov/study/NCT01594333" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://clinicaltrials.gov/study/NCT01594333" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://clinicaltrials.gov/study/NCT01594333</a></span></div></li><li id="https://www.nature.com/articles/s41569-022-00737-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41569-022-00737-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41569-022-00737-2</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/31894861/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/31894861/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/31894861/</a></span></div></li><li id="https://kevinmd.com/2025/10/re-examining-the-lipid-hypothesis-and-statin-use.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://kevinmd.com/2025/10/re-examining-the-lipid-hypothesis-and-statin-use.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://kevinmd.com/2025/10/re-examining-the-lipid-hypothesis-and-statin-use.html</a></span></div></li><li id="https://www.researchgate.net/publication/5236032_The_fallacies_of_the_lipid_hypothesis" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/5236032_The_fallacies_of_the_lipid_hypothesis" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/5236032_The_fallacies_of_the_lipid_hypothesis</a></span></div></li><li id="https://academic.oup.com/eurheartj/article/45/34/3152/7689554" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurheartj/article/45/34/3152/7689554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurheartj/article/45/34/3152/7689554</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/09/16/14/28/polygenic-risk-score-adds" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/09/16/14/28/polygenic-risk-score-adds" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/09/16/14/28/polygenic-risk-score-adds</a></span></div></li><li id="https://www.acc.org/Latest-in-Cardiology/Articles/2023/11/08/20/14/sun-445pm-heart1-aha-2023" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.acc.org/Latest-in-Cardiology/Articles/2023/11/08/20/14/sun-445pm-heart1-aha-2023" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.acc.org/Latest-in-Cardiology/Articles/2023/11/08/20/14/sun-445pm-heart1-aha-2023</a></span></div></li><li id="https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-reports-positive-additional-phase-1-data" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-reports-positive-additional-phase-1-data" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-reports-positive-additional-phase-1-data</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042476" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042476" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042476</a></span></div></li><li id="https://www.mdpi.com/1422-0067/26/7/3218" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/1422-0067/26/7/3218" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/1422-0067/26/7/3218</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001296" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001296" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000001296</a></span></div></li><li id="https://pubs.aip.org/aip/bpr/article/6/1/011301/3331507/Recent-advances-in-the-tools-and-techniques-for-AI" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubs.aip.org/aip/bpr/article/6/1/011301/3331507/Recent-advances-in-the-tools-and-techniques-for-AI" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubs.aip.org/aip/bpr/article/6/1/011301/3331507/Recent-advances-in-the-tools-and-techniques-for-AI</a></span></div></li><li id="https://healthcare-bulletin.co.uk/article/the-efficacy-of-wearable-cardiovascular-monitoring-devices-in-real-time-arrhythmia-detection-systematic-review-3415/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://healthcare-bulletin.co.uk/article/the-efficacy-of-wearable-cardiovascular-monitoring-devices-in-real-time-arrhythmia-detection-systematic-review-3415/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://healthcare-bulletin.co.uk/article/the-efficacy-of-wearable-cardiovascular-monitoring-devices-in-real-time-arrhythmia-detection-systematic-review-3415/</a></span></div></li><li id="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04582-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04582-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04582-2</a></span></div></li><li id="https://cardiovascularbusiness.com/topics/artificial-intelligence/revolution-here-ais-growing-role-cardiovascular-imaging-interventional-cardiology" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://cardiovascularbusiness.com/topics/artificial-intelligence/revolution-here-ais-growing-role-cardiovascular-imaging-interventional-cardiology" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://cardiovascularbusiness.com/topics/artificial-intelligence/revolution-here-ais-growing-role-cardiovascular-imaging-interventional-cardiology</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0022522322013277" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0022522322013277" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0022522322013277</a></span></div></li><li id="https://www.innovationsincrm.com/cardiac-rhythm-management/2013/february/395-three-dimensional-mapping-system-modification" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.innovationsincrm.com/cardiac-rhythm-management/2013/february/395-three-dimensional-mapping-system-modification" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.innovationsincrm.com/cardiac-rhythm-management/2013/february/395-three-dimensional-mapping-system-modification</a></span></div></li><li id="https://www.jacc.org/doi/10.1016/j.jacep.2024.12.026" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.jacc.org/doi/10.1016/j.jacep.2024.12.026" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.jacc.org/doi/10.1016/j.jacep.2024.12.026</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8386815/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8386815/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8386815/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0033350622001044" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0033350622001044" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0033350622001044</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000579" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000579" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIR.0000000000000579</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S003306202100133X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S003306202100133X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S003306202100133X</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw" id="_R_" async=""></script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Cardiovascular_disease\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Cardiovascular_disease\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Cardiovascular_disease\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T24bd2,"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"# Cardiovascular disease\n\nCardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic stroke.[](https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005) CVD is the leading cause of death globally, responsible for an estimated 19.8 million fatalities in 2022, representing about one-third of all deaths worldwide.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29)\n\nThe burden of CVD has intensified over recent decades, with 437 million disability-adjusted life-years (DALYs) lost in 2023, a 1.4-fold increase from 1990 levels, driven by aging populations and rising prevalence of modifiable risk factors.[](https://pubmed.ncbi.nlm.nih.gov/40990886/) Key behavioral contributors include tobacco smoking, physical inactivity, excessive alcohol consumption, and diets high in processed foods and sodium, which elevate intermediate risks such as hypertension, hyperlipidemia, diabetes, and obesity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9644238/) Empirical evidence from large cohort studies underscores that these factors causally drive endothelial dysfunction, inflammation, and plaque instability, with smoking alone accounting for up to 20% of attributable CVD burden in some populations.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2206916) While genetic predispositions exist, population-level data show that over 80% of premature CVD deaths could be averted through primary prevention targeting these modifiable elements, as demonstrated by declines in smoking and cholesterol levels offsetting rises in obesity.[](https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005)\n\n![Cardiovascular diseases world map - Deaths per million persons - WHO2012](./_assets_/Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png)\n\nTherapeutic advances, including statins for lipid management, antihypertensive agents, and revascularization procedures like angioplasty, have improved survival rates for acute events, yet controversies persist over over-reliance on pharmacological interventions without concurrent lifestyle modifications, as long-term adherence to drugs alone yields suboptimal outcomes compared to integrated approaches.[](https://pubmed.ncbi.nlm.nih.gov/31553287/) Globally, low- and middle-income countries bear 75% of CVD mortality despite lower historical incidence, highlighting disparities in access to diagnostics and the need for causal interventions over symptomatic treatments.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) Ongoing research emphasizes precision in risk stratification, incorporating biomarkers like C-reactive protein for inflammation, to better predict and mitigate progression from subclinical atherosclerosis to clinical disease.[](https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900287-4/fulltext)\n\n## Overview\n\n### Definition and Classification\n\nCardiovascular disease (CVD), also known as heart and circulatory disease, encompasses a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, congenital heart disease, and conditions like deep vein thrombosis and pulmonary embolism.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) These disorders primarily involve structural or functional abnormalities leading to impaired blood flow or cardiac function, often culminating in acute events like myocardial infarction or stroke.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) The term CVD is used interchangeably with circulatory system diseases in epidemiological contexts, emphasizing their collective impact on morbidity and mortality worldwide.[](https://www.ncbi.nlm.nih.gov/books/NBK535419/)\n\nStandard classification of CVD follows the International Classification of Diseases, 11th Revision (ICD-11), under Chapter 11: Diseases of the circulatory system, which organizes conditions into hierarchical codes for diagnostic and statistical purposes.[](https://icd.who.int/) Key categories include hypertensive diseases (BA00-BA04), ischaemic heart diseases (BA40-BA6Z), pulmonary heart disease and diseases of pulmonary circulation (BA80-BA8Z), and other forms such as cardiomyopathies (BC40-BC4Z) and cerebrovascular diseases (8B00-8B9Z).[](https://www.findacode.com/icd-11/chapter-11.html) This framework standardizes reporting across healthcare systems, facilitating global comparisons of prevalence and outcomes, though it excludes isolated hypertension unless complicated by organ damage.[](https://icd.who.int/dev11/l-m/en) Alternative categorizations, such as those from the Framingham Heart Study, focus on risk stratification rather than taxonomic grouping, estimating 10-year probabilities of CVD events based on factors like age, cholesterol levels, and blood pressure for primary prevention.[](https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/)\n\nThe scope of CVD is projected to expand significantly, with global prevalence expected to increase by 90% from 2025 to 2050 due to population aging, rising obesity, and socioeconomic shifts, despite potential declines in age-standardized rates in some regions.[](https://academic.oup.com/eurjpc/advance-article-abstract/doi/10.1093/eurjpc/zwae281/7756567) In the United States, clinical CVD (excluding uncomplicated hypertension) is forecasted to affect 45 million adults by 2050, up from current levels, representing about 15% of the adult population and driven by demographic changes and persistent risk factors.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256) These projections underscore the need for precise classification to track epidemiological trends and allocate resources effectively.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256)\n\n### Signs and Symptoms\n\nCardiovascular diseases often manifest asymptomatically in early stages, with symptoms emerging due to myocardial ischemia, reduced cardiac output, or vascular occlusion disrupting tissue perfusion.[](https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118) Common nonspecific indicators include chest pain or discomfort, shortness of breath (dyspnea) during exertion or at rest, persistent fatigue, and palpitations, which reflect inadequate oxygen delivery to the heart muscle or systemic hypoperfusion.[](https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease) [](https://www.cdc.gov/heart-disease/about/index.html)\n\nIn coronary artery disease, angina pectoris presents as substernal pressure, tightness, or aching exacerbated by physical activity and alleviated by rest, stemming from transient myocardial ischemia; acute myocardial infarction intensifies this with prolonged severe pain radiating to the arm, jaw, or back, often accompanied by nausea, diaphoresis, and dyspnea.[](https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613) [](https://www.nhlbi.nih.gov/health/coronary-heart-disease/symptoms) Heart failure symptoms arise from ventricular dysfunction causing pulmonary congestion or systemic venous backup, manifesting as orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, and exertional fatigue due to impaired forward flow and elevated filling pressures.[](https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142) [](https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure)\n\nPeripheral artery disease typically features intermittent claudication, a cramping leg pain in calves, thighs, or buttocks triggered by walking and relieved within minutes of rest, resulting from lower limb ischemia during increased metabolic demand; advanced cases may include rest pain, nonhealing ulcers, or tissue loss.[](https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557) [](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html) Cerebrovascular disease, particularly ischemic stroke, produces acute focal deficits from cerebral hypoperfusion, such as unilateral weakness or numbness, aphasia, visual field loss, ataxia, or sudden severe headache, often without preceding warning.[](https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113) [](https://www.cdc.gov/stroke/signs-symptoms/index.html)\n\nArrhythmias may cause irregular heartbeats, syncope, or presyncope from erratic electrical conduction impairing hemodynamics, while valvular disorders contribute symptoms like exertional dyspnea or angina from pressure or volume overload.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) Symptoms vary by subtype but universally signal underlying pathophysiological disruptions in blood flow or cardiac function rather than extrinsic factors.[](https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease)\n\n### Global Burden and Mortality\n\nCardiovascular disease (CVD) is the leading cause of mortality worldwide, responsible for 19.2 million deaths in 2023, equivalent to one in three global deaths.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) [](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) This figure reflects a rise from 13.1 million CVD deaths in 1990, driven by population growth, aging demographics, and persistent modifiable risk factors including hypertension, high body mass index, tobacco use, and dyslipidemia.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) In 2023, the global age-adjusted CVD death rate stood at 235.18 per 100,000 population, with a prevalence of 612.06 million cases.[](https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf)\n\n![Cardiovascular diseases world map - Deaths per million persons - WHO2012](./_assets_/Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png)\n\nThe burden extends beyond mortality to disability-adjusted life years (DALYs), a metric combining years of life lost (YLLs) due to premature death and years lived with disability (YLDs). CVD accounted for 437 million DALYs in 2023, marking a 1.4-fold increase from 320 million in 1990, with ischemic heart disease and stroke comprising the largest shares.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) [](https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023) YLLs dominate DALYs for CVD, reflecting its acute lethality, while YLDs highlight chronic impacts like heart failure. Projections from 2025 to 2050 forecast a 73.4% rise in crude mortality and a 54.7% increase in crude DALYs globally, attributable to demographic shifts rather than worsening age-specific risks, as effective interventions against modifiable factors could mitigate age-standardized declines.[](https://pubmed.ncbi.nlm.nih.gov/39270739/)\n\nRegional variations underscore the influence of lifestyle-driven risks over structural barriers alone. Low- and middle-income countries bear a disproportionate load, with CVD deaths rising sharply in regions like Southeast Asia and sub-Saharan Africa due to surging obesity, diabetes, and urbanization-linked sedentary behavior, despite lower historical exposure compared to high-income nations.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) In contrast, high-income areas exhibit stabilizing or declining age-adjusted rates through risk factor control, illustrating that behavioral modificationsâ€”such as reduced smoking and improved dietâ€”can substantially alleviate burden irrespective of economic context.[](https://pubmed.ncbi.nlm.nih.gov/39270739/) Economic costs amplify this impact; in the United States, CVD-related expenditures are projected to triple to $1.8 trillion by 2050, reflecting untreated modifiable risks amid population changes.[](https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050)\n\n## Types\n\n### Coronary Artery Disease\n\nCoronary artery disease (CAD), also known as coronary heart disease, involves the progressive accumulation of atherosclerotic plaques in the coronary arteries, which supply oxygenated blood to the myocardium. This buildup narrows the arterial lumen, impairs blood flow, and can lead to myocardial ischemia when oxygen demand exceeds supply. Plaques consist primarily of lipids, cholesterol, inflammatory cells, and fibrous tissue, with empirical studies showing that significant stenosis (â‰¥50% narrowing) often correlates with clinical symptoms, though subclinical atherosclerosis affects up to 42% of middle-aged adults in population-based imaging cohorts.[](https://www.ncbi.nlm.nih.gov/books/NBK564304/)[](https://www.ncbi.nlm.nih.gov/books/NBK507799/)[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055340)\n\nCAD manifests clinically along a spectrum from chronic stable ischemia to acute events. Stable angina pectoris presents as predictable, exertional chest discomfort relieved by rest or nitroglycerin, resulting from fixed obstructions typically exceeding 70% stenosis that limit flow reserve during increased demand. In contrast, acute coronary syndrome (ACS) encompasses unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI), driven by plaque rupture or erosion triggering thrombus formation and abrupt occlusion. Unstable angina differs from stable by occurring at rest or with minimal provocation, signaling imminent risk of infarction.[](https://www.ncbi.nlm.nih.gov/books/NBK564304/)[](https://my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome)[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.028991)\n\nAs the leading cause of death in the United States, CAD accounted for 371,506 fatalities in 2022, representing the most common form of heart disease and contributing substantially to overall cardiovascular mortality. Approximately 1 in 20 adults aged 20 and older have diagnosed CAD, with prevalence rising sharply with age and risk factors. Globally, CAD drives the majority of ischemic heart disease burdens, underscoring its role as the primary killer within cardiovascular pathologies.[](https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html)[](https://www.cdc.gov/heart-disease/about/index.html)[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209)\n\n### Cerebrovascular Disease\n\nCerebrovascular disease refers to pathological conditions affecting the blood vessels that supply the brain, primarily manifesting as stroke, which involves sudden interruption of blood flow leading to brain tissue damage. Strokes are classified into ischemic, accounting for approximately 65-87% of cases globally through arterial occlusion by thrombus or embolus, and hemorrhagic, comprising about 15-30% via vessel rupture causing intracerebral or subarachnoid bleeding.[](https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048033)[](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext) Ischemic subtypes include thrombotic strokes from local plaque buildup and embolic from distant clots, often originating from atrial fibrillation or cardiac sources.[](https://www.stroke.org/en/about-stroke/types-of-stroke) Hemorrhagic events typically stem from hypertension-induced vessel fragility or aneurysms. Transient ischemic attack (TIA), or \"mini-stroke,\" involves temporary focal ischemia without permanent infarction, resolving within 24 hours but signaling high risk for subsequent full stroke.[](https://www.hopkinsmedicine.org/health/conditions-and-diseases/stroke/types-of-stroke)\n\nEpidemiologically, cerebrovascular disease imposes a substantial global burden, with stroke incidence reaching over 7.8 million ischemic cases in 2021 alone, alongside rising trends in both ischemic and hemorrhagic subtypes due to aging populations and persistent risk factors.[](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext) In 2021, ischemic stroke constituted 65.3% of total stroke burden, intracerebral hemorrhage 28.8%, and subarachnoid hemorrhage the remainder, with overall prevalence exceeding 100 million cases worldwide.[](https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021) Unlike coronary artery disease, which primarily affects myocardial function, cerebrovascular events yield focal brain deficits, contributing to stroke as the second-leading cause of death and primary cause of long-term disability, with projections indicating a 50% increase in cases by 2050 absent interventions.[](https://www.ahajournals.org/doi/10.1161/JAHA.124.036142)\n\nRisk factors for cerebrovascular disease substantially overlap with those for coronary artery disease, including hypertension, smoking, diabetes, dyslipidemia, and atrial fibrillation, though hypertension exerts a particularly dominant causal role in both ischemic and hemorrhagic subtypes via endothelial damage and vessel wall stress.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8588679/) Modifying hypertension in midlife yields the greatest gains in life-years free of cardiovascular events, with a 2025 analysis estimating up to a decade of extended healthy lifespan when combined with smoking cessation, surpassing benefits from other factors like obesity control.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2415879) These shared risks underscore systemic atherosclerosis and thrombosis as common pathways, yet cerebrovascular outcomes diverge in emphasizing brain-specific vulnerabilities, such as collateral circulation limitations exacerbating ischemic penumbra.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12132760/)\n\nClinically, cerebrovascular disease produces distinct neurological sequelae, including hemiparesis, aphasia, visual field defects, and cognitive impairments, contrasting with the chest pain and heart failure predominant in coronary events; up to one-third of survivors develop dementia, and most retain partial deficits hindering workforce participation.[](https://www.ncbi.nlm.nih.gov/books/NBK430927/)[](https://www.ahajournals.org/doi/10.1161/STR.0000000000000430) TIA, while not causing infarction, correlates with 10-15% stroke risk within 90 days, necessitating urgent secondary prevention focused on antiplatelet therapy and risk factor optimization to avert progression to permanent deficits.[](https://www.cdc.gov/stroke/about/index.html)\n\n### Peripheral Artery Disease\n\nPeripheral artery disease (PAD) refers to the narrowing or occlusion of arteries supplying blood to the limbs, most commonly the lower extremities, resulting from atherosclerotic plaque buildup that impairs perfusion.[](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html) [](https://www.ncbi.nlm.nih.gov/books/NBK430745/) This condition manifests as a peripheral extension of systemic atherosclerosis, serving as an indicator of widespread vascular pathology that elevates risks for coronary and cerebrovascular events.[](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318258) [](https://pubmed.ncbi.nlm.nih.gov/40590724/)\n\nThe primary symptom is intermittent claudication, characterized by exertional muscle pain, cramping, or fatigue in the calves, thighs, or buttocks that resolves with rest due to inadequate oxygen delivery during activity.[](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535) [](https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html) In severe cases, critical limb ischemia develops, featuring rest pain, non-healing ulcers, or gangrene, which can necessitate amputation if untreated.[](https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557) Up to 50-90% of cases remain asymptomatic, contributing to delayed recognition.[](https://www.ahajournals.org/doi/10.1161/circresaha.116.303849)\n\nGlobally, PAD affected approximately 236 million adults as of 2019, with prevalence rising 72% from 65.8 million in 1990 to 113.4 million, driven by aging populations and rising comorbidities.[](https://pubmed.ncbi.nlm.nih.gov/36565779/) [](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535) Age-standardized prevalence reached about 5.6% by 2015, with projections estimating 360 million cases by 2050, particularly in low- and middle-income regions where rates exceed 20% in some areas.[](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535) [](https://spj.science.org/doi/10.34133/research.0702) In the United States, 7-12 million individuals are impacted.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001153) Despite this burden, PAD is frequently underdiagnosed, with 2024-2025 analyses attributing this to the predominance of silent disease, symptom variability, and disparities in screening, notably among women and those with limited healthcare access.[](https://www.ahajournals.org/doi/10.1161/ATVBAHA.125.323193) [](https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/22/17/25/PAD-Implications-For-Health-and-Quality-of-Life) [](https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research) PAD patients face a 2-3 times higher mortality risk from cardiovascular causes compared to those without, underscoring its role as a sentinel for multisite atherosclerosis.[](https://www.ncbi.nlm.nih.gov/books/NBK430745/)[](https://pubmed.ncbi.nlm.nih.gov/40590724/)\n\n### Heart Failure and Cardiomyopathies\n\nHeart failure manifests as a pathophysiological state in which the heart cannot generate sufficient cardiac output to satisfy tissue perfusion needs at rest or during exertion, stemming from impaired systolic or diastolic function.[](https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure) Systolic heart failure, also termed heart failure with reduced ejection fraction (HFrEF), involves diminished myocardial contractility, typically with left ventricular ejection fraction below 40%, leading to ventricular dilation and inadequate forward flow.[](https://www.healthline.com/health/heart-failure/systolic-vs-diastolic) In contrast, diastolic heart failure, or heart failure with preserved ejection fraction (HFpEF), arises from stiff ventricular walls that hinder relaxation and filling during diastole, preserving ejection fraction above 50% but compromising stroke volume through elevated end-diastolic pressures.[](https://www.medicalnewstoday.com/articles/systolic-vs-diastolic-heart-failure) These distinctions arise from underlying myocardial remodeling and extracellular matrix alterations, with HFrEF more often linked to myocyte loss and HFpEF to fibrosis and hypertrophy.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3891535/)\n\nEpidemiological data indicate heart failure prevalence escalates sharply with age, reflecting cumulative insults from comorbidities and demographic shifts toward older populations. In the United States, an estimated 6.7 million adults over age 20 had heart failure in recent assessments, with projections reaching 8.7 million by 2030 due to extended lifespans and improved acute cardiovascular survival.[](https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics) Globally, heart failure burdens approximately 64 million individuals, with incidence rates climbing in aging societies as diastolic variants predominate in the elderly, driven by factors like hypertension-induced stiffness rather than overt ischemia.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10398425/) Lifetime risk stands at about 24% in developed nations, underscoring the condition's progression from subclinical ventricular dysfunction to overt pump failure.[](https://escholarship.org/content/qt0pr7s2zr/qt0pr7s2zr.pdf)\n\nCardiomyopathies encompass primary disorders of the myocardium that directly precipitate heart failure through structural and functional derangements, distinct from secondary failures due to coronary or valvular pathology.[](https://www.ahajournals.org/doi/10.1161/circresaha.117.309711) Classified by etiology, genetic forms predominate in hypertrophic cardiomyopathy (HCM), where mutations in sarcomeric genes like MYH7 or MYBPC3 disrupt contractile proteins, yielding asymmetric septal hypertrophy and diastolic impairment in up to 1 in 500 individuals worldwide.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8484993/) Dilated cardiomyopathy (DCM) often blends genetic (e.g., titin variants) and acquired elements, manifesting as eccentric remodeling with systolic dysfunction and chamber enlargement.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11976403/) Acquired cardiomyopathies, such as those from viral myocarditis or cardiotoxic chemotherapies, induce inflammatory or infiltrative damage, while restrictive variants like amyloidosis feature rigid ventricles from protein deposition, severely limiting preload.[](https://www.ahajournals.org/doi/10.1161/circresaha.117.309711) Arrhythmogenic right ventricular cardiomyopathy involves fibrofatty replacement, genetically tied to desmosomal genes, but primarily affects systolic performance over electrical instability in isolation.[](https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults) These entities collectively amplify heart failure risk, with genetic screening revealing familial patterns in 20-50% of cases depending on subtype, enabling early intervention absent in purely acquired processes.[](https://www.sciencedirect.com/science/article/pii/S1525157812003042)\n\n### Arrhythmias and Valvular Disease\n\nArrhythmias encompass disorders of the heart's electrical conduction system, resulting in abnormal heart rates or rhythms that can originate from the atria, ventricles, or conduction pathways. These conditions are classified broadly as bradyarrhythmias (heart rates below 60 beats per minute) or tachyarrhythmias (rates exceeding 100 beats per minute), with further subdivision based on site of origin and mechanism.[](https://www.ncbi.nlm.nih.gov/books/NBK558923/) Atrial fibrillation (AFib), the most common sustained arrhythmia, affects approximately 44 million individuals worldwide and becomes increasingly prevalent with age, reaching up to 9% in those aged 80 to 89 years.[](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20703-6)[](https://www.ahajournals.org/doi/10.1161/01.str.0000166053.83476.4a) AFib predisposes to thromboembolism via stasis in the left atrial appendage, elevating ischemic stroke risk fivefold and accounting for 15 to 20% of such events.[](https://jamanetwork.com/journals/jamacardiology/fullarticle/2503080)[](https://www.mercy.net/service/atrial-fibrillation/prevent-stroke-while-living-with-afib/) Lifetime risk of developing AFib is about 1 in 4 for individuals aged 40 or older.[](https://www.sciencedirect.com/science/article/pii/S0146280623005984)\n\nVentricular arrhythmias, including tachycardia and fibrillation, contribute to 75 to 80% of sudden cardiac deaths, estimated at 184,000 to 450,000 annually in the United States.[](https://www.ahajournals.org/doi/10.1161/circep.118.006273) Non-atherosclerotic etiologies include structural abnormalities in the conduction system, such as disruptions in Purkinje fibers, which propagate electrical impulses. A 2025 Mayo Clinic study identified previously unrecognized intramyocardial Purkinje tissue comprising over 60% of human myocardial Purkinje fiber content, visualized via the biomarker myosin light chain 4 (MYL4), offering new insights into rhythm management and potential pacing targets.[](https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651)[](https://www.jacc.org/doi/10.1016/j.jacep.2025.03.039)\n\nValvular heart disease involves structural or functional impairment of one or more cardiac valves, leading to stenosis (narrowing) or regurgitation (leakage). Primary forms arise from intrinsic valve pathology rather than secondary effects like ischemia. Aortic stenosis, predominantly calcific and degenerative, affects about 9 million people globally and is the most common valvular lesion in developed nations, often manifesting in the elderly due to progressive leaflet calcification independent of coronary atherosclerosis.[](https://pubmed.ncbi.nlm.nih.gov/35736352/) Mitral regurgitation frequently stems from myxomatous degeneration or prolapse, a genetic predisposition causing leaflet redundancy and annular dilation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9228968/)\n\nRheumatic heart disease, resulting from autoimmune damage post-group A streptococcal infection, remains a leading cause of valvular pathology in low-income regions, primarily affecting mitral and aortic valves with fibrosis and fusion leading to stenosis.[](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.612716/full) In contrast, degenerative causes predominate in high-income settings, driven by age-related wear, calcification, or congenital anomalies like bicuspid aortic valves, which accelerate stenosis through mechanical stress and lipid-mediated inflammation distinct from plaque buildup in arteries.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001254) Overall, valvular disease impacts 5 to 10% of the population, with aortic stenosis as the predominant fatal type in epidemiological surveys.[](https://www.sciencedirect.com/science/article/abs/pii/S0140673623027551)[](https://www.ahajournals.org/doi/10.1161/JAHA.123.030895) These pathologies impair hemodynamics, promoting atrial enlargement and arrhythmias like AFib through volume overload or pressure gradients.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8885812/)\n\n## Pathophysiology\n\n### Atherosclerosis Mechanisms\n\nAtherosclerosis involves the progressive buildup of plaques in arterial walls, primarily driven by the retention and modification of low-density lipoprotein (LDL) particles in the intima layer. Endothelial dysfunction, often triggered by hemodynamic shear stress or risk factors such as hypertension and smoking, increases vascular permeability, allowing LDL to infiltrate the subendothelial space.[](https://www.ahajournals.org/doi/10.1161/circresaha.114.302721) Once retained by proteoglycans, LDL undergoes oxidative modification by reactive oxygen species (ROS) generated from sources like NADPH oxidase in endothelial cells and smooth muscle cells.[](https://pubmed.ncbi.nlm.nih.gov/12645638/) This oxidation transforms native LDL into oxidized LDL (oxLDL), which is more atherogenic than unmodified LDL due to its ability to promote inflammation and cellular uptake independent of regulatory feedback.[](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.925923/full) Oxidative stress, rather than mere lipid accumulation, serves as a critical initiator, as evidenced by the heightened ROS production in early lesion formation preceding significant plaque development.[](https://journals.physiology.org/doi/abs/10.1152/physrev.00047.2003)\n\nMacrophages recruited to the intima via chemokines bind and internalize oxLDL through scavenger receptors such as CD36 and LOX-1, bypassing the homeostatic LDL receptor pathway.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9043520/) This unregulated uptake leads to cholesterol ester accumulation within lysosomes, forming lipid-laden foam cells that characterize the initial fatty streak lesions.[](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381520/full) Foam cells secrete pro-inflammatory cytokines like interleukin-1Î² and tumor necrosis factor-Î±, amplifying local oxidative stress and attracting additional monocytes while impairing cholesterol efflux through downregulation of transporters such as ABCA1.[](https://www.sciencedirect.com/science/article/pii/S0010865018300560) Empirical data from animal models demonstrate that inhibiting foam cell formation reduces early plaque size, underscoring its causal role in lesion progression.[](https://www.ahajournals.org/doi/10.1161/atvbaha.114.303887)\n\nAs plaques advance, foam cells and dying macrophages contribute to a necrotic core, prompting vascular smooth muscle cells (SMCs) to migrate from the media, proliferate, and deposit extracellular matrix components like collagen and elastin to form a fibrous cap.[](https://www.ahajournals.org/doi/10.1161/circresaha.114.302721) Continued ROS-mediated signaling sustains SMC phenotypic switching toward a pro-inflammatory, synthetic state, further promoting plaque instability through matrix metalloproteinase activity.[](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00600/full) Human histopathological studies confirm that oxidative modifications correlate more strongly with advanced plaque features than total lipid content alone.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9735601/)\n\nAmong LDL subclasses, small dense LDL (sdLDL) particles exhibit greater atherogenicity than larger, buoyant ones, independent of total LDL cholesterol levels. SdLDL penetrates arterial walls more readily due to reduced size (diameter â‰¤257 Ã…ngstroms) and binds more avidly to proteoglycans, enhancing retention.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9197986/) These particles are also more susceptible to oxidation owing to lower antioxidant content and polyunsaturated fatty acid enrichment, yielding highly pro-inflammatory oxLDL.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8877621/) Prospective cohort studies, such as those analyzing NMR spectroscopy data, show sdLDL strongly predicts cardiovascular events, with odds ratios exceeding those for total LDL-C; for instance, elevated sdLDL associates with a 1.5- to 3-fold increased risk after adjusting for standard lipids.[](https://www.ahajournals.org/doi/10.1161/JAHA.120.019140) [](https://academic.oup.com/jcem/article/88/10/4525/2845681) This evidence challenges overreliance on total cholesterol metrics, as particle size and density better reflect causal oxidation propensity in causal realism frameworks.[](https://www.ahajournals.org/doi/10.1161/01.cir.0000131511.50734.44)\n\n### Thrombosis and Plaque Rupture\n\nThrombosis in cardiovascular disease often culminates from the acute rupture of atherosclerotic plaques, where disruption of the fibrous cap exposes thrombogenic substrates such as collagen, tissue factor, and lipid-rich necrotic core to circulating blood elements, triggering platelet adhesion, activation, and the coagulation cascade.[](https://www.ahajournals.org/doi/10.1161/circresaha.114.302721) This exposure leads to rapid thrombus formation, which can partially or completely occlude the vessel lumen, resulting in ischemia and events like myocardial infarction or stroke.[](https://www.ncbi.nlm.nih.gov/books/NBK534259/) Plaque rupture accounts for the majority of acute coronary syndromes, with pathological analyses indicating it as the underlying mechanism in 60-70% of fatal cases.[](https://www.sciencedirect.com/science/article/pii/S0735109705013963)\n\nThe process aligns with an adaptation of Virchow's triadâ€”endothelial (or plaque surface) injury, local hemodynamic disturbances, and hypercoagulabilityâ€”to arterial contexts. Rupture equates to vessel wall damage by breaching the endothelial barrier and revealing procoagulant surfaces; stenotic plaques induce flow stasis or turbulence proximally, promoting thrombus propagation; and systemic factors like elevated fibrinogen or platelet reactivity exacerbate clot stability.[](https://www.ncbi.nlm.nih.gov/books/NBK539697/) In non-ruptured scenarios, such as plaque erosion, thrombosis arises from denudation without cap fracture, but rupture predominates in thrombotic occlusions, comprising about 44-73% of culprit lesions in acute syndromes per intravascular imaging.[](https://academic.oup.com/eurheartj/article/34/10/719/496744)\n\nIntravascular optical coherence tomography (OCT) and ultrasound (IVUS) provide empirical visualization of rupture features, including cap discontinuities, cavity formation, and thrombus apposition, with OCT detecting these at resolutions up to 10-20 micrometers.[](https://www.jacc.org/doi/10.1016/j.jacc.2021.06.050) Studies using combined OCT-IVUS in ST-elevation myocardial infarction cohorts report plaque rupture in 64.8% of culprit sites, often with underlying large necrotic cores and minimal calcification, underscoring the acute destabilization's role over chronic progression.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9851427/) These imaging modalities confirm that ruptured plaques exhibit thinner caps (\u003c65 micrometers) pre-event in prospective data, though in vivo rupture incidence remains event-driven rather than routinely quantifiable in stable disease.[](https://www.sciencedirect.com/science/article/pii/S1936879815006950) Thrombus composition post-rupture typically includes platelet-rich aggregates initially, transitioning to fibrin-dominant structures, influenced by shear stress and local geometry.[](https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315754)\n\n### Inflammatory Processes\n\nInflammatory processes in cardiovascular disease involve the recruitment of immune cells, such as monocytes and T lymphocytes, to the arterial wall, where they differentiate into macrophages that engulf oxidized lipids and release pro-inflammatory cytokines including interleukin-1Î² (IL-1Î²), IL-6, and tumor necrosis factor-Î± (TNF-Î±).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9658900/) These cytokines amplify local inflammation, promote smooth muscle cell proliferation, and destabilize atherosclerotic plaques by inducing matrix metalloproteinases that degrade fibrous caps.[](https://pubmed.ncbi.nlm.nih.gov/36361701/) Adaptive immune responses, including T-cell activation, further sustain chronic inflammation, contributing to plaque progression independent of lipid accumulation alone.[](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03185-z)\n\nC-reactive protein (CRP), an acute-phase reactant produced by hepatocytes in response to IL-6, serves as a biomarker of systemic inflammation and predicts cardiovascular events, with high-sensitivity CRP (hsCRP) levels above 2 mg/L associated with increased risk of myocardial infarction and stroke.[](https://www.uscjournal.com/articles/high-sensitivity-c-reactive-protein-atherosclerotic-cardiovascular-disease-measure-or-not?language_content_entity=en) While mainstream paradigms prioritize lipid-driven atherogenesis, evidence indicates CRP may exert causal effects by impairing endothelial function, facilitating monocyte adhesion, and promoting plaque instability, as supported by observational data and animal models where CRP binding to oxidized LDL exacerbates lesion formation.[](https://pubmed.ncbi.nlm.nih.gov/16624260/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC3364506/) Mendelian randomization studies estimating genetically elevated CRP levels yield risk ratios for coronary heart disease comparable to observational associations, suggesting a direct pathogenic role beyond mere correlation.[](https://www.atherosclerosis-journal.com/article/S0021-9150%2810%2900663-5/abstract)\n\nClinical trials targeting inflammatory pathways provide empirical support for inflammation as a primary driver, challenging lipid-centric models. In the CANTOS trial, canakinumabâ€”an IL-1Î² inhibitorâ€”reduced major adverse cardiovascular events by 15% in post-myocardial infarction patients with elevated hsCRP, without altering lipid profiles, demonstrating that cytokine blockade mitigates risk through anti-inflammatory mechanisms.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1707914) Similarly, low-dose colchicine (0.5 mg daily), which inhibits inflammasome activation and cytokine release, lowered cardiovascular event rates by 25-30% in patients with coronary artery disease, further evidenced by reduced hsCRP and IL-6 levels.[](https://www.jacc.org/doi/10.1016/j.jacc.2023.05.055) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC8108024/) These findings underscore systemic cytokine-mediated inflammation as a modifiable causal factor, with benefits accruing irrespective of cholesterol reduction.\n\nUpstream triggers of these processes include chronic infections, which induce persistent immune activation and cytokine storms contributing to atherogenesis; for instance, pathogens like periodontal bacteria or Chlamydia pneumoniae correlate with accelerated plaque formation via endothelial activation and systemic inflammatory markers.[](https://www.jacc.org/doi/10.1016/j.jacc.2011.08.015) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC7729114/) Chronic psychosocial stress similarly drives inflammation by activating the hypothalamic-pituitary-adrenal axis, elevating cortisol and pro-inflammatory cytokines like IL-6, which foster a hypercoagulable state and lipid oxidation, accounting for elevated cardiovascular risk in stressed cohorts independent of traditional factors.[](https://pubmed.ncbi.nlm.nih.gov/11801260/) [](https://www.sciencedirect.com/science/article/abs/pii/S0022399901003026) This causal chainâ€”from stressors to immune dysregulationâ€”highlights inflammation's role as an integrator of environmental insults into vascular pathology.\n\n### Endothelial Dysfunction\n\nEndothelial dysfunction refers to the impaired functioning of the vascular endothelium, the monolayer of cells lining blood vessels, which serves as a critical barrier regulating vascular tone, permeability, inflammation, and thrombosis. This dysfunction manifests as a reduction in endothelium-dependent vasodilation, primarily due to decreased bioavailability of nitric oxide (NO), a key vasoprotective molecule produced by endothelial nitric oxide synthase (eNOS). Empirical evidence from human studies demonstrates that endothelial dysfunction precedes and contributes to cardiovascular disease progression by promoting vasoconstriction, leukocyte adhesion, and platelet aggregation, thereby increasing vascular resistance and thrombotic risk.[](https://pubmed.ncbi.nlm.nih.gov/8151263/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/)\n\nThe core mechanism involves impaired NO production and increased oxidative stress, where reactive oxygen species (ROS) such as superoxide inactivate NO, forming peroxynitrite and exacerbating barrier failure. In conditions like hypertension and hypercholesterolemia, eNOS uncouplingâ€”wherein the enzyme produces superoxide instead of NOâ€”further diminishes NO levels, leading to endothelial barrier disruption and heightened permeability. Studies in endothelial cell models confirm that inhibiting NO synthesis directly induces dysfunction, mimicking vascular failure observed in vivo. This foundational impairment contrasts with downstream effects like plaque formation, as it initiates the loss of the endothelium's anti-atherogenic and anti-thrombotic properties.[](https://www.ahajournals.org/doi/10.1161/01.res.87.10.840)[](https://cmbl.biomedcentral.com/articles/10.1186/s11658-023-00423-2)[](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.978378/full)\n\nEndothelial dysfunction exhibits a bidirectional relationship with insulin resistance, a hallmark of metabolic disorders preceding cardiovascular events. Insulin resistance selectively impairs insulin signaling in endothelium via disrupted phosphoinositide 3-kinase (PI3K)/Akt pathways, which normally activate eNOS, while preserving mitogenic pathways that promote inflammation. Clinical data from insulin-resistant individuals show reduced flow-mediated dilationâ€”a marker of endothelial functionâ€”correlating with hyperinsulinemia levels as low as those post-overnight fasting, independent of hyperglycemia. This linkage underscores causal realism in metabolic-vascular interplay, where endothelial NO deficiency worsens insulin-mediated glucose uptake, perpetuating resistance and vascular barrier failure.[](https://pubmed.ncbi.nlm.nih.gov/16618833/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3594115/)[](https://www.ahajournals.org/doi/10.1161/hc0502.103333)[](https://onlinelibrary.wiley.com/doi/10.1155/2016/3634948)\n\n## Risk Factors\n\n### Non-Modifiable Risk Factors\n\nAge is the most potent non-modifiable risk factor for cardiovascular disease (CVD), with incidence and mortality rates rising exponentially after approximately age 40, driven by cumulative vascular wear, reduced regenerative capacity, and progressive stiffening of arteries. In adults over 80 years, CVD prevalence reaches 89.3% in males and 91.8% in females, reflecting the dominance of chronological aging in disease manifestation. The percentage of adults with at least one CVD risk factor also escalates with age, from 27.0% in those aged 20-39 to 42.6% in those 65 and older, underscoring age's independent contribution beyond modifiable factors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6616540/)[](https://www.cdc.gov/nchs/products/databriefs/db540.htm)\n\nSex influences CVD risk profiles, with males exhibiting higher susceptibility prior to female menopause, attributable to protective effects of estrogen on endothelial function and lipid metabolism in premenopausal women. Premenopausal women experience lower age-adjusted CVD rates compared to men, but this gap narrows post-menopause, where women's risk accelerates and often surpasses men's when adjusted for age, leading to later but equally severe presentations. Women typically manifest CVD about 10 years later than men, yet postmenopausal prognosis for events like acute coronary syndrome worsens relative to age-matched males.[](https://www.archivesofmedicalscience.com/Menopause-and-women-s-cardiovascular-health-is-it-really-an-obvious-relationship%2C157308%2C0%2C2.html)[](https://www.sciencedirect.com/science/article/pii/S2590093519300256)[](https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2819%2930184-7/fulltext)\n\nGenetic predisposition, including family history, confers verifiable heritability for CVD outcomes, as evidenced by twin studies showing genetic contributions of 57% in males and 38% in females to coronary heart disease mortality. Conditions like familial hypercholesterolemia (FH), a monogenic disorder affecting LDL receptor function, illustrate causal genetic impact, with prevalence around 1 in 311 individuals and a twofold elevation in coronary heart disease risk even at moderate LDL-C levels. FH-affected individuals face markedly higher premature atherosclerotic CVD incidence, such as 14.9 per 1000 person-years for atherosclerotic CVD in primary prevention cohorts, emphasizing polygenic and monogenic pathways without implying determinism, as environmental interactions modulate expression.[](https://pubmed.ncbi.nlm.nih.gov/12270005/)[](https://www.cdc.gov/heart-disease-family-history/about/about-familial-hypercholesterolemia.html)[](https://jamanetwork.com/journals/jamacardiology/fullarticle/2814372)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6678686/)\n\n### Modifiable Lifestyle Risk Factors\n\nTobacco smoking exhibits a robust dose-response relationship with cardiovascular disease (CVD) risk, where even low levels of consumption substantially elevate incidence of coronary heart disease and stroke. A meta-analysis of prospective studies found that smoking approximately one cigarette per day confers about half the excess risk of smoking 20 cigarettes per day for these outcomes, underscoring the absence of a safe threshold. Current smoking at least doubles the risk for major CVD subtypes, including acute myocardial infarction and heart failure, with benefits from cessation accruing rapidlyâ€”heavy smokers quitting experience significant risk reduction within five years.[](https://www.bmj.com/content/360/bmj.j5855)[](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1351-4)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/)\n\nPhysical inactivity independently heightens CVD risk, with sedentary behavior linked to increased all-cause and cardiovascular mortality through mechanisms like impaired endothelial function and metabolic dysregulation. Prospective cohort data indicate that prolonged sitting, such as in occupational settings, associates with a 34% higher CVD mortality risk compared to more active patterns. Regular moderate-to-vigorous physical activity mitigates this, reducing nonfatal cardiac events by 18% and total cardiac events by 29%, highlighting the causal protective role of habitual movement over mere avoidance of sedentariness.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814094)[](https://www.sciencedirect.com/science/article/pii/S0828282X24012303)\n\nDietary patterns emphasizing refined sugars and processed carbohydrates drive inflammation and metabolic disturbances more directly than saturated fats, contrary to earlier emphases in some guidelines. High added sugar intake triples CVD mortality risk via elevated blood pressure and chronic low-grade inflammation, while replacing saturated fats with sugars exacerbates obesity and related complications. Meta-analyses challenge the saturated fat-CVD link, showing no consistent harm when contextualized against carbohydrate quality, with evidence favoring whole-food sources of fats over isolated nutrient fears.[](https://www.sciencedirect.com/science/article/abs/pii/S0033062015300256)[](https://www.health.harvard.edu/heart-health/the-sweet-danger-of-sugar)[](https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077)\n\nAlcohol consumption follows a J-shaped curve for CVD outcomes, where light-to-moderate intake (up to one drink daily) correlates with 22% lower cardiovascular mortality compared to abstinence, likely due to effects on HDL cholesterol and hemostasis, while heavy use (\u003e3 drinks daily) sharply elevates risks via hypertension and cardiomyopathy. This pattern holds in meta-analyses of cohort studies, though causality remains debated amid confounding by former drinkers in abstainer groups; excess consumption nullifies benefits and amplifies harm.[](https://www.jacc.org/doi/10.1016/j.jacc.2010.01.006)[](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02911-w)\n\nChronic sleep deprivation, defined as â‰¤5-6 hours nightly, elevates CVD incidence by 20-48% in prospective cohorts, through pathways including sympathetic overactivation and insulin resistance. Short sleep duration specifically heightens coronary heart disease risk, with irregularity compounding effects independent of duration.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10565718/)[](https://www.ahajournals.org/doi/10.1161/JAHA.122.025252)\n\nChronic stress, proxied by elevated cortisol levels, associates with up to fivefold higher myocardial infarction risk in cohort analyses, mediating via endothelial damage and plaque instability. Hair cortisol measurements confirm this link, with higher chronic exposure correlating to prevalent hypertension and prior CVD events, emphasizing behavioral management of psychosocial stressors.[](https://observatoireprevention.org/en/2021/04/07/association-between-chronic-stress-and-heart-attacks/)[](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04221-2)\n\n### Environmental and Occupational Risk Factors\n\nAir pollution, particularly fine particulate matter (PM2.5), has been empirically linked to increased cardiovascular disease (CVD) incidence and mortality through mechanisms including endothelial dysfunction, inflammation, and oxidative stress. A meta-analysis of 35 studies reported that a short-term increase of 10 Î¼g/mÂ³ in PM2.5 concentrations is associated with a 2.12% elevated risk of CVD-related hospitalization.[](https://www.jacc.org/doi/10.1016/j.jacadv.2023.100805) Long-term exposure to PM2.5 at moderate levels (e.g., 5-15 Î¼g/mÂ³) correlates with higher risks of acute myocardial infarction, ischemic heart disease mortality, and overall CVD mortality, with hazard ratios indicating approximately 10-20% increased risk per 10 Î¼g/mÂ³ increment in cohort studies.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801820) These associations persist after adjusting for confounders like smoking and socioeconomic status, underscoring direct causal pathways from particulate inhalation to vascular damage rather than indirect effects via inequality, as particulate-induced systemic inflammation drives outcomes independently of neighborhood deprivation metrics.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5132637/)\n\nOccupational exposures contribute to CVD risk via chronic stressors and toxicants. Shift work, especially night shifts, disrupts circadian rhythms, elevating CVD event risk by 17% overall and 26% for coronary heart disease morbidity compared to day work, based on systematic reviews of prospective studies.[](https://pubmed.ncbi.nlm.nih.gov/29247501/) This risk arises from prolonged sympathetic activation, sleep disruption, and metabolic dysregulation, with meta-analyses confirming higher odds for hypertension and arrhythmias among shift workers.[](https://pubmed.ncbi.nlm.nih.gov/40164421/) Chemical exposures, such as solvents, metals, and pesticides, further compound hazards; occupational solvent exposure is linked to electrocardiographic abnormalities and increased myocardial infarction incidence, while high pesticide exposure raises 10-year CVD event rates by up to 40% in exposed cohorts.[](https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12014)[](https://www.ahajournals.org/doi/10.1161/JAHA.119.012569) Metals like cadmium show probable but not definitive atherosclerotic effects, with prevalence rates of 8.5% for metal exposures in CVD cases.[](https://heart.bmj.com/content/105/6/439)[](https://www.sjweh.fi/article/1854)\n\nIonizing radiation exposure, often occupational in medical or nuclear workers, induces CVD through DNA damage, fibrosis, and accelerated atherosclerosis. In atomic bomb survivors, doses of 0-4 Gy (primarily 0-2 Gy) exhibit a dose-response relationship with heart disease and stroke risks, with excess relative risks of 14% per Gy for circulatory mortality.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2806940/) Systematic reviews of low-dose exposures (\u003c0.5 Gy) confirm elevated circulatory disease incidence, including in cohorts with cumulative doses from repeated medical imaging or occupational sources.[](https://www.bmj.com/content/380/bmj-2022-072924) These findings highlight radiation's role in endothelial injury and plaque instability, distinct from acute high-dose effects like burns.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3159113/)\n\n### Emerging Risk Factors\n\nEmerging risk factors for cardiovascular disease encompass understudied contributors supported by recent empirical evidence, including post-infectious sequelae, microbial dysbiosis, novel dietary exposures, and stress-mediated autonomic perturbations.[](https://www.nature.com/articles/s41591-024-03058-8) These factors highlight causal pathways beyond traditional risks, such as persistent inflammation or metabolic disruptions, with studies from 2024 onward quantifying their independent contributions through longitudinal cohorts and mechanistic analyses.[](https://www.bmj.com/content/384/bmj-2023-077310)\n\nPost-acute sequelae of SARS-CoV-2 infection, often termed long COVID, elevate cardiovascular risk through mechanisms like endothelial injury and chronic inflammation. A 2025 analysis found long COVID associated with significantly higher odds of subsequent cardiovascular diagnoses, including arrhythmias and heart failure, persisting beyond four weeks post-recovery.[](https://www.thecardiologyadvisor.com/news/long-covid-linked-to-development-of-cardiovascular-disease/) [](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1450470/full) Large-scale epidemiological data from September 2025 confirmed increased incidences of pericarditis, cardiomyopathy, and dysrhythmias, attributing these to viral-induced microvascular damage rather than mere correlation with acute severity.[](https://www.sciencedirect.com/science/article/abs/pii/S0022282825001786) Vaccination mitigates these risks by reducing infection-related cardiac events, underscoring a causal link via viral persistence.[](https://www.escardio.org/The-ESC/Press-Office/Press-releases/Major-new-report-sets-out-how-to-tackle-the-profound-and-lasting-impact-of-Covid-19-on-cardiovascular-health)\n\nGut microbiome composition influences cardiovascular outcomes via metabolite production, such as trimethylamine N-oxide (TMAO), which promotes atherosclerosis. April 2024 research identified specific cholesterol-consuming bacteria that lower serum lipids and heart disease risk, with abundance correlating inversely to event rates in cohort studies.[](https://www.nih.gov/news-events/nih-research-matters/gut-bacteria-may-reduce-cholesterol-lower-heart-disease-risk) [](https://www.broadinstitute.org/news/scientists-link-certain-gut-bacteria-lower-heart-disease-risk) A June 2024 study on microbial age showed that a \"younger\" gut profileâ€”rich in diverse, anti-inflammatory taxaâ€”counteracts elevated cardiovascular risk in metabolically unhealthy individuals, independent of chronological age.[](https://www.nature.com/articles/s41591-024-03058-8) Dysbiosis, often from antibiotic use or poor fiber intake, drives progression through short-chain fatty acid imbalances, as evidenced by multi-omics analyses linking taxa shifts to plaque instability.[](https://www.sciencedirect.com/science/article/pii/S0914508725001261)\n\nUltra-processed foods (UPFs), characterized by high additive content and low nutrient density, contribute via glycemic spikes, oxidative stress, and gut permeability alterations. A March 2025 NIH-linked study reported high UPF intake associated with elevated heart disease and stroke incidence in U.S. adults, with each 100 grams daily increase raising hypertension and event risks by measurable increments.[](https://www.nhlbi.nih.gov/news/2025/spotlight-upfs-nih-explores-link-between-ultra-processed-foods-and-heart-disease) [](https://www.acc.org/About-ACC/Press-Releases/2025/05/08/14/10/Eating-Ultra-Processed-Foods-May-Harm-Your-Health) February 2024 meta-analyses across millions confirmed UPF exposure heightens cardiometabolic mortality by 19%, mechanistically tied to systemic inflammation rather than caloric excess alone.[](https://www.bmj.com/content/384/bmj-2023-077310) [](https://academic.oup.com/eurjpc/advance-article/8173892) Subgroup data from 2024 trials differentiated harmful UPF subtypes, like emulsified snacks, from neutral ones, emphasizing formulation over processing category.[](https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900186-8/fulltext)\n\nChronic psychological stress and anxiety exert causal effects on cardiovascular disease through autonomic nervous system imbalance, reducing heart rate variability and favoring sympathetic dominance. June 2024 NHLBI findings linked lower variabilityâ€”indicative of vagal withdrawalâ€”to stress-induced myocardial vulnerability, with prospective data showing doubled event rates in high-stress cohorts.[](https://www.nhlbi.nih.gov/news/2024/why-mental-stress-can-take-toll-heart) Anxiety triggers this via hypothalamic-pituitary-adrenal activation, leading to endothelial dysfunction and plaque rupture, as quantified in 2024 reviews of sympathetic overdrive.[](https://www.jacc.org/doi/10.1016/j.jacadv.2024.101208) [](https://journals.lww.com/hhmi/fulltext/2024/08040/impact_of_chronic_psychological_stress_on.3.aspx) Unlike bidirectional associations, intervention trials demonstrate that autonomic modulation (e.g., via biofeedback) attenuates risk, supporting causality over confound.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11872152/)\n\n## Prevention\n\n### Primary Prevention Strategies\n\nPrimary prevention of cardiovascular disease targets individuals without established disease through population-level lifestyle modifications that address modifiable risk factors, reducing incidence by up to 80% in adherent groups according to cohort data.[](https://www.ahajournals.org/doi/10.1161/cir.0000000000000678) Empirical evidence from randomized controlled trials and meta-analyses prioritizes smoking avoidance, physical activity, nutrient-dense dietary patterns, and weight maintenance over pharmaceutical approaches in low-to-moderate risk populations.[](https://pubmed.ncbi.nlm.nih.gov/40611785/)\n\nAvoidance or cessation of tobacco use constitutes the most impactful single intervention, with risk of coronary heart disease declining by approximately 50% within one year of quitting and normalizing to never-smoker levels after 15 years.[](https://www.cdc.gov/tobacco/hcp/patient-care-settings/cardiovascular.html)[](https://www.sciencedirect.com/science/article/pii/S0828282X25000091) Prospective studies indicate that even brief cessation yields measurable reductions in endothelial dysfunction and atherogenesis, underscoring causal links via oxidative stress and platelet activation mechanisms.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/)\n\nRegular physical activity, specifically 150 minutes per week of moderate-intensity aerobic exercise, correlates with a 14% lower risk of coronary heart disease events in large prospective cohorts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3158733/) Dose-response meta-analyses affirm that this thresholdâ€”equivalent to 8.75 metabolic equivalent task-hours weeklyâ€”optimally balances CVD prevention with feasibility, yielding 20-30% reductions in all-cause mortality when sustained.[](https://bjsm.bmj.com/content/57/15/979)[](https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004) Resistance training adjuncts further enhance vascular compliance, though aerobic modalities predominate in risk attenuation.\n\nDietary strategies emphasizing whole, unprocessed foods outperform restrictive low-fat paradigms, which meta-analyses show yield inferior improvements in lipid profiles and inflammation markers.[](https://www.amjmed.com/article/S0002-9343%2811%2900410-4/fulltext) The PREDIMED trial demonstrated that a Mediterranean-style diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events by 30% relative to a advised low-fat diet in high-risk primary prevention participants, driven by polyphenols' anti-atherogenic effects rather than mere caloric restriction.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1800389) Low-carbohydrate variants similarly match or exceed low-fat outcomes for weight and triglyceride control without adverse cardiovascular shifts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/)\n\nMaintaining healthy body weight via consistent caloric deficits of 500-750 kcal daily facilitates 5-10% loss, directly lowering visceral adiposity and associated proinflammatory cytokines that propel atherosclerosis.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8017325/)[](https://www.sciencedirect.com/science/article/pii/S0002916522045798) Randomized interventions confirm this approach ameliorates insulin resistance and hypertension precursors independently of exercise volume, though long-term adherence challenges persist absent behavioral reinforcement.[](https://journals.physiology.org/doi/abs/10.1152/ajpendo.00102.2007)\n\nPharmacologic prophylaxis, such as statins or antihypertensives, is contraindicated for primary prevention in normotensive or low-cholesterol individuals due to net harm from side effects outweighing benefits in meta-analyses of low-risk cohorts; lifestyle primacy holds except in documented high-risk subsets like familial hypercholesterolemia.[](https://www.ahajournals.org/doi/10.1161/cir.0000000000000678)[](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.880054/full)\n\n### Secondary Prevention Approaches\n\nSecondary prevention strategies for cardiovascular disease (CVD) aim to reduce the incidence of recurrent events in individuals who have already experienced a major vascular occurrence, such as myocardial infarction, stroke, or peripheral artery disease revascularization. These interventions, grounded in clinical trial evidence and guidelines, emphasize multifactorial risk reduction through pharmacological therapies, structured rehabilitation, and targeted control of modifiable factors like hypertension and dyslipidemia. Implementation post-event has been associated with up to 75% relative risk reduction in recurrent events when comprehensive programs are adhered to, though global underutilization persists, with only about 20-30% of eligible patients participating in core components like cardiac rehabilitation.[](https://www.uscjournal.com/articles/strategies-secondary-prevention-atherosclerotic-cardiovascular-disease?language_content_entity=en)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10809857/)\n\nCardiac rehabilitation (CR) programs form a foundational element, delivering supervised exercise, behavioral counseling, and education on medication adherence and lifestyle factors. Meta-analyses of randomized trials demonstrate that CR reduces cardiovascular mortality by 20-30% and all-cause mortality by 13-26% in patients with coronary heart disease, with additional benefits including improved exercise capacity (mean increase of 1-2 METs) and reduced hospital readmissions by 20-30%. Core components, updated in 2024 guidelines, include initial risk stratification, medically supervised exercise (typically 36 sessions over 12 weeks), nutritional counseling, and smoking cessation support, with hybrid virtual options expanding access amid low referral rates (often \u003c50% in eligible populations).[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289)[](https://www.nature.com/articles/s44325-024-00017-7)\n\nBlood pressure (BP) control yields among the highest gains in life-years saved post-event, with modeling from global risk factor analyses estimating that achieving systolic BP \u003c130 mm Hg averts 10-15% of recurrent CVD events compared to higher thresholds. The 2025 AHA/ACC hypertension guideline recommends targeting \u003c130/80 mm Hg in most post-CVD patients using combinations of ACE inhibitors, ARBs, or beta-blockers, supported by trials showing 20-25% relative risk reductions in stroke and heart failure recurrence; intensive targets (\u003c120 mm Hg systolic) further lower major adverse cardiovascular events by 10-15% in high-risk subgroups like those with diabetes, though with increased risks of hypotension and renal impairment requiring individualized monitoring.[](https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249)[](https://www.nejm.org/doi/full/10.1056/NEJMoa2415879)\n\nPharmacological prophylaxis targets thrombosis and atherosclerosis progression. High-intensity statin therapy (e.g., atorvastatin 40-80 mg or rosuvastatin 20-40 mg daily) is recommended to reduce LDL cholesterol \u003c70 mg/dL or by â‰¥50%, achieving 20-30% relative reductions in major vascular events based on trials like IMPROVE-IT and ODYSSEY OUTCOMES. Antiplatelet agents, including lifelong low-dose aspirin (75-100 mg) and initial dual therapy with P2Y12 inhibitors (e.g., clopidogrel or ticagrelor for 6-12 months post-acute coronary syndrome), prevent stent thrombosis and recurrent infarction, with meta-analyses confirming 20-25% risk reductions. Renin-angiotensin system inhibitors (ACEIs or ARBs) and beta-blockers are indicated for patients with left ventricular dysfunction or persistent angina, reducing mortality by 15-20% in heart failure subsets. Adherence to these regimens via polypill formulations has shown 10-15% improvements in persistence rates, addressing the gap where only 40-60% of patients maintain full secondary prevention pharmacotherapy long-term.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7499366/)[](https://www.uptodate.com/contents/prevention-of-cardiovascular-disease-events-in-those-with-established-disease-secondary-prevention)[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309)\n\n### Dietary Interventions\n\nDietary interventions for preventing cardiovascular disease emphasize modifications to macronutrient composition and eating patterns to address causal factors such as insulin resistance, dyslipidemia, and inflammation, rather than solely targeting isolated nutrients like cholesterol. Randomized controlled trials, including the Women's Health Initiative Dietary Modification Trial involving 48,835 postmenopausal women followed for 8.1 years, demonstrated that a low-fat dietary pattern reducing total fat intake by 11.0% and saturated fat by 4.2% yielded no significant reduction in coronary heart disease (hazard ratio 0.97; 95% CI, 0.88-1.07), stroke (HR 0.98; 95% CI, 0.83-1.15), or total cardiovascular events.[](https://jamanetwork.com/journals/jama/fullarticle/202339) This outcome critiques longstanding guidelines prioritizing low-fat intake, as the intervention failed to alter CVD incidence despite promoting fruits, vegetables, and grains over fats.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8296783/)\n\nLow-carbohydrate diets, restricting carbohydrates to under 130 g/day while allowing higher fat and protein intake, have shown superior effects on cardiometabolic risk factors in meta-analyses of randomized trials. A 2020 systematic review of 23 studies found low-carbohydrate diets significantly lowered triglycerides by 0.31 mmol/L, increased HDL cholesterol by 0.06 mmol/L, and reduced body weight by 1.30 kg compared to low-fat diets, though LDL cholesterol rose modestly by 0.12 mmol/L; these shifts align with improved insulin sensitivity and reduced atherogenic dyslipidemia.[](https://pubmed.ncbi.nlm.nih.gov/31935216/) Long-term observational data from the Nurses' Health Study, tracking 82,802 women over 20 years, indicated that lower-carbohydrate scores (emphasizing plant-based sources) correlated with no increased coronary heart disease risk (relative risk 0.94 for lowest vs. highest quintile).[](https://www.nejm.org/doi/full/10.1056/NEJMoa055317) Such diets address root causes like hyperglycemia, outperforming low-fat approaches in reversing type 2 diabetesâ€”a key CVD driverâ€”in programs like Virta Health's continuous care intervention, where 60% of participants achieved diabetes remission at one year alongside improved lipid profiles.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6959586/)\n\nRegarding specific fats, saturated fatty acids exhibit neutrality or context-dependent effects on CVD risk, challenging demonization in dietary guidelines. A 2020 JACC review reassessed evidence, concluding that saturated fats from whole foods like dairy and meat do not independently elevate CVD when carbohydrate intake is controlled, as replacement with refined carbs exacerbates harm via glycation and inflammation; prospective cohorts like PURE (135,335 participants across 18 countries) linked higher saturated fat intake to lower stroke risk (HR 0.79 per 5% energy increase).[](https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077) In contrast, industrial trans fats unequivocally promote endothelial dysfunction and plaque formation; jurisdictions banning partially hydrogenated oils, such as New York counties from 2007, saw cardiovascular mortality decline by 4.5% (p=0.02) two years post-ban, attributing reductions to lowered LDL oxidation.[](https://pubmed.ncbi.nlm.nih.gov/26620830/) Polyunsaturated fats from seed oils (e.g., soybean, corn), rich in omega-6 linoleic acid, show mixed outcomes: while short-term RCTs suggest LDL-lowering when substituting saturated fats, long-term data raise concerns over oxidative stress and inflammation from high n-6:n-3 ratios, with no clear CVD mortality benefit in population studies.[](https://publichealth.jhu.edu/2025/the-evidence-behind-seed-oils-health-effects)[](https://www.heart.org/en/news/2024/08/20/theres-no-reason-to-avoid-seed-oils-and-plenty-of-reasons-to-eat-them)\n\nIntermittent fasting, such as time-restricted eating (e.g., 16:8 protocol), modulates circadian metabolism and caloric intake to mitigate obesity-related CVD risks. A 2025 meta-analysis of pairwise comparisons reported reductions in systolic blood pressure (mean difference -4.43 mmHg), fasting glucose (-3.72 mg/dL), and triglycerides (-10.86 mg/dL) across 11 randomized trials, supporting cardiometabolic improvements without adverse cardiac events.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12289860/) The INTERFAST-MI trial (n=112 post-myocardial infarction patients) found 16:8 fasting safe, enhancing left ventricular ejection fraction by 3% at 3 months versus controls.[](https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.123.010936) However, a 2024 observational analysis of NHANES data (20,078 adults) associated 8-hour eating windows with 91% higher CVD mortality risk (HR 1.91; 95% CI, 1.20-3.03), potentially confounded by self-selection or reverse causation in unhealthy individuals.[](https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death) Causal inference favors fasting's benefits in controlled settings, prioritizing empirical trial data over associative epidemiology.\n\n### Pharmacological Prevention\n\nLow-dose aspirin (75-100 mg daily) is recommended selectively for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in adults aged 40-59 years with a 10-year ASCVD risk of 10% or greater and low bleeding risk, as it reduces nonfatal myocardial infarction by approximately 26% relative risk but increases major bleeding by 58%.[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication)[](https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020) However, initiation is not advised for adults aged 60 years or older, where bleeding risks outweigh cardiovascular benefits, with no net reduction in all-cause mortality observed across trials.[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication)[](https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/27/20/41/New-USPSTF-Recommendation-on-Aspirin-in-CVD) This approach targets the causal pathway of platelet aggregation and thrombosis but requires individualized assessment, as absolute risk reductions are modest (e.g., 0.38% over 10 years for coronary events in high-risk groups).[](https://www.ahajournals.org/doi/10.1161/cir.0000000000000678)\n\nStatins, such as atorvastatin or rosuvastatin, are indicated for primary prevention in adults with elevated low-density lipoprotein cholesterol (LDL-C) or a 10-year ASCVD risk of 7.5% or higher, achieving relative reductions of 20-25% in major cardiovascular events through LDL-C lowering of 30-50%.[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication) Meta-analyses of randomized trials confirm efficacy in reducing nonfatal myocardial infarction and stroke, with one study reporting a 25% relative risk reduction for major vascular events per 1 mmol/L LDL-C decrease, though absolute benefits in primary prevention are small (e.g., 1.6% reduction in heart attacks over 5 years, number needed to treat of 62).[](https://jamanetwork.com/journals/jama/fullarticle/2795522)[](https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/) No significant all-cause mortality benefit emerges in low-risk populations (\u003c5% 10-year risk), and debates persist over overprescription driven by relative risk emphasis, with critics noting high numbers needed to treat (e.g., 140 for stroke prevention) and underreporting of adverse effects like myopathy (1-5% incidence) or diabetes risk increase (9% relative).[](https://www.thennt.com/cms/nnt/statins-persons-low-risk-cardiovascular-disease/)[](https://bjsm.bmj.com/cgi/rapidpdf/bjsports-2017-098497?ijkey=Rsap0XafljfcOCR\u0026keytype=ref) While statins address dyslipidemiaâ€”a proxy for atherogenic pathwaysâ€”their pleiotropic effects (e.g., anti-inflammatory) contribute, but evidence quality varies, with some analyses questioning net benefit in those under 7.5% risk due to pharma-funded trial biases.[](https://www.sciencedirect.com/science/article/pii/S002191502101474X)[](https://jamanetwork.com/journals/jama/fullarticle/2795522)\n\nAntihypertensive agents, including angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers, and thiazide diuretics, are recommended for primary prevention in adults with hypertension (systolic blood pressure â‰¥130 mm Hg or diastolic â‰¥80 mm Hg) and elevated cardiovascular risk per tools like the 2025 PREVENT equations (â‰¥7.5% 10-year risk).[](https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249) Blood pressure reduction of 5 mm Hg systolic lowers major cardiovascular event risk by 10% regardless of baseline levels, with trials showing 20-25% relative reductions in stroke and 10-15% in myocardial infarction.[](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900590-0/fulltext) Causal targeting of hemodynamic stress on endothelium and vessels yields benefits even in stage 1 hypertension with risk factors, though absolute reductions depend on baseline (e.g., 2-3% over 5 years in moderate cases), and combination therapy may be needed for goal attainment (\u003c130/80 mm Hg).[](https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4313888/) Side effects like orthostasis or electrolyte shifts necessitate monitoring, but overall, therapy prevents organ damage more effectively than risk proxies alone.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.001)\n\n## Diagnosis and Screening\n\n### Diagnostic Tests and Imaging\n\nElectrocardiography (ECG or EKG) is a primary noninvasive test that records the electrical activity of the heart to detect arrhythmias, ischemia, or infarction, typically performed within minutes using surface electrodes.[](https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619) It identifies abnormalities such as ST-segment elevation in acute coronary syndromes with high sensitivity for certain patterns, though specificity varies by clinical context.[](https://www.nhs.uk/conditions/heart-attack/diagnosis/)\n\nEchocardiography employs ultrasound waves to visualize cardiac structures, assess ventricular function, valvular integrity, and ejection fraction, often as a transthoracic or transesophageal variant for enhanced resolution.[](https://www.nhlbi.nih.gov/health/heart-tests) This modality detects wall motion abnormalities indicative of ischemia or cardiomyopathy, with Doppler techniques quantifying blood flow velocities and pressures noninvasively.[](https://www.michiganmedicine.org/health-lab/10-heart-tests-your-doctor-might-order-and-what-they-mean)\n\nCoronary angiography, an invasive procedure via catheter insertion, delivers contrast dye to opacify coronary arteries, confirming stenosis severity and guiding interventions like stenting.[](https://www.houstonmethodist.org/blog/articles/2023/apr/5-commonly-ordered-heart-tests-what-they-show/) It remains the gold standard for anatomical assessment of obstructive disease, achieving near-100% accuracy in lesion detection when combined with fractional flow reserve measurements.[](https://www.ncbi.nlm.nih.gov/books/NBK564304/)\n\nAdvanced imaging includes cardiac computed tomography (CT) angiography for noninvasive coronary lumen evaluation and magnetic resonance imaging (MRI) for myocardial viability and perfusion without ionizing radiation.[](https://www.ncbi.nlm.nih.gov/books/NBK448128/) Stress echocardiography or nuclear perfusion imaging complements these by revealing inducible ischemia under pharmacological or exercise provocation.[](https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85\u0026contentid=p00208)\n\nBy 2025, artificial intelligence (AI) integration has enhanced diagnostic precision across modalities, automating segmentation in echocardiography to reduce variability and improve ejection fraction quantification by up to 20% in multicenter trials.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11772728/) AI algorithms in CT and MRI accelerate reconstruction, minimizing artifacts and enabling rapid plaque characterization, with applications in real-time guidance for angiography showing reduced procedural times.[](https://pubs.rsna.org/doi/10.1148/radiol.240516) These tools, validated in prospective studies, prioritize empirical outcomes like sensitivity for stenosis detection exceeding 90% while addressing overfitting through diverse datasets.[](https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI)\n\n### Risk Assessment Tools\n\nRisk assessment tools for cardiovascular disease (CVD) utilize multivariable statistical models to estimate an individual's short- or long-term probability of experiencing events such as myocardial infarction, stroke, or CVD-related death, aiding in the prioritization of preventive measures like statin therapy or lifestyle changes. These models typically integrate factors including age, sex, blood pressure, lipid profiles, smoking status, and diabetes, derived from large cohort studies with Cox proportional hazards regression or similar methods. Validation involves metrics like C-statistic for discrimination and calibration plots for accuracy, though performance varies across populations due to differences in baseline risk and comorbidities.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/)\n\nThe Framingham Risk Score, developed from the Framingham Heart Study's prospective data collected since 1948, predicts 10-year risk of hard coronary heart disease (myocardial infarction or coronary death) in adults aged 30-79 without prior coronary disease or diabetes. It incorporates age, total cholesterol, HDL cholesterol, systolic blood pressure (untreated or treated), current smoking, and diabetes status, categorizing risk as low (\u003c10%), intermediate (10-20%), or high (\u003e20%). Validated in U.S. cohorts, it demonstrates a C-statistic of approximately 0.76 for coronary events but tends to overestimate risk in lower-prevalence European populations and underperforms in non-White groups due to cohort homogeneity.[](https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease)[](https://www.mdpi.com/2077-0383/14/21/7570)\n\nFor European populations, the SCORE2 algorithm, released by the European Society of Cardiology in 2021, estimates 10-year risk of first-onset fatal and non-fatal major CVD events (atherosclerotic and heart failure-related) in individuals aged 40-69 free of prior CVD. It uses age, sex, smoking, systolic blood pressure, and non-HDL cholesterol, recalibrated with data from 45 cohorts encompassing over 250,000 participants and contemporary event rates from 13 million person-years. SCORE2 improves calibration over its predecessor SCORE, with a pooled C-statistic of 0.72-0.74, and a variant SCORE2-OP extends predictions to ages 70-79 using adjusted baselines. It recommends thresholds of â‰¥5% for low-moderate risk and â‰¥10% for high-very high risk to initiate intensified prevention.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/)[](https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts)[](https://www.mdcalc.com/calc/10499/systematic-coronary-risk-evaluation-score2)\n\nEmerging polygenic risk scores (PRS) complement traditional models by quantifying genetic liability through weighted sums of thousands of common variants identified via genome-wide association studies. For coronary artery disease, PRS derived from European-ancestry meta-analyses (e.g., CARDIoGRAMplusC4D) can identify 8% of individuals with 2-3 times the average genetic risk, independent of clinical factors, with net reclassification improvements up to 10-20% when integrated into scores like Framingham or ASCVD. A 2022 American Heart Association scientific statement endorses PRS for coronary artery disease and atrial fibrillation risk stratification, noting enhanced prediction in early adulthood where traditional scores are less informative due to low absolute risk. Recent 2024-2025 advances include AI-optimized PRS and multi-ancestry adaptations, demonstrating clinical utility in reclassifying 5-10% of intermediate-risk patients toward statin eligibility, though implementation lags due to genotyping costs and equity concerns in non-European populations.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001077)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11837432/)[](https://www.jacc.org/doi/10.1016/j.jacadv.2025.101803)[](https://academic.oup.com/eurheartj/article-abstract/46/15/1372/8001983)\n\nCritiques of these tools highlight over-reliance on LDL cholesterol (often proxied via non-HDL or derived from total/HDL), which, while causally linked to atherosclerosis per Mendelian randomization evidence, fails as a standalone predictor due to overlapping distributions between cases and controls, yielding false positives/negatives in up to 50% of assessments. Small dense LDL subfractions, rather than total LDL concentration, correlate more strongly with plaque progression and events (hazard ratios 1.5-2.0 per standard deviation increase), yet standard models omit particle size or count via advanced assays like NMR spectroscopy. Variability in LDL levels over time independently doubles CVD risk beyond mean exposure, and cumulative \"cholesterol-years\" better capture lifetime atherogenic burden than snapshot measures. These limitations underscore the need for multimodal integration, including inflammation markers (e.g., hsCRP) or apolipoprotein B, to refine predictions without discounting LDL's centrality.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6097909/)[](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0)[](https://www.ahajournals.org/doi/10.1161/JAHA.122.027639)[](https://www.jacc.org/doi/10.1016/j.jacc.2020.08.004)\n\n### Early Detection Challenges\n\nCardiovascular disease frequently advances asymptomatically for years, complicating early identification as individuals may lack overt symptoms until advanced stages, such as myocardial infarction or heart failure. Studies indicate that subclinical coronary plaque is present in approximately 49% of asymptomatic middle-aged adults, with prevalence rising with age and risk factors like hypertension. Pre-heart failure stages affect 11% to 42.7% of populations, particularly the elderly and those with comorbidities, underscoring how silent progression evades routine clinical detection without proactive measures.[](https://www.sciencedirect.com/science/article/pii/S1936878X22001735)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9177493/)\n\nCurrent risk assessment tools, including the 2024 American Heart Association PREVENT equations, aim to predict cardiovascular events earlier by incorporating variables like age, blood pressure, cholesterol, and kidney function, enabling identification of high-risk individuals before symptoms emerge. However, challenges persist in model generalizability, interpretability, and external validation, limiting their applicability across diverse populations. Routine screening modalities like electrocardiography yield inadequate evidence of net benefit in asymptomatic adults, with potential harms from false positives outweighing advantages per U.S. Preventive Services Task Force assessments.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12059770/)[](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography)\n\nAccess disparities exacerbate detection barriers, with rural and socioeconomically disadvantaged areas facing shortages of cardiologists and lower screening rates for risk factors like hypertension. Racial and income-based inequities result in fewer preventive screenings among Black, Hispanic, and low-income groups, contributing to delayed diagnoses despite evidence that targeted, proactive strategies can double early CVD identification rates. While such screenings demonstrate cost-effectiveness and improved outcomes when implemented, systemic gaps in healthcare infrastructure hinder equitable application.[](https://www.jacc.org/doi/10.1016/j.jacc.2024.04.054)[](https://www.ahajournals.org/doi/10.1161/JAHA.123.032919)[](https://www.acc.org/Latest-in-Cardiology/Articles/2023/10/01/01/42/prioritizing-health-proactive-screening-doubles-early-cvd-diagnosis-in-community)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10492754/)\n\n## Management and Treatment\n\n### Acute Interventions\n\nPrimary percutaneous coronary intervention (PCI) represents the preferred reperfusion strategy for patients presenting with ST-elevation myocardial infarction (STEMI), demonstrating superior outcomes compared to thrombolytic therapy in reducing short-term mortality when performed promptly.[](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226907) Guidelines recommend achieving a door-to-balloon time of 90 minutes or less from hospital arrival, as delays beyond this threshold correlate with increased in-hospital and long-term mortality risks.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1208200) For instance, symptom onset-to-balloon times exceeding 2 hours or door-to-balloon times over 60 minutes independently predict higher 90-day mortality rates, with each 30-minute delay elevating risk by approximately 7-10% in observational cohorts.[](https://www.ahajournals.org/doi/10.1161/circoutcomes.110.945311) [](https://pubmed.ncbi.nlm.nih.gov/30778668/)\n\nThrombolytic therapy, involving agents such as alteplase or tenecteplase, serves as an alternative when primary PCI cannot be executed within 120 minutes of first medical contact, particularly in rural or resource-limited settings.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309) This approach achieves myocardial reperfusion in about 50-60% of cases but carries higher rates of hemorrhagic complications and reinfarction compared to PCI, resulting in 20-30% greater 30-day mortality in direct comparisons from randomized trials.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1301092) Prehospital fibrinolysis followed by routine angiography within 3-24 hours can mitigate some deficits in high-risk patients unable to access timely PCI, though overall survival benefits diminish with treatment delays beyond 3 hours from symptom onset.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2095752/)\n\nAdjunctive pharmacotherapies during acute reperfusion include immediate aspirin administration (162-325 mg chewed) to inhibit platelet aggregation, reducing early mortality by 23% in meta-analyses of STEMI trials, alongside P2Y12 inhibitors like ticagrelor or prasugrel for dual antiplatelet effects.[](https://www.aafp.org/pubs/afp/issues/2017/0215/p232.html) Anticoagulation with heparin or bivalirudin supports procedural success in PCI, while beta-blockers and statins are initiated concurrently to limit infarct expansion, though their acute mortality impact is secondary to timely revascularization.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309) In non-STEMI acute coronary syndromes, urgent angiography and revascularization within 2 hours for high-risk features (e.g., refractory angina or hemodynamic instability) further underscore the time-sensitive nature of interventions to avert progression to full infarction.[](https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/01/01/New-in-Clinical-Guidance)\n\n### Chronic Disease Management\n\nChronic management of cardiovascular disease emphasizes sustained pharmacological control of risk factors and symptoms to mitigate progression and recurrent events. Guideline-directed medical therapy (GDMT) typically includes combinations of antihypertensives, lipid-lowering agents, antiplatelet drugs, and disease-specific therapies such as beta-blockers or mineralocorticoid receptor antagonists for heart failure. The 2023 AHA/ACC guideline for chronic coronary disease recommends lifelong therapy with high-intensity statins for most patients with atherosclerotic cardiovascular disease, alongside blood pressure targets below 130/80 mmHg using ACE inhibitors or ARBs as first-line agents in those with comorbidities like diabetes or chronic kidney disease.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168) Similarly, the 2024 ESC guidelines for chronic coronary syndromes advocate for combination therapy including aspirin indefinitely and P2Y12 inhibitors for at least 12 months post-event, with proton pump inhibitors to reduce gastrointestinal bleeding risk.[](https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes)\n\nPolypharmacy, defined as concurrent use of five or more medications, is inherent to GDMT in chronic CVD, particularly in heart failure where patients often require diuretics, ACE inhibitors, beta-blockers, and aldosterone antagonists simultaneously. While this multimodal approach yields net benefitsâ€”such as a 20-30% relative risk reduction in major adverse cardiovascular events through optimized risk factor controlâ€”polypharmacy elevates risks of drug-drug interactions, adverse effects like hypotension or renal impairment, and hospitalization rates by up to 1.5-fold in older adults.[](https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.006977) Deprescribing strategies, informed by periodic reassessment of net benefit, are recommended to minimize burden without compromising efficacy, as evidenced by trials showing safe discontinuation of certain agents in stable patients.[](https://www.jacc.org/doi/10.1016/j.jacc.2019.03.467)\n\nMedication adherence directly influences outcomes, with meta-analyses demonstrating that high adherence (\u003e80%) to preventive pharmacotherapy correlates with 15-25% lower all-cause mortality and reduced hospitalizations compared to low adherence (\u003c50%).[](https://www.jacc.org/doi/10.1016/j.jacc.2016.06.005) Poor adherence, affecting 30-50% of CVD patients due to factors like pill burden or side effects, causally exacerbates disease progression, as non-adherent individuals exhibit 1.5-2-fold higher risks of cardiovascular death independent of baseline severity.[](https://pubmed.ncbi.nlm.nih.gov/36116032/) Interventions such as simplified regimens, patient education, and electronic reminders improve adherence rates by 10-20%, underscoring the need for routine monitoring via refill data or self-reports during follow-up visits every 3-6 months.[](https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06731) Long-term success hinges on balancing therapeutic intensity with tolerability, prioritizing evidence from randomized trials over observational associations.\n\n### Surgical and Interventional Procedures\n\nCoronary artery bypass grafting (CABG) involves surgically creating new pathways for blood flow around blocked coronary arteries using grafts from the saphenous vein or internal mammary artery, typically performed via median sternotomy on cardiopulmonary bypass.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5473156/) In randomized controlled trials such as the SYNTAX trial, CABG demonstrated lower rates of major adverse cardiac or cerebrovascular events (12.4% vs. 17.8% at 1 year) compared to percutaneous coronary intervention (PCI) in patients with complex multivessel disease, primarily due to reduced need for repeat revascularization.[](https://www.nejm.org/doi/full/10.1056/NEJMoa0804626) Long-term data from meta-analyses indicate CABG provides superior 10-year survival in multivessel coronary artery disease, with hazard ratios favoring CABG over PCI (e.g., HR 0.79 for mortality at 4 years in adjusted analyses).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9893531/) However, CABG carries higher perioperative risks, including stroke (1-2% incidence), particularly in trials like EXCEL for left main disease where excess cerebrovascular events occurred post-CABG.[](https://www.nejm.org/doi/full/10.1056/NEJMoa1909406)\n\nPercutaneous coronary intervention (PCI), including balloon angioplasty and drug-eluting stent placement, offers a less invasive alternative for revascularization, achieving procedural success rates exceeding 95% in contemporary practice.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6082779/) RCTs such as those pooled for left main disease show PCI noninferior to CABG for short-term safety in select patients without diabetes or complex anatomy, with lower early stroke risk but higher rates of target vessel revascularization (e.g., 12.9% vs. 7.6% at 5 years in EXCEL).[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571) In multivessel disease meta-analyses of over 4,000 patients, PCI matched CABG for 1-2 year composite outcomes but diverged at longer follow-up, with CABG reducing myocardial infarction and mortality in higher SYNTAX scores (\u003e22).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4234175/) PCI remains preferred for acute settings like ST-elevation myocardial infarction, where door-to-balloon times under 90 minutes correlate with improved survival.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10233454/)\n\nTranscatheter aortic valve replacement (TAVR) deploys a prosthetic valve via catheter access, primarily for severe aortic stenosis in patients at intermediate or high surgical risk, with procedural success rates around 96-98%.[](https://www.sciencedirect.com/science/article/abs/pii/S1936879824011701) Landmark trials like PARTNER 1 showed TAVR noninferior to surgical aortic valve replacement (SAVR) at 5 years for all-cause mortality in high-risk cohorts (67.8% vs. 62.4%), though with higher rates of vascular complications and paravalvular leak.[](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960308-7/abstract) In low-risk patients, the Evolut Low Risk trial reported TAVR noninferior for 2-year composite death or disabling stroke (7.7% vs. 9.2%), expanding indications since FDA approval for broader use in 2019.[](https://www.jacc.org/doi/10.1016/j.jacc.2021.11.062) Meta-analyses confirm comparable short-term (up to 2 years) mortality between TAVR and SAVR, but longer-term data (\u003e5 years) suggest potential TAVR disadvantages in durability and reintervention needs.[](https://pubmed.ncbi.nlm.nih.gov/39806748/)\n\nFor combined coronary and valvular disease, hybrid approaches like PCI plus TAVR versus CABG plus SAVR yield similar periprocedural mortality (0.7-0.8%) but differ in long-term outcomes, with surgical strategies showing lower 5-year death or stroke in some registries (16.2% vs. 27.8%).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12410434/) Patient selection via heart team evaluation, incorporating anatomic complexity and comorbidities, guides procedure choice, as evidenced by guideline-directed algorithms prioritizing CABG for diabetes with multivessel involvement.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6082775/) Ongoing trials continue to refine these interventions' roles amid evolving stent and valve technologies.[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571)\n\n### Lifestyle and Rehabilitation\n\nLifestyle modifications following a cardiovascular event or diagnosis emphasize sustained behavioral changes to mitigate recurrent risk, including smoking cessation, which halves the excess cardiovascular mortality risk within one year of quitting among former smokers with established disease.[](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825743) Combining smoking cessation with initiation of regular exercise post-event yields a 46% reduction in subsequent cardiovascular disease incidence compared to continued smoking without exercise.[](https://www.nature.com/articles/s41598-022-14603-1) Adoption of diets rich in whole grains, fruits, and vegetables, such as the Mediterranean pattern, supports weight control and endothelial function, with adherence linked to lower composite cardiovascular endpoints in secondary prevention cohorts.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10460604/) Regular physical activity, targeting 150 minutes weekly of moderate aerobic exercise, improves cardiorespiratory fitness and reduces all-cause mortality by approximately 15% per 1000-step daily increment in rehabilitated patients.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289)\n\nCardiac rehabilitation programs, typically spanning 8-12 weeks, integrate supervised exercise training with education on risk factor management, yielding dose-dependent improvements in prognosis; participation correlates with lower five-year mortality rates, with each additional session attended reducing all-cause death risk incrementally.[](https://www.mdpi.com/2077-0383/14/15/5573) Core components encompass physician-prescribed aerobic and resistance exercises, nutritional counseling, psychosocial evaluations for depression and anxiety, and monitoring of modifiable risks like hypertension and dyslipidemia.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289) Meta-analyses of randomized trials demonstrate that exercise-based rehabilitation reduces cardiovascular mortality by 20-30% and hospital readmissions in coronary heart disease patients, independent of contemporary pharmacotherapy.[](https://pubmed.ncbi.nlm.nih.gov/36746187/) [](https://academic.oup.com/eurheartj/article-abstract/44/6/452/7028725)\n\nOutcomes hinge on patient adherence and individual accountability, as non-completion rates exceed 50% in many programs due to barriers like transportation or motivation, underscoring the need for personalized strategies to foster long-term compliance.[](https://www.sciencedirect.com/science/article/pii/S0167527323007209) Programs incorporating psychosocial support address mental health factors that impede lifestyle persistence, with completers showing sustained gains in quality of life and reduced major adverse cardiovascular events.[](https://pubmed.ncbi.nlm.nih.gov/39337063/) Evidence from large cohorts affirms that rehabilitation's benefitsâ€”such as enhanced exercise capacity and risk factor controlâ€”partially mediate mortality reductions, emphasizing causal links via improved vascular function and metabolic health rather than mere correlation.[](https://www.ahajournals.org/doi/10.1161/JAHA.123.033568)\n\n## Epidemiology\n\n### Historical Trends\n\nIn high-income countries, age-adjusted mortality rates from cardiovascular disease (CVD) began declining in the mid-20th century, reversing earlier increases observed from the 1930s to 1950s. In the United States, age-adjusted heart disease mortality per 100,000 population fell by 56% from 307.4 in 1950 to 134.6 in 1996, using the 1940 population as reference; this trend continued, with an overall 66% reduction in age-adjusted heart disease mortality from 761 per 100,000 in 1970 to 258 in 2022. Similar patterns emerged across Western Europe and other high-income nations by the 1960s, where CVD mortality peaked before substantial declines, contributing to gains in life expectancy of approximately 0.15 years annually since the 1950s through reduced all-cause mortality.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/)[](https://www.ahajournals.org/doi/10.1161/JAHA.124.038644)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/)[](https://opencardiovascularmedicinejournal.com/VOLUME/12/PAGE/71/)\n\nKey drivers included reductions in modifiable risk factors, particularly smoking prevalence, alongside improvements in medical interventions. Declines in tobacco use accounted for a significant portion of the drop in coronary heart disease deaths, with population-level smoking reductions correlating to thousands of averted fatalities and extended life-years; for instance, post-1960s anti-smoking efforts in the US and Europe halved adult smoking rates by the 2000s, directly lowering CVD incidence.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2446467/)[](https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf) Smoking bans in public spaces, implemented widely from the 1990s onward (e.g., in California in 1995 and EU directives by 2000s), produced rapid effects, reducing hospital admissions for heart attacks by up to 20-40% within months to a year in affected regions, as secondhand smoke exposure fell sharply.[](https://www.npr.org/sections/health-shots/2012/10/29/163889012/after-smoking-is-banned-heart-attacks-drop)[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032302?doi=10.1161/CIRCULATIONAHA.117.032302)[](https://www.nytimes.com/2009/10/16/science/16smoke.html)\n\nTherapeutic advances amplified these prevention gains, with blood pressure control, lipid-lowering therapies, and acute care (e.g., thrombolysis and revascularization post-1980s) preventing secondary events and contributing roughly 40-50% of the mortality reduction in modeling studies from the US and Europe. Dietary shifts toward lower saturated fat intake and increased awareness of hypertension also played roles, though causal attributions vary; empirical data link these to parallel drops in serum cholesterol levels (e.g., 10-15% reductions in US adults from 1960-1990). Despite these trends, disparities persisted, with slower declines among lower socioeconomic groups due to uneven risk factor control.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/)\n\n### Current Global Patterns\n\nCardiovascular diseases (CVDs) accounted for 19.2 million deaths globally in 2023, comprising about 32% of all deaths and marking an increase from 13.1 million in 1990, driven by population growth and aging alongside persistent risk factors such as hypertension and poor diet.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) [](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) Ischemic heart disease and stroke represented the primary causes, responsible for roughly 85% of these fatalities, with disability-adjusted life years (DALYs) totaling 437 million, a 1.4-fold rise since 1990.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) [](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) The global prevalence of CVD reached approximately 612 million cases, with an age-standardized rate of 7,179 per 100,000 population.[](https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf)\n\nOver 80% of CVD deaths occur in low- and middle-income countries, where limited access to preventive care and treatment exacerbates outcomes compared to high-income regions.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) Age-standardized mortality rates remain highest in Central and Eastern Europe, Central Asia, and parts of sub-Saharan Africa, often exceeding 400 deaths per 100,000 due to elevated prevalence of smoking, alcohol use, and uncontrolled hypertension.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/) [](https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease) In contrast, Western Europe and North America exhibit lower age-adjusted ratesâ€”around 150-200 per 100,000â€”reflecting better management of risk factors through screening and pharmacotherapy, though absolute numbers persist due to aging populations.[](https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf)\n\nAsia bears a disproportionate absolute burden, with South and East Asia contributing the largest shares of deaths and DALYs owing to massive population sizes and accelerating urbanization, which has fueled rises in obesity, diabetes, and processed food consumption since the early 2000s.[](https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease) [](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29) For instance, high blood pressure underlies a significant portion of CVD events in these regions, with prevalence rates often surpassing 30% in adults.[](https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease) Latin America and the Middle East also show elevated rates linked to similar socioeconomic transitions, while sub-Saharan Africa faces growing ischemic heart disease alongside longstanding rheumatic conditions, though underreporting may inflate disparities.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015) These patterns underscore causal links to modifiable risks like tobacco use (active in 15-20% of global CVD deaths) and air pollution, which disproportionately affect densely populated developing areas.[](https://world-heart-federation.org/resource/world-heart-report-2024/)[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29)\n\n### Projections to 2050\n\nProjections from the Global Burden of Disease study indicate that between 2025 and 2050, global cardiovascular disease (CVD) prevalence will increase by 90.0%, crude mortality by 73.4%, and crude disability-adjusted life years (DALYs) by 54.7%.[](https://pubmed.ncbi.nlm.nih.gov/39270739/) These estimates account for current trends in demographics, epidemiology, and healthcare access, with population growth and aging identified as primary drivers adding substantial absolute burden despite potential declines in age-standardized rates.[](https://pubmed.ncbi.nlm.nih.gov/39270739/)[](https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015)\n\nAging populations, particularly in low- and middle-income countries where 80% of older individuals are expected to reside by 2050, will amplify CVD incidence as age remains the strongest non-modifiable risk factor.[](https://www.who.int/news-room/fact-sheets/detail/ageing-and-health) Demographic shifts, including rising life expectancy (projected to increase globally by 4.6 years from 2022 to 2050), will extend exposure to cumulative risks, outweighing gains from improved survival post-diagnosis.[](https://www.healthdata.org/sites/default/files/2024-05/GBD_2021_Forecasting_infographic_FINAL_2024.05.16.pdf) Population expansion in regions with high fertility rates and urbanization will further elevate crude metrics, even as metabolic risks like obesity and diabetes contribute to non-communicable disease transitions.[](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext)\n\nModifiable risk factors offer mitigation potential; age-standardized DALYs attributable to behavioral and metabolic risks, such as smoking, high body-mass index, and hypertension, are forecasted to decline through targeted interventions, reflecting historical successes in tobacco control and blood pressure management.[](https://www.jacc.org/doi/10.1016/j.jacc.2025.04.061) However, rising prevalences of obesity and diabetes in aging cohorts could offset these gains, necessitating sustained policy efforts in prevention to curb absolute increases.[](https://pubmed.ncbi.nlm.nih.gov/39270739/) Regional variations persist, with Asia anticipating a 91.2% rise in crude CVD mortality despite a 23.0% drop in age-standardized rates, underscoring the dominance of demographic forces over risk factor improvements.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11296249/)\n\n## History\n\n### Early Descriptions and Theories\n\nThe Ebers Papyrus, dating to approximately 1550 BCE, contains some of the earliest recorded descriptions of cardiovascular symptoms, including chest pain and conditions suggestive of heart involvement, such as references to the heart as the center of bodily functions, emotions, and vitality.[](https://pubmed.ncbi.nlm.nih.gov/16911907/)[](https://www.sciencedirect.com/science/article/pii/S0741521414008659) Ancient Egyptian texts portrayed the heart as a key organ connected to vessels throughout the body, with treatments involving herbal remedies and incantations aimed at restoring balance, though these lacked empirical validation for vascular pathologies later identified in mummified remains showing atherosclerosis.[](https://www.researchgate.net/publication/249102706_The_Cardiovascular_System_in_Ancient_Egyptian_Thought)[](https://thoracickey.com/a-historical-overview-of-cardiovascular-medicine-and-heart-failure/)\n\nIn ancient Greece, Hippocrates (c. 460â€“370 BCE) advanced humoral theory, positing that diseases, including those affecting the heart, arose from imbalances among four bodily fluidsâ€”blood, phlegm, yellow bile, and black bileâ€”without recognizing the heart's role as a pump or the circulatory system's mechanics.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/) This framework influenced Galen (c. 129â€“216 CE), who described the heart as a furnace processing vital spirits from inhaled air, attributing cardiac disorders to humoral excesses or deficiencies rather than structural or obstructive causes, a view perpetuated for centuries but ultimately contradicted by anatomical evidence of coronary narrowing.[](https://oyc.yale.edu/history/hist-234/lecture-2)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/)\n\nBy the 18th century, observational descriptions shifted toward symptom-based recognition without reliance on humoral explanations. William Heberden presented the first detailed account of angina pectoris in 1768 before the Royal College of Physicians, characterizing it as a \"disorder of the breast\" with violent chest pain exacerbated by motion and relieved by rest, affecting about 20 cases he documented, distinct from indigestion or rheumatism.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/)[](https://www.nejm.org/doi/abs/10.1056/NEJM197003262821311) Published in 1772, Heberden's work highlighted the condition's prognostic gravity, linking it empirically to exertion and older age, though causal mechanisms remained elusive until later vascular discoveries disproved purely humoral origins.[](http://www.epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/)[](https://jamanetwork.com/journals/jama/fullarticle/1845130)\n\n### 20th-Century Breakthroughs\n\nIn 1913, Russian pathologist Nikolai Anitschkow conducted experiments feeding rabbits pure cholesterol dissolved in vegetable oil, resulting in the development of atherosclerotic plaques in their aortas and coronary arteries, providing early experimental evidence for a causal link between elevated blood cholesterol and atherosclerosis.[](https://europepmc.org/article/pmc/1764970) These findings, published in St. Petersburg, marked a pivotal shift toward recognizing dietary lipids as a potential driver of vascular pathology, though the induced hypercholesterolemia in rabbits far exceeded typical human levels.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3793599/) Anitschkow's work laid foundational support for the lipid hypothesis, influencing subsequent research despite initial skepticism regarding its applicability to humans.[](https://pubmed.ncbi.nlm.nih.gov/9395267/)\n\nThe Framingham Heart Study, launched in 1948 by the U.S. Public Health Service, enrolled 5,209 residents of Framingham, Massachusetts, for long-term prospective observation, yielding landmark identifications of modifiable risk factors for coronary heart disease.[](https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs) By the early 1960s, analyses revealed hypertension, elevated serum cholesterol, and cigarette smoking as independent predictors of cardiovascular events, with high blood pressure linked to a 2-3 fold increased risk of heart disease.[](https://www.revespcardiol.org/en-cardiovascular-risk-factors-insights-from-articulo-13117552) The study further quantified obesity's role in exacerbating these factors and established the multifactorial nature of atherosclerosis progression, enabling population-level risk stratification models that reduced U.S. cardiovascular mortality by informing public health interventions.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4159698/)\n\nDiagnostic innovations transformed cardiovascular assessment in the early 20th century, beginning with Willem Einthoven's 1903 invention of the string galvanometer electrocardiograph, which enabled non-invasive detection of arrhythmias and ischemic changes, earning him the 1924 Nobel Prize in Physiology or Medicine.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/) In 1929, Werner Forssmann pioneered cardiac catheterization by self-inserting a ureteral catheter into his own right ventricle under fluoroscopy, proving safe access to the heart for pressure measurements and contrast imaging, a technique refined in the 1940s-1950s for coronary angiography to visualize blockages.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/)\n\nTherapeutic advances accelerated mid-century, with John Gibbon's 1953 development of the heart-lung machine enabling the first successful open-heart surgery for atrial septal defect closure in 1954, facilitating repairs of congenital defects and valvular diseases.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/) Coronary artery bypass grafting emerged in 1967 when RenÃ© Favaloro used the saphenous vein to bypass occlusions, improving survival in severe angina patients.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/) Pharmacologically, Akira Endo's 1970s isolation of microbial inhibitors of HMG-CoA reductase culminated in lovastatin's FDA approval in 1987 as the first statin, reducing LDL cholesterol by up to 30% and demonstrating efficacy in slowing atherosclerosis progression in clinical trials.[](https://www.news-medical.net/health/Statin-History.aspx) These interventions collectively halved age-adjusted cardiovascular death rates in developed nations by century's end through combined diagnostic precision, surgical repair, and lipid-lowering therapy.[](https://ourworldindata.org/cardiovascular-deaths-decline)\n\n### Post-2000 Developments\n\nThe completion of the Human Genome Project in 2003 catalyzed genomic advancements in cardiovascular disease, facilitating genome-wide association studies that identified over 200 genetic loci linked to coronary artery disease risk by 2010.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3683584/) These efforts expanded to polygenic risk scores by the 2010s, integrating thousands of variants to quantify inherited susceptibility to atherosclerotic events with improved predictive accuracy beyond traditional factors like LDL cholesterol.[](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.321999) Clinical guidelines began incorporating genetic testing for conditions such as familial hypercholesterolemia and cardiomyopathies around 2010, enabling earlier interventions based on monogenic causes.[](https://www.ahajournals.org/doi/10.1161/JAHA.124.035987)\n\nIn the 2010s and 2020s, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as liraglutide and semaglutide, transitioned from diabetes therapies to established cardiovascular protectants following cardiovascular outcome trials. The LEADER trial in 2016 demonstrated liraglutide reduced major adverse cardiovascular events (MACE) by 13% in patients with type 2 diabetes and high CVD risk, prompting regulatory approvals for cardioprotective indications.[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595) Semaglutide's SELECT trial, reported in 2023, extended these benefits to non-diabetic individuals with obesity and preexisting CVD, showing a 20% MACE reduction driven by fewer myocardial infarctions and strokes, with effects linked to weight loss, reduced inflammation, and hemodynamic improvements rather than solely glucose control.01375-3/fulltext) Multiple meta-analyses confirmed class-wide MACE reductions of 12-15% across GLP-1 RAs in diverse high-risk populations.[](https://pubmed.ncbi.nlm.nih.gov/40539787/)\n\nAdvancements in understanding the cardiac conduction system emerged in the 2020s, with innovations in physiological mapping and pacing techniques. Conduction system pacing, introduced clinically around 2017, targeted the His-Purkinje network to restore synchronized ventricular activation, outperforming traditional right ventricular pacing in preserving ejection fraction and reducing heart failure hospitalizations in randomized trials by 2020.[](https://www.jacc.org/doi/10.1016/j.jacep.2023.06.005) In October 2025, Mayo Clinic researchers identified a novel biomarker exclusive to the human Purkinje network using advanced imaging, revealing previously unrecognized anatomical features that enhance targeting for arrhythmias and regenerative therapies.[](https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651) These discoveries built on single-cell sequencing from the early 2020s, which delineated conduction cell heterogeneity and glial interactions, informing potential gene-editing strategies for conduction defects.[](https://www.news-medical.net/news/20201117/Scientists-reveal-new-evidence-of-electrical-pathway-in-the-heart.aspx)\n\n## Controversies and Debates\n\n### Lipid Hypothesis Critiques\n\nCritics contend that the lipid hypothesis, which posits elevated serum cholesterolâ€”particularly low-density lipoprotein cholesterol (LDL-C)â€”as a primary causal factor in atherosclerosis and cardiovascular disease (CVD), rests on flawed observational associations rather than robust causal evidence. Numerous reviews highlight that contradictory studies outnumber supportive ones, with correlations often failing to establish causation due to confounding factors like reverse causality, where early disease elevates cholesterol as a response rather than a driver.[](https://pubmed.ncbi.nlm.nih.gov/18615352/) [](https://www.tandfonline.com/doi/full/10.1080/14017430801983082) This perspective is echoed in analyses questioning the hypothesis's foundational postulates, including the assumption that saturated fat intake directly raises blood cholesterol to pathogenic levels.[](https://www.tandfonline.com/doi/full/10.1080/14017430801983082)\n\nA key empirical challenge arises from findings in older populations, where higher total cholesterol (TC) and LDL-C levels correlate inversely with all-cause mortality. A 2016 systematic review in *BMJ Open*, analyzing 19 cohort studies involving over 68,000 participants aged 60 and older, reported that high LDL-C was associated with reduced mortality in most cohorts, with no studies showing increased risk from elevated levels.[](https://bmjopen.bmj.com/content/6/6/e010401) This inverse relationship persists after adjustments for confounders, suggesting low cholesterol may signal frailty, malnutrition, or terminal illness rather than confer protection, thus undermining the hypothesis's universality.[](https://bmjopen.bmj.com/content/6/6/e010401) [](https://pubmed.ncbi.nlm.nih.gov/27292972/) Similar patterns appear in subsequent analyses, such as a 2023 study linking optimal long-term survival to LDL-C ranges of 100â€“189 mg/dL, far above aggressive lowering targets.[](https://bmjopen.bmj.com/content/14/3/e077949)\n\nNuances in LDL composition further complicate the hypothesis's reliance on aggregate LDL-C measures. Small, dense LDL particles exhibit greater atherogenicityâ€”due to easier arterial penetration, oxidative susceptibility, and prolonged circulationâ€”compared to large, buoyant subtypes, yet standard assays capture only cholesterol mass, not particle size or number.[](https://pubmed.ncbi.nlm.nih.gov/28460374/) [](https://www.jwatch.org/jw199610010000006/1996/10/01/ldl-particle-size-risk-factor-how-important) Prospective data indicate that adjusting for particle characteristics attenuates or eliminates LDL-C's apparent risk association, with metrics like LDL particle number (LDL-P) or apolipoprotein B (reflecting particle count) providing superior CVD prediction.[](https://precisionhealthreports.com/ldl-p-vs-apob) [](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0) Critics argue this heterogeneity implies that uniform LDL-C targeting overlooks metabolic contexts, such as insulin resistance promoting dense particles independently of total cholesterol.[](https://www.healthcentral.com/condition/high-cholesterol/cholesterol-particle-size)\n\nEven proponents acknowledge evidential shifts; the American Heart Association's 2019 science advisory concluded that dietary cholesterol minimally influences blood levels in most individuals, decoupling intake from serum causality and highlighting genetic variability in absorption.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000000743) [](https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/12/30/15/23/dietary-cholesterol-and-cardiovascular-risk) Reappraisals of randomized trials further note that while LDL-C reduction via statins yields CVD event benefits, all-cause mortality gains remain modest (e.g., 1% absolute risk reduction over 5 years in primary prevention), raising questions about broad causal attribution amid potential pleiotropic effects or harms like muscle toxicity.[](https://www.amjmed.com/article/S0002-9343%2818%2930404-2/fulltext) [](https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391) These critiques, often from researchers outside dominant pharmaceutical-aligned consensus, emphasize the need for causal validation beyond correlations, including Mendelian randomization studies showing familial hypercholesterolemia's risks tied more to lifelong exposure than acute levels.[](https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391)\n\n### Dietary Fat and Carbohydrate Roles\n\nMultiple meta-analyses of randomized controlled trials and prospective cohort studies have concluded that dietary saturated fat intake is not significantly associated with increased risk of cardiovascular disease (CVD) events or mortality, challenging long-standing dietary guidelines that recommended strict limitation of saturated fats.[](https://www.sciencedirect.com/science/article/pii/S0735109720356874)[](https://ajcn.nutrition.org/article/S0002-9165%2823%2901672-6/fulltext) For instance, a 2020 reassessment in the Journal of the American College of Cardiology found no beneficial effects on CVD outcomes from reducing saturated fat consumption, particularly when replaced by refined carbohydrates rather than polyunsaturated fats.[](https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077) This evidence has prompted critiques of nutritional guidelines, such as those from the American Heart Association, for overemphasizing saturated fat restriction based on early observational data that conflated saturated fats with trans fats and processed foods.[](https://www.ahajournals.org/doi/10.1161/cir.0000000000000510)\n\nIn contrast, replacement of saturated fats with polyunsaturated fatty acids in controlled trials has shown modest reductions in CVD risk, estimated at 19-21% in some analyses, but benefits diminish or reverse when substituted with carbohydrates, highlighting the importance of what replaces saturated fats rather than saturated fats themselves.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/)[](https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1396576/full) A 2018 BMJ review on dietary fats and cardiometabolic health underscored these nuances, noting that guidelines often fail to distinguish between food matricesâ€”such as whole-fat dairy or unprocessed meats, which show neutral or protective effectsâ€”and isolated saturated fatty acids, while ignoring potential harms from carbohydrate-driven metabolic shifts.[](https://www.bmj.com/content/361/bmj.k2139)\n\nHigh intake of refined and processed carbohydrates, including added sugars like sucrose and high-fructose corn syrup, promotes insulin resistance, a key causal pathway in atherosclerosis and CVD progression, independent of total fat consumption.[](https://openheart.bmj.com/content/4/2/e000729)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6139832/) Epidemiological and mechanistic studies link excessive refined carbohydrate consumption to elevated triglycerides, small dense LDL particles, and endothelial dysfunction via chronic hyperinsulinemia and hepatic de novo lipogenesis.[](https://ajcn.nutrition.org/article/S0002-9165%2822%2903918-1/fulltext) For example, prospective data indicate that diets high in glycemic load from processed carbs increase coronary heart disease risk by fostering visceral adiposity and inflammation, effects exacerbated in insulin-resistant individuals.[](https://nutritionsource.hsph.harvard.edu/carbohydrates/carbohydrates-and-blood-sugar/)\n\nRandomized trials comparing low-carbohydrate, higher-fat diets to low-fat, higher-carbohydrate regimens demonstrate superior improvements in CVD risk markersâ€”such as HDL cholesterol, triglycerides, and insulin sensitivityâ€”with the former, alongside greater weight loss, suggesting that carbohydrate restriction may mitigate CVD risk more effectively than fat restriction in metabolically vulnerable populations.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4428290/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/) These findings align with causal evidence from metabolic ward studies, where high-carb intake induces postprandial hyperglycemia and oxidative stress, contrasting with the metabolic stability of fats from whole foods.[](https://answers.childrenshospital.org/low-carb-diet/) However, long-term adherence and individual variability, including genetic factors influencing fat metabolism, remain areas of ongoing debate, with some observational data showing elevated LDL in strict low-carb contexts warranting personalized approaches over blanket guidelines.[](https://www.jacc.org/doi/10.1016/j.jacadv.2024.100924)\n\n### Statin Overuse and Pharmaceutical Influence\n\nCritics have argued that the widespread prescription of statins for cardiovascular disease prevention reflects commercial distortion by pharmaceutical interests, leading to overuse particularly in primary prevention among low-risk populations. Cardiologist Aseem Malhotra, in analyses published in 2025, contended that industry-funded trials and guidelines exaggerate benefits while minimizing harms, influencing clinical practice to prioritize lipid-lowering drugs over lifestyle measures.[](https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins)[](https://singjupost.com/transcript-what-big-pharma-doesnt-want-you-to-know-about-statins-dr-aseem-malhotra/) This perspective aligns with broader evidence of drug company practices that overplay relative risk reductions in marketing while downplaying absolute benefits and adverse events.[](https://theconversation.com/time-to-end-drug-company-distortion-of-medical-evidence-127495)\n\nIn primary prevention, the absolute risk reduction (ARR) from statins is typically low, often less than 1% over five years for major cardiovascular events, translating to a number needed to treat (NNT) exceeding 50 to prevent one heart attack. For instance, meta-analyses of trials in individuals without prior heart disease show a 1.6% ARR for avoiding myocardial infarction after five years of therapy, with even smaller gains for stroke (0.37%) or mortality.[](https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/) These modest effects contrast with relative risk reductions of 20-30% often highlighted in promotional materials, potentially misleading prescribers and patients about net benefits in low-risk groups.[](https://www.aafp.org/pubs/afp/issues/2010/1001/p741.html)\n\nStatin side effects, including muscle pain, weakness, elevated diabetes risk, and hepatic dysfunction, appear underreported in clinical trials and post-marketing surveillance, with U.S. Food and Drug Administration data indicating that only 0.01% to 44% of adverse drug events for statins are captured. Observational studies report muscle symptoms in up to 10-20% of users, higher than the 5% or less in randomized controlled trials, which may exclude susceptible individuals or rely on subjective reporting biased toward continuation.[](https://pubmed.ncbi.nlm.nih.gov/28447485/)[](https://www.ahajournals.org/doi/10.1161/atv.0000000000000073) This discrepancy contributes to overuse, as evidenced by retrospective analyses showing potential statin excess in 60% of older community-dwelling patients without clear indications.[](https://www.researchgate.net/publication/334547485_Potential_Statin_Overuse_in_Older_Patients_A_Retrospective_Cross-Sectional_Study_Using_French_Health_Insurance_Databases)\n\nFor primary prevention, lifestyle interventionsâ€”such as adopting a Mediterranean-style diet, regular physical activity, and smoking cessationâ€”demonstrate superior risk reduction compared to statins alone, with healthy behaviors linked to up to 50% lower coronary artery disease incidence in population studies. Modeling suggests that comprehensive lifestyle strategies outperform moderate statin regimens in averting events among those without established disease, emphasizing their role as first-line options before pharmacological escalation.[](https://advances.massgeneral.org/cardiovascular/article.aspx?id=1022)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8836845/) Pharmaceutical influence on guidelines has been critiqued for sidelining such non-drug approaches, potentially driven by revenue incentives from blockbuster statin sales exceeding billions annually.[](https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins)\n\n### Inflammation as Primary Driver\n\nProponents of inflammation as the primary causal driver of cardiovascular disease argue that inflammatory processes initiate and propagate atherosclerosis, with lipid accumulation serving as a secondary response rather than the root cause. Experimental and histopathological evidence demonstrates that endothelial dysfunction, triggered by inflammatory cytokines and immune activation, precedes plaque formation, independent of cholesterol levels.[](https://www.ahajournals.org/doi/10.1161/hc0902.104353) This view challenges lipid-centric models by emphasizing innate immunity's role in oxidizing trapped lipoproteins and recruiting monocytes, which amplify lesion progression.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9682196/)\n\nC-reactive protein (CRP), an acute-phase reactant and marker of systemic inflammation, has been shown to predict cardiovascular events more robustly than low-density lipoprotein (LDL) cholesterol in multiple cohorts. In a prospective analysis of 27,939 apparently healthy women followed for up to eight years, CRP levels stratified risk across LDL categories, with each standard deviation increase in CRP conferring a 1.5-fold higher relative risk of first cardiovascular events, surpassing LDL's predictive power.[](https://www.nejm.org/doi/full/10.1056/NEJMoa021993) Similarly, among statin-treated patients post-acute coronary syndrome, residual inflammatory risk indexed by high-sensitivity CRP outperformed LDL in forecasting recurrent events, suggesting inflammation sustains atherothrombosis even when lipids are controlled.[](https://www.tctmd.com/news/crp-more-predictive-future-events-ldl-statin-treated-patients) These findings support causal inference from trials like JUPITER, where rosuvastatin's benefits correlated more closely with CRP reduction than LDL lowering.[](https://pubmed.ncbi.nlm.nih.gov/12432042/)\n\nInfectious and immune mechanisms further bolster inflammation's primacy, as detailed in a 2018 review synthesizing human, experimental, and biomarker data. Pathogens such as *Chlamydia pneumoniae* and periodontal bacteria provoke chronic vascular inflammation, linking infection to plaque instability and thrombosis via Toll-like receptor activation and cytokine storms.[](https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1043) This refutes pure atherothrombosis models by highlighting how immune dysregulation integrates traditional risksâ€”smoking, hypertensionâ€”into inflammatory cascades, with clinical trials like CANTOS demonstrating interleukin-1Î² inhibition reduces events by 15-20% irrespective of lipid profiles.[](https://clinicaltrials.gov/study/NCT01594333)\n\nGut-derived endotoxemia exemplifies an upstream inflammatory trigger, where dysbiosis-induced lipopolysaccharide (LPS) translocation from permeable barriers elevates circulating endotoxins, fostering metabolic inflammation and endothelial damage. In patients with coronary artery disease, LPS levels correlate with plaque burden and adverse outcomes, independent of dyslipidemia, as LPS activates NLRP3 inflammasomes to promote foam cell formation.[](https://www.nature.com/articles/s41569-022-00737-2) Observational data from high-risk cohorts show metabolic endotoxemia amplifies atherosclerosis in obesity and diabetes, with interventions like prebiotics modulating microbiota to lower CVD markers.[](https://pubmed.ncbi.nlm.nih.gov/31894861/)\n\nCritiques of the lipid hypothesis underscore these shifts, positing that elevated LDL reflects oxidative stress and inflammation rather than causing it de novo. Epidemiological reanalyses reveal weak causal links between saturated fats and heart disease when confounders like trans fats or refined carbs are isolated, with inflammation metrics like CRP explaining variance better in familial hypercholesterolemia cases lacking early events.[](https://pubmed.ncbi.nlm.nih.gov/18615352/) This perspective, advanced by researchers questioning statin universality, urges mechanistic reframing toward anti-inflammatory strategies, though mainstream consensus retains lipids' contributory role amid ongoing debates over trial designs favoring pharmaceutical endpoints.[](https://kevinmd.com/2025/10/re-examining-the-lipid-hypothesis-and-statin-use.html)[](https://www.researchgate.net/publication/5236032_The_fallacies_of_the_lipid_hypothesis)\n\n## Research Directions\n\n### Genetic and Molecular Advances\n\nRecent advances in genomics have enabled the development of polygenic risk scores (PRS) that integrate thousands of common genetic variants to estimate an individual's susceptibility to coronary artery disease and other cardiovascular conditions. These scores capture the cumulative effect of low-penetrance alleles, providing incremental prognostic value beyond traditional clinical risk factors such as age, hypertension, and cholesterol levels. A 2024 study in the European Heart Journal demonstrated that incorporating a CVD-PRS into standard risk models reclassified 10-15% of intermediate-risk individuals into higher or lower categories, enhancing net reclassification improvement by up to 5%. Similarly, analyses from the American College of Cardiology in 2024 confirmed that PRS refines subclinical atherosclerosis prediction when combined with coronary artery calcium scoring, with high PRS individuals showing elevated event rates independent of lifestyle factors.[](https://academic.oup.com/eurheartj/article/45/34/3152/7689554)[](https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/09/16/14/28/polygenic-risk-score-adds)\n\nFor monogenic disorders like familial hypercholesterolemia (FH), which affects approximately 1 in 250 individuals and elevates LDL cholesterol due to mutations in genes such as LDLR, PCSK9, or APOB, CRISPR-Cas9-based gene editing has emerged as a transformative therapy. In phase 1 trials reported in 2023, a single intravenous dose of VERVE-101, targeting the PCSK9 gene in heterozygous FH patients, achieved durable LDL reductions of 55% at 180 days post-infusion, with no serious adverse events linked to off-target editing. Ongoing trials as of June 2025, including CTX310 and CTX320 from CRISPR Therapeutics, extend this approach to both heterozygous and homozygous FH, demonstrating sustained PCSK9 suppression and LDL lowering without the need for lifelong lipid-lowering drugs. Preclinical studies using AAV-delivered CRISPR to correct LDLR mutations in FH mouse models reduced atherosclerosis burden by restoring receptor function, supporting translation to human applications. These interventions address causal genetic defects directly, potentially preventing premature cardiovascular events in high-risk pedigrees.[](https://www.acc.org/Latest-in-Cardiology/Articles/2023/11/08/20/14/sun-445pm-heart1-aha-2023)[](https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-reports-positive-additional-phase-1-data)[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042476)\n\nAt the molecular level, novel biomarkers reflecting endothelial dysfunction, inflammation, and fibrosis are advancing early detection and risk stratification. Growth differentiation factor-15 (GDF-15), a stress-responsive cytokine, independently predicts major adverse cardiovascular events in population cohorts, with levels elevated prior to clinical manifestation in up to 20% of at-risk individuals. MicroRNAs (miRNAs), such as miR-208a and miR-499, serve as circulating indicators of myocardial injury, offering higher sensitivity than troponins for subclinical damage detection in recent 2024-2025 validations. Extracellular vesicles carrying proteomic cargo have also shown promise in profiling plaque instability, with lipidomic signatures correlating to acute coronary syndrome progression. These biomarkers, when integrated with genetic data, facilitate precision phenotyping, though challenges like assay standardization and population-specific validation persist. An American Heart Association advisory in November 2024 emphasized gene therapy's role in targeting molecular pathways, including AAV-vectors for angiogenic factors in ischemic disease, underscoring the shift toward causal, genotype-guided interventions.[](https://www.mdpi.com/1422-0067/26/7/3218)[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001296)\n\n### Technological Innovations\n\nWearable devices equipped with photoplethysmography (PPG) and electrocardiogram (ECG) capabilities have advanced atrial fibrillation (AFib) detection, enabling real-time monitoring outside clinical settings. For instance, smartwatches like the Apple Watch incorporate ECG signals for AFib identification, with algorithms achieving high sensitivity and specificity in ambulatory populations.[](https://pubs.aip.org/aip/bpr/article/6/1/011301/3331507/Recent-advances-in-the-tools-and-techniques-for-AI) A 2025 systematic review confirmed the efficacy of these wearables in detecting arrhythmias, including paroxysmal AFib, through AI-enhanced analysis of heart rate variability, supporting timely interventions in asymptomatic cases.[](https://healthcare-bulletin.co.uk/article/the-efficacy-of-wearable-cardiovascular-monitoring-devices-in-real-time-arrhythmia-detection-systematic-review-3415/) Comparative studies of consumer wearables, such as ECG smart chest patches versus PPG smartwatches, reported diagnostic accuracies exceeding 90% for distinguishing sinus rhythm from AFib, though chest patches demonstrated marginally superior performance in prolonged monitoring.[](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04582-2)\n\nArtificial intelligence applications in cardiovascular imaging have progressed toward automated analysis and predictive modeling, particularly in cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In 2025, AI tools facilitate image segmentation, noise reduction, and tissue characterization in MRI, evolving from basic tasks to prognostic assessments of myocardial viability and fibrosis.[](https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI) Scientific statements highlight AI's role in streamlining workflows, including patient selection and automated reporting in cardiac CT/MRI, with emerging models predicting adverse events by integrating imaging data with clinical variables.[](https://pubs.rsna.org/doi/10.1148/radiol.240516) Trends include AI-driven image enhancement and generation techniques, which improve diagnostic precision in interventional cardiology, such as real-time guidance during procedures, though challenges persist in validation across diverse populations.[](https://cardiovascularbusiness.com/topics/artificial-intelligence/revolution-here-ais-growing-role-cardiovascular-imaging-interventional-cardiology)\n\nConduction mapping technologies have refined the visualization of the heart's electrical pathways, aiding arrhythmia management and surgical planning. Intraoperative techniques employing multielectrode catheters and fiberoptic confocal microscopy localize the His bundle and conduction tissues during congenital heart surgery, using clockface schematics to generate predictive models and minimize injury risk.[](https://www.sciencedirect.com/science/article/pii/S0022522322013277) A Mayo Clinic study in October 2025 revealed novel anatomical details of the conduction system via advanced mapping, providing a bioanatomical framework to enhance understanding of myocardial synchrony and arrhythmogenesis.[](https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651) Three-dimensional electroanatomical mapping systems, modified for pediatric use, reduce radiation exposure while enabling precise velocity assessments near regions of interest, improving accuracy in complex cases.[](https://www.innovationsincrm.com/cardiac-rhythm-management/2013/february/395-three-dimensional-mapping-system-modification)[](https://www.jacc.org/doi/10.1016/j.jacep.2024.12.026)\n\n### Public Health Policy Implications\n\n![Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png][float-right]\nCardiovascular diseases accounted for 19.2 million deaths worldwide in 2023, representing approximately one in three global deaths, with projections indicating a 90% increase in prevalence from 2025 to 2050 driven primarily by aging populations and rising rates of modifiable risk factors such as hypertension, obesity, and smoking.[](https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023)[](https://pubmed.ncbi.nlm.nih.gov/39270739/) Public health policies must target these factors through evidence-supported strategies, including widespread screening and management of hypertension, which can be implemented cost-effectively at primary care levels, potentially averting millions of deaths if treatment coverage reaches 70%.[](https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29)[](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160) Community-based educational interventions have demonstrated effectiveness in enhancing knowledge of CVD risks, promoting physical activity, and improving dietary practices, thereby reducing incidence without relying on coercive measures.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8386815/)\n\nWhile regulatory policies such as tobacco taxes and sodium reduction initiatives show population-level benefits in lowering CVD events, skepticism persists regarding broad mandates due to their potential to overlook individual variability in risk and compliance, with evidence favoring voluntary adoption of healthy behaviors like smoking cessation and weight management for sustained risk reduction.[](https://www.sciencedirect.com/science/article/abs/pii/S0033350622001044)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/) Policies emphasizing personal risk assessment tools, such as Framingham or ASCVD calculators, enable targeted education on individual modifiable factors, empowering informed decision-making over uniform interventions that may not account for causal heterogeneity in disease onset. Limited health literacy exacerbates CVD morbidity, underscoring the value of accessible, non-mandated educational campaigns to improve outcomes across populations.[](https://www.ahajournals.org/doi/10.1161/CIR.0000000000000579)\n\nTo address escalating projections, policies should prioritize modifiable behavioral risksâ€”evidenced by the role of physical inactivity, poor nutrition, and tobacco use in driving the global burdenâ€”rather than narratives centered on socioeconomic equity, which often conflate correlation with causation and divert resources from direct interventions like lifestyle promotion. Empirical data indicate that scaling evidence-based behavioral changes, including regular exercise and smoking avoidance, yields significant CVD prevention independent of structural reforms. Such approaches align with causal mechanisms linking personal habits to arterial health, promoting accountability and efficacy in resource allocation.[](https://www.sciencedirect.com/science/article/pii/S003306202100133X)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/)"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761882342771,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"Cardiovascular diseases (CVDs) - World Health Organization (WHO)\",\"description\":\"Jul 31, 2025 Â· Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels. They include: Heart attacks and strokes are usually acute events.Cardiovascular risk charts Â· WHO reveals leading causes Â· Sodium reduction\",\"url\":\"https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"The Global Burden of Cardiovascular Diseases and Risk - JACC\",\"description\":\"In this review, we report on the burden due to these risk factors and recent advances in addressing them to help guide the development of research goals andÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"Global, Regional, and National Burden of Cardiovascular Diseases ...\",\"description\":\"Sep 24, 2025 Â· As of 2023, there were 437 million (95% UI: 401 to 465 million) CVD DALYs globally, a 1.4-fold increase from the number in 1990 of 320 million (Â ...Missing:  statistics | Show results with:statistics\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40990886/\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"A Systematic Review of Major Cardiovascular Risk Factors\",\"description\":\"Oct 10, 2022 Â· According to the researchers, potential risk factors for coronary artery diseases are hypertension, obesity, and physical inactivity [23-25]. AÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9644238/\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"Global Effect of Modifiable Risk Factors on Cardiovascular Disease ...\",\"description\":\"Aug 26, 2023 Â· We examined associations between the risk factors (body-mass index, systolic blood pressure, nonâ€“high-density lipoprotein cholesterol, current smoking, andÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2206916\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"A Brief Review of Cardiovascular Diseases, Associated Risk Factors ...\",\"description\":\"The aetiological risk factors leading to the onset of CVDs are well recognized and include hyperlipidaemia, hypertension, diabetes, obesity, smoking and, lackÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/31553287/\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"the epidemiology of cardiovascular disease and its risk factors - The ...\",\"description\":\"Trends in CV risk factor levels have been mixed, with declines in smoking and mean cholesterol counterbalanced by higher prevalence of obesity and diabetes.\",\"url\":\"https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900287-4/fulltext\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"Cardiovascular Disease - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Cardiovascular disease, also known as heart disease, refers to the following 4 entities: coronary artery disease (CAD) which is also referred to as coronaryÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK535419/\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"ICD-11\",\"description\":\"ICD-11. International Classification of Diseases 11th Revision. The global standard for diagnostic health information. Use ICDâ€‘11. ICD-11 Browser; for seeingÂ ...WHO-FIC Maintenance Platform Â· Coding Tool Â· ICD-11 Training Package Â· ICD-API\",\"url\":\"https://icd.who.int/\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"11 - Diseases of the circulatory system - ICD-11 MMS - Find-A-Code\",\"description\":\"Hypertensive diseases (BA00-BA04. Â· Hypotension (BA20-BA2Z) Â· Ischaemic heart diseases (BA40-BA6Z) Â· Diseases of coronary artery (BA81-BA8Z) Â· Pulmonary heartÂ ...\",\"url\":\"https://www.findacode.com/icd-11/chapter-11.html\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"\",\"description\":\"\",\"url\":\"https://icd.who.int/dev11/l-m/en\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"Cardiovascular Disease (10-year risk) - Framingham Heart Study\",\"description\":\"The Risk Calculator enables health care providers and patients to estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD).\",\"url\":\"https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"\",\"description\":\"\",\"url\":\"https://academic.oup.com/eurjpc/advance-article-abstract/doi/10.1093/eurjpc/zwae281/7756567\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"Forecasting the Burden of Cardiovascular Disease and Stroke in the ...\",\"description\":\"Jun 4, 2024 Â· Clinical CVD will affect 45 million adults, and CVD including hypertension will affect more than 184 million adults by 2050 (\u003e61%). SimilarÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"Heart disease - Symptoms and causes - Mayo Clinic\",\"description\":\"Aug 13, 2024 Â· Getting very short of breath during exercise or activity. Easily tiring during exercise or activity. Swelling of the hands, ankles or feet.\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"Cardiovascular Disease: Types, Causes \u0026 Symptoms\",\"description\":\"Cardiovascular disease is a group of diseases affecting your heart and blood vessels. These diseases can affect one or many parts of your heart and/or bloodÂ ...\",\"url\":\"https://my.clevelandclinic.org/health/diseases/21493-cardiovascular-disease\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"About Heart Disease - CDC\",\"description\":\"May 15, 2024 Â· Symptoms Â· Heart attack: Chest pain or discomfort, upper back or neck pain, heartburn, nausea or vomiting, extreme fatigue, dizziness, andÂ ...\",\"url\":\"https://www.cdc.gov/heart-disease/about/index.html\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Coronary artery disease - Symptoms and causes - Mayo Clinic\",\"description\":\"Jun 14, 2024 Â· Symptoms are from the lack of blood flow to the heart. They may include chest pain and shortness of breath. A complete blockage of blood flowÂ ...\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Coronary Heart Disease - Symptoms | NHLBI, NIH\",\"description\":\"Dec 27, 2024 Â· Symptoms of a heart attack Â· Dizziness Â· Extreme tiredness Â· Nausea Â· Pressure or tightness in the chest Â· Stomach pain.\",\"url\":\"https://www.nhlbi.nih.gov/health/coronary-heart-disease/symptoms\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Heart failure - Symptoms and causes - Mayo Clinic\",\"description\":\"Jan 21, 2025 Â· Rapid or irregular heartbeat with shortness of breath, chest pain or fainting. Sudden, severe shortness of breath and coughing up white or pink,Â ...Diagnosis and treatment Â· Heart failure action plan Â· Care at Mayo Clinic\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"Heart Failure Signs and Symptoms | American Heart Association\",\"description\":\"May 29, 2025 Â· Learn the most common signs and symptoms of heart failure which include shortness of breath, fatigue and excess fluid.\",\"url\":\"https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"Peripheral artery disease (PAD) - Symptoms and causes - Mayo Clinic\",\"description\":\"Aug 9, 2024 Â· Claudication is pain in the legs or arms that occurs while walking or using the arms. The pain is caused by too little blood flow to the legsÂ ...\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/peripheral-artery-disease/symptoms-causes/syc-20350557\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"About Peripheral Arterial Disease (PAD) - CDC\",\"description\":\"May 15, 2024 Â· Signs and symptoms Â· Muscle atrophy (weakness). Â· Hair loss. Â· Smooth, shiny skin. Â· Skin that is cool to the touch, especially if there is painÂ ...\",\"url\":\"https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"Stroke - Symptoms and causes - Mayo Clinic\",\"description\":\"Dec 13, 2024 Â· Headache. A sudden, severe headache may be a symptom of a stroke. Vomiting, dizziness and a change in consciousness may occur with the headache.\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Signs and Symptoms of Stroke - CDC\",\"description\":\"Oct 24, 2024 Â· Sudden trouble walking, dizziness, loss of balance, or lack of coordination. Sudden severe headache with no known cause. Call 9-1-1 right awayÂ ...About Men and Heart Disease Â· About Â· Treatment and Intervention Â· Risk Factors\",\"url\":\"https://www.cdc.gov/stroke/signs-symptoms/index.html\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"Global, Regional, and National Burden of Cardiovascular Diseases ...\",\"description\":\"Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the leading cardiovascular causes of DALYs in 2023Â ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2025.08.015\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"[PDF] 2025 Heart Disease \u0026 Stroke Statistics Update Fact Sheet Global ...\",\"description\":\"Jan 27, 2025 Â· Cardiovascular Disease (CVD)â€‹â€‹ death rate per 100 000 population was 235.18. The global prevalence of CVD was 612.06 million. The age-adjustedÂ ...\",\"url\":\"https://professional.heart.org/-/media/phd-files-2/science-news/2/2025-heart-and-stroke-stat-update/factsheets/2025-stats-update-fact-sheet-global-burden-of-disease.pdf\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"Report: cardiovascular diseases caused 1 in 3 global deaths in 2023\",\"description\":\"Sep 24, 2025 Â· The number of cardiovascular disease deaths worldwide has risen sharply, climbing from 13.1 million in 1990 to 19.2 million in 2023. Share.\",\"url\":\"https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"Global burden of cardiovascular diseases: projections from 2025 to ...\",\"description\":\"Aug 25, 2025 Â· Between 2025 and 2050, a 90.0% increase in cardiovascular prevalence, 73.4% increase in crude mortality, and 54.7% increase in crude DALYs are projected.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/39270739/\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"Population shifts, risk factors may triple U.S. cardiovascular disease ...\",\"description\":\"Jun 4, 2024 Â· Cardiovascular disease, including stroke, (but not including high blood pressure) will increase from 11.3% to 15.0%, from 28 million to 45Â ...\",\"url\":\"https://newsroom.heart.org/news/population-shifts-risk-factors-may-triple-u-s-cardiovascular-disease-costs-by-2050\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"Coronary Artery Disease - StatPearls - NCBI Bookshelf\",\"description\":\"Oct 9, 2024 Â· ACS presents as sudden-onset substernal chest pain or pressure, typically radiating to the neck and left arm, and may be accompanied by dyspnea,Â ...Epidemiology Â· Pathophysiology Â· Evaluation Â· Treatment / Management\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK564304/\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"Atherosclerosis - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Atherosclerosis is a chronic inflammatory disease in which there is a build up of plaques inside arteries. These plaques are principally composed of lipids thatÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK507799/\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"Prevalence of Subclinical Coronary Artery Atherosclerosis in the ...\",\"description\":\"Sep 20, 2021 Â· Using coronary computed tomography angiography, we show that silent coronary atherosclerosis was common (42.1%), significant stenosis (â‰¥50%) wasÂ ...Missing:  buildup empirical\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055340\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"Acute Coronary Syndrome (ACS): Symptoms \u0026 Treatment\",\"description\":\"Acute coronary syndrome is when a blockage in a coronary artery reduces blood flow to your heart. It's an umbrella term for unstable angina, STEMI andÂ ...\",\"url\":\"https://my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"Stable Coronary Syndromes: The Case for Consolidating the ...\",\"description\":\"Aug 1, 2017 Â· By contrast, acute coronary syndrome is a unifying hierarchical term that subtends the distinct subgroups of unstable angina and myocardialÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.028991\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"Heart Disease Facts - CDC\",\"description\":\"Oct 24, 2024 Â· In 2023, 919,032 people died from cardiovascular disease. That's the equivalent of 1 in every 3 deaths.1; Heart disease cost about $417.9Â ...Healthy People 2030 Â· About Heart Attack Symptoms... Â· Risk Factors Â· Heart diseas\",\"url\":\"https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"2024 Heart Disease and Stroke Statistics: A Report of US and ...\",\"description\":\"Jan 24, 2024 Â· The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001209\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"Global, Regional, and National Burden of Stroke, 1990â€“2021\",\"description\":\"Oct 17, 2024 Â· The actual stroke burden showed an increasing trend for stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and ischemic stroke in 2021Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048033\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"Global, regional, and national burden of ischemic stroke, 1990â€“2021\",\"description\":\"Jul 27, 2024 Â· The global incidence of ischemic stroke reached 7,804,449.4 cases (95% UI: 6,719,760.4â€“8,943,692.1) in 2021, marking an 87.69% increase fromÂ ...\",\"url\":\"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2824%2900337-7/fulltext\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"Types of Stroke and Treatment\",\"description\":\"Types of Stroke and Treatment Â· Ischemic Stroke (Clots) Â· Hemorrhagic Stroke (Bleeds) Â· Transient Ischemic Attack (TIA) Â· Cryptogenic Stroke Â· Brain Stem Stroke.\",\"url\":\"https://www.stroke.org/en/about-stroke/types-of-stroke\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Types of Stroke | Johns Hopkins Medicine\",\"description\":\"... ischemic attacks, or TIAs. TIAs may last for ... Although usually mild and transient, the symptoms caused by a TIA are similar to those caused by a stroke.\",\"url\":\"https://www.hopkinsmedicine.org/health/conditions-and-diseases/stroke/types-of-stroke\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"Global, regional, and national burden of stroke and its risk factors ...\",\"description\":\"Sep 18, 2024 Â· Globally, ischaemic stroke constituted 65Â·3% (62Â·4â€“67Â·7), intracerebral haemorrhage constituted 28Â·8% (28Â·3â€“28Â·8), and subarachnoid haemorrhageÂ ...\",\"url\":\"https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"Projections of the Stroke Burden at the Global, Regional, and ...\",\"description\":\"Nov 22, 2024 Â· From 2021 to 2050, there was a declining trend in the global ageâ€adjusted stroke rates, with âˆ’7% in incidence, âˆ’4% in prevalence, âˆ’28% in deathsÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.124.036142\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"Comparison of risk factors for ischemic stroke and coronary events ...\",\"description\":\"Nov 12, 2021 Â· The main result of this study is that most cardiovascular risk factors show broadly similar associations with CE and ischemic stroke, but there are someÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8588679/\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"Global Effect of Cardiovascular Risk Factors on Lifetime Estimates\",\"description\":\"Mar 30, 2025 Â· Persons who modified hypertension and smoking in midlife had the most additional life-years free of cardiovascular disease and death from anyÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2415879\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"Burden of Coronary Artery Disease as a Predictor of New Vascular ...\",\"description\":\"Mar 13, 2025 Â· Ischemic stroke and coronary artery disease (CAD) share the same cardiovascular disease (CVD) risk factors and frequently coexist, and both areÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12132760/\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Cerebrovascular Disease - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"Most patients following a stroke remain disabled or have partial neurological deficits that prevent them from being active in the workforce.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK430927/\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"Cognitive Impairment After Ischemic and Hemorrhagic Stroke\",\"description\":\"May 1, 2023 Â· Although cognitive impairment is reversible in some cases early after stroke, up to one-third of individuals with stroke develop dementia withinÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/STR.0000000000000430\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"About Stroke - CDC\",\"description\":\"Oct 24, 2024 Â· Transient ischemic attack (TIA or â€œmini-strokeâ€). TIAs are sometimes known as \\\"warning strokes.\\\" It's important to know that: A TIA is a warningÂ ...Missing:  subtypes | Show results with:subtypes\",\"url\":\"https://www.cdc.gov/stroke/about/index.html\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Peripheral Arterial Disease - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"... PAD acts as a marker for systemic atherosclerosis. Patients with PAD have an ... Etiology. Peripheral artery disease is usually caused by atherosclerosis.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK430745/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"Contemporary Medical Management of Peripheral Artery Disease\",\"description\":\"Jun 10, 2021 Â· Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis with common treatment approaches to reduce cardiovascular risk.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318258\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"Comprehensive insights into peripheral artery disease - PubMed\",\"description\":\"Jul 1, 2025 Â· PAD is a manifestation of systemic atherosclerosis that is often associated with coronary and cerebrovascular disease, underscoring itsÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40590724/\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"Epidemiology of Peripheral Artery Disease and Polyvascular Disease\",\"description\":\"Jun 10, 2021 Â· PAD can affect any artery perfusing the lower extremities. The classic symptom of PAD is intermittent claudication (IC), characterized byÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318535\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment\",\"description\":\"Mar 15, 2019 Â· Intermittent claudication is the hallmark of PAD and is defined as fatigue, discomfort, cramping, or pain of vascular origin in the calf musclesÂ ...\",\"url\":\"https://www.aafp.org/pubs/afp/issues/2019/0315/p362.html\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Epidemiology of Peripheral Artery Disease | Circulation Research\",\"description\":\"Apr 24, 2015 Â· The most common symptom of PAD is intermittent claudication, but noninvasive measures, such as the ankle-brachial index, show that asymptomaticÂ ...Incidence And Prevalence Of... Â· Pad Risk Factors Â· Pad As A Predictor Of...\u003c|separator|\u003e\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circresaha.116.303849\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"The global burden of peripheral artery disease - PubMed\",\"description\":\"Results: We observed a 72% increase in the global prevalence of PAD from an estimated 65,764,499 persons in 1990 to 113,443,016 in 2019. Prevalence per 100,000Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/36565779/\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"Forecasting the Global Burden of Peripheral Artery Disease from ...\",\"description\":\"Jul 1, 2025 Â· The number of PAD cases worldwide is projected to increase by 220% by 2050, reaching a staggering 360 million (95% uncertainty interval, 270 to 450).\",\"url\":\"https://spj.science.org/doi/10.34133/research.0702\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Health Disparities in Peripheral Artery Disease: A Scientific ...\",\"description\":\"Jun 15, 2023 Â· Overall prevalence estimates indicate that there are 7 to 12 million affected individuals in the United States and 200 million people worldwide.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001153\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"Nontraditional Risk Factors for Peripheral Artery Disease\",\"description\":\"Aug 7, 2025 Â· Despite this high burden of disease, PAD is underdiagnosed due to the high prevalence of asymptomatic disease, variability in reported legÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/ATVBAHA.125.323193\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"Peripheral Artery Disease: Implications For Health and Quality of Life\",\"description\":\"Oct 22, 2024 Â· However, PAD remains underdiagnosed, rendering these statistics inaccurate, especially among patients with limited health care access orÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2024/10/22/17/25/PAD-Implications-For-Health-and-Quality-of-Life\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"Women with PVD often underdiagnosed \u0026 undertreated ...\",\"description\":\"Mar 11, 2025 Â· Significant disparities exist for women with peripheral vascular disease (PVD), particularly in risk factors, symptoms, screening, treatment and outcomes.\",\"url\":\"https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"Types of Heart Failure | American Heart Association\",\"description\":\"May 21, 2025 Â· Congestive heart failure (CHF) is a form of heart failure in which the heart cannot pump enough blood to meet the body's needs. Left-sided heartÂ ...\",\"url\":\"https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Systolic vs. Diastolic Heart Failure: What's the Difference? - Healthline\",\"description\":\"In systolic heart failure, the heart cannot effectively contract with each heartbeat. In diastolic heart failure, your heart cannot relax between heartbeats.Systolic Â· Diastolic Â· Left-sided heart failure Â· Treatment\",\"url\":\"https://www.healthline.com/health/heart-failure/systolic-vs-diastolic\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"Systolic vs. diastolic heart failure: Difference, treatment, outlook\",\"description\":\"Mar 15, 2021 Â· Systolic heart failure occurs during a heartbeat and relates to the pumping function, whereas diastolic heart failure occurs between heartbeats and is due toÂ ...\",\"url\":\"https://www.medicalnewstoday.com/articles/systolic-vs-diastolic-heart-failure\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Similarities and Differences between the Pathogenesis and ... - NIH\",\"description\":\"The main differences between diastolic and systolic heart failure are the presence of contractile dysfunction and left ventricular remodeling (Table 1). InÂ ...2. Diastolic Dysfunction Â· Figure 1 Â· 5. Diastolic Heart Failure...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3891535/\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"HF Stats 2024: Heart Failure Epidemiology and Outcomes Statistics\",\"description\":\"Sep 24, 2024 Â· Approximately 6.7 million Americans over 20 years of age have heart failure (HF), and the prevalence is expected to rise to 8.7 million in 2030,Â ...\",\"url\":\"https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"Global Public Health Burden of Heart Failure: An Updated Review\",\"description\":\"Jul 27, 2023 Â· Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10398425/\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"[PDF] HF STATS 2024: Heart Failure Epidemiology and Outcomes ...\",\"description\":\"The lifetime risk of HF has increased to 24%; approxi- mately 1 in 4 persons will develop HF in their lifetime. 3. The proportion of younger patients with HF is.\",\"url\":\"https://escholarship.org/content/qt0pr7s2zr/qt0pr7s2zr.pdf\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"Classification, Epidemiology, and Global Burden of Cardiomyopathies\",\"description\":\"Sep 15, 2017 Â· The primary cardiomyopathies were classified as genetic (HCM, ARVC), acquired (myocarditis), or mixed (both genetic and acquired DCM).\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circresaha.117.309711\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"Genetics of Cardiomyopathy: Clinical and Mechanistic Implications ...\",\"description\":\"Hypertrophic cardiomyopathy caused by pathogenic variants in genes encoding sarcomeric proteins.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8484993/\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"Understanding inherited cardiomyopathies: clinical aspects and ...\",\"description\":\"Apr 8, 2025 Â· HCM and DCM, the most prevalent genetic cardiomyopathies. HCM is morphologically characterized by left ventricular hypertrophy, DCM byÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11976403/\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"What Is Cardiomyopathy? - American Heart Association\",\"description\":\"May 28, 2024 Â· The main types of cardiomyopathy are: Dilated cardiomyopathy Â· Hypertrophic cardiomyopathy Â· Restrictive cardiomyopathy Â· Arrhythmogenic rightÂ ...Dilated Cardiomyopathy (DCM) Â· Symptoms and Diagnosis of...\u003c|separator|\u003e\",\"url\":\"https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"Inherited Cardiomyopathies: Molecular Genetics and Clinical ...\",\"description\":\"This review provides an overview of inherited cardiomyopathies with a focus on their genetic etiology and diagnostic testing in the postgenomic era.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1525157812003042\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"Arrhythmias - StatPearls - NCBI Bookshelf\",\"description\":\"Arrhythmia is broadly categorized into bradyarrhythmias and tachyarrhythmia based on the heart rate. They are further divided according to the origin, means ofÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK558923/\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"Associations between cardiac arrhythmias and cardiovascular ...\",\"description\":\"Nov 25, 2024 Â· Among these arrhythmias, atrial fibrillation (AF) stands out as the most prevalent sustained arrhythmia, with around 44 million people estimatedÂ ...\",\"url\":\"https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20703-6\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"Contribution of Atrial Fibrillation to Incidence and Outcome of ...\",\"description\":\"May 5, 2005 Â· Its prevalence is \u003c1% in the general population, â‰ˆ6% in people older than 65 years of age, and increases up to 9% at the age of 80 to 89 years.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/01.str.0000166053.83476.4a\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"Preventing Stroke in Patients With Atrial Fibrillation - JAMA Network\",\"description\":\"Mar 16, 2016 Â· Atrial fibrillation (AF) increases the risk of stroke by 5-fold, and more than 40% of all strokes in patients older than 80 years areÂ ...\",\"url\":\"https://jamanetwork.com/journals/jamacardiology/fullarticle/2503080\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"7 Ways to Help Prevent Stroke While Living with Afib - Mercy.net\",\"description\":\"People with AFib are five times more likely to suffer stroke. According to the Centers for Disease Control, 15 to 20 percent of ischemic strokes, which happenÂ ...Missing:  statistics | Show results with:statistics\u003c|separator|\u003e\",\"url\":\"https://www.mercy.net/service/atrial-fibrillation/prevent-stroke-while-living-with-afib/\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"Atrial fibrillation and stroke: State-of-the-art and future directions\",\"description\":\"In the Framingham Heart Study population, the lifetime risk of developing AF was estimated to be 1 in 4 for men and women at an index age of 40 years or older.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0146280623005984\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults\",\"description\":\"Jun 28, 2018 Â· Ventricular arrhythmias are thought to cause 75% to 80% of cases of sudden cardiac death, which are estimated to result in 184 000 to 450 000Â ...\u003c|separator|\u003e\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circep.118.006273\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/new-anatomy-for-the-cardiac-conduction-system-discovered-by-mayo-clinic-cardiology-researchers/mac-20590651\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"MYL4 Identifies Intramural Anatomy of Purkinje Fibers in Human ...\",\"description\":\"Jun 4, 2025 Â· This previously unrecognized distribution of the cardiac conduction system accounted for over 60% of human myocardial PF content. Conclusions.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacep.2025.03.039\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"Valvular Heart Disease Epidemiology - PubMed\",\"description\":\"Jun 15, 2022 Â· Aortic valve stenotic disease is the most commonly occurring valvular pathology in developed nations (afflicting 9 million people worldwide) andÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/35736352/\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"Valvular Heart Disease Epidemiology - PMC - NIH\",\"description\":\"Jun 15, 2022 Â· Primary mitral regurgitation arises as a consequence of myxomatous degeneration and mitral valve prolapse, which is largely due to geneticÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9228968/\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"Rheumatic Heart Valve Disease Pathophysiology and Underlying ...\",\"description\":\"This disease shows different natural history and clinical presentations as compared to other degenerative heart valve diseases. Although more than fiveÂ ...\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2020.612716/full\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"Unraveling the Mechanisms of Valvular Heart Disease to Identify ...\",\"description\":\"Jun 17, 2024 Â· We focus on the most common primary valvular heart diseases, including calcific aortic stenosis, bicuspid aortic valves, mitral valve prolapse,Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001254\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"Series Valvular heart disease: from mechanisms to management\",\"description\":\"Apr 26, 2024 Â· Valvular heart disease is caused by the malfunction of one or more heart valves. This common cardiovascular condition affects 5â€“10% of peopleÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0140673623027551\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"Trends and Disparities in Valvular Heart Disease Mortality in the ...\",\"description\":\"Apr 8, 2024 Â· Aortic stenosis was the most common type of valvular heart disease in patients who died from valvular heart disease.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.123.030895\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"Arrhythmias in Patients With Valvular Heart Disease - NIH\",\"description\":\"Feb 15, 2022 Â· VHD-induced left ventricular dysfunction/hypertrophy and left atrial dilation lead to both atrial and ventricular arrhythmias. On the other handÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8885812/\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"Mechanisms of Plaque Formation and Rupture | Circulation Research\",\"description\":\"Jun 6, 2014 Â· In early stages of atherosclerosis, selective inhibition of macrophage apoptosis increases foam cell number, indicating that apoptosis, althoughÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circresaha.114.302721\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"Role of oxidative stress in atherosclerosis - PubMed\",\"description\":\"The common risk factors for atherosclerosis increase production of reactive oxygen species (ROS) by endothelial, vascular smooth muscle, and adventitial cells.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/12645638/\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and ...\",\"description\":\"May 31, 2022 Â· A series of pathophysiological changes caused by oxidized LDL (oxLDL) enhance the formation of foam cells and atherosclerotic plaques. OxLDLÂ ...\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.925923/full\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"Role of Oxidative Modifications in Atherosclerosis\",\"description\":\"Atherosclerosis represents a state of heightened oxidative stress characterized by lipid and protein oxidation in the vascular wall.\",\"url\":\"https://journals.physiology.org/doi/abs/10.1152/physrev.00047.2003\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"Foam Cells in Atherosclerosis: Novel Insights Into Its Origins ...\",\"description\":\"The lipid overload by macrophages and VSMCs induces foam cell formation and triggers apoptosis in atherosclerotic plaques (61). Numerous papers have shown thatÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9043520/\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"Mechanisms modulating foam cell formation in the arterial intima\",\"description\":\"In this review, we describe several mechanisms underlying the formation of intimal foam-like cells in atherosclerotic plaques.\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1381520/full\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"Foam cell formation and cholesterol trafficking and metabolism ...\",\"description\":\"Jul 25, 2018 Â· Foam cells are typical components of atherosclerotic plaques, where they actively participate in the intracellular cholesterol accumulation.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0010865018300560\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"Oxidized Low-Density Lipoprotein Induces Long-Term ...\",\"description\":\"Jun 5, 2014 Â· In the vessel wall, the uptake of oxLDL by macrophages leads to the generation of foam cells, thereby contributing to the formation ofÂ ...Oxldl But Not Ldl Induces... Â· Foam Cell Formation Is... Â· Training Of Oxldl Is Induced...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/atvbaha.114.303887\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"Oxidative Stress-Mediated Atherosclerosis: Mechanisms and ...\",\"description\":\"This study focuses on the method by which inflammation, mitochondria, autophagy, apoptosis, and epigenetics induce oxidative stress to accelerateÂ ...Macrophages Induce... Â· Inflammation Induces... Â· Epigenetic, DNA Methylation...\",\"url\":\"https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00600/full\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"The Role of Oxidative Stress in Atherosclerosis - PMC - NIH\",\"description\":\"Nov 30, 2022 Â· ... the accumulation of inflammatory cells and lipids in the blood vessel wall. ... lipid-laden necrotic core and a thin fibrous cap [124].\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9735601/\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"Small Dense LDL Particles: Clinically Relevant? - PMC - NIH\",\"description\":\"Small, dense, lipid depleted LDL particles (sdLDL) have been found to be particularly strongly associated with risk of atherosclerotic cardiovascular disease (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9197986/\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"The Role of Atherogenic Small, Dense LDL - NIH\",\"description\":\"Feb 16, 2022 Â· These particles have greater arterial entry and retention, higher susceptibility to oxidation, as well as reduced affinity for the LDL receptor.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8877621/\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"Small Dense Lowâ€Density Lipoprotein Cholesterol Is the Most ...\",\"description\":\"Feb 15, 2021 Â· Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter. Nonstandard Abbreviations and Acronyms. lbLDLâ€C: largeÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.120.019140\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"Low-Density Lipoprotein Size and Cardiovascular Disease\",\"description\":\"Small, dense LDL has several characteristics that are linked to atherogenesis: long residence time in plasma, and enhanced oxidizability, arterial proteoglycanÂ ...What is small, dense LDL and... Â· LDL subfractions to predict...\",\"url\":\"https://academic.oup.com/jcem/article/88/10/4525/2845681\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"Atherogenic Lipoprotein Particles in Atherosclerosis | Circulation\",\"description\":\"Small, dense LDL particles are more atherogenic than large, buoyant LDL particles, and oxidation of LDL also increases its atherogenicity.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/01.cir.0000131511.50734.44\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"Mechanisms of Plaque Rupture - NCBI - NIH\",\"description\":\"This process of 'plaque rupture' is responsible for the majority of acute coronary syndromes (unstable angina, MI) 4 - 6 , 7 and ischaemic cerebral events.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK534259/\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts\",\"description\":\"Rupture of high-risk, vulnerable plaques is responsible for coronary thrombosis, the main cause of unstable angina, acute myocardial infarction, and suddenÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0735109705013963\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"Virchow Triad - StatPearls - NCBI Bookshelf\",\"description\":\"The function of Virchow's triad is to demonstrate the underlying physiology that drives the formation of a thrombus. Clots within the vasculature place theÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK539697/\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"Update on acute coronary syndromes: the pathologists' view\",\"description\":\"The coronary artery plaque morphologies primarily responsible for thrombosis are plaque rupture, and plaque erosion, with plaque rupture being the most commonÂ ...\",\"url\":\"https://academic.oup.com/eurheartj/article/34/10/719/496744\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"Optical Coherence Tomography of Plaque Vulnerability and Rupture\",\"description\":\"Sep 13, 2021 Â· This review details major investigations with intravascular OCT into the biology and clinical implications of plaque vulnerability and plaque rupture.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2021.06.050\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"Plaque Vulnerability and Plaque Rupture: In Vivo Biology with OCT\",\"description\":\"A follow up study looked at the underlying mechanisms in STEMI with OCT and IVUS (19). In this cohort, plaque rupture was present at the culprit lesion in 64.8%Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9851427/\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"A Combined Optical Coherence Tomography and Intravascular ...\",\"description\":\"This study sought to evaluate the incidence of plaque rupture (PR), plaque erosion (PE), and calcified nodule (CN) using optical coherence tomography (OCT)\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1936879815006950\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"Thrombus Structural Composition in Cardiovascular Disease\",\"description\":\"Jul 15, 2021 Â· VTE is triggered by 3 fundamental mechanisms, endothelial dysfunction, altered blood flow, and hypercoagulability, also called Virchow's Triad.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315754\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"The Role of Inflammation in Cardiovascular Disease - PubMed Central\",\"description\":\"Macrophages and smooth muscle cells secrete inflammatory cytokines including interleukins IL-1Î², IL-12, and IL-6. Within the arterial wall, low-densityÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9658900/\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"The Role of Inflammation in Cardiovascular Disease - PubMed\",\"description\":\"Oct 26, 2022 Â· Anti-inflammatory interventions specifically blocking the cytokine pathways reduce the risk of myocardial infarction and stroke, although theyÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/36361701/\",\"favicon\":\"\"},{\"id\":\"115\",\"title\":\"Immunity and inflammation in cardiovascular disorders\",\"description\":\"Mar 23, 2023 Â· The role of the adaptive immune system has shown an association with CVD risk due to a sustained and chronic inflammatory state. T and B cellsÂ ...\",\"url\":\"https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03185-z\",\"favicon\":\"\"},{\"id\":\"116\",\"title\":\"High-sensitivity C-reactive Protein in Atherosclerotic Cardiovascular ...\",\"description\":\"Mar 21, 2025 Â· Research over the past 20 years has identified C-reactive protein (CRP) as a key marker of inflammation with atherosclerosis. The association ofÂ ...\",\"url\":\"https://www.uscjournal.com/articles/high-sensitivity-c-reactive-protein-atherosclerotic-cardiovascular-disease-measure-or-not?language_content_entity=en\",\"favicon\":\"\"},{\"id\":\"117\",\"title\":\"C-reactive protein in atherosclerosis: A causal factor? - PubMed\",\"description\":\"Since CRP is present in the atherosclerotic lesion, it may actively contribute to the progression and/or instability of the atherosclerotic plaque.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/16624260/\",\"favicon\":\"\"},{\"id\":\"118\",\"title\":\"The connection between C-reactive protein and atherosclerosis - PMC\",\"description\":\"These findings indicated that the binding property of CRP to LDL may play a role in slowing the development of atherosclerosis in these mice. It was suggestedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3364506/\",\"favicon\":\"\"},{\"id\":\"119\",\"title\":\"Estimating the causal role of C-reactive protein in coronary heart ...\",\"description\":\"We compared risk ratios (RRs) for CHD with genetically elevated CRP to equivalent differences in CRP concentration itself. Atherosclerosis home. Opens inÂ ...\",\"url\":\"https://www.atherosclerosis-journal.com/article/S0021-9150%2810%2900663-5/abstract\",\"favicon\":\"\"},{\"id\":\"120\",\"title\":\"Antiinflammatory Therapy with Canakinumab for Atherosclerotic ...\",\"description\":\"Aug 27, 2017 Â· Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascularÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1707914\",\"favicon\":\"\"},{\"id\":\"121\",\"title\":\"Low-Dose Colchicine for Secondary Prevention of Coronary Artery ...\",\"description\":\"Aug 7, 2023 Â· Low-dose (0.5 mg/d) colchicine, an anti-inflammatory drug, reduces cardiovascular events rates by 25% to 30% in patients with coronaryÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2023.05.055\",\"favicon\":\"\"},{\"id\":\"122\",\"title\":\"Colchicine and Cardiovascular Outcomes: a Critical Appraisal of ...\",\"description\":\"May 10, 2021 Â· Colchicine treatment was associated with a lower risk of major adverse cardiovascular events (RR 0.67; 95%CI 0.6â€“0.92, P = 0.004); CRP and IL-6Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8108024/\",\"favicon\":\"\"},{\"id\":\"123\",\"title\":\"Chronic Infection and Coronary Atherosclerosis - JACC\",\"description\":\"Oct 24, 2011 Â· One proposed additional contributory participant to atherosclerosis is chronic infection. Indeed, much research over the past 20 years hasÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2011.08.015\",\"favicon\":\"\"},{\"id\":\"124\",\"title\":\"Inflammation and cardiovascular diseases - PMC - NIH\",\"description\":\"Infections have been known to cause atherogenesis or to precipitate acute cardiovascular events.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7729114/\",\"favicon\":\"\"},{\"id\":\"125\",\"title\":\"Stress, inflammation and cardiovascular disease - PubMed\",\"description\":\"Stress also induces an atherosclerotic lipid profile with oxidation of lipids and, if chronic, a hypercoagulable state that may result in arterial thromboses.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/11801260/\",\"favicon\":\"\"},{\"id\":\"126\",\"title\":\"Stress, inflammation and cardiovascular disease - ScienceDirect.com\",\"description\":\"These inflammatory events, caused by stress, may account for the approximately 40% of atherosclerotic patients with no other known risk factors. Stress, byÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0022399901003026\",\"favicon\":\"\"},{\"id\":\"127\",\"title\":\"Endothelial Nitric Oxide and Cardiovascular Disease - PubMed\",\"description\":\"Endothelial dysfunction leads to an impaired tissue perfusion, increased local vascular resistance, decreased defense against thrombus formation, andÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/8151263/\",\"favicon\":\"\"},{\"id\":\"128\",\"title\":\"Nitric Oxide and Endothelial Dysfunction - PMC - PubMed Central\",\"description\":\"The concept of endothelial dysfunction (ED) is centrally linked to decreased NO production and sensitivity, which ultimately results in an imbalance inÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9015729/\",\"favicon\":\"\"},{\"id\":\"129\",\"title\":\"Endothelial Dysfunction in Cardiovascular Diseases: The Role of ...\",\"description\":\"Inactivation of nitric oxide (NOÂ·) by superoxide and other reactive oxygen species (ROS) seems to occur in conditions such as hypertension, hypercholesterolemiaÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/01.res.87.10.840\",\"favicon\":\"\"},{\"id\":\"130\",\"title\":\"Endothelial dysfunction due to eNOS uncoupling\",\"description\":\"Mar 9, 2023 Â· Endothelial dysfunction is characterized by impaired endothelium-dependent vasorelaxation due to diminished nitric oxide bioavailabilityÂ ...\",\"url\":\"https://cmbl.biomedcentral.com/articles/10.1186/s11658-023-00423-2\",\"favicon\":\"\"},{\"id\":\"131\",\"title\":\"Endothelial dysfunction due to the inhibition of the synthesis of nitric ...\",\"description\":\"Nov 16, 2022 Â· The goal of this study was to induce an in vitro condition to mimic endothelial dysfunction by inhibiting NO synthesis in cells.\u003c|separator|\u003e\",\"url\":\"https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.978378/full\",\"favicon\":\"\"},{\"id\":\"132\",\"title\":\"Reciprocal relationships between insulin resistance and endothelial ...\",\"description\":\"Studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolicÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/16618833/\",\"favicon\":\"\"},{\"id\":\"133\",\"title\":\"Role of Insulin Resistance in Endothelial Dysfunction - PMC\",\"description\":\"Mar 1, 2014 Â· Insulin resistance is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular diseases.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3594115/\",\"favicon\":\"\"},{\"id\":\"134\",\"title\":\"Insulin Causes Endothelial Dysfunction in Humans | Circulation\",\"description\":\"In summary, modest hyperinsulinemia of the same degree seen in insulin-resistant patients after an overnight fast causes severe endothelial dysfunction in largeÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/hc0502.103333\",\"favicon\":\"\"},{\"id\":\"135\",\"title\":\"Insulin Resistance and Endothelial Dysfunction Constitute a ...\",\"description\":\"Jun 20, 2016 Â· An imbalance between the PI3-K/Akt and MAPK/ERK pathways links insulin resistance and endothelial dysfunction. Pathology of decreased activationÂ ...Insulin Resistance (Figures and ) Â· Glucotoxicity in Insulin... Â· Nonpharmacological...\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1155/2016/3634948\",\"favicon\":\"\"},{\"id\":\"136\",\"title\":\"Cardiovascular Risks Associated with Gender and Aging - PMC\",\"description\":\"Apr 27, 2019 Â· Furthermore, the incidence of CVD was reported to be 89.3% in males, and 91.8% in females, in adults above 80 years of age [6]. With respect toÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6616540/\",\"favicon\":\"\"},{\"id\":\"137\",\"title\":\"Prevalence of Cardiovascular Disease Risk Factors in Adults - CDC\",\"description\":\"The percentage of adults with one CVD risk factor increased with age, from 27.0% among adults ages 20â€“39 to 35.9% among adults ages 40â€“59 to 42.6% among thoseÂ ...\",\"url\":\"https://www.cdc.gov/nchs/products/databriefs/db540.htm\",\"favicon\":\"\"},{\"id\":\"138\",\"title\":\"Menopause and women's cardiovascular health: is it really an ...\",\"description\":\"Dec 10, 2022 Â· CVD occurs more frequently in men than in women before menopause [2]. As the increased risk of CVD coincides with menopause, studies have shownÂ ...\",\"url\":\"https://www.archivesofmedicalscience.com/Menopause-and-women-s-cardiovascular-health-is-it-really-an-obvious-relationship%2C157308%2C0%2C2.html\",\"favicon\":\"\"},{\"id\":\"139\",\"title\":\"Gender differences in cardiovascular disease - ScienceDirect.com\",\"description\":\"In summary, women and men show similar cardiovascular characteristics, but the age-specific risk is apparently lower in women before the menopause [8].\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2590093519300256\",\"favicon\":\"\"},{\"id\":\"140\",\"title\":\"Early menopause and risk of cardiovascular disease: an issue for ...\",\"description\":\"Oct 3, 2019 Â· Women tend to present with cardiovascular disease up to 10 years later than men, although age-adjusted rates of cardiovascular disease mortalityÂ ...\",\"url\":\"https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2819%2930184-7/fulltext\",\"favicon\":\"\"},{\"id\":\"141\",\"title\":\"Heritability of death from coronary heart disease: a 36-year follow-up ...\",\"description\":\"The heritability was 0.57 (95% CI, 0.45-0.69) amongst male twins, and 0.38 (0.26-0.50) amongst female twins. Conclusions: The genetic contribution to theÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/12270005/\",\"favicon\":\"\"},{\"id\":\"142\",\"title\":\"About Familial Hypercholesterolemia - CDC\",\"description\":\"Sep 10, 2025 Â· Familial hypercholesterolemia (FH) is a genetic disorder that affects about 1 in 311 people and increases the chance of having coronary arteryÂ ...\",\"url\":\"https://www.cdc.gov/heart-disease-family-history/about/about-familial-hypercholesterolemia.html\",\"favicon\":\"\"},{\"id\":\"143\",\"title\":\"Familial Hypercholesterolemia Variant and Cardiovascular Risk in ...\",\"description\":\"Jan 31, 2024 Â· FH variants were associated with a 2-fold higher CHD risk, even among individuals with moderately elevated LDL-C.\",\"url\":\"https://jamanetwork.com/journals/jamacardiology/fullarticle/2814372\",\"favicon\":\"\"},{\"id\":\"144\",\"title\":\"Incidence of Cardiovascular Disease in Patients with Familial ...\",\"description\":\"Jul 23, 2019 Â· In primary prevention, patients with FH-P had incidences of ASCVD and coronary heart disease (CHD) of 14.9/1000 and 5.8/1000 person-years,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6678686/\",\"favicon\":\"\"},{\"id\":\"145\",\"title\":\"Low cigarette consumption and risk of coronary heart disease and ...\",\"description\":\"Jan 24, 2018 Â· Smoking only about one cigarette per day carries a risk of developing coronary heart disease and stroke much greater than expected: around half that for peopleÂ ...\",\"url\":\"https://www.bmj.com/content/360/bmj.j5855\",\"favicon\":\"\"},{\"id\":\"146\",\"title\":\"Tobacco smoking and risk of 36 cardiovascular disease subtypes\",\"description\":\"Jul 3, 2019 Â· Current smoking increases the risk of virtually all CVD subtypes, at least doubling the risk of many, including AMI, cerebrovascular disease and heart failure.\",\"url\":\"https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1351-4\",\"favicon\":\"\"},{\"id\":\"147\",\"title\":\"Cardiovascular risk of smoking and benefits of smoking cessation\",\"description\":\"Heavy smokers (â‰¥20 pack-years) who quit smoking showed a lower risk of CVD within 5 years compared to current heavy smokers and this reduction was significant (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/\",\"favicon\":\"\"},{\"id\":\"148\",\"title\":\"Occupational Sitting Time, Leisure Physical Activity, and All-Cause ...\",\"description\":\"Jan 19, 2024 Â· Individuals who predominantly engaged in sitting at work exhibited a higher risk of mortality from all causes (16%) and cardiovascular disease (34%).\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814094\",\"favicon\":\"\"},{\"id\":\"149\",\"title\":\"Physical Activity and Sedentary Behaviour Thresholds for ...\",\"description\":\"Meeting MVPA thresholds was associated with an 18% lower risk for nonfatal cardiac events, 29% lower risk of total cardiac events, and 23% lower risk of MACEÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0828282X24012303\",\"favicon\":\"\"},{\"id\":\"150\",\"title\":\"The Evidence for Saturated Fat and for Sugar Related to Coronary ...\",\"description\":\"A diet high in added sugars has been found to cause a 3-fold increased risk of death due to cardiovascular disease, but sugars, like saturated fats, are aÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0033062015300256\",\"favicon\":\"\"},{\"id\":\"151\",\"title\":\"The sweet danger of sugar - Harvard Health\",\"description\":\"Jan 6, 2022 Â· Consuming too much added sugar can raise blood pressure and increase chronic inflammation, both of which are pathological pathways to heartÂ ...\",\"url\":\"https://www.health.harvard.edu/heart-health/the-sweet-danger-of-sugar\",\"favicon\":\"\"},{\"id\":\"152\",\"title\":\"Saturated Fats and Health: A Reassessment and Proposal for Food ...\",\"description\":\"Some meta-analyses find no evidence that reduction in saturated fat consumption may reduce CVD incidence or mortality (3â€“6), whereas others report a significantÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2020.05.077\",\"favicon\":\"\"},{\"id\":\"153\",\"title\":\"Alcohol Consumption and Mortality in Patients With Cardiovascular ...\",\"description\":\"Mar 23, 2010 Â· Results: The meta-analysis on cardiovascular mortality showed a J-shaped pooled curve with a significant maximal protection (average 22%) byÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2010.01.006\",\"favicon\":\"\"},{\"id\":\"154\",\"title\":\"The relationship between alcohol consumption and health: J ...\",\"description\":\"Jul 3, 2023 Â· The â€œJ-shapedâ€ relationship refers to a protective health effect at a lower level of consumption; while above a certain threshold, it greatly increases healthÂ ...\",\"url\":\"https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02911-w\",\"favicon\":\"\"},{\"id\":\"155\",\"title\":\"The association between sleep deprivation and the risk of ... - NIH\",\"description\":\"In conclusion, the present study indicated that sleep deprivation, characterized by â‰¤5 or â‰¤6 h of sleep per day, increased the risk of CVDs.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10565718/\",\"favicon\":\"\"},{\"id\":\"156\",\"title\":\"Redefining Cardiovascular Health to Include Sleep\",\"description\":\"Oct 19, 2022 Â· Metaâ€analyses of cohort studies demonstrate that short sleep duration is associated with up to 48% higher risk of developing or dying from CHDÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.122.025252\",\"favicon\":\"\"},{\"id\":\"157\",\"title\":\"Association between chronic stress and heart attacks\",\"description\":\"Apr 7, 2021 Â· The risk of myocardial infarction was approximately 5 times higher in people with high cortisol levels compared to those with normal cortisolÂ ...\",\"url\":\"https://observatoireprevention.org/en/2021/04/07/association-between-chronic-stress-and-heart-attacks/\",\"favicon\":\"\"},{\"id\":\"158\",\"title\":\"Higher hair cortisol levels associated with previous cardiovascular ...\",\"description\":\"Oct 4, 2024 Â· Long-term stress, measured by hair cortisol, was significantly associated with the classical cardiovascular risk factors hypertension and high cholesterol, butÂ ...\",\"url\":\"https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-024-04221-2\",\"favicon\":\"\"},{\"id\":\"159\",\"title\":\"Environmental Pollution and Cardiovascular Disease: Part 1 of 2\",\"description\":\"Dec 29, 2023 Â· A meta-analysis of 35 studies found that a short-term increase of 10 Î¼g/m3 in PM2.5 and PM10 was associated with 2.12% and 1.63% increased riskÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacadv.2023.100805\",\"favicon\":\"\"},{\"id\":\"160\",\"title\":\"Association of Long-term Exposure to Particulate Air Pollution With ...\",\"description\":\"Feb 24, 2023 Â· In this study, long-term PM 2.5 exposure at moderate concentrations was associated with increased risks of incident AMI, IHD mortality, and CVD mortality.\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801820\",\"favicon\":\"\"},{\"id\":\"161\",\"title\":\"Individual and Neighborhood Socioeconomic Status and the ...\",\"description\":\"We examined the roles that individual- and neighborhood-level SES (NSES) play in the association between PM2.5 exposure and cardiovascular disease.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5132637/\",\"favicon\":\"\"},{\"id\":\"162\",\"title\":\"Shift work and the risk of cardiovascular disease. A systematic ...\",\"description\":\"May 1, 2018 Â· The risk of any CVD event was 17% higher among shift workers than day workers. The risk of coronary heart disease (CHD) morbidity was 26% higherÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/29247501/\",\"favicon\":\"\"},{\"id\":\"163\",\"title\":\"Night shift work and indicators of cardiovascular risk - PubMed\",\"description\":\"Jul 1, 2025 Â· This comprehensive systematic review and meta-analysis aimed to assess the association between night shift work and cardiovascular risk indicators.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40164421/\",\"favicon\":\"\"},{\"id\":\"164\",\"title\":\"Electrocardiographic changes and exposure to solvents - 2018\",\"description\":\"Dec 14, 2017 Â· Occupational exposures can cause cardiovascular disorders. Some exposures may be harmful, and exposures to chemicals such as metal weldingÂ ...1 Introduction Â· 3 Results Â· 4 Discussion\",\"url\":\"https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12014\",\"favicon\":\"\"},{\"id\":\"165\",\"title\":\"Association Between Occupational Exposure to Pesticides and ...\",\"description\":\"Sep 25, 2019 Â· High level of occupational pesticide exposure is associated with 10â€year incidence of cardiovascular diseases. What Are the ClinicalÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.119.012569\",\"favicon\":\"\"},{\"id\":\"166\",\"title\":\"Association of occupational exposures with cardiovascular disease ...\",\"description\":\"Dec 11, 2018 Â· The most commonly reported exposure was to metals (8.5%), followed by solvents (6.5%) and pesticides (4.7%). Male gender, higher physicalÂ ...\",\"url\":\"https://heart.bmj.com/content/105/6/439\",\"favicon\":\"\"},{\"id\":\"167\",\"title\":\"Cardiovascular diseases and the work environment. A critical review ...\",\"description\":\"Exposure to carbon monoxide increases the acute risk of CVD but has probably no lasting atherosclerotic effect. Cadmium and organic solvents are probably notÂ ...\",\"url\":\"https://www.sjweh.fi/article/1854\",\"favicon\":\"\"},{\"id\":\"168\",\"title\":\"Radiation exposure and circulatory disease risk: Hiroshima ... - NIH\",\"description\":\"This study found dose-response evidence for risk of heart disease and stroke among atomic bomb survivors over the radiation dose range 0-4 Gy (mostly 0-2 Gy)Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2806940/\",\"favicon\":\"\"},{\"id\":\"169\",\"title\":\"Ionising radiation and cardiovascular disease: systematic review ...\",\"description\":\"Mar 8, 2023 Â· The Life Span Study of the Japanese atomic bomb survivors provides evidence of increased risk of cardiovascular disease at lower levels of doseÂ ...\",\"url\":\"https://www.bmj.com/content/380/bmj-2022-072924\",\"favicon\":\"\"},{\"id\":\"170\",\"title\":\"Radiation as a Risk Factor for Cardiovascular Disease - PMC\",\"description\":\"A recent report indicates that radiation increases the rates of heart disease in the atomic bomb survivors at moderate dose levels (mainly 0.5â€“2 Gy) (Fig. 2) (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3159113/\",\"favicon\":\"\"},{\"id\":\"171\",\"title\":\"Gut microbial age modulates cardiovascular disease risk in ... - Nature\",\"description\":\"Jun 11, 2024 Â· Longitudinal analysis showed that younger microbial age seems to counteract the increased cardiovascular disease risk in metabolically unhealthy older people.\",\"url\":\"https://www.nature.com/articles/s41591-024-03058-8\",\"favicon\":\"\"},{\"id\":\"172\",\"title\":\"Ultra-processed food exposure and adverse health outcomes\",\"description\":\"Feb 28, 2024 Â· Greater exposure to ultra-processed food was associated with a higher risk of adverse health outcomes, especially cardiometabolic, common mental disorder, andÂ ...\",\"url\":\"https://www.bmj.com/content/384/bmj-2023-077310\",\"favicon\":\"\"},{\"id\":\"173\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.thecardiologyadvisor.com/news/long-covid-linked-to-development-of-cardiovascular-disease/\",\"favicon\":\"\"},{\"id\":\"174\",\"title\":\"Cardiovascular outcomes in long COVID-19: a systematic review ...\",\"description\":\"Jan 28, 2025 Â· The risk of cardiovascular disease increased significantly four weeks or more after recovering from acute COVID-19.\u003c|separator|\u003e\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1450470/full\",\"favicon\":\"\"},{\"id\":\"175\",\"title\":\"Decoding long COVID-associated cardiovascular dysfunction\",\"description\":\"Sep 30, 2025 Â· Large-scale epidemiological studies have confirmed significantly increased risks of pericarditis, cardiomyopathy, dysrhythmias, and heartÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0022282825001786\",\"favicon\":\"\"},{\"id\":\"176\",\"title\":\"Major new report sets out how to tackle the 'profound and lasting ...\",\"description\":\"Sep 18, 2025 Â· Vaccination reduces the cardiac risks of Covid, so vaccination programmes must continue. Millions of people around the world are suffering withÂ ...Missing:  2024 | Show results with:2024\",\"url\":\"https://www.escardio.org/The-ESC/Press-Office/Press-releases/Major-new-report-sets-out-how-to-tackle-the-profound-and-lasting-impact-of-Covid-19-on-cardiovascular-health\",\"favicon\":\"\"},{\"id\":\"177\",\"title\":\"Gut bacteria may reduce cholesterol and lower heart disease risk - NIH\",\"description\":\"Apr 16, 2024 Â· A healthy diet can help lower cholesterol and the risk for heart disease. New research shows that certain gut microbes can affect your risk, too.\",\"url\":\"https://www.nih.gov/news-events/nih-research-matters/gut-bacteria-may-reduce-cholesterol-lower-heart-disease-risk\",\"favicon\":\"\"},{\"id\":\"178\",\"title\":\"Scientists link certain gut bacteria to lower heart disease risk\",\"description\":\"Apr 2, 2024 Â· The team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people.\",\"url\":\"https://www.broadinstitute.org/news/scientists-link-certain-gut-bacteria-lower-heart-disease-risk\",\"favicon\":\"\"},{\"id\":\"179\",\"title\":\"The role of gut microbiota in cardiovascular diseases and their ...\",\"description\":\"Recent clinical and basic studies suggest that the gut microbiota and their metabolites play critical roles in the onset and progression of CVDs.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0914508725001261\",\"favicon\":\"\"},{\"id\":\"180\",\"title\":\"Spotlight on UPFs: NIH explores link between ultra-processed foods ...\",\"description\":\"Mar 5, 2025 Â· It showed that high consumption of UPFs was linked to an increased risk of heart disease and stroke in US adults.Missing:  2024 | Show results with:2024\",\"url\":\"https://www.nhlbi.nih.gov/news/2025/spotlight-upfs-nih-explores-link-between-ultra-processed-foods-and-heart-disease\",\"favicon\":\"\"},{\"id\":\"181\",\"title\":\"Eating Ultra-Processed Foods May Harm Your Health\",\"description\":\"May 8, 2025 Â· Study finds each additional 100 grams/day consumption of ultra-processed foods increased risk of hypertension, cardiovascular events, cancer and more\",\"url\":\"https://www.acc.org/About-ACC/Press-Releases/2025/05/08/14/10/Eating-Ultra-Processed-Foods-May-Harm-Your-Health\",\"favicon\":\"\"},{\"id\":\"182\",\"title\":\"Exposure to ultra-processed food and risk of cardiovascular mortality\",\"description\":\"We found that people eating and drinking higher amounts of ultra-processed food had a 19% higher risk of dying from heart disease compared to those who ate lessÂ ...\",\"url\":\"https://academic.oup.com/eurjpc/advance-article/8173892\",\"favicon\":\"\"},{\"id\":\"183\",\"title\":\"Ultra-processed foods and cardiovascular disease: analysis of three ...\",\"description\":\"Sep 2, 2024 Â· Conversely, ultra-processed savoury snacks, cold cereals, and yoghurt/dairy-based desserts were inversely associated with CVD and CHD risk.\",\"url\":\"https://www.thelancet.com/journals/lanam/article/PIIS2667-193X%2824%2900186-8/fulltext\",\"favicon\":\"\"},{\"id\":\"184\",\"title\":\"Why mental stress can take a toll on the heart - NHLBI - NIH\",\"description\":\"Jun 13, 2024 Â· Lower heart rate variability may reflect dysfunction in these two systems and a state where the sympathetic nervous system is more dominant. TheÂ ...Missing:  anxiety causal\",\"url\":\"https://www.nhlbi.nih.gov/news/2024/why-mental-stress-can-take-toll-heart\",\"favicon\":\"\"},{\"id\":\"185\",\"title\":\"Anxiety and Depression Associated With Increased Cardiovascular ...\",\"description\":\"The impact of psychosocial stress on the development of CVDRFs through autonomic nervous system dysfunction and chronic inflammation has also been partiallyÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacadv.2024.101208\",\"favicon\":\"\"},{\"id\":\"186\",\"title\":\"Impact of Chronic Psychological Stress on Cardiovascular Disease ...\",\"description\":\"It is now widely agreed that there is an association between chronic stress and CVD risk. This increased risk is driven by an interaction between physiologicalÂ ...\",\"url\":\"https://journals.lww.com/hhmi/fulltext/2024/08040/impact_of_chronic_psychological_stress_on.3.aspx\",\"favicon\":\"\"},{\"id\":\"187\",\"title\":\"\",\"description\":\"\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11872152/\",\"favicon\":\"\"},{\"id\":\"188\",\"title\":\"2019 ACC/AHA Guideline on the Primary Prevention of ...\",\"description\":\"1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/cir.0000000000000678\",\"favicon\":\"\"},{\"id\":\"189\",\"title\":\"a systematic review and hierarchical network meta-analysis of RCTs\",\"description\":\"Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchicalÂ ...Missing:  based | Show results with:based\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40611785/\",\"favicon\":\"\"},{\"id\":\"190\",\"title\":\"Cardiovascular Care Settings and Smoking Cessation - CDC\",\"description\":\"May 15, 2024 Â· Reduces the risk of coronary heart disease, with risk falling sharply 1 to 2 years after cessation and then declining more slowly over theÂ ...\",\"url\":\"https://www.cdc.gov/tobacco/hcp/patient-care-settings/cardiovascular.html\",\"favicon\":\"\"},{\"id\":\"191\",\"title\":\"Canadian Cardiovascular Society Clinical Practice Update on ...\",\"description\":\"Within 1 year of smoking cessation, the risk of CVD events decreases by 50%; after 15 years, the risk is the same as that of someone who has never smoked.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0828282X25000091\",\"favicon\":\"\"},{\"id\":\"192\",\"title\":\"Dose-Response Between Physical Activity and Risk of Coronary ...\",\"description\":\"Individuals who engaged in the equivalent of 150 min/week of moderate-intensity LTPA (minimum amount, 2008 US federal guidelines) had a 14% lower CHD risk (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3158733/\",\"favicon\":\"\"},{\"id\":\"193\",\"title\":\"a doseâ€“response meta-analysis of large prospective studies\",\"description\":\"Shifting population levels of activity towards achieving the equivalent to 150 min/week of moderate-to-vigorous aerobic PA (8.75 mMET-hours/week) potentiallyÂ ...\",\"url\":\"https://bjsm.bmj.com/content/57/15/979\",\"favicon\":\"\"},{\"id\":\"194\",\"title\":\"Exercise for Primary and Secondary Prevention of Cardiovascular ...\",\"description\":\"Regular exercise that meets or exceeds the current physical activity guidelines is associated with a reduced risk of cardiovascular disease (CVD) and mortality.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2022.07.004\",\"favicon\":\"\"},{\"id\":\"195\",\"title\":\"Meta-Analysis Comparing Mediterranean to Low-Fat Diets for ...\",\"description\":\"Conclusion. Mediterranean diets appear to be more effective than low-fat diets in inducing clinically relevant long-term changes in cardiovascular risk factorsÂ ...\",\"url\":\"https://www.amjmed.com/article/S0002-9343%2811%2900410-4/fulltext\",\"favicon\":\"\"},{\"id\":\"196\",\"title\":\"Primary Prevention of Cardiovascular Disease with a Mediterranean ...\",\"description\":\"Jun 13, 2018 Â· Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229-241. Go to Citation. Crossref Â· PubMed Â· Web ofÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1800389\",\"favicon\":\"\"},{\"id\":\"197\",\"title\":\"The low-carbohydrate diet and cardiovascular risk factors\",\"description\":\"All of these trials demonstrated that low-carbohydrate diets were as effective as isocaloric low-fat diets at reducing body weight and inducing favorableÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4351995/\",\"favicon\":\"\"},{\"id\":\"198\",\"title\":\"Optimal Diet Strategies for Weight Loss and Weight Loss Maintenance\",\"description\":\"A low-calorie diet involves consumption of 1,000â€“1,500 calories per day; deficits of 500â€“750 calories per day have been used for weight loss and areÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8017325/\",\"favicon\":\"\"},{\"id\":\"199\",\"title\":\"Effects of matched weight loss from calorie restriction, exercise, or ...\",\"description\":\"Objective: We tested the hypothesis that weight loss from calorie restriction and exercise combined (CREX) improves cardiovascular disease (CVD) risk factorsÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0002916522045798\",\"favicon\":\"\"},{\"id\":\"200\",\"title\":\"Calorie restriction or exercise: effects on coronary heart disease risk ...\",\"description\":\"Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderatelyÂ ...\",\"url\":\"https://journals.physiology.org/doi/abs/10.1152/ajpendo.00102.2007\",\"favicon\":\"\"},{\"id\":\"201\",\"title\":\"Polypills for Primary Prevention of Cardiovascular Disease - Frontiers\",\"description\":\"Our meta-analysis suggests that a polypill regimen for primary prevention in patients with intermediate- to high- cardiovascular risk reduces the incidence ofÂ ...\",\"url\":\"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.880054/full\",\"favicon\":\"\"},{\"id\":\"202\",\"title\":\"Secondary Prevention of Atherosclerotic Cardiovascular Disease\",\"description\":\"Apr 28, 2025 Â· Traditional management of secondary prevention patients involves lipid-lowering with statins, blood pressure control, and anti-platelet treatment.\",\"url\":\"https://www.uscjournal.com/articles/strategies-secondary-prevention-atherosclerotic-cardiovascular-disease?language_content_entity=en\",\"favicon\":\"\"},{\"id\":\"203\",\"title\":\"World Heart Federation Roadmap for Secondary Prevention of ...\",\"description\":\"Jan 22, 2024 Â· 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Developed by the Task Force for Cardiovascular Disease PreventionÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10809857/\",\"favicon\":\"\"},{\"id\":\"204\",\"title\":\"Core Components of Cardiac Rehabilitation Programs: 2024 Update\",\"description\":\"Sep 24, 2024 Â· Cardiac rehabilitation (CR) reduces mortality rates and improves the quality of life of patients with cardiovascular disease (CVD), and its useÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001289\",\"favicon\":\"\"},{\"id\":\"205\",\"title\":\"Cardiac rehabilitation and secondary prevention of CVD - Nature\",\"description\":\"Sep 30, 2024 Â· These advancements have resulted in more people surviving initial events and having reduced length of stay in hospital; consequently, there isÂ ...\",\"url\":\"https://www.nature.com/articles/s44325-024-00017-7\",\"favicon\":\"\"},{\"id\":\"206\",\"title\":\"2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC ...\",\"description\":\"Aug 14, 2025 Â· High blood pressure is the most prevalent and modifiable risk factor ... stroke, dementia, chronic kidney disease, and all-cause mortality.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/HYP.0000000000000249\",\"favicon\":\"\"},{\"id\":\"207\",\"title\":\"Update to Evidence-Based Secondary Prevention Strategies After ...\",\"description\":\"High-intensity statin therapy (ie, atorvastatin 40-80 mg/day or rosuvastatin 20-40 mg/day) remains the cornerstone of lipid-lowering treatment in patients postÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7499366/\",\"favicon\":\"\"},{\"id\":\"208\",\"title\":\"Prevention of cardiovascular disease events in those with ...\",\"description\":\"Jan 2, 2025 Â· Outline Â· Diet Â· Weight reduction Â· Physical activity Â· Smoking cessation Â· Alcohol Â· Cardiac rehabilitation programs.\",\"url\":\"https://www.uptodate.com/contents/prevention-of-cardiovascular-disease-events-in-those-with-established-disease-secondary-prevention\",\"favicon\":\"\"},{\"id\":\"209\",\"title\":\"2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the ...\",\"description\":\"Feb 27, 2025 Â· After discharge, focus on secondary prevention is fundamental. A fasting lipid panel is recommended 4 to 8 weeks after initiating or adjustingÂ ...Volume 151, Number 13 Â· Correction to Â· Crossref\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309\",\"favicon\":\"\"},{\"id\":\"210\",\"title\":\"Low-Fat Dietary Pattern and Risk of Cardiovascular Disease\",\"description\":\"Feb 8, 2006 Â· Epidemiologic studies have demonstrated that diets low in saturated fat and cholesterol are associated with lower rates of CVD and haveÂ ...Missing:  failure | Show results with:failure\",\"url\":\"https://jamanetwork.com/journals/jama/fullarticle/202339\",\"favicon\":\"\"},{\"id\":\"211\",\"title\":\"Hiding unhealthy heart outcomes in a low-fat diet trial - NIH\",\"description\":\"Jul 21, 2021 Â· Low-fat dietary pattern and risk of cardiovascular disease: the women's health Initiative randomized controlled dietary modification trial.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8296783/\",\"favicon\":\"\"},{\"id\":\"212\",\"title\":\"The effects of low-carbohydrate diets on cardiovascular risk factors\",\"description\":\"Jan 14, 2020 Â· This meta-analysis confirms that low-carbohydrate diets have a beneficial effect on cardiovascular risk factors but that the long-termÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/31935216/\",\"favicon\":\"\"},{\"id\":\"213\",\"title\":\"Low-Carbohydrate-Diet Score and the Risk of Coronary Heart ...\",\"description\":\"Our findings suggest that diets lower in carbohydrate and higher in protein and fat are not associated with increased risk of coronary heart disease in women.\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa055317\",\"favicon\":\"\"},{\"id\":\"214\",\"title\":\"The effects of low-carbohydrate diets on cardiovascular risk factors\",\"description\":\"Jan 14, 2020 Â· This meta-analysis confirms that low-carbohydrate diets have a beneficial effect on cardiovascular risk factors but that the long-term effectsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6959586/\",\"favicon\":\"\"},{\"id\":\"215\",\"title\":\"Trans fat and cardiovascular disease mortality: Evidence from bans ...\",\"description\":\"This paper analyzes the impact of trans fat bans on cardiovascular disease (CVD) mortality rates. Several New York State jurisdictions have restricted the useÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/26620830/\",\"favicon\":\"\"},{\"id\":\"216\",\"title\":\"The Evidence Behind Seed Oils' Health Effects | Johns Hopkins\",\"description\":\"Jun 6, 2025 Â· As a nutrition scientist, Marklund researches how different fats can affect chronic disease. â€œThe fatty acids typical in seed oilsâ€”like linoleicÂ ...\",\"url\":\"https://publichealth.jhu.edu/2025/the-evidence-behind-seed-oils-health-effects\",\"favicon\":\"\"},{\"id\":\"217\",\"title\":\"There's no reason to avoid seed oils and plenty of reasons to eat them\",\"description\":\"Aug 20, 2024 Â· ... seed oils are high in omega-6 fatty acids that break ... fats and replacing them with unsaturated fats lowers the risk for heart disease.\\\".\",\"url\":\"https://www.heart.org/en/news/2024/08/20/theres-no-reason-to-avoid-seed-oils-and-plenty-of-reasons-to-eat-them\",\"favicon\":\"\"},{\"id\":\"218\",\"title\":\"Intermittent Fasting for the Prevention of Cardiovascular Disease Risks\",\"description\":\"Jul 24, 2025 Â· Previous pairwise meta-analysis studies have shown some promise for intermittent fasting in reducing risk factors for cardiovascular disease.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12289860/\",\"favicon\":\"\"},{\"id\":\"219\",\"title\":\"Intermittent Fasting After ST-Segmentâ€“Elevation Myocardial ...\",\"description\":\"May 2, 2024 Â· The INTERFAST-MI trial suggests that intermittent fasting is safe and may improve cardiac function and clinical outcomes. A randomizedÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.123.010936\",\"favicon\":\"\"},{\"id\":\"220\",\"title\":\"8-hour time-restricted eating linked to a 91% higher risk of ...\",\"description\":\"Mar 18, 2024 Â· ... an 8-hour time-restricted eating schedule, a type of intermittent fasting, had a 91% higher risk of death from cardiovascular disease.\",\"url\":\"https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death\",\"favicon\":\"\"},{\"id\":\"221\",\"title\":\"Recommendation: Aspirin Use to Prevent Cardiovascular Disease\",\"description\":\"Apr 26, 2022 Â· The USPSTF recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults 60 years or older. D. ClinicianÂ ...\",\"url\":\"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication\",\"favicon\":\"\"},{\"id\":\"222\",\"title\":\"Aspirin for the Primary Prevention of Cardiovascular Disease\",\"description\":\"Sep 1, 2022 Â· The USPSTF recommends the following: (1) low-dose aspirin should not be initiated for primary prevention in individuals ages 60 years or older,Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020\",\"favicon\":\"\"},{\"id\":\"223\",\"title\":\"New USPSTF Recommendation on Aspirin in CVD: No For Primary ...\",\"description\":\"Apr 27, 2022 Â· Low-dose aspirin (75-100 mg orally daily) might be considered for the primary prevention of ASCVD among select adults 40 to 70 years of age whoÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2022/04/27/20/41/New-USPSTF-Recommendation-on-Aspirin-in-CVD\",\"favicon\":\"\"},{\"id\":\"224\",\"title\":\"Statin Use for the Primary Prevention of Cardiovascular Disease in ...\",\"description\":\"Aug 23, 2022 Â· In patients who have a cardiovascular risk factor and an estimated 10-year CVD risk of 7.5% to less than 10%, the benefit of starting a statinÂ ...\",\"url\":\"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication\",\"favicon\":\"\"},{\"id\":\"225\",\"title\":\"Statin Use for the Primary Prevention of Cardiovascular Disease in ...\",\"description\":\"Similar to meta-analyses of primary and secondary prevention trials, statins were not associated with increased risk of muscle-related harms. AlthoughÂ ...\",\"url\":\"https://jamanetwork.com/journals/jama/fullarticle/2795522\",\"favicon\":\"\"},{\"id\":\"226\",\"title\":\"Statins for Heart Disease Prevention (Without Prior Heart ... - TheNNT\",\"description\":\"It takes 5 years of daily statin therapy to achieve a 1.6% chance of avoiding a heart attack, and a 0.37% chance of avoiding a stroke. Most disappointing,Â ...\",\"url\":\"https://www.thennt.com/nnt/statins-for-heart-disease-prevention-without-prior-heart-disease/\",\"favicon\":\"\"},{\"id\":\"227\",\"title\":\"Statins in Persons at Low Risk of Cardiovascular Disease - TheNNT\",\"description\":\"The CTT meta-analysis, which included 22 trials with more than 130,000 patients, showed no statistically significant mortality benefit from statins in the twoÂ ...\",\"url\":\"https://www.thennt.com/cms/nnt/statins-persons-low-risk-cardiovascular-disease/\",\"favicon\":\"\"},{\"id\":\"228\",\"title\":\"Statin wars: have we been misled about the evidence? A narrative ...\",\"description\":\"Jan 21, 2018 Â· A bitter dispute has erupted among doctors over suggestions that statins should be prescribed to millions of healthy people at low risk of heartÂ ...\",\"url\":\"https://bjsm.bmj.com/cgi/rapidpdf/bjsports-2017-098497?ijkey=Rsap0XafljfcOCR\u0026keytype=ref\",\"favicon\":\"\"},{\"id\":\"229\",\"title\":\"Guidelines versus trial-evidence for statin use in primary prevention\",\"description\":\"1). For example, only 16% of individuals with a PCE risk \u003c0.7% had direct RCT evidence documenting efficacy of statin therapy compared to 88â€“91%Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S002191502101474X\",\"favicon\":\"\"},{\"id\":\"230\",\"title\":\"Pharmacological blood pressure lowering for primary ... - The Lancet\",\"description\":\"May 1, 2021 Â· Overall, a 5 mm Hg systolic blood pressure reduction reduced the risk of major cardiovascular events, regardless of stratification byÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900590-0/fulltext\",\"favicon\":\"\"},{\"id\":\"231\",\"title\":\"Antihypertensive Treatment and Secondary Prevention of ...\",\"description\":\"Several randomized controlled trials of blood pressure lowering for the prevention of CVD have demonstrated benefit among persons with prehypertension or normalÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4313888/\",\"favicon\":\"\"},{\"id\":\"232\",\"title\":\"Use of Risk Assessment to Guide Decision-Making for Blood ... - JACC\",\"description\":\"The 2025 High Blood Pressure Guideline recommend initiation of antihypertensive drug therapy for adults with PREVENT-CVD score â‰¥7.5%. The SupplementalÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2025.08.001\",\"favicon\":\"\"},{\"id\":\"233\",\"title\":\"Coronary artery disease - Diagnosis and treatment - Mayo Clinic\",\"description\":\"Jun 14, 2024 Â· Electrocardiogram (ECG or EKG). This quick test checks the electrical activity of the heart. It shows how the heart is beating. Sticky patchesÂ ...Tests Â· Treatment Â· Preparing For Your...\",\"url\":\"https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619\",\"favicon\":\"\"},{\"id\":\"234\",\"title\":\"diagnosing a heart attack - NHS\",\"description\":\"An electrocardiogram (ECG) is an important test in suspected heart attacks. It should be done within 10 minutes of being admitted to hospital.Electrocardiogram Â· Types Of Heart Attack Â· Other Tests\u003c|separator|\u003e\",\"url\":\"https://www.nhs.uk/conditions/heart-attack/diagnosis/\",\"favicon\":\"\"},{\"id\":\"235\",\"title\":\"Heart Tests - NHLBI - NIH\",\"description\":\"Mar 24, 2022 Â· Heart imaging tests take pictures of your heart or its arteries or blood vessels to help your doctor see whether there are any problems.\",\"url\":\"https://www.nhlbi.nih.gov/health/heart-tests\",\"favicon\":\"\"},{\"id\":\"236\",\"title\":\"10 Heart Tests Your Doctor Might Order, and What They Mean\",\"description\":\"Feb 3, 2020 Â· 1. Echocardiogram: Uses sound waves to produce images of your heart. This common test allows your physician to see how your heart is beatingÂ ...\",\"url\":\"https://www.michiganmedicine.org/health-lab/10-heart-tests-your-doctor-might-order-and-what-they-mean\",\"favicon\":\"\"},{\"id\":\"237\",\"title\":\"5 Commonly Ordered Heart Tests \u0026 What They Show\",\"description\":\"Apr 25, 2023 Â· 5 Commonly Ordered Heart Tests \u0026 What They Show Â· Electrocardiogram (EKG or ECG) Â· Echocardiogram Â· Stress test Â· CT scan Â· Coronary angiogram.\",\"url\":\"https://www.houstonmethodist.org/blog/articles/2023/apr/5-commonly-ordered-heart-tests-what-they-show/\",\"favicon\":\"\"},{\"id\":\"238\",\"title\":\"Cardiac Imaging - StatPearls - NCBI Bookshelf - NIH\",\"description\":\"These modalities include echocardiography, myocardial perfusion imaging via nuclear scintigraphy, magnetic resonance imaging (MRI), and computed tomography (CT)Â ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK448128/\",\"favicon\":\"\"},{\"id\":\"239\",\"title\":\"Tests to Diagnose Heart Problems\",\"description\":\"Tests to Diagnose Heart Problems Â· Electrocardiogram (ECG). Â· Stress test. Â· Transthoracic echocardiogram (echo or TTE). Â· Transesophageal echocardiogram (TEE).\",\"url\":\"https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85\u0026contentid=p00208\",\"favicon\":\"\"},{\"id\":\"240\",\"title\":\"Advancements in Artificial Intelligence in Noninvasive Cardiac Imaging\",\"description\":\"Jan 27, 2025 Â· Findings indicate that AI integration in cardiac imaging enhances image quality, reduces processing times, and improves diagnostic precision.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11772728/\",\"favicon\":\"\"},{\"id\":\"241\",\"title\":\"Use of AI in Cardiac CT and MRI: A Scientific Statement from the ...\",\"description\":\"Jan 28, 2025 Â· Artificial intelligence (AI) offers promising solutions for many steps of the cardiac imaging workflow, from patient and test selection throughÂ ...skipMainNavigation\\\" Â· Abstract Â· Introduction Â· Key Questions\",\"url\":\"https://pubs.rsna.org/doi/10.1148/radiol.240516\",\"favicon\":\"\"},{\"id\":\"242\",\"title\":\"For the FITs | Navigating the Integration of AI in Cardiovascular ...\",\"description\":\"Aug 1, 2025 Â· Nuclear cardiology has similarly seen significant advances, with AI improving both image reconstruction and interpretation of perfusion defectsÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2025/08/01/01/For-the-FITs-Navigating-the-Integration-of-AI\",\"favicon\":\"\"},{\"id\":\"243\",\"title\":\"SCORE2 risk prediction algorithms: new models to estimate 10-year ...\",\"description\":\"The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascularÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8248998/\",\"favicon\":\"\"},{\"id\":\"244\",\"title\":\"Framingham Risk Score for Hard Coronary Heart Disease - MDCalc\",\"description\":\"Framingham Risk Score for Hard Coronary Heart Disease. Estimates 10-year risk of heart attack in patients 30-79 years with no history of CHD or diabetes.\",\"url\":\"https://www.mdcalc.com/calc/38/framingham-risk-score-hard-coronary-heart-disease\",\"favicon\":\"\"},{\"id\":\"245\",\"title\":\"Comparison of SCORE, SCORE2 and Framingham Risk ... - MDPI\",\"description\":\"In our present study, the SCORE2-based vascular age calculation method attenuated the previously found differences between SCORE and FRS, but FRS stillÂ ...\",\"url\":\"https://www.mdpi.com/2077-0383/14/21/7570\",\"favicon\":\"\"},{\"id\":\"246\",\"title\":\"SCORE2 and SCORE2-OP - European Society of Cardiology\",\"description\":\"Calculate your patients' 10-year risk of fatal and nonfatal cardiovascular disease events with two new algorithms, SCORE2 and SCORE2-OP (older persons).Missing:  Framingham | Show results with:Framingham\",\"url\":\"https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts\",\"favicon\":\"\"},{\"id\":\"247\",\"title\":\"Systematic Coronary Risk Evaluation 2 (SCORE2) - MDCalc\",\"description\":\"The Systematic Coronary Risk Evaluation 2 (SCORE2) predicts 10-year CVD risk in patients without prior CVD or diabetes.Missing:  Framingham | Show results with:Framingham\",\"url\":\"https://www.mdcalc.com/calc/10499/systematic-coronary-risk-evaluation-score2\",\"favicon\":\"\"},{\"id\":\"248\",\"title\":\"Polygenic Risk Scores for Cardiovascular Disease: A Scientific ...\",\"description\":\"Jul 18, 2022 Â· Systematic cataloging for cardiovascular risk alleles also enabled the development of polygenic risk scores.Polygenic Versus Monogenic... Â· Atrial Fibrillation Â· Coronary Artery Disease\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001077\",\"favicon\":\"\"},{\"id\":\"249\",\"title\":\"Advances and Applications of Polygenic Scores for Coronary Artery ...\",\"description\":\"These newer-generation polygenic scores identify up to 8% of the population with triple the normal risk based on genetic variation alone, and these individualsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11837432/\",\"favicon\":\"\"},{\"id\":\"250\",\"title\":\"Artificial Intelligence in Optimizing Polygenic Risk Scores: A ... - JACC\",\"description\":\"Jun 25, 2025 Â· AI-optimized polygenic risk scores show promising potential for improving early detection and personalized prevention of cardiovascular diseasesÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacadv.2025.101803\",\"favicon\":\"\"},{\"id\":\"251\",\"title\":\"Clinical utility and implementation of polygenic risk scores for ...\",\"description\":\"Feb 5, 2025 Â· This clinical consensus statement provides an overview of the scientific basis of PRS and evidence to date on their role in CVD risk prediction.\",\"url\":\"https://academic.oup.com/eurheartj/article-abstract/46/15/1372/8001983\",\"favicon\":\"\"},{\"id\":\"252\",\"title\":\"LDL-Cholesterol is not the only clinically relevant biomarker for ... - NIH\",\"description\":\"LDL-c alone is not an efficient screening test because the distributions of blood LDL-c among patients with and without CAD overlap, resulting in false positiveÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6097909/\",\"favicon\":\"\"},{\"id\":\"253\",\"title\":\"Association of LDL-cholesterol subfractions with cardiovascular ...\",\"description\":\"Nov 1, 2023 Â· The results of the study revealed that participants with higher concentrations of small dense LDL were at a higher risk for CVDs.Missing:  critiques | Show results with:critiques\",\"url\":\"https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03578-0\",\"favicon\":\"\"},{\"id\":\"254\",\"title\":\"Variability in Lipid Levels and Risk for Cardiovascular Disease\",\"description\":\"Mar 4, 2023 Â· In a large EHRâ€based population cohort, high variability in total cholesterol, HDLâ€C, and LDLâ€C was associated with an increased risk of CVD,Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.122.027639\",\"favicon\":\"\"},{\"id\":\"255\",\"title\":\"â€œCholesterol-Yearsâ€ for ASCVD Risk Prediction and Treatment - JACC\",\"description\":\"Sep 21, 2020 Â· Moreover, early exposure to a similar level of LDL-C appears to be associated with a greater risk of future ASCVD than later exposure. One ofÂ ...Missing:  critiques | Show results with:critiques\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2020.08.004\",\"favicon\":\"\"},{\"id\":\"256\",\"title\":\"Coronary Atherosclerosis in an Asymptomatic U.S. Population\",\"description\":\"The Miami Heart Study confirms substantial prevalence of coronary plaque in asymptomatic individuals. Overall, 49% of participants had coronary plaque.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1936878X22001735\",\"favicon\":\"\"},{\"id\":\"257\",\"title\":\"Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review\",\"description\":\"Mar 30, 2022 Â· Prevalence estimates of pre-HF ranged from 11 to 42.7% (10 sources) with higher estimates found in the elderly, in patients with hypertension, and in men.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9177493/\",\"favicon\":\"\"},{\"id\":\"258\",\"title\":\"Opportunities and Challenges of Cardiovascular Disease Risk ...\",\"description\":\"However, fundamental barriers persist, including limited generalizability, challenges in interpretability, and the absence of rigorous external validation, allÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12059770/\",\"favicon\":\"\"},{\"id\":\"259\",\"title\":\"Cardiovascular Disease Risk: Screening With Electrocardiography\",\"description\":\"Jun 12, 2018 Â· The USPSTF found adequate evidence that screening with resting or exercise ECG in asymptomatic adults leads to harms that are at least small and may beÂ ...\",\"url\":\"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-risk-screening-with-electrocardiography\",\"favicon\":\"\"},{\"id\":\"260\",\"title\":\"Geographic Disparities in Access to Cardiologists in the United States\",\"description\":\"Jul 8, 2024 Â· Nearly one-half of US counties do not have cardiologists. These counties are more rural and socioeconomically disadvantaged, with a greater burden of CVD.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2024.04.054\",\"favicon\":\"\"},{\"id\":\"261\",\"title\":\"Disparities in the Use of Annual Heart Health Screenings Among ...\",\"description\":\"Oct 18, 2024 Â· Adequate heart health screenings can also help reduce the disparities in CVD outcomes among different populations, such as racial and ethnicÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.123.032919\",\"favicon\":\"\"},{\"id\":\"262\",\"title\":\"Prioritizing Health | Proactive Screening Doubles Early CVD ...\",\"description\":\"Sep 28, 2023 Â· An easy systematic screening strategy carried out by primary care clinicians in the RED-CVD trial more than doubled the number of new diagnosesÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2023/10/01/01/42/prioritizing-health-proactive-screening-doubles-early-cvd-diagnosis-in-community\",\"favicon\":\"\"},{\"id\":\"263\",\"title\":\"Health Economic Research Assessing the Value of Early Detection ...\",\"description\":\"Jun 16, 2023 Â· Current evidence suggests that early CVD detection strategies are predominantly cost effective and may reduce CVD-related costs compared with no earlyÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10492754/\",\"favicon\":\"\"},{\"id\":\"264\",\"title\":\"Contemporary Mortality Differences Between Primary Percutaneous ...\",\"description\":\"Mar 28, 2011 Â· Our findings indicate that the mortality benefit of PPCI compared with thrombolysis in STEMI patients has been substantially attenuated,Â ...\",\"url\":\"https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/226907\",\"favicon\":\"\"},{\"id\":\"265\",\"title\":\"Door-to-Balloon Time and Mortality among Patients Undergoing ...\",\"description\":\"Sep 5, 2013 Â· Current guidelines for the treatment of ST-segment elevation myocardial infarction recommend a door-to-balloon time of 90 minutes or less for patientsÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1208200\",\"favicon\":\"\"},{\"id\":\"266\",\"title\":\"Mortality Implications of Primary Percutaneous Coronary ...\",\"description\":\"Feb 8, 2011 Â· Both symptom onset-to-balloon time and hospital door-to-balloon time are strongly associated with 90-day mortality following STEMI.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/circoutcomes.110.945311\",\"favicon\":\"\"},{\"id\":\"267\",\"title\":\"Relation of lowering door-to-balloon time and mortality in ST ...\",\"description\":\"Conclusions: Among STEMI patients undergoing primary PCI within 90 min of admission DBT \u003c 60 min was independently associated with better 1-year mortality.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/30778668/\",\"favicon\":\"\"},{\"id\":\"268\",\"title\":\"Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial ...\",\"description\":\"Mar 10, 2013 Â· Prehospital fibrinolysis with timely coronary angiography resulted in effective reperfusion in patients with early STEMI who could not undergo primary PCIÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1301092\",\"favicon\":\"\"},{\"id\":\"269\",\"title\":\"Relationship of treatment delays and mortality in patients ... - NIH\",\"description\":\"We found that treatment delays with either fibrinolytic therapy or primary PCI were associated with a higher 6â€month mortality in patients with STEMI receivingÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2095752/\",\"favicon\":\"\"},{\"id\":\"270\",\"title\":\"Acute Coronary Syndrome: Current Treatment - AAFP\",\"description\":\"Feb 15, 2017 Â· Dual antiplatelet therapy is highly recommended in the treatment of STEMI to support primary PCI and fibrinolytic treatment strategies. WithÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.aafp.org/pubs/afp/issues/2017/0215/p232.html\",\"favicon\":\"\"},{\"id\":\"271\",\"title\":\"New in Clinical Guidance | ACC/AHA ACS Guideline, More\",\"description\":\"Apr 3, 2025 Â· In addition, the guideline recommends a strategy of complete revascularization in patients with STEMI or NSTE-ACS, with the choice ofÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2025/04/01/01/New-in-Clinical-Guidance\",\"favicon\":\"\"},{\"id\":\"272\",\"title\":\"2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the ...\",\"description\":\"Jul 20, 2023 Â· This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168\",\"favicon\":\"\"},{\"id\":\"273\",\"title\":\"ESC Guidelines for the management of chronic coronary syndromes\",\"description\":\"Aug 30, 2024 Â· The current guidelines for managing chronic coronary syndromes (CCS) are intended to assist in diagnosing and initiating treatment for individuals withÂ ...\",\"url\":\"https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Chronic-Coronary-Syndromes\",\"favicon\":\"\"},{\"id\":\"274\",\"title\":\"Polypharmacy in Older Adults Hospitalized for Heart Failure\",\"description\":\"Oct 13, 2020 Â· Defining polypharmacy as taking â‰¥10 medications might be more ideal in the HF population as most patients already take â‰¥5 medications.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.120.006977\",\"favicon\":\"\"},{\"id\":\"275\",\"title\":\"Deprescribing in Older Adults With Cardiovascular Disease - JACC\",\"description\":\"May 20, 2019 Â· Incorporating deprescribing into routine cardiovascular care can reduce treatment burden and morbidity in older adults. The aims of drug therapyÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2019.03.467\",\"favicon\":\"\"},{\"id\":\"276\",\"title\":\"Assessing the Impact of Medication Adherence on Long ... - JACC\",\"description\":\"Aug 15, 2016 Â· Full adherence to guideline-recommended therapies was associated with a lower rate of MACE and cost savings, with a threshold effect at \u003e80% adherence in theÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2016.06.005\",\"favicon\":\"\"},{\"id\":\"277\",\"title\":\"Adherence with cardiovascular medications and the outcomes in ...\",\"description\":\"Sep 18, 2022 Â· This meta-analysis aims to determine the magnitude of adherence to vascular medications that influences the absolute and relative risks (RRs) of mortality inÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/36116032/\",\"favicon\":\"\"},{\"id\":\"278\",\"title\":\"Medication Adherence and the Risk of Cardiovascular Mortality and ...\",\"description\":\"Jan 25, 2016 Â· A meta-analysis reported that patients adherent to antihypertensive medications showed better blood pressure control, compared with those whoÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/hypertensionaha.115.06731\",\"favicon\":\"\"},{\"id\":\"279\",\"title\":\"CABG Versus PCI: Greater Benefit in Long-Term Outcomes With ...\",\"description\":\"This study principally comparing SA-CABG to predominantly DES-PCI reported an adjusted 4-year mortality of 16.4% with CABG versus 20.8% for PCI (HR: 0.79; 95%Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5473156/\",\"favicon\":\"\"},{\"id\":\"280\",\"title\":\"Percutaneous Coronary Intervention versus Coronary-Artery Bypass ...\",\"description\":\"Feb 18, 2009 Â· In conclusion, the results of our trial show that CABG, as compared with PCI, is associated with a lower rate of major adverse cardiac orÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa0804626\",\"favicon\":\"\"},{\"id\":\"281\",\"title\":\"Ten-year outcomes after percutaneous coronary intervention versus ...\",\"description\":\"Feb 2, 2023 Â· Evidence from our study and prior studies suggested the superiority of CABG over PCI in improving 5- but not 10-year survival among patients with MVCA.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9893531/\",\"favicon\":\"\"},{\"id\":\"282\",\"title\":\"Five-Year Outcomes after PCI or CABG for Left Main Coronary ...\",\"description\":\"Whereas previous studies have shown higher rates of stroke after CABG than after PCI, the excess of cerebrovascular events after CABG in the present trial wasÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa1909406\",\"favicon\":\"\"},{\"id\":\"283\",\"title\":\"Coronary artery bypass grafting (CABG) vs. percutaneous ... - NIH\",\"description\":\"Despite being underpowered, all-cause mortality was 5.0% for CABG and 21% for PCI at 2 years follow-up, while the risk for nonfatal MI was 15% for CABG and 6.2%Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6082779/\",\"favicon\":\"\"},{\"id\":\"284\",\"title\":\"Findings From a Pooled Analysis of 4 Randomized Clinical Trials\",\"description\":\"Mar 11, 2024 Â· The aim of this study was to investigate outcomes in patients with left main disease with and without diabetes randomized to PCI versus CABG.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065571\",\"favicon\":\"\"},{\"id\":\"285\",\"title\":\"Short, Intermediate and long term outcomes of CABG vs. PCI with ...\",\"description\":\"In this meta-analysis of RCTs comparing outcomes following PCI or CABG in patients with multivessel disease, PCI was non-inferior to CABG at 1 and 2 years forÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4234175/\",\"favicon\":\"\"},{\"id\":\"286\",\"title\":\"Percutaneous Coronary Intervention vs Coronary Artery Bypass ...\",\"description\":\"May 31, 2023 Â· PCI and CABG resulted in similar rates of all-cause death over 5 years regardless of ACS.Clinical Outcomes Â· Acs Vs Not Acs Â· Pci Vs Cabg\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10233454/\",\"favicon\":\"\"},{\"id\":\"287\",\"title\":\"Surgical vs Transcatheter Treatment in Patients With Coronary ...\",\"description\":\"Nov 11, 2024 Â· Technical success rates were 96% for PCI + TAVR and 98.4% for CABG + SAVR (P = 0.008), with similar periprocedural mortality (0.8% vs 0.7%; P =Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1936879824011701\",\"favicon\":\"\"},{\"id\":\"288\",\"title\":\"5-year outcomes of transcatheter aortic valve replacement or ...\",\"description\":\"At 5 years, risk of death was 67Â·8% in the TAVR group compared with 62Â·4% in the SAVR group (hazard ratio 1Â·04, 95% CI 0Â·86â€“1Â·24; p=0Â·76). We recorded noÂ ...\",\"url\":\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960308-7/abstract\",\"favicon\":\"\"},{\"id\":\"289\",\"title\":\"2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve ...\",\"description\":\"Feb 28, 2022 Â· The complete 2-year follow-up from the Evolut Low Risk Trial found that TAVR is noninferior to surgery for the primary endpoint of all-cause mortality orÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2021.11.062\",\"favicon\":\"\"},{\"id\":\"290\",\"title\":\"Meta-analysis of longitudinal comparison of transcatheter versus ...\",\"description\":\"Dec 1, 2024 Â· TAVR and SAVR demonstrated comparable rates of all-cause death up to 2 years of follow-up. However, at 5 years or longer follow-up, TAVR wasÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/39806748/\",\"favicon\":\"\"},{\"id\":\"291\",\"title\":\"Outcomes of Transcatheter or Surgical Treatment of Severe Aortic ...\",\"description\":\"Sep 7, 2025 Â· During follow-up, the composite primary outcome of death or stroke was observed in 27.8% of patients in the TAVR + PCI group and 16.2% ofÂ ...Missing:  success | Show results with:success\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12410434/\",\"favicon\":\"\"},{\"id\":\"292\",\"title\":\"Pivotal contemporary trials of percutaneous coronary intervention vs ...\",\"description\":\"RCTs comparing CABG and PCI have demonstrated the superiority of CABG in patients with multivessel CAD, specifically in terms of survival and MACE/MACCE.\u003c|separator|\u003e\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6082775/\",\"favicon\":\"\"},{\"id\":\"293\",\"title\":\"Smoking Cessation and Incident Cardiovascular Disease | Cardiology\",\"description\":\"Nov 1, 2024 Â· As smoking cessation may reduce CVD risk,5,6 guidelines strongly recommend smoking cessation for primary and secondary prevention of CVD.7,8Â ...\",\"url\":\"https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825743\",\"favicon\":\"\"},{\"id\":\"294\",\"title\":\"Effects of exercise initiation and smoking cessation after new-onset ...\",\"description\":\"Jun 23, 2022 Â· Those who quit smoking and started exercising had a 46% reduced risk of CVD (HR 0.54; 95% CI 0.41â€“0.71) and a 22% reduced risk in all-causeÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/s41598-022-14603-1\",\"favicon\":\"\"},{\"id\":\"295\",\"title\":\"Impact of Lifestyle Modifications on Cardiovascular Health - NIH\",\"description\":\"These include a healthy diet, regular physical activity, smoking cessation, and weight management. Dietary patterns: The ESC recommends the Mediterranean dietÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10460604/\",\"favicon\":\"\"},{\"id\":\"296\",\"title\":\"Cardiac Rehabilitation in the Modern Era: Evidence, Equity ... - MDPI\",\"description\":\"A Medicare analysis of over 600,000 patients demonstrated significantly lower 5-year mortality among CR participants, with a clear doseâ€“response relationshipâ€”Â ...\",\"url\":\"https://www.mdpi.com/2077-0383/14/15/5573\",\"favicon\":\"\"},{\"id\":\"297\",\"title\":\"Exercise-based cardiac rehabilitation for coronary heart disease\",\"description\":\"Feb 7, 2023 Â· This review confirms that participation in exercise-based CR by patients with coronary heart disease receiving contemporary medical management reducesÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/36746187/\",\"favicon\":\"\"},{\"id\":\"298\",\"title\":\"Exercise-based cardiac rehabilitation for coronary heart disease\",\"description\":\"Feb 7, 2023 Â· This review confirms that participation in exercise-based CR by patients with coronary heart disease receiving contemporary medical management reducesÂ ...\",\"url\":\"https://academic.oup.com/eurheartj/article-abstract/44/6/452/7028725\",\"favicon\":\"\"},{\"id\":\"299\",\"title\":\"Optimal outcomes from cardiac rehabilitation are associated with ...\",\"description\":\"Sep 1, 2023 Â· A key objective of CR is to improve the cardiovascular prognosis by reducing cardiovascular risk factors â€“ e.g. lowering body mass index (BMI),Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0167527323007209\",\"favicon\":\"\"},{\"id\":\"300\",\"title\":\"Physical and Mental Components of Quality of Life after a Cardiac ...\",\"description\":\"Sep 20, 2024 Â· This study highlights the significant benefits of cardiac rehabilitation programs on health-related quality of life, particularly in the physical domain at 6Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/39337063/\",\"favicon\":\"\"},{\"id\":\"301\",\"title\":\"Mortality Benefits of Cardiac Rehabilitation in Coronary Artery ...\",\"description\":\"May 18, 2024 Â· Cardiorespiratory fitness and lipid control partly explain the mortality benefits of CR and represent important secondary prevention targets.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.123.033568\",\"favicon\":\"\"},{\"id\":\"302\",\"title\":\"Decline in Cardiovascular Mortality: Possible Causes and Implications\",\"description\":\"Using the 1940 US population as reference, the age-adjusted annual heart disease mortality per 100,000 fell by 56% from 307.4 in 1950 to 134.6 in 1996, whileÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5268076/\",\"favicon\":\"\"},{\"id\":\"303\",\"title\":\"Heart Disease Mortality in the United States, 1970 to 2022\",\"description\":\"Jun 25, 2025 Â· From 1970 to 2022, overall ageâ€adjusted heart disease mortality decreased by 66% from 1970 to 2022 (from 761 to 258 per 100 000).\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.124.038644\",\"favicon\":\"\"},{\"id\":\"304\",\"title\":\"The contributions of risk factor trends and medical care to ...\",\"description\":\"By the 1960s, CVD mortality was declining in most western high-income countries. This reversal in the trend was initially missed or even dismissed by someÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4945698/\",\"favicon\":\"\"},{\"id\":\"305\",\"title\":\"Trends of Cardiovascular Disease Mortality in Relation to Population ...\",\"description\":\"Jul 31, 2018 Â· The decrement in all-cause mortality rate since the 1950s was associated with an annual increase in life expectancy by approximately 0.15Â ...\",\"url\":\"https://opencardiovascularmedicinejournal.com/VOLUME/12/PAGE/71/\",\"favicon\":\"\"},{\"id\":\"306\",\"title\":\"Coronary Heart Disease Deaths And Decreased Smoking ...\",\"description\":\"In conclusion, smoking plays an important role in health outcomes, and thousands of extra life-years can be gained through prevention of major tobacco-relatedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2446467/\",\"favicon\":\"\"},{\"id\":\"307\",\"title\":\"[PDF] The Health Consequences of Smokingâ€”50 Years of Progress\",\"description\":\"Even so, the evidence is clear that reductions in smoking and exposure to secondhand smoke have con- tributed to the decline in death rates from cardiovascular.\u003c|separator|\u003e\",\"url\":\"https://www.hhs.gov/sites/default/files/consequences-smoking-exec-summary.pdf\",\"favicon\":\"\"},{\"id\":\"308\",\"title\":\"After Smoking Is Banned, Heart Attacks Drop - NPR\",\"description\":\"Oct 29, 2012 Â· When smoking is banned in bars and workplaces, the number of people who suffer heart attacks and die drops within months, according to two new studies.\",\"url\":\"https://www.npr.org/sections/health-shots/2012/10/29/163889012/after-smoking-is-banned-heart-attacks-drop\",\"favicon\":\"\"},{\"id\":\"309\",\"title\":\"Longitudinal Associations of Smoke-Free Policies and Incident ...\",\"description\":\"Smoke-free legislation has been associated with lower rates of cardiovascular disease hospital admissions in ecological studies.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.032302?doi=10.1161/CIRCULATIONAHA.117.032302\",\"favicon\":\"\"},{\"id\":\"310\",\"title\":\"Smoking Bans Reduce Heart Attacks and Disease\",\"description\":\"Oct 15, 2009 Â· Bans on smoking in places like restaurants, offices and public buildings reduce cases of heart attacks and heart disease, according to a reportÂ ...\",\"url\":\"https://www.nytimes.com/2009/10/16/science/16smoke.html\",\"favicon\":\"\"},{\"id\":\"311\",\"title\":\"The Heart of the World - PMC - PubMed Central\",\"description\":\"Jan 25, 2024 Â· The Central Europe, Eastern Europe, and Central Asia region face the highest levels of CVD mortality globally. Although CVD mortality levelsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/\",\"favicon\":\"\"},{\"id\":\"312\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2024/01/01/01/42/feature-new-study-reveals-latest-data-on-global-burden-of-cardiovascular-disease\",\"favicon\":\"\"},{\"id\":\"313\",\"title\":\"World Heart Report 2024\",\"description\":\"The 2024 World Heart Report highlights air pollution as the leading environmental health risk, causing millions of preventable deaths annually from heartÂ ...\",\"url\":\"https://world-heart-federation.org/resource/world-heart-report-2024/\",\"favicon\":\"\"},{\"id\":\"314\",\"title\":\"Ageing and health - World Health Organization (WHO)\",\"description\":\"Oct 1, 2025 Â· In 2050, 80% of older people will be living in low- and middle-income countries. The pace of population ageing is much faster than in the past.\",\"url\":\"https://www.who.int/news-room/fact-sheets/detail/ageing-and-health\",\"favicon\":\"\"},{\"id\":\"315\",\"title\":\"[PDF] Forecasts of disease burden through 2050\",\"description\":\"Our forecasts reveal that life expectancy will continue to climb globally, increasing by 4.6 years from 2022 to 2050,.\",\"url\":\"https://www.healthdata.org/sites/default/files/2024-05/GBD_2021_Forecasting_infographic_FINAL_2024.05.16.pdf\",\"favicon\":\"\"},{\"id\":\"316\",\"title\":\"Burden of disease scenarios for 204 countries and territories, 2022 ...\",\"description\":\"May 18, 2024 Â· Our reference forecast shows a global increase in death and DALY counts (50Â·8% [95% UI 40Â·2â€“64Â·6] increase in number of deaths from 2022 to 2050Â ...\u003c|separator|\u003e\",\"url\":\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900685-8/fulltext\",\"favicon\":\"\"},{\"id\":\"317\",\"title\":\"The Global Syndemic of Modifiable Cardiovascular Risk Factors ...\",\"description\":\"Jul 14, 2025 Â· The age-standardized DALY burden of modifiable CV risk factors is projected to fall from 2025 to 2050, a reflection of the effectiveness ofÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2025.04.061\",\"favicon\":\"\"},{\"id\":\"318\",\"title\":\"The burden of cardiovascular disease in Asia from 2025 to 2050\",\"description\":\"Between 2025 and 2050, crude cardiovascular mortality is expected to rise 91.2% despite a 23.0% decrease in the age-standardised cardiovascular mortality rate (Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11296249/\",\"favicon\":\"\"},{\"id\":\"319\",\"title\":\"Ancient Egyptian medicine and the concept of heart failure - PubMed\",\"description\":\"We sought to analyze some of the cardiac glosses of the Ebers papyrus, focusing on those which may describe early concepts of the syndrome of heart failure.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/16911907/\",\"favicon\":\"\"},{\"id\":\"320\",\"title\":\"Vascular medicine and surgery in ancient Egypt - ScienceDirect.com\",\"description\":\"The Ebers Papyrus (ca 1500 bce) provides the greatest insight into Egyptian anatomy and physiology generally as well as on the cardiovascular systemÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0741521414008659\",\"favicon\":\"\"},{\"id\":\"321\",\"title\":\"(PDF) The Cardiovascular System in Ancient Egyptian Thought\",\"description\":\"... From the Pharaonic Egypt (3000---332 BCE), we dispose of four manuscripts dedicated to the heart and cardiovascular diseases, contained in the Smith papyrusÂ ...\",\"url\":\"https://www.researchgate.net/publication/249102706_The_Cardiovascular_System_in_Ancient_Egyptian_Thought\",\"favicon\":\"\"},{\"id\":\"322\",\"title\":\"A Historical Overview of Cardiovascular Medicine and Heart Failure\",\"description\":\"Jul 18, 2017 Â· The papyrus described the heart as bearing the ponderous role as the center of emotion, memory, thought, will, and personality.\",\"url\":\"https://thoracickey.com/a-historical-overview-of-cardiovascular-medicine-and-heart-failure/\",\"favicon\":\"\"},{\"id\":\"323\",\"title\":\"Medicine from Galen to the Present: A Short History - PMC - NIH\",\"description\":\"Galen believed that the body contained four important liquids called humors, which were phlegm, blood, yellow bile, and black bile. These humors must remain inÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/\",\"favicon\":\"\"},{\"id\":\"324\",\"title\":\"Classical Views of Disease: Hippocrates, Galen, and Humoralism\",\"description\":\"Now, note that there is no real humoral physiology, no idea of the circulation of the blood. The heart is not a pump but a furnace, drawing air from the lungs,Â ...\",\"url\":\"https://oyc.yale.edu/history/hist-234/lecture-2\",\"favicon\":\"\"},{\"id\":\"325\",\"title\":\"Chest pain and angina pectoris â€“ or the ugly swan ... - PubMed Central\",\"description\":\"His concise and remarkably accurate description of angina pectoris was presented at the Royal College of Physicians in London in 1768. He described some 20Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/\",\"favicon\":\"\"},{\"id\":\"326\",\"title\":\"Angina Pectoris 1768â€“1970 | New England Journal of Medicine\",\"description\":\"Mar 26, 1970 Â· THE year 1968 marked the 200th anniversary of William Heberden's classic description of angina pectoris. Just over 100 years ago Sir LauderÂ ...\",\"url\":\"https://www.nejm.org/doi/abs/10.1056/NEJM197003262821311\",\"favicon\":\"\"},{\"id\":\"327\",\"title\":\"William Heberden on Angina Pectoris, 1772 Â« Heart Attack Prevention\",\"description\":\"A disorder of the breast marked with strong and peculiar symptoms, considerable for the kind of danger belonging to it, and not extremely rare.\",\"url\":\"http://www.epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/\",\"favicon\":\"\"},{\"id\":\"328\",\"title\":\"Angina Pectoris: The Eighteenth-Century Origins of ... - JAMA Network\",\"description\":\"Historically, the first description of angina pectoris by a medical person, Dr William Heberden, was in 1768. During the next decade, the number of similarÂ ...\",\"url\":\"https://jamanetwork.com/journals/jama/fullarticle/1845130\",\"favicon\":\"\"},{\"id\":\"329\",\"title\":\"Nikolai N. Anichkov and his theory of atherosclerosis. - Europe PMC\",\"description\":\"Then, in 1913, Nikolai N. Anichkov showed that cholesterol alone caused the atheromatous changes in the vascular wall. This discovery introduced a new era inÂ ...\",\"url\":\"https://europepmc.org/article/pmc/1764970\",\"favicon\":\"\"},{\"id\":\"330\",\"title\":\"In celebration of the 100th anniversary of the lipid hypothesis of ...\",\"description\":\"Aug 23, 2013 Â· Another reason Anitschkow's findings were not taken seriously is that the blood cholesterol levels in his rabbits were extraordinarily highâ€“500Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3793599/\",\"favicon\":\"\"},{\"id\":\"331\",\"title\":\"Nikolaj Nikolajewitsch Anitschkow (1885-1964 ... - PubMed\",\"description\":\"Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis. 1997 Nov;135(1):Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/9395267/\",\"favicon\":\"\"},{\"id\":\"332\",\"title\":\"Framingham Heart Study (FHS) - NHLBI - NIH\",\"description\":\"This long-term, multigenerational study is designed to identify common factors or characteristics that contribute to cardiovascular disease.\",\"url\":\"https://www.nhlbi.nih.gov/science/framingham-heart-study-fhs\",\"favicon\":\"\"},{\"id\":\"333\",\"title\":\"Cardiovascular Risk Factors. Insights From Framingham Heart Study\",\"description\":\"Four years after the Framingham Heart Study started, researchers had identified high cholesterol and high blood pressure levels as important factors in theÂ ...\",\"url\":\"https://www.revespcardiol.org/en-cardiovascular-risk-factors-insights-from-articulo-13117552\",\"favicon\":\"\"},{\"id\":\"334\",\"title\":\"The Framingham Heart Study and the Epidemiology of ... - NIH\",\"description\":\"The study has provided substantial insight into the epidemiology of cardiovascular disease and its risk factors.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4159698/\",\"favicon\":\"\"},{\"id\":\"335\",\"title\":\"Cardiology's 10 Greatest Discoveries of the 20th Century - PMC - NIH\",\"description\":\"We present a brief summary of the 10 greatest cardiologic developments and discoveries of the 20th century. Described are electrocardiography; preventiveÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC124754/\",\"favicon\":\"\"},{\"id\":\"336\",\"title\":\"Statin History - News-Medical\",\"description\":\"On September 1, 1987, lovastatin became the first statin to be approved in the United States by the Food and Drug Administration (FDA). This agent isÂ ...\",\"url\":\"https://www.news-medical.net/health/Statin-History.aspx\",\"favicon\":\"\"},{\"id\":\"337\",\"title\":\"Death rates from cardiovascular disease have fallen dramatically\",\"description\":\"Aug 4, 2025 Â· In the United States alone, the age-standardized death rate from cardiovascular disease has fallen by three-quarters since 1950. This meansÂ ...Missing:  adjusted | Show results with:adjusted\",\"url\":\"https://ourworldindata.org/cardiovascular-deaths-decline\",\"favicon\":\"\"},{\"id\":\"338\",\"title\":\"Genomics in Cardiovascular Disease - PMC\",\"description\":\"This revolutionary concept received a major boost with the sequencing of the human genome in 2000 (2). In fact, sequencing of the human genome may be to theÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3683584/\",\"favicon\":\"\"},{\"id\":\"339\",\"title\":\"Genomic Innovation in Early Life Cardiovascular Disease ...\",\"description\":\"Jun 8, 2023 Â· The current review focuses on innovations in the field of genomics and their applications to monogenic and polygenic CVD prevention and treatment.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.321999\",\"favicon\":\"\"},{\"id\":\"340\",\"title\":\"The Past, the Present, and the Future of Genomic Therapies in ...\",\"description\":\"Nov 22, 2024 Â· Clinical guidelines now recommend genetic testing for cardiomyopathies, arrhythmias, aortopathies, and familial hypercholesterolemia to betterÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.124.035987\",\"favicon\":\"\"},{\"id\":\"341\",\"title\":\"GLP-1 Receptor Agonists for the Reduction of Atherosclerotic ...\",\"description\":\"Dec 12, 2022 Â· In conclusion, multiple trials have shown GLP-1 RA to reduce cardiovascular risk in patients with diabetes and ASCVD or high cardiovascular riskÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595\",\"favicon\":\"\"},{\"id\":\"342\",\"title\":\"The Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1 ...\",\"description\":\"Jun 20, 2025 Â· Multiple cardiovascular outcome trials demonstrated that GLP-1 RAs cause a significant reduction in major adverse cardiovascular events,Â ...Missing:  post- 2000\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40539787/\",\"favicon\":\"\"},{\"id\":\"343\",\"title\":\"Cardiac Conduction System Pacing: A Comprehensive Update - JACC\",\"description\":\"The aim of this review is to provide a comprehensive update on recent advances in conduction system pacing.Missing:  2020s | Show results with:2020s\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacep.2023.06.005\",\"favicon\":\"\"},{\"id\":\"344\",\"title\":\"Scientists reveal new evidence of electrical pathway in the heart\",\"description\":\"Nov 17, 2020 Â· But Virginia Tech researchers have shown that the heart relies on at least two key communication channels to keep abnormal heart rhythms inÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.news-medical.net/news/20201117/Scientists-reveal-new-evidence-of-electrical-pathway-in-the-heart.aspx\",\"favicon\":\"\"},{\"id\":\"345\",\"title\":\"The fallacies of the lipid hypothesis - PubMed\",\"description\":\"The lipid hypothesis has dominated cardiovascular research and prevention for almost half a century although the number of contradictory studies may exceedÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/18615352/\",\"favicon\":\"\"},{\"id\":\"346\",\"title\":\"Full article: The fallacies of the lipid hypothesis\",\"description\":\"Jul 12, 2009 Â· The lipid hypothesis consists of two main postulates. The first says that a high intake of saturated fat raises blood cholesterol and the second that highÂ ...\",\"url\":\"https://www.tandfonline.com/doi/full/10.1080/14017430801983082\",\"favicon\":\"\"},{\"id\":\"347\",\"title\":\"Lack of an association or an inverse association ... - BMJ Open\",\"description\":\"High LDL-C is inversely associated with mortality in most people over 60 years. This finding is inconsistent with the cholesterol hypothesis.\",\"url\":\"https://bmjopen.bmj.com/content/6/6/e010401\",\"favicon\":\"\"},{\"id\":\"348\",\"title\":\"Lack of an association or an inverse association between ... - PubMed\",\"description\":\"High LDL-C is inversely associated with mortality in most people over 60 years. This finding is inconsistent with the cholesterol hypothesis.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/27292972/\",\"favicon\":\"\"},{\"id\":\"349\",\"title\":\"Is LDL cholesterol associated with long-term mortality ... - BMJ Open\",\"description\":\"The lowest risk for long-term mortality appears to exist in the wide LDL-C range of 100â€“189 mg/dL, which is much higher than current recommendations.\",\"url\":\"https://bmjopen.bmj.com/content/14/3/e077949\",\"favicon\":\"\"},{\"id\":\"350\",\"title\":\"LDL particle number and size and cardiovascular risk - PubMed\",\"description\":\"LDL particle size, on the other hand, has not been independently associated with CVD risk after adjustment for other risk factors such as LDL cholesterol,Â ...Missing:  nuance | Show results with:nuance\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/28460374/\",\"favicon\":\"\"},{\"id\":\"351\",\"title\":\"LDL PARTICLE SIZE: A RISK FACTOR, BUT HOW IMPORTANT?\",\"description\":\"Oct 1, 1996 Â· Small, dense low-density lipoprotein (LDL) particles have been correlated with increased coronary disease rates in some cross-sectional studies,Â ...\",\"url\":\"https://www.jwatch.org/jw199610010000006/1996/10/01/ldl-particle-size-risk-factor-how-important\",\"favicon\":\"\"},{\"id\":\"352\",\"title\":\"LDL-P vs ApoB: Which Better Measures Cardiovascular Risk?\",\"description\":\"Both LDL-P and ApoB are better risk indicators than LDL-C because they measure particle number instead of just cholesterol mass. LDL-P = counts LDL particlesÂ ...\",\"url\":\"https://precisionhealthreports.com/ldl-p-vs-apob\",\"favicon\":\"\"},{\"id\":\"353\",\"title\":\"Why Cholesterol Particle Size Matters - HealthCentral\",\"description\":\"Apr 27, 2023 Â· Smaller particles of LDL (bad) cholesterol carry greater heart disease risk than larger ones. But testing particle size isn't recommended for everyone.Cholesterol Particle Size Â· Particle Size Range Â· Testing Particle Size Â· TakeawaysMissing:  nuance | Show results with:nuance\",\"url\":\"https://www.healthcentral.com/condition/high-cholesterol/cholesterol-particle-size\",\"favicon\":\"\"},{\"id\":\"354\",\"title\":\"Dietary Cholesterol and Cardiovascular Risk: A Science Advisory ...\",\"description\":\"Dec 16, 2019 Â· Previously, the Dietary Guidelines for Americans recommended that cholesterol intake be limited to no more than 300 milligrams per day. The 2015Â ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000000743\",\"favicon\":\"\"},{\"id\":\"355\",\"title\":\"Dietary Cholesterol and Cardiovascular Risk: AHA Advisory\",\"description\":\"Jan 10, 2020 Â· The following are key points to remember from the American Heart Association (AHA) Advisory on dietary cholesterol and cardiovascular risk.\",\"url\":\"https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/12/30/15/23/dietary-cholesterol-and-cardiovascular-risk\",\"favicon\":\"\"},{\"id\":\"356\",\"title\":\"A Reappraisal of the Lipid Hypothesis\",\"description\":\"May 10, 2018 Â· The lipid hypothesis, which postulates that lowering serum cholesterol saves lives and prevents cardiovascular disease, has been supported by a prodigiousÂ ...\",\"url\":\"https://www.amjmed.com/article/S0002-9343%2818%2930404-2/fulltext\",\"favicon\":\"\"},{\"id\":\"357\",\"title\":\"Full article: LDL-C does not cause cardiovascular disease\",\"description\":\"If high LDL-C was the major cause of atherosclerosis and CVD, people with the highest LDL-C should have shorter lives than people with low values. However, in aÂ ...\",\"url\":\"https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391\",\"favicon\":\"\"},{\"id\":\"358\",\"title\":\"Saturated Fats and Health: A Reassessment and Proposal for Food ...\",\"description\":\"Most recent meta-analyses of randomized trials and observational studies found no beneficial effects of reducing SFA intake on cardiovascular disease (CVD) andÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0735109720356874\",\"favicon\":\"\"},{\"id\":\"359\",\"title\":\"Meta-analysis of prospective cohort studies evaluating the ...\",\"description\":\"Objective: The objective of this meta-analysis was to summarize the evidence related to the association of dietary saturated fat with risk of coronary heartÂ ...\",\"url\":\"https://ajcn.nutrition.org/article/S0002-9165%2823%2901672-6/fulltext\",\"favicon\":\"\"},{\"id\":\"360\",\"title\":\"Dietary Fats and Cardiovascular Disease: A Presidential Advisory ...\",\"description\":\"Jun 15, 2017 Â· Well-publicized results of a meta-analysis reporting that saturated fat is not associated with CVD implicitly compare a high saturated fat dietÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/cir.0000000000000510\",\"favicon\":\"\"},{\"id\":\"361\",\"title\":\"Rethinking Saturated Fat and Cardiovascular Health - PMC - NIH\",\"description\":\"Apr 4, 2025 Â· Among these, saturated fatty acids (SFAs) have been identified as a critical nutrient affecting public health, along with total fat, cholesterolÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12095710/\",\"favicon\":\"\"},{\"id\":\"362\",\"title\":\"Effect of reducing saturated fat intake on cardiovascular disease in ...\",\"description\":\"There was a 21% reduction in combined cardiovascular events in people who had reduced SFA compared with those on higher SFA intake (RR 0.79, 95%CI 0.66â€“0.93, I2Â ...Abstract Â· Materials and methods Â· Results Â· Discussion\",\"url\":\"https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1396576/full\",\"favicon\":\"\"},{\"id\":\"363\",\"title\":\"Dietary fat and cardiometabolic health: evidence, controversies, and ...\",\"description\":\"Jun 13, 2018 Â· For example, evidence from clinical trials suggests that saturated fat may have little effect on LDL cholesterol levels in people with obesity.Importance Of Lipid... Â· Role Of Omega 6 And Omega 3... Â· Use Of Plant Oils To Replace...\",\"url\":\"https://www.bmj.com/content/361/bmj.k2139\",\"favicon\":\"\"},{\"id\":\"364\",\"title\":\"Added sugars drive coronary heart disease via insulin resistance ...\",\"description\":\"Nov 29, 2017 Â· Overconsuming added sugars (sucrose or high-fructose corn syrup) may lead to an increased risk of CHD through raised insulin levels.\",\"url\":\"https://openheart.bmj.com/content/4/2/e000729\",\"favicon\":\"\"},{\"id\":\"365\",\"title\":\"Death by Carbs: Added Sugars and Refined Carbohydrates Cause ...\",\"description\":\"A diet that is high in processed foods, added sugars and other refined carbohydrates is a principle factor driving the growing epidemics of type 2 diabetes (T2D)Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6139832/\",\"favicon\":\"\"},{\"id\":\"366\",\"title\":\"Increased consumption of refined carbohydrates and the epidemic ...\",\"description\":\"Recent data suggest that a high intake of refined carbohydrates may increase the risk of insulin resistance (13-16 ... 43. Reaven, GM. Role of insulin resistanceÂ ...\",\"url\":\"https://ajcn.nutrition.org/article/S0002-9165%2822%2903918-1/fulltext\",\"favicon\":\"\"},{\"id\":\"367\",\"title\":\"Carbohydrates and Blood Sugar - The Nutrition Source\",\"description\":\"Numerous epidemiologic studies have shown a positive association between higher dietary glycemic index and increased risk of type 2 diabetes and coronary heartÂ ...\",\"url\":\"https://nutritionsource.hsph.harvard.edu/carbohydrates/carbohydrates-and-blood-sugar/\",\"favicon\":\"\"},{\"id\":\"368\",\"title\":\"Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial\",\"description\":\"The low-carbohydrate diet was more effective for weight loss and cardiovascular risk factor reduction than the low-fat diet. Restricting carbohydrate may be anÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4428290/\",\"favicon\":\"\"},{\"id\":\"369\",\"title\":\"Low-carb or low-fat? Study pinpoints better diet\",\"description\":\"Sep 30, 2021 Â· Low-carb diets produce better cardiovascular and metabolic profiles than low-fat diets, finds one of the largest, most rigorous studies toÂ ...\",\"url\":\"https://answers.childrenshospital.org/low-carb-diet/\",\"favicon\":\"\"},{\"id\":\"370\",\"title\":\"Association of a Low-Carbohydrate High-Fat Diet With Plasma Lipid ...\",\"description\":\"Consumption of a LCHF diet was associated with increased LDL-C and apolipoprotein B levels, and an increased risk of incident MACE.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacadv.2024.100924\",\"favicon\":\"\"},{\"id\":\"371\",\"title\":\"Activist Cardiologist Says Commercial Interests Are Distorting ...\",\"description\":\"Feb 18, 2025 Â· Malhotra's colleagues filed a defamation lawsuit in the UK, arguing that these articles falsely portrayed doctors advising against the overuseÂ ...\",\"url\":\"https://www.nad.com/news/self-proclaimed-activist-and-cardiologist-says-commercial-interests-are-distorting-evidence-behind-statins\",\"favicon\":\"\"},{\"id\":\"372\",\"title\":\"Transcript: What Big Pharma Doesn't Want You to Know About Statins\",\"description\":\"Aug 22, 2025 Â· Aseem Malhotra's interview on The Dr. Hyman Show titled â€œWhat Big Pharma Doesn't Want You to Know About Statinsâ€, January 30, 2025.\",\"url\":\"https://singjupost.com/transcript-what-big-pharma-doesnt-want-you-to-know-about-statins-dr-aseem-malhotra/\",\"favicon\":\"\"},{\"id\":\"373\",\"title\":\"Time to end drug company distortion of medical evidence\",\"description\":\"Dec 3, 2019 Â· Drug company-funded studies have overplayed their benefits and downplayed their harms, contributing to overuse and unnecessary side effects.\",\"url\":\"https://theconversation.com/time-to-end-drug-company-distortion-of-medical-evidence-127495\",\"favicon\":\"\"},{\"id\":\"374\",\"title\":\"Looking at the Benefit of Statins from a Different Perspective - AAFP\",\"description\":\"Oct 1, 2010 Â· That translates into an absolute risk reduction of 0.6 percent and a number needed to treat (NNT) of 167. This means that 167 patients wouldÂ ...\",\"url\":\"https://www.aafp.org/pubs/afp/issues/2010/1001/p741.html\",\"favicon\":\"\"},{\"id\":\"375\",\"title\":\"Empirical estimation of under-reporting in the U.S. Food and Drug ...\",\"description\":\"Results: The majority of drug-ADE pairs showed significant under-reporting. For example, roughly 0.01% to 44% of statin events were reported (z-test p \u003c 0.0001)Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/28447485/\",\"favicon\":\"\"},{\"id\":\"376\",\"title\":\"Statin Safety and Associated Adverse Events: A Scientific Statement ...\",\"description\":\"Dec 10, 2018 Â· Many patients report adverse events during statin therapy, most commonly muscle symptoms (muscle pain or weakness), and some find the symptomsÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/atv.0000000000000073\",\"favicon\":\"\"},{\"id\":\"377\",\"title\":\"Potential Statin Overuse in Older Patients: A Retrospective Cross ...\",\"description\":\"Of those living in the community, 22,132 (60.0%) patients had potential statin overuse: 12,352 (55.8%) for primary and 9780 (44.2%) for secondary prevention.\",\"url\":\"https://www.researchgate.net/publication/334547485_Potential_Statin_Overuse_in_Older_Patients_A_Retrospective_Cross-Sectional_Study_Using_French_Health_Insurance_Databases\",\"favicon\":\"\"},{\"id\":\"378\",\"title\":\"Expanding the Primary Prevention Role of Lifestyle and Statins\",\"description\":\"Feb 9, 2018 Â· A healthy lifestyle reduces CAD risk by 50%. Healthy behaviors include abstaining from smoking, eating a healthful diet, exercising regularly and avoidingÂ ...\",\"url\":\"https://advances.massgeneral.org/cardiovascular/article.aspx?id=1022\",\"favicon\":\"\"},{\"id\":\"379\",\"title\":\"Effectiveness of Lifestyle Modification vs. Therapeutic, Preventative ...\",\"description\":\"Jan 28, 2022 Â· Conclusion: A strategy based on lifestyle modifications in a population without established CVD could be more effective than the moderateÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8836845/\",\"favicon\":\"\"},{\"id\":\"380\",\"title\":\"Inflammation and Atherosclerosis | Circulation\",\"description\":\"Current evidence supports a central role for inflammation in all phases of the atherosclerotic process. Substantial biological data implicate inflammatoryÂ ...The Scientific Basis Of... Â· Triggers For Inflammation In... Â· Inflammatory Biomarkers And...Missing:  driver | Show results with:driver\",\"url\":\"https://www.ahajournals.org/doi/10.1161/hc0902.104353\",\"favicon\":\"\"},{\"id\":\"381\",\"title\":\"The critical issue linking lipids and inflammation - PubMed Central\",\"description\":\"Entrapped lipoproteins become oxidized and activate the innate immune system. This immunity represents the primary association between lipids and inflammation.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9682196/\",\"favicon\":\"\"},{\"id\":\"382\",\"title\":\"Comparison of C-Reactive Protein and Low-Density Lipoprotein ...\",\"description\":\"These data suggest that the C-reactive protein level is a stronger predictor of cardiovascular events than the LDL cholesterol level.\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa021993\",\"favicon\":\"\"},{\"id\":\"383\",\"title\":\"CRP More Predictive of Future Events Than LDL in Statin-Treated ...\",\"description\":\"Mar 14, 2023 Â· For patients already receiving statins, inflammation is more tightly linked than LDL cholesterol to future adverse events, a new meta-analysis shows.\u003c|separator|\u003e\",\"url\":\"https://www.tctmd.com/news/crp-more-predictive-future-events-ldl-statin-treated-patients\",\"favicon\":\"\"},{\"id\":\"384\",\"title\":\"Comparison of C-reactive protein and low-density lipoprotein ...\",\"description\":\"These data suggest that the C-reactive protein level is a stronger predictor of cardiovascular events than the LDL cholesterol level.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/12432042/\",\"favicon\":\"\"},{\"id\":\"385\",\"title\":\"Inflammation, Immunity, and Infection in Atherothrombosis - JACC\",\"description\":\"Observations on human and experimental atherosclerosis, biomarker studies, and now a large-scale clinical trial support the operation of immune andÂ ...\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1043\",\"favicon\":\"\"},{\"id\":\"386\",\"title\":\"Study Details | Cardiovascular Inflammation Reduction Trial\",\"description\":\"The primary aim of the Cardiovascular Inflammation Reduction Trial (CIRT) is to directly test the inflammatory hypothesis of atherothrombosis by evaluatingÂ ...\",\"url\":\"https://clinicaltrials.gov/study/NCT01594333\",\"favicon\":\"\"},{\"id\":\"387\",\"title\":\"Gut-derived low-grade endotoxaemia, atherothrombosis and ...\",\"description\":\"Jul 15, 2022 Â· Gut permeability-derived low-grade endotoxaemia might contribute to atherosclerosis and be associated with cardiovascular events in patients atÂ ...\",\"url\":\"https://www.nature.com/articles/s41569-022-00737-2\",\"favicon\":\"\"},{\"id\":\"388\",\"title\":\"Metabolic endotoxemia and cardiovascular disease - PubMed\",\"description\":\"In this review, we discuss how prebiotics and probiotics modulate gut microbiota and consequently might help with prevention and/or treatment of CVD associatedÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/31894861/\",\"favicon\":\"\"},{\"id\":\"389\",\"title\":\"\",\"description\":\"\",\"url\":\"https://kevinmd.com/2025/10/re-examining-the-lipid-hypothesis-and-statin-use.html\",\"favicon\":\"\"},{\"id\":\"390\",\"title\":\"(PDF) The fallacies of the lipid hypothesis - ResearchGate\",\"description\":\"Aug 9, 2025 Â· Most researchers to-day consider that a high intake of saturated fat and elevated LDL cholesterol are the most important causes ofÂ ...Missing:  critiques | Show results with:critiques\",\"url\":\"https://www.researchgate.net/publication/5236032_The_fallacies_of_the_lipid_hypothesis\",\"favicon\":\"\"},{\"id\":\"391\",\"title\":\"Polygenic risk score adds to a clinical risk score in the prediction of ...\",\"description\":\"Jun 7, 2024 Â· A cardiovascular disease polygenic risk score (CVD-PRS) can stratify individuals into different categories of cardiovascular risk, but whetherÂ ...Abstract Â· Introduction Â· Results Â· Discussion\",\"url\":\"https://academic.oup.com/eurheartj/article/45/34/3152/7689554\",\"favicon\":\"\"},{\"id\":\"392\",\"title\":\"Polygenic Risk Score Adds to Clinical Risk Score for CVD Prediction\",\"description\":\"Sep 16, 2024 Â· The PRS is the weighted sum of the total number of risk alleles in an individual that can be used to identify the genetic risk for CVD in large prospectiveÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/09/16/14/28/polygenic-risk-score-adds\",\"favicon\":\"\"},{\"id\":\"393\",\"title\":\"VERVE-101: CRISPR-Based Gene Editing Therapy Shows Promise ...\",\"description\":\"Nov 12, 2023 Â· A single infusion of a CRISPR-based gene editing therapy significantly reduced LDL-C and PCSK9 levels in patients with heterozygous familialÂ ...\",\"url\":\"https://www.acc.org/Latest-in-Cardiology/Articles/2023/11/08/20/14/sun-445pm-heart1-aha-2023\",\"favicon\":\"\"},{\"id\":\"394\",\"title\":\"Press Release - CRISPR Therapeutics\",\"description\":\"Jun 26, 2025 Â· CTX310 and CTX320 are in ongoing clinical trials in patients with heterozygous familial hypercholesterolemia, homozygous familialÂ ...\",\"url\":\"https://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-reports-positive-additional-phase-1-data\",\"favicon\":\"\"},{\"id\":\"395\",\"title\":\"In Vivo AAV-CRISPR/Cas9â€“Mediated Gene Editing Ameliorates ...\",\"description\":\"Nov 29, 2019 Â· Our work shows that in vivo AAV-CRISPR/Cas9â€“mediated Ldlr gene correction can partially rescue LDLR expression and effectively ameliorate atherosclerosisÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042476\",\"favicon\":\"\"},{\"id\":\"396\",\"title\":\"Cardiovascular Biomarkers: Tools for Precision Diagnosis and ...\",\"description\":\"Emerging biomarkers, including microRNAs, myeloperoxidase (MPO), and growth differentiation factor-15 (GDF-15), hold promise for enhancing early detection andÂ ...\",\"url\":\"https://www.mdpi.com/1422-0067/26/7/3218\",\"favicon\":\"\"},{\"id\":\"397\",\"title\":\"Gene Therapy in Cardiovascular Disease: Recent Advances and ...\",\"description\":\"Nov 11, 2024 Â· This science advisory reviews core concepts of gene therapy, key obstacles, patient risks, and ongoing research endeavors to enable clinicians to understandÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000001296\",\"favicon\":\"\"},{\"id\":\"398\",\"title\":\"Recent advances in the tools and techniques for AI-aided diagnosis ...\",\"description\":\"Jan 15, 2025 Â· Atrial fibrillation (AF) screening devices: (a) Apple watch incorporating ECG signal for real-time AF detection and heart rate monitoring.\u003c|separator|\u003e\",\"url\":\"https://pubs.aip.org/aip/bpr/article/6/1/011301/3331507/Recent-advances-in-the-tools-and-techniques-for-AI\",\"favicon\":\"\"},{\"id\":\"399\",\"title\":\"The Efficacy of Wearable Cardiovascular Monitoring Devices in Real ...\",\"description\":\"May 14, 2025 Â· Wearable cardiac monitors provide accurate, patient-friendly arrhythmia detection and support timely clinical intervention, reinforcing their role in modernÂ ...\",\"url\":\"https://healthcare-bulletin.co.uk/article/the-efficacy-of-wearable-cardiovascular-monitoring-devices-in-real-time-arrhythmia-detection-systematic-review-3415/\",\"favicon\":\"\"},{\"id\":\"400\",\"title\":\"Diagnostic accuracy of ECG smart chest patches versus PPG ...\",\"description\":\"Feb 25, 2025 Â· Both ECG smart chest patches and PPG smartwatches are highly effective for detecting atrial fibrillation. However, further advancements areÂ ...\",\"url\":\"https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-025-04582-2\",\"favicon\":\"\"},{\"id\":\"401\",\"title\":\"The revolution is here: AI's growing role in cardiovascular imaging ...\",\"description\":\"Mar 18, 2025 Â· The 4 primary AI techniques found in cardiac imaging Â· 1. Image processing and generation. AI's ability to enhance images and even generate newÂ ...\",\"url\":\"https://cardiovascularbusiness.com/topics/artificial-intelligence/revolution-here-ais-growing-role-cardiovascular-imaging-interventional-cardiology\",\"favicon\":\"\"},{\"id\":\"402\",\"title\":\"Conduction mapping during complex congenital heart surgery\",\"description\":\"Conduction mapping uses a multielectrode catheter to collect His bundle electrograms during surgery, to localize the His bundle and create a predictive model.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0022522322013277\",\"favicon\":\"\"},{\"id\":\"403\",\"title\":\"Three-dimensional Mapping System Modification to Allow a Near ...\",\"description\":\"The use of 3D mapping systems has substantially reduced the radiation exposure in patients undergoing electrophysiology procedures. However, due to the sizeÂ ...\",\"url\":\"https://www.innovationsincrm.com/cardiac-rhythm-management/2013/february/395-three-dimensional-mapping-system-modification\",\"favicon\":\"\"},{\"id\":\"404\",\"title\":\"Rethinking Conduction Velocity in Electroanatomical Mapping | JACC\",\"description\":\"Feb 26, 2025 Â· These results emphasize the importance of pacing close to the region of interest to improve the accuracy of conduction velocity assessments.\",\"url\":\"https://www.jacc.org/doi/10.1016/j.jacep.2024.12.026\",\"favicon\":\"\"},{\"id\":\"405\",\"title\":\"Three Public Health Interventions Could Save 94 Million Lives in 25 ...\",\"description\":\"Jun 10, 2019 Â· Increasing coverage of antihypertensive medications to 70% alone would delay 39.4 million deaths (35.9â€“43.0), whereas reducing sodium intake byÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038160\",\"favicon\":\"\"},{\"id\":\"406\",\"title\":\"Community-Based Interventions for Cardiovascular Disease ...\",\"description\":\"Community-based interventions successfully improved population knowledge on CVD and risk factors and influenced physical activity and dietary practices.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8386815/\",\"favicon\":\"\"},{\"id\":\"407\",\"title\":\"Effects of public policies in the prevention of cardiovascular diseases\",\"description\":\"Overall, our study showed an increasing consensus in the literature about the beneficial effects of public policies for reducing CVDs. Few studies that reportedÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0033350622001044\",\"favicon\":\"\"},{\"id\":\"408\",\"title\":\"Lifestyle Strategies for Risk Factor Reduction, Prevention, and ...\",\"description\":\"Regular physical activity, sound nutrition, weight management, and not smoking cigarettes have all been demonstrated to significantly reduce the risk of CVD.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6378495/\",\"favicon\":\"\"},{\"id\":\"409\",\"title\":\"Health Literacy and Cardiovascular Disease: Fundamental ...\",\"description\":\"Jun 4, 2018 Â· Limited health literacy is highly prevalent in the United States and is strongly associated with patient morbidity, mortality, healthcare use, and costs.\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000000579\",\"favicon\":\"\"},{\"id\":\"410\",\"title\":\"The importance of healthy lifestyle behaviors in the prevention of ...\",\"description\":\"HL behaviors, such as regular exercise, healthy eating habits, adequate sleep, and smoking cessation, can influence a number of traditional CVD risk factors.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S003306202100133X\",\"favicon\":\"\"}],\"images\":[{\"id\":\"3da65635c95e\",\"caption\":\"Cardiovascular diseases world map - Deaths per million persons - WHO2012\",\"url\":\"./_assets_/Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"3da65635c95e\",\"caption\":\"Cardiovascular diseases world map - Deaths per million persons - WHO2012\",\"url\":\"./_assets_/Cardiovascular_diseases_world_map-Deaths_per_million_persons-WHO2012.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"Cardiovascular_disease\",\"title\":\"Cardiovascular disease\",\"content\":\"$1f\",\"description\":\"Cardiovascular disease\\n\\nCardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke),...\",\"metadata\":{\"categories\":[\"CVD\",\"Heart disease\",\"Cardio disease\"],\"lastModified\":\"1761584669\",\"contentLength\":\"150482\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"559677\",\"recentViews\":\"559677\",\"dailyAvgViews\":18655.900390625,\"qualityScore\":1,\"lastViewed\":\"1761882340\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761882342762,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Cardiovascular_disease\"],\"queryHash\":\"[\\\"page\\\",\\\"Cardiovascular_disease\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Cardiovascular disease\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"CVD, Heart disease, Cardio disease\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Cardiovascular_disease\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Cardiovascular disease\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Cardiovascular_disease\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Cardiovascular disease\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:44.669Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Cardiovascular disease\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, cerebrovascular disease (such as stroke), peripheral arterial disease, rheumatic heart disease, and congenital heart defects. These conditions often arise from pathological processes like atherosclerosis, where plaque buildup narrows arteries, and thrombosis, which can acutely block blood flow, precipitating events such as myocardial infarction or ischemic...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="M2ZiNjUyMmQtNTY5Zi00OWRmLWI1ZDEtNzgxMzhjOTM5MDEw">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Cardiovascular_disease\"}]}]\n"])</script></body></html>